Virus name	Accession ID	Collection date	Location	Host	Passage	Specimen	Additional host information	Sequencing technology	Assembly method	Comment	Comment type	Lineage	Clade
hCoV-19/England/PORT-2EF7D3/2021	EPI_ISL_1000610	2021-01-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Switzerland/AG-ETHZ-480935/2021	EPI_ISL_1001865	2021-01-06	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Switzerland/AG-ETHZ-460935/2021	EPI_ISL_1001866	2021-01-17	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Switzerland/AG-ETHZ-461157/2021	EPI_ISL_1001867	2021-01-19	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Switzerland/VD-ETHZ-461154/2021	EPI_ISL_1001868	2021-01-20	Europe / Switzerland / Vaud	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Switzerland/SO-ETHZ-470318/2021	EPI_ISL_1001869	2021-01-24	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Switzerland/BL-ETHZ-470969/2021	EPI_ISL_1001870	2021-01-26	Europe / Switzerland / Basel-Landschaft	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Switzerland/SO-ETHZ-480178/2021	EPI_ISL_1001871	2021-01-30	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Switzerland/SO-ETHZ-480246/2021	EPI_ISL_1001872	2021-01-31	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Switzerland/ZH-ETHZ-480553/2021	EPI_ISL_1004092	2021-02-02	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177	GV
hCoV-19/Poland/2142828634_gx1/2021	EPI_ISL_1007969	2021-02-02	Europe / Poland / Wielkopolska / Niepruszewo	Human	Original	Oropharyngeal and nasopharyngeal swab		Oxford Nanopore	ARTICv3			B.1.177.62	GV
hCoV-19/England/MILK-1231EE9/2021	EPI_ISL_1012532	2021-02-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Netherlands/FR-RIVM-12074/2021	EPI_ISL_1013837	2021-01-27	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/FR-RIVM-12083/2021	EPI_ISL_1013839	2021-01-29	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/GE-RIVM-11977/2021	EPI_ISL_1013873	2021-01-24	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-11982/2021	EPI_ISL_1013878	2021-01-26	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Scotland/QEUH-109BD3D/2021	EPI_ISL_1019921	2021-01-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-109C947/2021	EPI_ISL_1019922	2021-01-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-109C8FF/2021	EPI_ISL_1019982	2021-01-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-42837/2021	EPI_ISL_1023115	2021-02-08	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-42848/2021	EPI_ISL_1023126	2021-02-08	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-42911/2021	EPI_ISL_1023189	2021-02-08	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-42929/2021	EPI_ISL_1023207	2021-02-08	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44096/2021	EPI_ISL_1024474	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44104/2021	EPI_ISL_1024482	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44110/2021	EPI_ISL_1024488	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-45369/2020	EPI_ISL_1025747	2020-12-21	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-45384/2020	EPI_ISL_1025762	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-45425/2020	EPI_ISL_1025803	2020-12-21	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-45440/2020	EPI_ISL_1025818	2020-12-21	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (FRAMESHIFT confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-45454/2020	EPI_ISL_1025832	2020-12-21	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-45483/2020	EPI_ISL_1025861	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/QEUH-129DCF0/2021	EPI_ISL_1042406	2021-02-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-12943D6/2021	EPI_ISL_1044938	2021-02-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-128F365/2021	EPI_ISL_1044977	2021-02-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-4C9BD1/2021	EPI_ISL_1053093	2021-02-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C9BE0/2021	EPI_ISL_1053094	2021-02-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Canada/NS-NML-16208/2021	EPI_ISL_1055729	2021-01-11	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Canada/NS-NML-16214/2021	EPI_ISL_1055733	2021-01-13	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Canada/NS-NML-16215/2021	EPI_ISL_1055734	2021-01-13	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-45621/2021	EPI_ISL_1065131	2021-02-15	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46762/2021	EPI_ISL_1066272	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46787/2021	EPI_ISL_1066297	2021-02-15	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46794/2021	EPI_ISL_1066304	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46921/2021	EPI_ISL_1066432	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46940/2020	EPI_ISL_1066451	2020-12-21	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Sweden/SUS0000023/2021	EPI_ISL_1081865	2021-02-01	Europe / Sweden / Skane	Human	Original			Illumina NextSeq	bwa + iVar trim + iVar consensus	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Sweden/SUS0000026/2021	EPI_ISL_1081868	2021-02-01	Europe / Sweden / Skane	Human	Original			Illumina NextSeq	bwa + iVar trim + iVar consensus	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Sweden/SUS0000030/2021	EPI_ISL_1081872	2021-02-01	Europe / Sweden / Skane	Human	Original			Illumina NextSeq	bwa + iVar trim + iVar consensus	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 12 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Sweden/SUS0000033/2021	EPI_ISL_1081875	2021-02-01	Europe / Sweden / Skane	Human	Original			Illumina NextSeq	bwa + iVar trim + iVar consensus	NS7b_E39stop results in 11.6% truncation of the protein sequence. NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Sweden/SUS0000034/2021	EPI_ISL_1081876	2021-02-01	Europe / Sweden / Skane	Human	Original			Illumina NextSeq	bwa + iVar trim + iVar consensus			B.1.177.80	GV
hCoV-19/Sweden/SUS0000038/2021	EPI_ISL_1081880	2021-02-02	Europe / Sweden / Skane	Human	Original			Illumina NextSeq	bwa + iVar trim + iVar consensus	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Sweden/SUS0000045/2021	EPI_ISL_1081887	2021-02-05	Europe / Sweden / Skane	Human	Original			Illumina NextSeq	bwa + iVar trim + iVar consensus	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 12 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Sweden/SUS0000058/2021	EPI_ISL_1081900	2021-02-09	Europe / Sweden / Skane	Human	Original			Illumina NextSeq	bwa + iVar trim + iVar consensus	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Sweden/SUS0000062/2021	EPI_ISL_1081904	2021-02-09	Europe / Sweden / Skane	Human	Original			Illumina NextSeq	bwa + iVar trim + iVar consensus	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Sweden/SUS0000078/2021	EPI_ISL_1081920	2021-02-12	Europe / Sweden / Skane	Human	Original			Illumina NextSeq	bwa + iVar trim + iVar consensus	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Sweden/SUS0000085/2021	EPI_ISL_1081933	2021-02-14	Europe / Sweden / Skane	Human	Original			Illumina NextSeq	bwa + iVar trim + iVar consensus	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Sweden/SUS0000086/2021	EPI_ISL_1081936	2021-02-14	Europe / Sweden / Skane	Human	Original			Illumina NextSeq	bwa + iVar trim + iVar consensus	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Netherlands/OV-RIVM-13937/2021	EPI_ISL_1090024	2021-02-08	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Wales/MILK-9A5532/2020	EPI_ISL_550036	2020-09-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-974B3A/2020	EPI_ISL_552549	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-974B76/2020	EPI_ISL_552643	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/CVR4273/2020	EPI_ISL_559947	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR4277/2020	EPI_ISL_559950	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR4283/2020	EPI_ISL_559956	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4295/2020	EPI_ISL_559967	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR4299/2020	EPI_ISL_559970	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-997A9E/2020	EPI_ISL_559991	2020-08-28	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-99B62D/2020	EPI_ISL_559997	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9BE536/2020	EPI_ISL_568000	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BEA0A/2020	EPI_ISL_568018	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BE114/2020	EPI_ISL_568033	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BDA38/2020	EPI_ISL_568044	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BDE69/2020	EPI_ISL_568048	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BE8A6/2020	EPI_ISL_568100	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BDD6C/2020	EPI_ISL_568110	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BE1BA/2020	EPI_ISL_568128	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BC8F3/2020	EPI_ISL_568130	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BC8E4/2020	EPI_ISL_568134	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BE3E1/2020	EPI_ISL_568143	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.65	GV
hCoV-19/England/ALDP-9BE378/2020	EPI_ISL_568155	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BE0F9/2020	EPI_ISL_568158	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BC91E/2020	EPI_ISL_568180	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9B3EEB/2020	EPI_ISL_572946	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/Wales/PHWC-16C274/2020	EPI_ISL_574030	2020-09-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16C283/2020	EPI_ISL_574031	2020-09-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-9DC1C5/2020	EPI_ISL_575344	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DC1A7/2020	EPI_ISL_575351	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9DAA44/2020	EPI_ISL_575357	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9DAA71/2020	EPI_ISL_575358	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DA983/2020	EPI_ISL_575362	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9DA992/2020	EPI_ISL_575364	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DBF35/2020	EPI_ISL_575375	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9DA83B/2020	EPI_ISL_575377	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9D7977/2020	EPI_ISL_576603	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9D7B08/2020	EPI_ISL_576613	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9D8A91/2020	EPI_ISL_576647	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9D8B70/2020	EPI_ISL_576653	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9D8CC8/2020	EPI_ISL_576661	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9D8CF5/2020	EPI_ISL_576663	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9D8D89/2020	EPI_ISL_576670	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9D8F29/2020	EPI_ISL_576684	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9D8F74/2020	EPI_ISL_576685	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Netherlands/GE-EMC-305/2020	EPI_ISL_577832	2020-09-19	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.177	GV
hCoV-19/England/MILK-9E237B/2020	EPI_ISL_581113	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-9E2DF5/2020	EPI_ISL_581143	2020-09-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9E235D/2020	EPI_ISL_581147	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9E24C3/2020	EPI_ISL_581185	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-9E21AE/2020	EPI_ISL_581188	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9E2BBF/2020	EPI_ISL_581199	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.65	GV
hCoV-19/Wales/PHWC-16F745/2020	EPI_ISL_586013	2020-09-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16F7EB/2020	EPI_ISL_586022	2020-10-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-A2F57B/2020	EPI_ISL_587119	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2F0E3/2020	EPI_ISL_587131	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2F9F7/2020	EPI_ISL_587138	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2F001/2020	EPI_ISL_587140	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2EE08/2020	EPI_ISL_587148	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2F775/2020	EPI_ISL_587149	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2F11D/2020	EPI_ISL_587153	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2FBA6/2020	EPI_ISL_587154	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-A2FBB5/2020	EPI_ISL_587161	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2F405/2020	EPI_ISL_587162	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2EBE3/2020	EPI_ISL_587178	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2FE07/2020	EPI_ISL_587184	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2FCFE/2020	EPI_ISL_587194	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2F863/2020	EPI_ISL_587237	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2F7EE/2020	EPI_ISL_587244	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2EECC/2020	EPI_ISL_587274	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2F3AE/2020	EPI_ISL_587281	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2F739/2020	EPI_ISL_587301	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2E961/2020	EPI_ISL_587302	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A1E4FA/2020	EPI_ISL_587327	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A1DCF3/2020	EPI_ISL_587335	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A222EA/2020	EPI_ISL_587350	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	G
hCoV-19/England/QEUH-9F481D/2020	EPI_ISL_588450	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F6611/2020	EPI_ISL_588457	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F524B/2020	EPI_ISL_588475	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F3AEB/2020	EPI_ISL_588486	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F3F37/2020	EPI_ISL_588503	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F35EA/2020	EPI_ISL_588507	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F3E49/2020	EPI_ISL_588509	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F2FED/2020	EPI_ISL_588515	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F38C3/2020	EPI_ISL_588571	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F3B9D/2020	EPI_ISL_588576	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F3B51/2020	EPI_ISL_588579	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F5524/2020	EPI_ISL_588589	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F35CC/2020	EPI_ISL_588591	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F3887/2020	EPI_ISL_588613	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F407F/2020	EPI_ISL_588614	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F3720/2020	EPI_ISL_588636	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F340B/2020	EPI_ISL_588658	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F3B06/2020	EPI_ISL_588662	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F3E58/2020	EPI_ISL_588665	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F341A/2020	EPI_ISL_588670	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F3007/2020	EPI_ISL_588677	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F3F19/2020	EPI_ISL_588682	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F2E3B/2020	EPI_ISL_588687	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F4024/2020	EPI_ISL_588688	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9DE58B/2020	EPI_ISL_589790	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-9E0692/2020	EPI_ISL_589798	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-9E05FF/2020	EPI_ISL_589799	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9CFFE9/2020	EPI_ISL_589824	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9D0B78/2020	EPI_ISL_589842	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9D0510/2020	EPI_ISL_589922	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9D0923/2020	EPI_ISL_589938	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9D0AF3/2020	EPI_ISL_589957	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E7482/2020	EPI_ISL_594472	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47EEE1/2020	EPI_ISL_595609	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-9F6BE5/2020	EPI_ISL_595619	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-9F6CB5/2020	EPI_ISL_595623	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/QEUH-9F7883/2020	EPI_ISL_595709	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-9F9A03/2020	EPI_ISL_595744	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-A58245/2020	EPI_ISL_596935	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A5855B/2020	EPI_ISL_596940	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A591CF/2020	EPI_ISL_596957	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A5803C/2020	EPI_ISL_596961	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A595D2/2020	EPI_ISL_596972	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A22578/2020	EPI_ISL_599100	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A1F848/2020	EPI_ISL_599104	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A1FE0A/2020	EPI_ISL_599109	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A1F602/2020	EPI_ISL_599112	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1F918/2020	EPI_ISL_599117	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A1F990/2020	EPI_ISL_599122	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A20DCD/2020	EPI_ISL_599134	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1FEBF/2020	EPI_ISL_599137	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A0AE11/2020	EPI_ISL_599145	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A0AF0F/2020	EPI_ISL_599155	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A0B89A/2020	EPI_ISL_599161	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A0B496/2020	EPI_ISL_599169	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A0B575/2020	EPI_ISL_599216	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-A0B618/2020	EPI_ISL_599229	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A0B6BE/2020	EPI_ISL_599239	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A0BBEC/2020	EPI_ISL_599244	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A0B1F9/2020	EPI_ISL_599247	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A0B8B8/2020	EPI_ISL_599249	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A0BD5F/2020	EPI_ISL_599286	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A0AE5D/2020	EPI_ISL_599293	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A0BEE3/2020	EPI_ISL_599295	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A0B7BB/2020	EPI_ISL_599299	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A0BCE9/2020	EPI_ISL_599311	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A0C2E6/2020	EPI_ISL_599333	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/QEUH-9FB500/2020	EPI_ISL_600607	2020-09-28	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9FA96F/2020	EPI_ISL_600617	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9F4A26/2020	EPI_ISL_600620	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F4A35/2020	EPI_ISL_600705	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F5DC2/2020	EPI_ISL_600709	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9F4534/2020	EPI_ISL_600717	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F4CD5/2020	EPI_ISL_600718	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F5DB3/2020	EPI_ISL_600721	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9F440A/2020	EPI_ISL_600727	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9F4CB7/2020	EPI_ISL_600734	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F4507/2020	EPI_ISL_600741	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9F6B03/2020	EPI_ISL_600743	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9F4A44/2020	EPI_ISL_600747	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9F672D/2020	EPI_ISL_600750	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9F4543/2020	EPI_ISL_600751	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F3DE2/2020	EPI_ISL_600767	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-9F39DF/2020	EPI_ISL_600782	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F3D1F/2020	EPI_ISL_600796	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F4394/2020	EPI_ISL_600797	2020-09-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/QEUH-9F37C6/2020	EPI_ISL_600798	2020-09-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9CF4BD/2020	EPI_ISL_601923	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9CF2FF/2020	EPI_ISL_601925	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9CE551/2020	EPI_ISL_601937	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9CEA16/2020	EPI_ISL_601939	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9CF2E0/2020	EPI_ISL_601944	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9CE5D9/2020	EPI_ISL_601945	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9CF6A8/2020	EPI_ISL_601958	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-A7ACB8/2020	EPI_ISL_606800	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A797A9/2020	EPI_ISL_606811	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/MILK-A79E1D/2020	EPI_ISL_606828	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7A4CF/2020	EPI_ISL_606877	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6FE0B/2020	EPI_ISL_606927	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6D9DF/2020	EPI_ISL_606939	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6F7B5/2020	EPI_ISL_606941	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6F76A/2020	EPI_ISL_606943	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6FACB/2020	EPI_ISL_606945	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-A6D623/2020	EPI_ISL_606967	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6F2D2/2020	EPI_ISL_606969	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6D562/2020	EPI_ISL_606975	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6FB40/2020	EPI_ISL_606976	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6DD2E/2020	EPI_ISL_606997	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A6C1AB/2020	EPI_ISL_609066	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A64808/2020	EPI_ISL_609072	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A67DAC/2020	EPI_ISL_609107	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A692C9/2020	EPI_ISL_609153	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/CAMC-A586C1/2020	EPI_ISL_609172	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A5DF76/2020	EPI_ISL_609179	2020-10-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A5DDA9/2020	EPI_ISL_609184	2020-10-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-AA02F3/2020	EPI_ISL_611372	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-A9B765/2020	EPI_ISL_611381	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A9F6DD/2020	EPI_ISL_611386	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A9FBCF/2020	EPI_ISL_611406	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-A9E89C/2020	EPI_ISL_611432	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A9F53A/2020	EPI_ISL_611448	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A9F497/2020	EPI_ISL_611458	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AA01F6/2020	EPI_ISL_611482	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-47F68E/2020	EPI_ISL_612709	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47F76D/2020	EPI_ISL_612721	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47F8B5/2020	EPI_ISL_612739	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47F9C1/2020	EPI_ISL_612754	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47FC13/2020	EPI_ISL_612787	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47FC22/2020	EPI_ISL_612788	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-7920/2020	EPI_ISL_618843	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-7887/2020	EPI_ISL_618854	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-7922/2020	EPI_ISL_618897	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-7938/2020	EPI_ISL_618899	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Denmark/DCGC-7116/2020	EPI_ISL_618958	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-7234/2020	EPI_ISL_618959	2020-10-12	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-7480/2020	EPI_ISL_618960	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/MILK-AB84C5/2020	EPI_ISL_623350	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ABB0DD/2020	EPI_ISL_623365	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AB015D/2020	EPI_ISL_623366	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AAFB26/2020	EPI_ISL_623390	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AAFD8A/2020	EPI_ISL_623393	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-ABB680/2020	EPI_ISL_623460	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AB743F/2020	EPI_ISL_623470	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A960F6/2020	EPI_ISL_624703	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A953FE/2020	EPI_ISL_624704	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A9609C/2020	EPI_ISL_624716	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A95EB1/2020	EPI_ISL_624722	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A95CE4/2020	EPI_ISL_624751	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A9580E/2020	EPI_ISL_624766	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-A956B9/2020	EPI_ISL_624776	2020-10-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A94465/2020	EPI_ISL_624782	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A9613F/2020	EPI_ISL_624786	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A94B24/2020	EPI_ISL_624795	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A95349/2020	EPI_ISL_624796	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-485254/2020	EPI_ISL_628161	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4852DC/2020	EPI_ISL_628165	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-485403/2020	EPI_ISL_628181	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-485597/2020	EPI_ISL_628194	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48561C/2020	EPI_ISL_628200	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4858DA/2020	EPI_ISL_628233	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-485B2C/2020	EPI_ISL_628253	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-485C1A/2020	EPI_ISL_628265	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-485E05/2020	EPI_ISL_628283	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-485F5D/2020	EPI_ISL_628294	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-485F6C/2020	EPI_ISL_628295	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-485F99/2020	EPI_ISL_628298	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-486147/2020	EPI_ISL_628311	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A32214/2020	EPI_ISL_628335	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A3229C/2020	EPI_ISL_628339	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A32690/2020	EPI_ISL_628357	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-ACEB5E/2020	EPI_ISL_629517	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ACF425/2020	EPI_ISL_629522	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ACE81B/2020	EPI_ISL_629595	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AC8F67/2020	EPI_ISL_629610	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AC84C2/2020	EPI_ISL_629637	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A66B76/2020	EPI_ISL_630488	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A66B1C/2020	EPI_ISL_630490	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A67AA5/2020	EPI_ISL_630493	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6745C/2020	EPI_ISL_630500	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A66C28/2020	EPI_ISL_630501	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A66DBC/2020	EPI_ISL_630538	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A67726/2020	EPI_ISL_630549	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A674E3/2020	EPI_ISL_630574	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A67814/2020	EPI_ISL_630582	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6860A/2020	EPI_ISL_630590	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A677F9/2020	EPI_ISL_630596	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68716/2020	EPI_ISL_630598	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A678AB/2020	EPI_ISL_630603	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A66EC8/2020	EPI_ISL_630623	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A66A6A/2020	EPI_ISL_630625	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A674C5/2020	EPI_ISL_630631	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6760B/2020	EPI_ISL_630663	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A66F2F/2020	EPI_ISL_630664	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A67C63/2020	EPI_ISL_630671	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A66BB2/2020	EPI_ISL_630673	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD3725/2020	EPI_ISL_634012	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD0C65/2020	EPI_ISL_634017	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD243E/2020	EPI_ISL_634025	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD3BFC/2020	EPI_ISL_634033	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD2C90/2020	EPI_ISL_634035	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD23B9/2020	EPI_ISL_634051	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD3CF9/2020	EPI_ISL_634065	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD0263/2020	EPI_ISL_634070	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD527D/2020	EPI_ISL_634075	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD3734/2020	EPI_ISL_634083	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD48F4/2020	EPI_ISL_634091	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD2067/2020	EPI_ISL_634101	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD2BB1/2020	EPI_ISL_634110	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD0C74/2020	EPI_ISL_634134	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD528C/2020	EPI_ISL_634144	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD23E6/2020	EPI_ISL_634145	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-AD200D/2020	EPI_ISL_634153	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD2B75/2020	EPI_ISL_634154	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD2A0F/2020	EPI_ISL_634167	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD2B48/2020	EPI_ISL_634168	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD3084/2020	EPI_ISL_634174	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-AD4645/2020	EPI_ISL_634181	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD2498/2020	EPI_ISL_634185	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD4627/2020	EPI_ISL_634189	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/C200036211/2020	EPI_ISL_636722	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/Scotland/QEUH-A79457/2020	EPI_ISL_639000	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-AADAFE/2020	EPI_ISL_639002	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-B13166/2020	EPI_ISL_642463	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B12EBB/2020	EPI_ISL_642489	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B12C39/2020	EPI_ISL_642515	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B12422/2020	EPI_ISL_642521	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B120D3/2020	EPI_ISL_642527	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B12C0C/2020	EPI_ISL_642528	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B122CE/2020	EPI_ISL_642530	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B12B5A/2020	EPI_ISL_642540	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B12B78/2020	EPI_ISL_642569	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B12B2D/2020	EPI_ISL_642594	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B11308/2020	EPI_ISL_642619	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B12BD2/2020	EPI_ISL_642626	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B12B0F/2020	EPI_ISL_642640	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B12A99/2020	EPI_ISL_642644	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B124AA/2020	EPI_ISL_642650	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B0838C/2020	EPI_ISL_643848	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B07C64/2020	EPI_ISL_643849	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B08331/2020	EPI_ISL_643854	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B075F0/2020	EPI_ISL_643885	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B0861A/2020	EPI_ISL_643911	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B08C09/2020	EPI_ISL_643914	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B08AB4/2020	EPI_ISL_643919	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1ACC8/2020	EPI_ISL_646004	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1F5E6/2020	EPI_ISL_646006	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1AD3E/2020	EPI_ISL_646013	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1C455/2020	EPI_ISL_646040	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1A3C3/2020	EPI_ISL_646050	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1F971/2020	EPI_ISL_646068	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1A31E/2020	EPI_ISL_646071	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1AD2F/2020	EPI_ISL_646080	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/CAMC-B21D52/2020	EPI_ISL_646101	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B2210A/2020	EPI_ISL_646102	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1C121/2020	EPI_ISL_646103	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B22216/2020	EPI_ISL_646128	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B31D22/2020	EPI_ISL_646141	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-B31FD1/2020	EPI_ISL_646158	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B32073/2020	EPI_ISL_646175	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B31B82/2020	EPI_ISL_646177	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24056/2020	EPI_ISL_646185	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B31AD0/2020	EPI_ISL_646195	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B2295D/2020	EPI_ISL_647313	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B21C46/2020	EPI_ISL_647369	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/CAMC-B2103B/2020	EPI_ISL_647379	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B22E4F/2020	EPI_ISL_647380	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B21A2E/2020	EPI_ISL_647406	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B229F3/2020	EPI_ISL_647409	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B22D7F/2020	EPI_ISL_647420	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B21860/2020	EPI_ISL_647436	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B20281/2020	EPI_ISL_647472	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B209C8/2020	EPI_ISL_647484	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B20825/2020	EPI_ISL_647486	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B20CDE/2020	EPI_ISL_647487	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5C00A/2020	EPI_ISL_655771	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B678D7/2020	EPI_ISL_655804	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B65FC5/2020	EPI_ISL_655806	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6C6E7/2020	EPI_ISL_655819	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-B5BE3E/2020	EPI_ISL_655836	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-B5C5CF/2020	EPI_ISL_655840	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5CC60/2020	EPI_ISL_655849	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5C028/2020	EPI_ISL_655888	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5C644/2020	EPI_ISL_655903	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-B5C019/2020	EPI_ISL_655909	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5C556/2020	EPI_ISL_655923	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5C5FC/2020	EPI_ISL_655927	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5C398/2020	EPI_ISL_655936	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5CDC7/2020	EPI_ISL_655937	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5C459/2020	EPI_ISL_655944	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5C750/2020	EPI_ISL_655958	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B54B01/2020	EPI_ISL_658006	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B51CE3/2020	EPI_ISL_658008	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B5215C/2020	EPI_ISL_658012	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/CAMC-B5114E/2020	EPI_ISL_658024	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B54A40/2020	EPI_ISL_658044	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B55EDA/2020	EPI_ISL_658143	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B518FE/2020	EPI_ISL_658171	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B55D37/2020	EPI_ISL_658174	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B517A6/2020	EPI_ISL_658179	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B560F1/2020	EPI_ISL_658183	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B32BAF/2020	EPI_ISL_659342	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B34A46/2020	EPI_ISL_659437	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B32B81/2020	EPI_ISL_659452	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B34DB6/2020	EPI_ISL_659459	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B3576C/2020	EPI_ISL_659470	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B34DA7/2020	EPI_ISL_659488	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B68A3A/2020	EPI_ISL_661605	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B82724/2020	EPI_ISL_661655	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7ECFF/2020	EPI_ISL_661663	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7EFAB/2020	EPI_ISL_661776	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF55BA/2020	EPI_ISL_662988	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/EXET-13B01A/2020	EPI_ISL_665106	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/LIVE-DBAD98/2020	EPI_ISL_665118	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DBB67E/2020	EPI_ISL_665125	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DBB6BA/2020	EPI_ISL_665126	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DBB6F6/2020	EPI_ISL_665127	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LOND-1250233/2020	EPI_ISL_665205	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LOND-12504A6/2020	EPI_ISL_665212	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LOND-1250664/2020	EPI_ISL_665224	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LOND-12508C8/2020	EPI_ISL_665238	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48C40C/2020	EPI_ISL_666428	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48CABF/2020	EPI_ISL_666503	2020-11-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48CB43/2020	EPI_ISL_666510	2020-11-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48CC8C/2020	EPI_ISL_666525	2020-10-31	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48CE0E/2020	EPI_ISL_666543	2020-11-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48CFA1/2020	EPI_ISL_666562	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/QEUH-A60C88/2020	EPI_ISL_666591	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-B81AD1/2020	EPI_ISL_667824	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B816BF/2020	EPI_ISL_667825	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B78AEC/2020	EPI_ISL_667826	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B81682/2020	EPI_ISL_667843	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7E961/2020	EPI_ISL_667849	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B79948/2020	EPI_ISL_667865	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-B81646/2020	EPI_ISL_667883	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7EBB6/2020	EPI_ISL_667919	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7EAC8/2020	EPI_ISL_667928	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B816EC/2020	EPI_ISL_667938	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-11601/2020	EPI_ISL_671016	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.80	GV
hCoV-19/Denmark/DCGC-11880/2020	EPI_ISL_671192	2020-10-26	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.8	GV
hCoV-19/England/MILK-B950E7/2020	EPI_ISL_673642	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B988DD/2020	EPI_ISL_673670	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B99915/2020	EPI_ISL_673699	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B952A5/2020	EPI_ISL_673796	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B9806C/2020	EPI_ISL_674924	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B97FBB/2020	EPI_ISL_674946	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B980D5/2020	EPI_ISL_674973	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B9862E/2020	EPI_ISL_674998	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B3B07A/2020	EPI_ISL_679739	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3B089/2020	EPI_ISL_679740	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3B317/2020	EPI_ISL_679753	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3C501/2020	EPI_ISL_679814	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3CC0C/2020	EPI_ISL_679821	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3E0E0/2020	EPI_ISL_679848	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B59832/2020	EPI_ISL_679874	2020-11-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/MILK-B599E4/2020	EPI_ISL_679896	2020-11-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/MILK-B59C72/2020	EPI_ISL_679922	2020-11-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Wales/PHWC-48DABE/2020	EPI_ISL_680722	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48DC8B/2020	EPI_ISL_680742	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48E08E/2020	EPI_ISL_680801	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48E19A/2020	EPI_ISL_680818	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48E25B/2020	EPI_ISL_680829	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48E2A6/2020	EPI_ISL_680834	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48E2B5/2020	EPI_ISL_680835	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48E31C/2020	EPI_ISL_680841	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48E32B/2020	EPI_ISL_680842	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48E358/2020	EPI_ISL_680845	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48E68C/2020	EPI_ISL_680892	2020-11-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-BC0A8B/2020	EPI_ISL_705041	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC0BE2/2020	EPI_ISL_705049	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/CAMC-BC0BF1/2020	EPI_ISL_705076	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/CAMC-BC0827/2020	EPI_ISL_705080	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC1C57/2020	EPI_ISL_705092	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-BC0E9E/2020	EPI_ISL_705097	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC0BB5/2020	EPI_ISL_705107	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC01D1/2020	EPI_ISL_705109	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BA9B58/2020	EPI_ISL_705199	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/NORT-1B710A2/2020	EPI_ISL_706302	2020-11-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-1B71109/2020	EPI_ISL_706303	2020-11-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-1B71303/2020	EPI_ISL_706306	2020-11-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-1B71312/2020	EPI_ISL_706307	2020-11-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-1B713C7/2020	EPI_ISL_706309	2020-11-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-1B7142E/2020	EPI_ISL_706310	2020-11-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-1B715B2/2020	EPI_ISL_706311	2020-11-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-28D2A9/2020	EPI_ISL_706334	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-28D2F4/2020	EPI_ISL_706337	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-28D528/2020	EPI_ISL_706344	2020-11-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-28D564/2020	EPI_ISL_706347	2020-11-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-28D69E/2020	EPI_ISL_706351	2020-11-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORW-F63F5/2020	EPI_ISL_706365	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NOTT-11F43E/2020	EPI_ISL_706432	2020-11-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-490168/2020	EPI_ISL_706450	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49053F/2020	EPI_ISL_706486	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4905B7/2020	EPI_ISL_706490	2020-11-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-BE9345/2020	EPI_ISL_708955	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BE91D2/2020	EPI_ISL_708976	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BE93CD/2020	EPI_ISL_708982	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BEE36E/2020	EPI_ISL_708984	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BE8F60/2020	EPI_ISL_708987	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BFB850/2020	EPI_ISL_708992	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BFBFE2/2020	EPI_ISL_708996	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-13508/2020	EPI_ISL_712249	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-12949/2020	EPI_ISL_712250	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-12979/2020	EPI_ISL_712251	2020-12-07	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13005/2020	EPI_ISL_712253	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13054/2020	EPI_ISL_712254	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13073/2020	EPI_ISL_712255	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13079/2020	EPI_ISL_712256	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13150/2020	EPI_ISL_712258	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13171/2020	EPI_ISL_712259	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13175/2020	EPI_ISL_712260	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13252/2020	EPI_ISL_712261	2020-11-30	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13311/2020	EPI_ISL_712262	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13322/2020	EPI_ISL_712264	2020-11-30	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13339/2020	EPI_ISL_712266	2020-11-30	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13383/2020	EPI_ISL_712268	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13389/2020	EPI_ISL_712270	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13395/2020	EPI_ISL_712271	2020-11-30	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13418/2020	EPI_ISL_712272	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13427/2020	EPI_ISL_712273	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13440/2020	EPI_ISL_712274	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13489/2020	EPI_ISL_712275	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13524/2020	EPI_ISL_712276	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13531/2020	EPI_ISL_712277	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13567/2020	EPI_ISL_712278	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13673/2020	EPI_ISL_712282	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13709/2020	EPI_ISL_712283	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13715/2020	EPI_ISL_712284	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13757/2020	EPI_ISL_712285	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13780/2020	EPI_ISL_712286	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13791/2020	EPI_ISL_712287	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13821/2020	EPI_ISL_712289	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13838/2020	EPI_ISL_712290	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13861/2020	EPI_ISL_712291	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13888/2020	EPI_ISL_712292	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-13896/2020	EPI_ISL_712293	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/CAMC-C46891/2020	EPI_ISL_718379	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C44B9A/2020	EPI_ISL_718386	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C459EA/2020	EPI_ISL_718423	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C44DFE/2020	EPI_ISL_718475	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C3F9F2/2020	EPI_ISL_718476	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C3F998/2020	EPI_ISL_718492	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BA00DA/2020	EPI_ISL_719693	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BA00AD/2020	EPI_ISL_719716	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BA03D1/2020	EPI_ISL_719738	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-BA06F6/2020	EPI_ISL_719780	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB0F43/2020	EPI_ISL_720630	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAC2F6/2020	EPI_ISL_720657	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAC87C/2020	EPI_ISL_720665	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-C01249/2020	EPI_ISL_720672	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BFDEC5/2020	EPI_ISL_720673	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C03E9E/2020	EPI_ISL_720726	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BFF4EF/2020	EPI_ISL_720736	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-C01434/2020	EPI_ISL_720755	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C05CB0/2020	EPI_ISL_720773	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BFF968/2020	EPI_ISL_720774	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BFF6E9/2020	EPI_ISL_720789	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BBCBAD/2020	EPI_ISL_724193	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/CVR6062/2020	EPI_ISL_724211	2020-11-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6073/2020	EPI_ISL_724212	2020-11-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR6120/2020	EPI_ISL_724214	2020-12-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR6122/2020	EPI_ISL_724216	2020-12-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6129/2020	EPI_ISL_724220	2020-12-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB10799/2020	EPI_ISL_724238	2020-12-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB10822/2020	EPI_ISL_724240	2020-12-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Wales/PHWC-49725F/2020	EPI_ISL_726800	2020-11-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4973E3/2020	EPI_ISL_726825	2020-11-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-497495/2020	EPI_ISL_726834	2020-11-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4974C2/2020	EPI_ISL_726837	2020-11-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4976BD/2020	EPI_ISL_726866	2020-11-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-497AB1/2020	EPI_ISL_726929	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-497C60/2020	EPI_ISL_726954	2020-11-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-497C9D/2020	EPI_ISL_726957	2020-11-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-497CCA/2020	EPI_ISL_726960	2020-11-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-C31301/2020	EPI_ISL_731314	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C39530/2020	EPI_ISL_731339	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3AD0A/2020	EPI_ISL_731352	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-C3A854/2020	EPI_ISL_731358	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C3119E/2020	EPI_ISL_731382	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C30B28/2020	EPI_ISL_731386	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C3133E/2020	EPI_ISL_731403	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C35F54/2020	EPI_ISL_731404	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3AD82/2020	EPI_ISL_731446	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C30BBF/2020	EPI_ISL_731459	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C31037/2020	EPI_ISL_731488	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C23CBC/2020	EPI_ISL_733901	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C2667F/2020	EPI_ISL_733906	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C23074/2020	EPI_ISL_733912	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C342F2/2020	EPI_ISL_733926	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C3473F/2020	EPI_ISL_733937	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C343A4/2020	EPI_ISL_733941	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C34474/2020	EPI_ISL_733969	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C342C5/2020	EPI_ISL_733974	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C3426B/2020	EPI_ISL_733978	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C3485A/2020	EPI_ISL_733980	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C34544/2020	EPI_ISL_733997	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-C58577/2020	EPI_ISL_736199	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/SHEF-10D107E/2020	EPI_ISL_742031	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Northern Ireland/NIRE-2356A4/2020	EPI_ISL_742127	2020-11-09	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.58	GV
hCoV-19/Northern Ireland/NIRE-23571A/2020	EPI_ISL_742133	2020-11-12	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.58	GV
hCoV-19/Northern Ireland/NIRE-235738/2020	EPI_ISL_742135	2020-11-12	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.58	GV
hCoV-19/Northern Ireland/NIRE-235923/2020	EPI_ISL_742164	2020-11-10	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Northern Ireland/NIRE-23598D/2020	EPI_ISL_742168	2020-11-10	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Northern Ireland/NIRE-23599C/2020	EPI_ISL_742169	2020-11-10	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/EDB10908/2020	EPI_ISL_742183	2020-12-10	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Wales/PHWC-49FA22/2020	EPI_ISL_743307	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49FAD7/2020	EPI_ISL_743318	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-4A002C/2020	EPI_ISL_743385	2020-11-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A01DE/2020	EPI_ISL_743409	2020-12-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A0402/2020	EPI_ISL_743442	2020-12-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A0693/2020	EPI_ISL_743478	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A06C0/2020	EPI_ISL_743481	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-18760/2020	EPI_ISL_748282	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18770/2020	EPI_ISL_748283	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18774/2020	EPI_ISL_748284	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18782/2020	EPI_ISL_748285	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18783/2020	EPI_ISL_748286	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18800/2020	EPI_ISL_748287	2020-12-07	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18820/2020	EPI_ISL_748288	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18831/2020	EPI_ISL_748289	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18846/2020	EPI_ISL_748290	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18956/2020	EPI_ISL_748291	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19039/2020	EPI_ISL_748293	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19095/2020	EPI_ISL_748294	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19119/2020	EPI_ISL_748295	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19151/2020	EPI_ISL_748296	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19158/2020	EPI_ISL_748297	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19168/2020	EPI_ISL_748298	2020-12-07	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-16841/2020	EPI_ISL_750596	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177	GV
hCoV-19/Germany/BE-ChVir-D2028-8264/2020	EPI_ISL_754191	2020-10-14	Europe / Germany / Berlin	Human	Original			Illumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-C88EA0/2020	EPI_ISL_756616	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C8B7EE/2020	EPI_ISL_756639	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C8B818/2020	EPI_ISL_756663	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C7C838/2020	EPI_ISL_756748	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C78535/2020	EPI_ISL_756757	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-C7B63F/2020	EPI_ISL_756770	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-21433/2020	EPI_ISL_757900	2020-12-21	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21435/2020	EPI_ISL_757901	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21465/2020	EPI_ISL_757902	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21504/2020	EPI_ISL_757903	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21508/2020	EPI_ISL_757904	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21527/2020	EPI_ISL_757905	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21559/2020	EPI_ISL_757906	2020-12-21	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21568/2020	EPI_ISL_757907	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21585/2020	EPI_ISL_757908	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21591/2020	EPI_ISL_757909	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21599/2020	EPI_ISL_757910	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21616/2020	EPI_ISL_757911	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21621/2020	EPI_ISL_757912	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21666/2020	EPI_ISL_757913	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21713/2020	EPI_ISL_757914	2020-12-21	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21715/2020	EPI_ISL_757915	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21721/2020	EPI_ISL_757916	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21760/2020	EPI_ISL_757918	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21788/2020	EPI_ISL_757920	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21793/2020	EPI_ISL_757921	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21836/2020	EPI_ISL_757922	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21892/2020	EPI_ISL_757923	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21897/2020	EPI_ISL_757924	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21937/2020	EPI_ISL_757925	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21965/2020	EPI_ISL_757926	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21977/2020	EPI_ISL_757927	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21978/2020	EPI_ISL_757928	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21994/2020	EPI_ISL_757929	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22094/2020	EPI_ISL_757933	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22110/2020	EPI_ISL_757934	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22169/2020	EPI_ISL_757935	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22173/2020	EPI_ISL_757936	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22224/2020	EPI_ISL_757939	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22229/2020	EPI_ISL_757940	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22232/2020	EPI_ISL_757941	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22234/2020	EPI_ISL_757942	2020-12-14	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22305/2020	EPI_ISL_757943	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22327/2020	EPI_ISL_757944	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-CB44D6/2020	EPI_ISL_761124	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB6780/2020	EPI_ISL_761140	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB49E6/2020	EPI_ISL_761169	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB48DA/2020	EPI_ISL_761184	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CADE2D/2020	EPI_ISL_761187	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB40D2/2020	EPI_ISL_761188	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CADDD5/2020	EPI_ISL_761191	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB404B/2020	EPI_ISL_761195	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB652C/2020	EPI_ISL_761234	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB354D/2020	EPI_ISL_761238	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB3589/2020	EPI_ISL_761240	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB689C/2020	EPI_ISL_761246	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB4D44/2020	EPI_ISL_761277	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CADF75/2020	EPI_ISL_761283	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB39AB/2020	EPI_ISL_761297	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-CA4758/2020	EPI_ISL_762445	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-CA9A0F/2020	EPI_ISL_762450	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-CA511D/2020	EPI_ISL_762491	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-C04ECA/2020	EPI_ISL_767308	2020-12-04	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-C04EF7/2020	EPI_ISL_767309	2020-12-04	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Germany/TH-IIMK-CaSe-29/2020	EPI_ISL_768633	2020-12-08	Europe / Germany / Thuringia	Human	Original			Nanopore MinION	ARTIC			B.1.177	GV
hCoV-19/Japan/IC-0444/2020	EPI_ISL_768653	2020-11-28	Asia / Japan	Human	Original		COVID-19 positive case who entered from England.	Illumina iSeq	SKESA v. 2.3.0			B.1.177.8	GV
hCoV-19/England/ALDP-CBF9CD/2020	EPI_ISL_778043	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CBF444/2020	EPI_ISL_778044	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CC0747/2020	EPI_ISL_778059	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-CC260C/2020	EPI_ISL_778077	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-CB7233/2020	EPI_ISL_778099	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC2851/2020	EPI_ISL_778168	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D07EE4/2020	EPI_ISL_781798	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C2FD80/2020	EPI_ISL_782901	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	GV
hCoV-19/England/MILK-C2FE23/2020	EPI_ISL_782999	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-DA273B/2020	EPI_ISL_797112	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-DA6825/2020	EPI_ISL_797113	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D741DA/2020	EPI_ISL_798412	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D70095/2020	EPI_ISL_798418	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/MILK-D7243D/2020	EPI_ISL_798503	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D6B8E0/2020	EPI_ISL_798504	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D4140A/2020	EPI_ISL_798508	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D40359/2020	EPI_ISL_798519	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D3FA58/2020	EPI_ISL_798524	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-D3FA85/2020	EPI_ISL_798539	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D41516/2020	EPI_ISL_798548	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D7242E/2020	EPI_ISL_798559	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D74231/2020	EPI_ISL_798596	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D1BE1A/2020	EPI_ISL_799725	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D1493E/2020	EPI_ISL_799729	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-CE268E/2020	EPI_ISL_799734	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-D1BF71/2020	EPI_ISL_799788	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-D1495C/2020	EPI_ISL_799792	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-CE1B80/2020	EPI_ISL_799814	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/BIRM-6826A/2020	EPI_ISL_813007	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Denmark/DCGC-27458/2020	EPI_ISL_815503	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27478/2020	EPI_ISL_815504	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27492/2020	EPI_ISL_815505	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27505/2020	EPI_ISL_815506	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	GV
hCoV-19/Denmark/DCGC-27509/2020	EPI_ISL_815507	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27552/2020	EPI_ISL_815508	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27579/2020	EPI_ISL_815509	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27610/2020	EPI_ISL_815511	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27611/2020	EPI_ISL_815512	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27627/2020	EPI_ISL_815513	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27644/2020	EPI_ISL_815514	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27653/2020	EPI_ISL_815515	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27666/2020	EPI_ISL_815516	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27680/2020	EPI_ISL_815517	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27693/2020	EPI_ISL_815518	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27710/2020	EPI_ISL_815519	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27732/2020	EPI_ISL_815521	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27797/2020	EPI_ISL_815522	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27895/2020	EPI_ISL_815523	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27899/2020	EPI_ISL_815524	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28076/2020	EPI_ISL_815525	2020-11-23	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27582/2020	EPI_ISL_815557	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 7 nucleotide(s) found at refpos 27794 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 21 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/England/TFCI-26FA9A8/2020	EPI_ISL_816839	2020-12-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Spain/IB-IBV-99012772/2020	EPI_ISL_819171	2020-12-29	Europe / Spain / Balear Islands / Palma de Mallorca	Human	Original			Illumina MiSeq	BWA/IVAR	NS7a_E95stop results in 22.3% truncation of the protein sequence.	info	B.1.177.61	GV
hCoV-19/Spain/IB-IBV-99012798/2020	EPI_ISL_819172	2020-12-23	Europe / Spain / Balear Islands / Palma de Mallorca	Human	Original			Illumina MiSeq	BWA/IVAR	NS7a_E95stop results in 22.3% truncation of the protein sequence.	info	B.1.177.61	GV
hCoV-19/Spain/IB-IBV-99012845/2020	EPI_ISL_819173	2020-12-23	Europe / Spain / Balear Islands / Palma de Mallorca	Human	Original			Illumina MiSeq	BWA/IVAR	NS7a_E95stop results in 22.3% truncation of the protein sequence.	info	B.1.177.61	GV
hCoV-19/Spain/IB-IBV-99012760/2020	EPI_ISL_819174	2020-12-22	Europe / Spain / Balear Islands / Palma de Mallorca	Human	Original			Illumina MiSeq	BWA/IVAR	NS7a_E95stop results in 22.3% truncation of the protein sequence.	info	B.1.177.61	GV
hCoV-19/Spain/IB-IBV-99012828/2020	EPI_ISL_819176	2020-12-22	Europe / Spain / Balear Islands / Palma de Mallorca	Human	Original			Illumina MiSeq	BWA/IVAR	NS7a_E95stop results in 22.3% truncation of the protein sequence.	info	B.1.177.61	GV
hCoV-19/Wales/PHWC-4AF764/2020	EPI_ISL_822605	2020-12-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AF3AC/2020	EPI_ISL_822685	2020-12-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AF816/2020	EPI_ISL_822699	2020-12-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B026F/2020	EPI_ISL_822783	2020-12-31	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B02D8/2020	EPI_ISL_822787	2020-12-31	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/USA/NY-NYCPHL-001585/2020	EPI_ISL_823955	2020-12-03	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Iceland/3737/2020	EPI_ISL_827428	2020-10-16	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	MPileup			B.1.177	GV
hCoV-19/Scotland/CVR6214/2020	EPI_ISL_838112	2020-12-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6339/2020	EPI_ISL_838132	2020-12-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR6346/2020	EPI_ISL_838136	2020-12-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR6363/2020	EPI_ISL_838153	2020-12-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6383/2020	EPI_ISL_838171	2020-12-24	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6411/2020	EPI_ISL_838197	2020-12-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6412/2020	EPI_ISL_838198	2020-12-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		Gap of 19 nucleotide(s) found at refpos 27568 (FRAMESHIFT confirmed by the submitter). NS7a without BLAST coverage. NSP11 without BLAST coverage.	info	B.1.177.5	GV
hCoV-19/Scotland/CVR6477/2020	EPI_ISL_838212	2020-12-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/England/MILK-B5A0EE/2020	EPI_ISL_839409	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B5AA77/2020	EPI_ISL_839443	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B5AB0B/2020	EPI_ISL_839449	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B5AB1A/2020	EPI_ISL_839450	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B088B/2020	EPI_ISL_840407	2020-12-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B0C61/2020	EPI_ISL_840469	2020-12-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B72FF/2021	EPI_ISL_841709	2021-01-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-29965/2020	EPI_ISL_844012	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30000/2020	EPI_ISL_844047	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30001/2020	EPI_ISL_844048	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30006/2020	EPI_ISL_844053	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30021/2020	EPI_ISL_844068	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30023/2020	EPI_ISL_844070	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30040/2020	EPI_ISL_844087	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30069/2020	EPI_ISL_844116	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30078/2020	EPI_ISL_844125	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30108/2020	EPI_ISL_844155	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30133/2020	EPI_ISL_844180	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30147/2020	EPI_ISL_844194	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30151/2020	EPI_ISL_844198	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31647/2021	EPI_ISL_856063	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31697/2021	EPI_ISL_856113	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31737/2021	EPI_ISL_856153	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31779/2021	EPI_ISL_856195	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Scotland/QEUH-D94471/2021	EPI_ISL_858601	2021-01-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-D9AE5F/2021	EPI_ISL_858604	2021-01-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-D94417/2021	EPI_ISL_858613	2021-01-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-D8C8AD/2020	EPI_ISL_858619	2020-12-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-D92947/2020	EPI_ISL_858632	2020-12-31	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-DD2BFA/2021	EPI_ISL_858665	2021-01-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-DA64E5/2020	EPI_ISL_858680	2020-12-31	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-D529CB/2020	EPI_ISL_858715	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-D52961/2020	EPI_ISL_858716	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-D545A7/2020	EPI_ISL_858722	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-D53414/2020	EPI_ISL_858740	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-D53A03/2020	EPI_ISL_858742	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-D52A40/2020	EPI_ISL_858745	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-D50848/2020	EPI_ISL_858746	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-D5080C/2020	EPI_ISL_858755	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-D52A31/2020	EPI_ISL_858758	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-D52A5F/2020	EPI_ISL_858761	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-D51EFA/2020	EPI_ISL_858762	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-D508FD/2020	EPI_ISL_858765	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-D5461D/2020	EPI_ISL_858766	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-D50927/2020	EPI_ISL_858767	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-D509AF/2020	EPI_ISL_858773	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-D509DC/2020	EPI_ISL_858775	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-D142F7/2020	EPI_ISL_858793	2020-12-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-D14CBD/2020	EPI_ISL_858794	2020-12-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-D19C5E/2020	EPI_ISL_858796	2020-12-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-FB5E3E/2021	EPI_ISL_863104	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-FAA379/2021	EPI_ISL_864444	2021-01-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-FAED77/2021	EPI_ISL_864449	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/LOND-12E8ADE/2020	EPI_ISL_865734	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-32275/2021	EPI_ISL_869279	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32290/2021	EPI_ISL_869294	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-32300/2021	EPI_ISL_869304	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32301/2021	EPI_ISL_869305	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32311/2021	EPI_ISL_869315	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-32318/2021	EPI_ISL_869322	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32331/2021	EPI_ISL_869335	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32383/2021	EPI_ISL_869387	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32433/2021	EPI_ISL_869437	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33308/2021	EPI_ISL_870313	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33344/2021	EPI_ISL_870354	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33348/2021	EPI_ISL_870358	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-33371/2021	EPI_ISL_870381	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33397/2021	EPI_ISL_870407	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33401/2021	EPI_ISL_870411	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33434/2021	EPI_ISL_870444	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33450/2021	EPI_ISL_870460	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34578/2020	EPI_ISL_871589	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34589/2020	EPI_ISL_871600	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34612/2020	EPI_ISL_871623	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34613/2020	EPI_ISL_871624	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34618/2020	EPI_ISL_871629	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34621/2020	EPI_ISL_871632	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34622/2020	EPI_ISL_871633	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34625/2020	EPI_ISL_871636	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34626/2020	EPI_ISL_871637	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34631/2020	EPI_ISL_871642	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34638/2020	EPI_ISL_871649	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34647/2020	EPI_ISL_871658	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 4 nucleotide(s) found at refpos 27579 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence. NS7a without BLAST coverage.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34649/2020	EPI_ISL_871660	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34673/2020	EPI_ISL_871684	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34689/2020	EPI_ISL_871700	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34711/2020	EPI_ISL_871722	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34749/2020	EPI_ISL_871760	2020-12-07	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34761/2020	EPI_ISL_871772	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-1091599/2021	EPI_ISL_877771	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-101B0C3/2021	EPI_ISL_881023	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10173EC/2021	EPI_ISL_881026	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10173A0/2021	EPI_ISL_881048	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-101A55C/2021	EPI_ISL_881054	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-101A71A/2021	EPI_ISL_881060	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10169AF/2021	EPI_ISL_881114	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1016CC4/2021	EPI_ISL_881115	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1016990/2021	EPI_ISL_881135	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-101C29F/2021	EPI_ISL_881139	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FB58B8/2021	EPI_ISL_882244	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-FB4FB4/2021	EPI_ISL_882279	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FB593D/2021	EPI_ISL_882283	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-F755EA/2021	EPI_ISL_882330	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-F755CC/2021	EPI_ISL_882342	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-F75517/2021	EPI_ISL_882355	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-F7540B/2021	EPI_ISL_882395	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-F750CB/2021	EPI_ISL_882425	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-F74C7D/2021	EPI_ISL_882448	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Germany/SN-DcGC-L62664/2020	EPI_ISL_887109	2020-09-10	Europe / Germany / Saxony / Dresden	Human	Original			Illumina NovaSeq 6000	Nfcore viralrecon, ivar			B.1.177	GV
hCoV-19/Switzerland/BL-ETHZ-430906/2020	EPI_ISL_899166	2020-12-26	Europe / Switzerland / Basel-Landschaft	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GH
hCoV-19/Netherlands/DR-RIVM-10065/2021	EPI_ISL_905416	2021-01-06	Europe / Netherlands / Drenthe	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/ZH-RIVM-10083/2021	EPI_ISL_905442	2021-01-04	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.177.5	GV
hCoV-19/Netherlands/FR-RIVM-10103/2021	EPI_ISL_905474	2021-01-05	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/FR-RIVM-10104/2021	EPI_ISL_905475	2021-01-05	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/FR-RIVM-10107/2021	EPI_ISL_905478	2021-01-06	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/FR-RIVM-10109/2021	EPI_ISL_905480	2021-01-05	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/FR-RIVM-10111/2021	EPI_ISL_905482	2021-01-05	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Norway/0671/2021	EPI_ISL_906797	2021-01-15	Europe / Norway / Rogaland	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Norway/0732/2021	EPI_ISL_906799	2021-01-06	Europe / Norway / Nordland	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/England/MILK-108978F/2021	EPI_ISL_909115	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-BB9214/2020	EPI_ISL_916126	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-112166D/2021	EPI_ISL_917427	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/BIRM-6E52F/2020	EPI_ISL_918759	2020-12-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/TFCI-2701697/2021	EPI_ISL_924683	2021-01-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/TFCI-27016A6/2021	EPI_ISL_924684	2021-01-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Denmark/DCGC-36973/2021	EPI_ISL_928114	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37013/2021	EPI_ISL_928154	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37035/2021	EPI_ISL_928176	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37122/2021	EPI_ISL_928263	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37124/2021	EPI_ISL_928265	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37134/2021	EPI_ISL_928275	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38314/2021	EPI_ISL_929455	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-38324/2021	EPI_ISL_929465	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38340/2021	EPI_ISL_929481	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38341/2021	EPI_ISL_929482	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38419/2021	EPI_ISL_929560	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-38425/2021	EPI_ISL_929566	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38428/2021	EPI_ISL_929569	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39269/2021	EPI_ISL_930411	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39293/2021	EPI_ISL_930435	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-39312/2021	EPI_ISL_930454	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39392/2021	EPI_ISL_930534	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-1185E6F/2021	EPI_ISL_931771	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11855E2/2021	EPI_ISL_931861	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1186709/2021	EPI_ISL_931894	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11457BB/2021	EPI_ISL_948569	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1128BB2/2021	EPI_ISL_948574	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1145548/2021	EPI_ISL_948730	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1145D7D/2021	EPI_ISL_948747	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1145D8C/2021	EPI_ISL_948761	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1128A97/2021	EPI_ISL_948765	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/OXON-F45D54/2020	EPI_ISL_950865	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F461A2/2020	EPI_ISL_950882	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F469D7/2020	EPI_ISL_950915	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F46A2F/2020	EPI_ISL_950916	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-119718F/2021	EPI_ISL_959238	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1196D04/2021	EPI_ISL_959240	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1196539/2021	EPI_ISL_959264	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Poland/2142627650-gx1/2021	EPI_ISL_959410	2021-01-20	Europe / Poland / Wielkopolska / Poznan	Human	Original	Oropharyngeal and nasopharyngeal swab		Oxford Nanopore	ARTICv3	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Norway/0907/2021	EPI_ISL_962904	2021-01-05	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Norway/0908/2021	EPI_ISL_962905	2021-01-05	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Norway/0948/2021	EPI_ISL_962910	2021-01-11	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-39602/2020	EPI_ISL_971006	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39603/2021	EPI_ISL_971007	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-39612/2021	EPI_ISL_971018	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-39637/2021	EPI_ISL_971065	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40545/2021	EPI_ISL_972222	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40567/2020	EPI_ISL_972244	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40587/2021	EPI_ISL_972264	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40675/2021	EPI_ISL_972352	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40685/2021	EPI_ISL_972362	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40691/2021	EPI_ISL_972368	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40720/2021	EPI_ISL_972397	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 2 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41825/2021	EPI_ISL_973527	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41884/2021	EPI_ISL_973647	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41889/2021	EPI_ISL_973656	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-121EAEE/2021	EPI_ISL_985641	2021-02-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-121ECE8/2021	EPI_ISL_985668	2021-02-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-11719FC/2021	EPI_ISL_990059	2021-01-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-117108E/2021	EPI_ISL_990077	2021-01-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-11719ED/2021	EPI_ISL_990092	2021-01-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-1171482/2021	EPI_ISL_990097	2021-01-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-11972B9/2021	EPI_ISL_990169	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11986E9/2021	EPI_ISL_990185	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1197608/2021	EPI_ISL_990197	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-114D7E0/2021	EPI_ISL_991392	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-115BDED/2021	EPI_ISL_991573	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-115BBC5/2021	EPI_ISL_991577	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10EEBC8/2021	EPI_ISL_992850	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10E97F6/2021	EPI_ISL_992870	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10E97D8/2021	EPI_ISL_992897	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ARCH-000055C1/2021	EPI_ISL_996221	2021	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 12 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ARCH-000055C2/2021	EPI_ISL_996223	2021	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 12 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/NORW-227CFE/2020	EPI_ISL_998821	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-227DCE/2020	EPI_ISL_998822	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-22802E/2020	EPI_ISL_998827	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-2291C0/2020	EPI_ISL_998835	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NOTT-24EA24/2020	EPI_ISL_998927	2020-12-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 59 nucleotide(s) found at refpos 27577 (FRAMESHIFT confirmed by the submitter).	info	B.1.177	GV
hCoV-19/England/NOTT-24EA60/2020	EPI_ISL_998930	2020-12-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 59 nucleotide(s) found at refpos 27577 (FRAMESHIFT confirmed by the submitter).	info	B.1.177	GV
hCoV-19/England/PORT-2EF6A9/2021	EPI_ISL_1000599	2021-01-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Wales/ALDP-121FB26/2021	EPI_ISL_1012563	2021-02-04	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1277D17/2021	EPI_ISL_1018525	2021-02-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1277DAE/2021	EPI_ISL_1018540	2021-02-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1277F3F/2021	EPI_ISL_1018562	2021-02-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-1067383/2021	EPI_ISL_1019848	2021-01-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-10673FC/2021	EPI_ISL_1019850	2021-01-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Denmark/DCGC-42935/2021	EPI_ISL_1023213	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-42986/2021	EPI_ISL_1023264	2021-02-08	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-43842/2021	EPI_ISL_1024220	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-43863/2021	EPI_ISL_1024241	2021-02-01	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44171/2021	EPI_ISL_1024549	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44175/2021	EPI_ISL_1024553	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44185/2021	EPI_ISL_1024563	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44199/2021	EPI_ISL_1024577	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-45143/2020	EPI_ISL_1025521	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Netherlands/NB-RIVM-12388/2021	EPI_ISL_1035098	2021-01-25	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/RAND-1287D50/2021	EPI_ISL_1043406	2021-02-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1283A8A/2021	EPI_ISL_1044702	2021-02-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/BIRM-BCYYSF/2021	EPI_ISL_1047068	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Wales/PHWC-4C9B3B/2021	EPI_ISL_1053083	2021-02-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-11A88E0/2021	EPI_ISL_1054060	2021-01-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Canada/NS-NML-5138/2021	EPI_ISL_1055462	2021-01-07	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Canada/NS-NML-5140/2021	EPI_ISL_1055463	2021-01-05	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Canada/NS-NML-5145/2021	EPI_ISL_1055465	2021-01-04	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Canada/NS-NML-5146/2021	EPI_ISL_1055466	2021-01-04	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/MILK-12A6D3D/2021	EPI_ISL_1062695	2021-02-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-46540/2021	EPI_ISL_1066050	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46563/2020	EPI_ISL_1066073	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46701/2020	EPI_ISL_1066211	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46720/2021	EPI_ISL_1066230	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46860/2021	EPI_ISL_1066371	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47842/2021	EPI_ISL_1067377	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47893/2021	EPI_ISL_1067428	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47900/2021	EPI_ISL_1067435	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Sweden/SUS0000001/2021	EPI_ISL_1081843	2021-01-30	Europe / Sweden / Skane	Human	Original			Illumina NextSeq	bwa + iVar trim + iVar consensus	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Sweden/SUS0000007/2021	EPI_ISL_1081849	2021-02-01	Europe / Sweden / Skane	Human	Original			Illumina NextSeq	bwa + iVar trim + iVar consensus	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 12 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Scotland/QEUH-96E1AA/2020	EPI_ISL_534502	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-96D3F0/2020	EPI_ISL_534595	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9990F4/2020	EPI_ISL_541820	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-99913D/2020	EPI_ISL_541839	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-975A5A/2020	EPI_ISL_552469	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-974FA7/2020	EPI_ISL_552493	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9AF2AA/2020	EPI_ISL_559831	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9BDB26/2020	EPI_ISL_568054	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BE3D2/2020	EPI_ISL_568057	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BC732/2020	EPI_ISL_568067	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BE387/2020	EPI_ISL_568074	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BE83D/2020	EPI_ISL_568079	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BDF66/2020	EPI_ISL_568089	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9D7643/2020	EPI_ISL_576574	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9D7661/2020	EPI_ISL_576575	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Netherlands/GE-EMC-303/2020	EPI_ISL_577830	2020-09-19	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.177	GV
hCoV-19/Wales/MILK-9E102A/2020	EPI_ISL_581093	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9E1048/2020	EPI_ISL_581097	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/NOTT-1149A3/2020	EPI_ISL_584758	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-115201/2020	EPI_ISL_584801	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11531D/2020	EPI_ISL_584802	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-9DEB2F/2020	EPI_ISL_584818	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-9DEB5C/2020	EPI_ISL_584819	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-9E35FC/2020	EPI_ISL_584858	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-A005DA/2020	EPI_ISL_584891	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-A00604/2020	EPI_ISL_584893	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-A00B41/2020	EPI_ISL_584899	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/ALDP-A2F04D/2020	EPI_ISL_587015	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2F1C2/2020	EPI_ISL_587018	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2FEBC/2020	EPI_ISL_587031	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2EFF6/2020	EPI_ISL_587045	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2F380/2020	EPI_ISL_587054	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2F05C/2020	EPI_ISL_587058	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2FEAD/2020	EPI_ISL_587061	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2EA6E/2020	EPI_ISL_587073	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2F2CF/2020	EPI_ISL_587080	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2F02F/2020	EPI_ISL_587100	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9FB4C7/2020	EPI_ISL_588237	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9FA5A7/2020	EPI_ISL_588238	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9FAD63/2020	EPI_ISL_588242	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F5946/2020	EPI_ISL_588355	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F5D3B/2020	EPI_ISL_588361	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F482C/2020	EPI_ISL_588370	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F64F9/2020	EPI_ISL_588389	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F47C5/2020	EPI_ISL_588415	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F465F/2020	EPI_ISL_588416	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F583A/2020	EPI_ISL_588422	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F4E84/2020	EPI_ISL_588426	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F4B6F/2020	EPI_ISL_588428	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F581C/2020	EPI_ISL_588429	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F44A0/2020	EPI_ISL_588443	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F39FD/2020	EPI_ISL_588527	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F2E2C/2020	EPI_ISL_588551	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F38D2/2020	EPI_ISL_588562	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F3474/2020	EPI_ISL_588565	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9F1E1E/2020	EPI_ISL_589662	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9F1E4B/2020	EPI_ISL_589687	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9F1E3C/2020	EPI_ISL_589696	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/MILK-9F0C06/2020	EPI_ISL_589736	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9F1F0C/2020	EPI_ISL_589738	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-9E609E/2020	EPI_ISL_589762	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9D012B/2020	EPI_ISL_589809	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9B738E/2020	EPI_ISL_590531	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-47E8C5/2020	EPI_ISL_595517	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47E8D4/2020	EPI_ISL_595518	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47E9C2/2020	EPI_ISL_595533	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47E9FF/2020	EPI_ISL_595536	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47EC7E/2020	EPI_ISL_595573	2020-10-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47ECF6/2020	EPI_ISL_595580	2020-09-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47EDA8/2020	EPI_ISL_595589	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-9F70A9/2020	EPI_ISL_595658	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-9F70B8/2020	EPI_ISL_595659	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1FDD0/2020	EPI_ISL_599002	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A1F7B4/2020	EPI_ISL_599008	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1F63F/2020	EPI_ISL_599013	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1F796/2020	EPI_ISL_599016	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1F523/2020	EPI_ISL_599017	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A1F884/2020	EPI_ISL_599020	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A1F7A5/2020	EPI_ISL_599025	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A20D18/2020	EPI_ISL_599027	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A1F6D5/2020	EPI_ISL_599032	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A20E42/2020	EPI_ISL_599033	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A1FB9A/2020	EPI_ISL_599035	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A1F66C/2020	EPI_ISL_599039	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1F73C/2020	EPI_ISL_599046	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1FAE8/2020	EPI_ISL_599048	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A226EE/2020	EPI_ISL_599052	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A1FB8B/2020	EPI_ISL_599055	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A1FECE/2020	EPI_ISL_599058	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A20950/2020	EPI_ISL_599063	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A1FA33/2020	EPI_ISL_599065	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A1F541/2020	EPI_ISL_599067	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1F7D2/2020	EPI_ISL_599071	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A1F6C6/2020	EPI_ISL_599072	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A20D36/2020	EPI_ISL_599080	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A1F80C/2020	EPI_ISL_599087	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A20404/2020	EPI_ISL_599090	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A225B4/2020	EPI_ISL_599098	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-A0C32F/2020	EPI_ISL_599203	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A0BCDA/2020	EPI_ISL_599209	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9FFE2F/2020	EPI_ISL_600481	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9FF7AC/2020	EPI_ISL_600511	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Wales/ALDP-9FDBDF/2020	EPI_ISL_600521	2020-10-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-9FDBA2/2020	EPI_ISL_600529	2020-10-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-9FDCAF/2020	EPI_ISL_600532	2020-10-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-9FC781/2020	EPI_ISL_600537	2020-10-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9FA9F6/2020	EPI_ISL_600544	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9FB236/2020	EPI_ISL_600569	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/QEUH-9FB51F/2020	EPI_ISL_600586	2020-09-28	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9FA9BA/2020	EPI_ISL_600592	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9FB5B5/2020	EPI_ISL_600595	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9FB193/2020	EPI_ISL_600597	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9FA3CB/2020	EPI_ISL_600598	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F6B4F/2020	EPI_ISL_600628	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F6A7F/2020	EPI_ISL_600642	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.60	GV
hCoV-19/Scotland/QEUH-9F6A15/2020	EPI_ISL_600648	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9F44FB/2020	EPI_ISL_600654	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9F5F53/2020	EPI_ISL_600656	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F6541/2020	EPI_ISL_600659	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9F66F3/2020	EPI_ISL_600663	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9F45F8/2020	EPI_ISL_600675	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9F4789/2020	EPI_ISL_600682	2020-09-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F6699/2020	EPI_ISL_600686	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9F4AEA/2020	EPI_ISL_600697	2020-09-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9CFF25/2020	EPI_ISL_601800	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9CFD0D/2020	EPI_ISL_601813	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9D0A7B/2020	EPI_ISL_601858	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9D0E24/2020	EPI_ISL_601859	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9CE6C7/2020	EPI_ISL_601870	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9CE68B/2020	EPI_ISL_601887	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9CF514/2020	EPI_ISL_601896	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9CEA34/2020	EPI_ISL_601898	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9CE788/2020	EPI_ISL_601906	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9CF7B4/2020	EPI_ISL_601911	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9CE6B8/2020	EPI_ISL_601955	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9CF4DB/2020	EPI_ISL_601975	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9CE348/2020	EPI_ISL_601978	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9CEF53/2020	EPI_ISL_601983	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9CE8EF/2020	EPI_ISL_601984	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9CF67B/2020	EPI_ISL_601989	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9CF541/2020	EPI_ISL_601990	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9CF64E/2020	EPI_ISL_601992	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9CEC6B/2020	EPI_ISL_601998	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9CF2D1/2020	EPI_ISL_601999	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A79E4A/2020	EPI_ISL_606610	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7A8C3/2020	EPI_ISL_606664	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A79F56/2020	EPI_ISL_606710	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A79C40/2020	EPI_ISL_606713	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A79EFF/2020	EPI_ISL_606763	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A79EC2/2020	EPI_ISL_606788	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6F9BF/2020	EPI_ISL_607905	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6E8C2/2020	EPI_ISL_607929	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-A6E473/2020	EPI_ISL_607940	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6E938/2020	EPI_ISL_607964	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6CDA7/2020	EPI_ISL_607992	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A6C105/2020	EPI_ISL_609008	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A67D06/2020	EPI_ISL_609019	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A6BE0F/2020	EPI_ISL_609030	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A92CE7/2020	EPI_ISL_611147	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A92D11/2020	EPI_ISL_611151	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A93642/2020	EPI_ISL_611163	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A926BC/2020	EPI_ISL_611164	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A94016/2020	EPI_ISL_611200	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A93F1A/2020	EPI_ISL_611208	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A94395/2020	EPI_ISL_611210	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-A9283E/2020	EPI_ISL_611214	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A935CD/2020	EPI_ISL_611219	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A9E911/2020	EPI_ISL_611322	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A9B738/2020	EPI_ISL_611327	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AA0590/2020	EPI_ISL_611344	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AA032D/2020	EPI_ISL_611357	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A1932F/2020	EPI_ISL_612503	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORT-1B6BF08/2020	EPI_ISL_612552	2020-09-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11677A/2020	EPI_ISL_612571	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11690B/2020	EPI_ISL_612572	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-116D69/2020	EPI_ISL_612574	2020-10-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-117F44/2020	EPI_ISL_612591	2020-10-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-117F80/2020	EPI_ISL_612592	2020-10-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-117F9F/2020	EPI_ISL_612593	2020-10-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11817A/2020	EPI_ISL_612596	2020-10-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-118189/2020	EPI_ISL_612597	2020-10-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-1181A7/2020	EPI_ISL_612598	2020-10-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-118444/2020	EPI_ISL_612605	2020-10-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-118471/2020	EPI_ISL_612606	2020-10-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-47F1AB/2020	EPI_ISL_612640	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47F211/2020	EPI_ISL_612646	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47F28A/2020	EPI_ISL_612653	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-7758/2020	EPI_ISL_618669	2020-10-19	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Denmark/DCGC-7759/2020	EPI_ISL_618679	2020-10-19	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Denmark/DCGC-7756/2020	EPI_ISL_618719	2020-10-19	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Denmark/DCGC-7757/2020	EPI_ISL_618731	2020-10-19	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/England/MILK-AB7350/2020	EPI_ISL_623218	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AB7402/2020	EPI_ISL_623223	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/MILK-AB7AA6/2020	EPI_ISL_623277	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AB802B/2020	EPI_ISL_623285	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AB73E7/2020	EPI_ISL_623290	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AB7A2E/2020	EPI_ISL_623297	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/CAMC-AAFEB4/2020	EPI_ISL_623312	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AB7657/2020	EPI_ISL_623314	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA3B8C/2020	EPI_ISL_624442	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA43FC/2020	EPI_ISL_624443	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA240A/2020	EPI_ISL_624454	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA1562/2020	EPI_ISL_624456	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA21C7/2020	EPI_ISL_624457	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-AA1535/2020	EPI_ISL_624466	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA20AC/2020	EPI_ISL_624469	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA4C1F/2020	EPI_ISL_624479	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA215E/2020	EPI_ISL_624486	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-AA209D/2020	EPI_ISL_624487	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA4BD6/2020	EPI_ISL_624493	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA15EA/2020	EPI_ISL_624496	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA1A18/2020	EPI_ISL_624511	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA4839/2020	EPI_ISL_624523	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA482A/2020	EPI_ISL_624528	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA3C4D/2020	EPI_ISL_624539	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA43ED/2020	EPI_ISL_624540	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA2446/2020	EPI_ISL_624545	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA4BB8/2020	EPI_ISL_624548	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A945BD/2020	EPI_ISL_624569	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A9530D/2020	EPI_ISL_624573	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A945DB/2020	EPI_ISL_624603	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A953C1/2020	EPI_ISL_624641	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A953B2/2020	EPI_ISL_624651	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A95E93/2020	EPI_ISL_624656	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A94A27/2020	EPI_ISL_624662	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A9477B/2020	EPI_ISL_624675	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Denmark/DCGC-8557/2020	EPI_ISL_625930	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Wales/PHWC-48448C/2020	EPI_ISL_628007	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-484C2A/2020	EPI_ISL_628089	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-484E06/2020	EPI_ISL_628115	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48500F/2020	EPI_ISL_628136	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-485166/2020	EPI_ISL_628152	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-485175/2020	EPI_ISL_628153	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4851FD/2020	EPI_ISL_628157	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-ACC631/2020	EPI_ISL_629301	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ACBD97/2020	EPI_ISL_629355	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ACE21D/2020	EPI_ISL_629369	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AC9643/2020	EPI_ISL_629373	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AC929A/2020	EPI_ISL_629416	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ACE2A4/2020	EPI_ISL_629443	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ACF2A3/2020	EPI_ISL_629449	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ACE7E1/2020	EPI_ISL_629452	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ACE7C3/2020	EPI_ISL_629470	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ACDD77/2020	EPI_ISL_630315	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ACD07E/2020	EPI_ISL_630336	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-A677EA/2020	EPI_ISL_630355	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A66E04/2020	EPI_ISL_630363	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A686FB/2020	EPI_ISL_630372	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A685FE/2020	EPI_ISL_630380	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A66B85/2020	EPI_ISL_630386	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A67146/2020	EPI_ISL_630393	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A671CE/2020	EPI_ISL_630394	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A66D43/2020	EPI_ISL_630412	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A66D16/2020	EPI_ISL_630422	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A66930/2020	EPI_ISL_630433	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A66B0D/2020	EPI_ISL_630448	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A67401/2020	EPI_ISL_630451	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A66A4C/2020	EPI_ISL_630454	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6695E/2020	EPI_ISL_630463	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-A67489/2020	EPI_ISL_630465	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A66DAD/2020	EPI_ISL_630467	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B1199D/2020	EPI_ISL_642307	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B127B0/2020	EPI_ISL_642334	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B12853/2020	EPI_ISL_642341	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B12149/2020	EPI_ISL_642353	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B128BD/2020	EPI_ISL_642390	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B130C3/2020	EPI_ISL_642401	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B114BA/2020	EPI_ISL_642427	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B126D1/2020	EPI_ISL_642430	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B1157B/2020	EPI_ISL_642445	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B1147E/2020	EPI_ISL_642452	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B11863/2020	EPI_ISL_642454	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/CAMC-B0C643/2020	EPI_ISL_643622	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B0AA94/2020	EPI_ISL_643630	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B08146/2020	EPI_ISL_643651	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B071ED/2020	EPI_ISL_643707	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B07420/2020	EPI_ISL_643716	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B07323/2020	EPI_ISL_643719	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B075A5/2020	EPI_ISL_643736	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B082F8/2020	EPI_ISL_643740	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B0928E/2020	EPI_ISL_643748	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B08AF0/2020	EPI_ISL_643751	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B08823/2020	EPI_ISL_643770	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B245EE/2020	EPI_ISL_647104	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24CAD/2020	EPI_ISL_647107	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24AD0/2020	EPI_ISL_647112	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2D794/2020	EPI_ISL_647114	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2D749/2020	EPI_ISL_647115	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B239B6/2020	EPI_ISL_647122	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B214E4/2020	EPI_ISL_647127	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B22CFA/2020	EPI_ISL_647129	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B22559/2020	EPI_ISL_647131	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B218D9/2020	EPI_ISL_647134	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GH
hCoV-19/England/CAMC-B22C27/2020	EPI_ISL_647136	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B21EB9/2020	EPI_ISL_647149	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B216EE/2020	EPI_ISL_647201	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B21B1C/2020	EPI_ISL_647240	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B227BD/2020	EPI_ISL_647244	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B221A0/2020	EPI_ISL_647287	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B21350/2020	EPI_ISL_647305	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD0500/2020	EPI_ISL_649728	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AD668F/2020	EPI_ISL_649729	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AD4144/2020	EPI_ISL_649730	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AD2119/2020	EPI_ISL_649736	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD2173/2020	EPI_ISL_649738	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AD2128/2020	EPI_ISL_649745	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD0C29/2020	EPI_ISL_649747	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AD20FE/2020	EPI_ISL_649748	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AD2137/2020	EPI_ISL_649752	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AD492E/2020	EPI_ISL_649753	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AD052E/2020	EPI_ISL_649762	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AD21BF/2020	EPI_ISL_649767	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD6740/2020	EPI_ISL_649771	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD2155/2020	EPI_ISL_649772	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AD2094/2020	EPI_ISL_649773	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AD04F4/2020	EPI_ISL_649774	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AD07FB/2020	EPI_ISL_649779	2020-10-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AD055B/2020	EPI_ISL_649783	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-AAEDE5/2020	EPI_ISL_653008	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-AAF133/2020	EPI_ISL_653014	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-AAF142/2020	EPI_ISL_653015	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AAF3B5/2020	EPI_ISL_653019	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-AAF4B2/2020	EPI_ISL_653026	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-AF5F61/2020	EPI_ISL_653036	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.58	GV
hCoV-19/England/QEUH-AF5F8F/2020	EPI_ISL_653037	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.58	GV
hCoV-19/England/SHEF-D31F4/2020	EPI_ISL_653096	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/ALDP-B5E69D/2020	EPI_ISL_655605	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62C94/2020	EPI_ISL_655615	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B997/2020	EPI_ISL_655633	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B1DB/2020	EPI_ISL_655636	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5C705/2020	EPI_ISL_655640	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6C711/2020	EPI_ISL_655677	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5CDB8/2020	EPI_ISL_655685	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5C468/2020	EPI_ISL_655689	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5BE01/2020	EPI_ISL_655692	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5CCCA/2020	EPI_ISL_655742	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5C1E9/2020	EPI_ISL_655763	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B56B69/2020	EPI_ISL_656910	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B54318/2020	EPI_ISL_656928	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B56941/2020	EPI_ISL_656947	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B53777/2020	EPI_ISL_656959	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B56A6C/2020	EPI_ISL_656966	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B537FF/2020	EPI_ISL_656981	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B522FF/2020	EPI_ISL_656986	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B56AE4/2020	EPI_ISL_656987	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B337E6/2020	EPI_ISL_659117	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/CAMC-B33995/2020	EPI_ISL_659121	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B323D4/2020	EPI_ISL_659122	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B337B9/2020	EPI_ISL_659126	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B33731/2020	EPI_ISL_659137	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B33D5D/2020	EPI_ISL_659166	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/CAMC-B33B44/2020	EPI_ISL_659189	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B339E0/2020	EPI_ISL_659204	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B33D3F/2020	EPI_ISL_659245	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B33EB4/2020	EPI_ISL_659246	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/CAMC-B3243B/2020	EPI_ISL_659266	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/CAMC-B33D7B/2020	EPI_ISL_659269	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B33133/2020	EPI_ISL_659275	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B69996/2020	EPI_ISL_661406	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B679E3/2020	EPI_ISL_661409	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B697C9/2020	EPI_ISL_661423	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6978D/2020	EPI_ISL_661435	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B693E3/2020	EPI_ISL_661456	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B67AFF/2020	EPI_ISL_661487	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B67B74/2020	EPI_ISL_661556	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6936B/2020	EPI_ISL_661568	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B68487/2020	EPI_ISL_661569	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B663B9/2020	EPI_ISL_661575	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B68F1D/2020	EPI_ISL_661586	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF1017/2020	EPI_ISL_662713	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF27D5/2020	EPI_ISL_662739	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-AF0FDF/2020	EPI_ISL_662757	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AEFCCD/2020	EPI_ISL_662758	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AEFDF7/2020	EPI_ISL_662768	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF0BDB/2020	EPI_ISL_662789	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF0670/2020	EPI_ISL_662829	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF2896/2020	EPI_ISL_662843	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF00AF/2020	EPI_ISL_662846	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF27A8/2020	EPI_ISL_662850	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-AF0C50/2020	EPI_ISL_662860	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-AEF9E4/2020	EPI_ISL_662880	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AEFE21/2020	EPI_ISL_662887	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF4A25/2020	EPI_ISL_662891	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF559C/2020	EPI_ISL_662900	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF68ED/2020	EPI_ISL_662903	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF4C4D/2020	EPI_ISL_662906	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/CAMB-1BB2EF/2020	EPI_ISL_665005	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1BB416/2020	EPI_ISL_665007	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/CAMB-1BB443/2020	EPI_ISL_665008	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/CAMB-1BB49E/2020	EPI_ISL_665010	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1BB7D1/2020	EPI_ISL_665021	2020-11-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/CAMC-B231EB/2020	EPI_ISL_665029	2020-11-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/EXET-13ADC9/2020	EPI_ISL_665097	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/LIVE-DBE8FD/2020	EPI_ISL_665137	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/LIVE-DC12EA/2020	EPI_ISL_665142	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-48B93B/2020	EPI_ISL_666302	2020-11-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48B968/2020	EPI_ISL_666304	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48B9C2/2020	EPI_ISL_666308	2020-11-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48BA56/2020	EPI_ISL_666316	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48BB17/2020	EPI_ISL_666325	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48BC41/2020	EPI_ISL_666338	2020-10-31	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48BCAB/2020	EPI_ISL_666343	2020-10-31	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	G
hCoV-19/Wales/PHWC-48BD4E/2020	EPI_ISL_666351	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48BF0C/2020	EPI_ISL_666369	2020-11-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48C044/2020	EPI_ISL_666383	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48C141/2020	EPI_ISL_666398	2020-11-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48C25D/2020	EPI_ISL_666410	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48C2B7/2020	EPI_ISL_666413	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48C34B/2020	EPI_ISL_666420	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48C703/2020	EPI_ISL_666460	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48C78B/2020	EPI_ISL_666465	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48C7A9/2020	EPI_ISL_666466	2020-11-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48C82E/2020	EPI_ISL_666474	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48CA64/2020	EPI_ISL_666499	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-B9907A/2020	EPI_ISL_673439	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B9A04C/2020	EPI_ISL_673449	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B99C49/2020	EPI_ISL_673457	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B9A167/2020	EPI_ISL_673529	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/CAMC-B99B2E/2020	EPI_ISL_673543	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B98D92/2020	EPI_ISL_673551	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B99942/2020	EPI_ISL_673574	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7F58A/2020	EPI_ISL_674723	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8F903/2020	EPI_ISL_674732	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8F833/2020	EPI_ISL_674767	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7CE55/2020	EPI_ISL_674786	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B95955/2020	EPI_ISL_674814	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B971B5/2020	EPI_ISL_674842	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B96D85/2020	EPI_ISL_674848	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B959CE/2020	EPI_ISL_674857	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B97434/2020	EPI_ISL_674884	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B39786/2020	EPI_ISL_679639	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3A961/2020	EPI_ISL_679693	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/MILK-B3B793/2020	EPI_ISL_679769	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48D25C/2020	EPI_ISL_680595	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48D27A/2020	EPI_ISL_680597	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48D571/2020	EPI_ISL_680644	2020-11-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48D720/2020	EPI_ISL_680669	2020-11-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48DEEF/2020	EPI_ISL_680775	2020-11-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-BB4FC7/2020	EPI_ISL_701682	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBB2C7/2020	EPI_ISL_701685	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBB0BE/2020	EPI_ISL_701692	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB3DEC/2020	EPI_ISL_701695	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB5421/2020	EPI_ISL_701705	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBA37A/2020	EPI_ISL_701708	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB51C0/2020	EPI_ISL_701711	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-BBB0CD/2020	EPI_ISL_701721	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBAC33/2020	EPI_ISL_701723	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB9FC2/2020	EPI_ISL_701742	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBA88A/2020	EPI_ISL_701748	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB9E3E/2020	EPI_ISL_701750	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBB1E8/2020	EPI_ISL_701756	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBAC7F/2020	EPI_ISL_701769	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB5412/2020	EPI_ISL_701770	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-BB9E5C/2020	EPI_ISL_701773	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB38AF/2020	EPI_ISL_701780	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB5254/2020	EPI_ISL_701791	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBAF67/2020	EPI_ISL_701797	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB9E89/2020	EPI_ISL_701815	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB9F0E/2020	EPI_ISL_701818	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB5245/2020	EPI_ISL_701827	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB50C3/2020	EPI_ISL_701829	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB3D73/2020	EPI_ISL_701833	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBA85D/2020	EPI_ISL_701859	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BC3AE2/2020	EPI_ISL_704013	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BC4A69/2020	EPI_ISL_704023	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BCC6D6/2020	EPI_ISL_704056	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BC4AB4/2020	EPI_ISL_704059	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-BC4A4B/2020	EPI_ISL_704066	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-490784/2020	EPI_ISL_706509	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-490793/2020	EPI_ISL_706510	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-490A30/2020	EPI_ISL_706531	2020-11-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-490B00/2020	EPI_ISL_706537	2020-11-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-490C58/2020	EPI_ISL_706553	2020-11-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-490D28/2020	EPI_ISL_706564	2020-11-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-490D64/2020	EPI_ISL_706568	2020-11-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-490E61/2020	EPI_ISL_706579	2020-11-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-490E9E/2020	EPI_ISL_706581	2020-11-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4914F5/2020	EPI_ISL_706662	2020-11-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-491826/2020	EPI_ISL_706698	2020-11-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/QEUH-B2DE26/2020	EPI_ISL_711001	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/QEUH-B2B893/2020	EPI_ISL_711004	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B246DC/2020	EPI_ISL_711016	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-B24BDD/2020	EPI_ISL_711018	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B1A83D/2020	EPI_ISL_711028	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B1A8D3/2020	EPI_ISL_711031	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B1A82E/2020	EPI_ISL_711033	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B19F2A/2020	EPI_ISL_711034	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B1A053/2020	EPI_ISL_711037	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B1A581/2020	EPI_ISL_711041	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C44B7C/2020	EPI_ISL_718527	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C4663D/2020	EPI_ISL_718543	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C45C3C/2020	EPI_ISL_718594	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C40396/2020	EPI_ISL_718595	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C44DEF/2020	EPI_ISL_718600	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C45A8D/2020	EPI_ISL_718608	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C49C65/2020	EPI_ISL_718650	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-C48158/2020	EPI_ISL_718657	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C4755D/2020	EPI_ISL_718683	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/CAMC-C472A1/2020	EPI_ISL_718684	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq			info	B.1.177	GV
hCoV-19/England/CAMC-C473EA/2020	EPI_ISL_718685	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C4805B/2020	EPI_ISL_718687	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BA1FBE/2020	EPI_ISL_719839	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B9ED6F/2020	EPI_ISL_719841	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B9E673/2020	EPI_ISL_719921	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BA2199/2020	EPI_ISL_719963	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BA23A2/2020	EPI_ISL_719975	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB1267/2020	EPI_ISL_719997	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C01364/2020	EPI_ISL_720805	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C04BA5/2020	EPI_ISL_720842	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C04BE1/2020	EPI_ISL_720846	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BFCF5A/2020	EPI_ISL_720862	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C04A5D/2020	EPI_ISL_720885	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C04B4B/2020	EPI_ISL_720886	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C04A11/2020	EPI_ISL_720894	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C01443/2020	EPI_ISL_720904	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BA2D4A/2020	EPI_ISL_720921	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-BA2DD1/2020	EPI_ISL_720932	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-B9FDC8/2020	EPI_ISL_720933	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B9FB82/2020	EPI_ISL_720939	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B9E206/2020	EPI_ISL_720952	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BA2CF2/2020	EPI_ISL_720957	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-BA3480/2020	EPI_ISL_720963	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B9E136/2020	EPI_ISL_720983	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-BA39AF/2020	EPI_ISL_720988	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/EXET-13E660/2020	EPI_ISL_724340	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/LIVE-DCA788/2020	EPI_ISL_724384	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DCBE37/2020	EPI_ISL_724468	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DCC04F/2020	EPI_ISL_724483	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DCC12E/2020	EPI_ISL_724490	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DCC258/2020	EPI_ISL_724496	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49289E/2020	EPI_ISL_725713	2020-11-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-492913/2020	EPI_ISL_725720	2020-11-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-492AE3/2020	EPI_ISL_725747	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-492C56/2020	EPI_ISL_725768	2020-11-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-492C65/2020	EPI_ISL_725769	2020-11-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-492C74/2020	EPI_ISL_725770	2020-11-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-492C92/2020	EPI_ISL_725772	2020-11-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-492CA1/2020	EPI_ISL_725773	2020-11-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-492CED/2020	EPI_ISL_725777	2020-11-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-492CFC/2020	EPI_ISL_725778	2020-11-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-492D53/2020	EPI_ISL_725782	2020-11-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-492E41/2020	EPI_ISL_725796	2020-11-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-492FC6/2020	EPI_ISL_725819	2020-11-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-C394CA/2020	EPI_ISL_731500	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C394E8/2020	EPI_ISL_731520	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3D6DF/2020	EPI_ISL_731562	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3B273/2020	EPI_ISL_731592	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	GV
hCoV-19/England/ALDP-C3D350/2020	EPI_ISL_731610	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3DE13/2020	EPI_ISL_731614	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3C728/2020	EPI_ISL_731636	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3CB68/2020	EPI_ISL_731645	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3AFD7/2020	EPI_ISL_731649	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3D709/2020	EPI_ISL_731661	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3BC2A/2020	EPI_ISL_731683	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3B8BD/2020	EPI_ISL_731687	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C57A3D/2020	EPI_ISL_736316	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C52C78/2020	EPI_ISL_736329	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C579E5/2020	EPI_ISL_736394	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/MILK-C52391/2020	EPI_ISL_736449	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-C52CC3/2020	EPI_ISL_736463	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C53E53/2020	EPI_ISL_736464	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C541A4/2020	EPI_ISL_736471	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/CAMC-B7A051/2020	EPI_ISL_741079	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-B7CDB2/2020	EPI_ISL_742248	2020-11-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B7D7A4/2020	EPI_ISL_742249	2020-11-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-B7D80B/2020	EPI_ISL_742250	2020-11-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B7DDC0/2020	EPI_ISL_742251	2020-11-13	Europe / United Kingdom / Scotland	Human	Original			Illumina		NS8_K53stop results in 57.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/Scotland/QEUH-B7DE09/2020	EPI_ISL_742252	2020-11-13	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B7DE54/2020	EPI_ISL_742253	2020-11-12	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B7DEDC/2020	EPI_ISL_742255	2020-11-13	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B7DF51/2020	EPI_ISL_742256	2020-11-13	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B7DFAC/2020	EPI_ISL_742257	2020-11-12	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Wales/PHWC-49AE67/2020	EPI_ISL_742262	2020-12-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49B130/2020	EPI_ISL_742300	2020-10-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49B1C7/2020	EPI_ISL_742307	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49B3B2/2020	EPI_ISL_742328	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49B446/2020	EPI_ISL_742337	2020-11-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49B482/2020	EPI_ISL_742341	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49B507/2020	EPI_ISL_742348	2020-11-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49B5E9/2020	EPI_ISL_742359	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49B5F8/2020	EPI_ISL_742360	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49B622/2020	EPI_ISL_742361	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49B798/2020	EPI_ISL_742383	2020-12-04	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/Wales/PHWC-49B8B3/2020	EPI_ISL_742399	2020-12-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A09F4/2020	EPI_ISL_743527	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A0A88/2020	EPI_ISL_743536	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A0C73/2020	EPI_ISL_743565	2020-12-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A1243/2020	EPI_ISL_743642	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A1270/2020	EPI_ISL_743645	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A13C8/2020	EPI_ISL_743665	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A151D/2020	EPI_ISL_743685	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-19255/2020	EPI_ISL_748300	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19287/2020	EPI_ISL_748301	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19297/2020	EPI_ISL_748302	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19369/2020	EPI_ISL_748303	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19378/2020	EPI_ISL_748304	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19397/2020	EPI_ISL_748305	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19405/2020	EPI_ISL_748306	2020-12-07	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19409/2020	EPI_ISL_748307	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19415/2020	EPI_ISL_748308	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19421/2020	EPI_ISL_748309	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19428/2020	EPI_ISL_748310	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19436/2020	EPI_ISL_748311	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19481/2020	EPI_ISL_748312	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19494/2020	EPI_ISL_748313	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19552/2020	EPI_ISL_748314	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19560/2020	EPI_ISL_748315	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19617/2020	EPI_ISL_748317	2020-12-07	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19623/2020	EPI_ISL_748318	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19732/2020	EPI_ISL_748320	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17148/2020	EPI_ISL_750787	2020-12-14	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177	GV
hCoV-19/England/204881368/2020	EPI_ISL_754295	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/204941388/2020	EPI_ISL_754299	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/204980829/2020	EPI_ISL_754306	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205260445/2020	EPI_ISL_754313	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205260446/2020	EPI_ISL_754314	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205260447/2020	EPI_ISL_754315	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205260458/2020	EPI_ISL_754316	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205260460/2020	EPI_ISL_754317	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205260466/2020	EPI_ISL_754321	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205260454/2020	EPI_ISL_754365	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205260456/2020	EPI_ISL_754366	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205260461/2020	EPI_ISL_754367	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205260448/2020	EPI_ISL_754378	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205260450/2020	EPI_ISL_754379	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205260457/2020	EPI_ISL_754381	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205260459/2020	EPI_ISL_754382	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/MILK-C78A36/2020	EPI_ISL_756841	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C7D7B2/2020	EPI_ISL_756889	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-C7C22B/2020	EPI_ISL_756940	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 1 nucleotide(s) found at refpos 28254 (FRAMESHIFT not confirmed by the submitter). NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 20 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177	GV
hCoV-19/England/MILK-C78483/2020	EPI_ISL_756985	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB44B8/2020	EPI_ISL_761321	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.177	GV
hCoV-19/England/ALDP-CB3DFA/2020	EPI_ISL_761345	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB51ED/2020	EPI_ISL_761347	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB402D/2020	EPI_ISL_761352	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-CB410C/2020	EPI_ISL_761356	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-C8A266/2020	EPI_ISL_762606	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C7CB20/2020	EPI_ISL_762614	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C82046/2020	EPI_ISL_762619	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C7C689/2020	EPI_ISL_762652	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C80A3B/2020	EPI_ISL_762677	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C7CA8D/2020	EPI_ISL_762739	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-4A617E/2020	EPI_ISL_765007	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A62F3/2020	EPI_ISL_765024	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A6448/2020	EPI_ISL_765038	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A6466/2020	EPI_ISL_765039	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/205081475/2020	EPI_ISL_766293	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205091160/2020	EPI_ISL_766300	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205100232/2020	EPI_ISL_766301	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205120383/2020	EPI_ISL_766303	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.8	GV
hCoV-19/England/205120833/2020	EPI_ISL_766313	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.5	GV
hCoV-19/England/MILK-CAA109/2020	EPI_ISL_768883	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C73716/2020	EPI_ISL_768929	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC28AC/2020	EPI_ISL_778111	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC3067/2020	EPI_ISL_778133	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CBF480/2020	EPI_ISL_778190	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC3058/2020	EPI_ISL_778192	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-CC0783/2020	EPI_ISL_778212	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CC09AB/2020	EPI_ISL_778234	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-CC2815/2020	EPI_ISL_778236	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CC0219/2020	EPI_ISL_778239	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC2E6E/2020	EPI_ISL_778248	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-CC2763/2020	EPI_ISL_778263	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC2824/2020	EPI_ISL_778279	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC25B4/2020	EPI_ISL_778281	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CBF4BD/2020	EPI_ISL_778287	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-C6BEEF/2020	EPI_ISL_778333	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC96D8/2020	EPI_ISL_781882	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CF133A/2020	EPI_ISL_781883	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CEFC16/2020	EPI_ISL_781893	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-CF158F/2020	EPI_ISL_781927	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CED146/2020	EPI_ISL_781929	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CF1482/2020	EPI_ISL_781957	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC969C/2020	EPI_ISL_781960	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-CED164/2020	EPI_ISL_781975	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/205180668/2020	EPI_ISL_791212	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.5	GV
hCoV-19/England/205201047/2020	EPI_ISL_791220	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/CAMC-DED330/2020	EPI_ISL_797460	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-DB61BE/2021	EPI_ISL_797484	2021-01-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D6B9B0/2020	EPI_ISL_798627	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D41376/2020	EPI_ISL_798641	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D3EAB3/2020	EPI_ISL_798661	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D40896/2020	EPI_ISL_798667	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D402D4/2020	EPI_ISL_798669	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D40438/2020	EPI_ISL_798671	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D40447/2020	EPI_ISL_798695	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D40887/2020	EPI_ISL_798744	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D40465/2020	EPI_ISL_798784	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D40869/2020	EPI_ISL_798791	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D4073F/2020	EPI_ISL_798798	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D1A08E/2020	EPI_ISL_799923	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CE16CB/2020	EPI_ISL_799964	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-CE12E5/2020	EPI_ISL_799978	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CE19C2/2020	EPI_ISL_799989	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC2C1A/2020	EPI_ISL_801049	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC288F/2020	EPI_ISL_801051	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC24A9/2020	EPI_ISL_801099	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC2861/2020	EPI_ISL_801100	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC2B68/2020	EPI_ISL_801121	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC2816/2020	EPI_ISL_801134	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAFF56/2020	EPI_ISL_801182	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAFD98/2020	EPI_ISL_801196	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/BIRM-6830D/2020	EPI_ISL_813016	2020-11-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6C58B/2020	EPI_ISL_813065	2020-12-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6C5B8/2020	EPI_ISL_813067	2020-12-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6C5C7/2020	EPI_ISL_813068	2020-12-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6C66A/2020	EPI_ISL_813074	2020-12-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6C6A6/2020	EPI_ISL_813078	2020-12-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6C70D/2020	EPI_ISL_813080	2020-12-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6C767/2020	EPI_ISL_813083	2020-12-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6C7FE/2020	EPI_ISL_813087	2020-12-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6DD28/2020	EPI_ISL_813094	2020-12-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/BIRM-6DD91/2020	EPI_ISL_813099	2020-12-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6DF04/2020	EPI_ISL_813108	2020-12-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6DF40/2020	EPI_ISL_813111	2020-12-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A99099/2020	EPI_ISL_813215	2020-12-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A99169/2020	EPI_ISL_813220	2020-12-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORW-2240B9/2020	EPI_ISL_820244	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-C64921/2020	EPI_ISL_820295	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-E2F42F/2021	EPI_ISL_821599	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Wales/PHWC-4AF843/2020	EPI_ISL_822701	2020-12-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AF852/2020	EPI_ISL_822702	2020-12-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B0074/2020	EPI_ISL_822713	2020-12-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B00A1/2020	EPI_ISL_822715	2020-12-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AF8F8/2020	EPI_ISL_822747	2020-12-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-4AFFF3/2020	EPI_ISL_822752	2020-12-30	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/Iceland/4125/2020	EPI_ISL_827820	2020-12-27	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Belgium/ULG-11257/2021	EPI_ISL_832230	2021-01-07	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.177.62	GV
hCoV-19/USA/NY-NYCPHL-001859/2020	EPI_ISL_832260	2020-12-18	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/USA/NY-NYCPHL-001860/2020	EPI_ISL_832261	2020-12-18	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/USA/NY-NYCPHL-001861/2020	EPI_ISL_832262	2020-12-18	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-EE4AAC/2021	EPI_ISL_834830	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-EE6D65/2021	EPI_ISL_834854	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/205240068/2020	EPI_ISL_837033	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205340566/2020	EPI_ISL_837043	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177.5	GV
hCoV-19/England/205340568/2020	EPI_ISL_837044	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.5	GV
hCoV-19/England/205340571/2020	EPI_ISL_837045	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.5	GV
hCoV-19/Scotland/EDB11672/2020	EPI_ISL_838279	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		NS8_K53stop results in 57.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/NORT-1B73240/2020	EPI_ISL_839566	2020-12-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	G
hCoV-19/Wales/PHWC-4B11F8/2020	EPI_ISL_840550	2020-12-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B18E4/2020	EPI_ISL_840646	2020-12-31	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B194B/2020	EPI_ISL_840651	2020-12-30	Europe / United Kingdom / Wales	Human	Original			Illumina		Insertion of 9 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/LOND-12884C3/2020	EPI_ISL_843091	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-30352/2020	EPI_ISL_844240	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30155/2020	EPI_ISL_844241	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30173/2020	EPI_ISL_844242	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30198/2020	EPI_ISL_844243	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30215/2020	EPI_ISL_844244	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30216/2020	EPI_ISL_844245	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30245/2020	EPI_ISL_844246	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30256/2020	EPI_ISL_844247	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30271/2020	EPI_ISL_844248	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30290/2020	EPI_ISL_844249	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30354/2020	EPI_ISL_844250	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30421/2020	EPI_ISL_844251	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30466/2020	EPI_ISL_844252	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31797/2021	EPI_ISL_856213	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31814/2021	EPI_ISL_856230	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31827/2021	EPI_ISL_856243	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31842/2021	EPI_ISL_856258	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31855/2021	EPI_ISL_856271	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31860/2021	EPI_ISL_856276	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31878/2021	EPI_ISL_856294	2021-01-04	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31928/2021	EPI_ISL_856344	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31947/2021	EPI_ISL_856363	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Switzerland/BE-SNRCI-8076/2020	EPI_ISL_857501	2020-11-30	Europe / Switzerland / Berne	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-FB46CE/2021	EPI_ISL_857559	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/CAMC-FB3692/2021	EPI_ISL_857597	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-D12A97/2020	EPI_ISL_858806	2020-12-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/QEUH-D12596/2020	EPI_ISL_858810	2020-12-27	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-CE1801/2020	EPI_ISL_858813	2020-12-27	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/QEUH-D125F0/2020	EPI_ISL_858815	2020-12-27	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-CE12B8/2020	EPI_ISL_858818	2020-12-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-CE184D/2020	EPI_ISL_858821	2020-12-27	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/QEUH-D124C6/2020	EPI_ISL_858830	2020-12-27	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-CE176E/2020	EPI_ISL_858856	2020-12-27	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-CE2439/2020	EPI_ISL_858880	2020-12-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-CC98F0/2020	EPI_ISL_858943	2020-12-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 12 nucleotides when compared to the reference sequence.	info	B.1.177.5	GV
hCoV-19/Scotland/QEUH-CC9359/2020	EPI_ISL_858945	2020-12-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-CED498/2020	EPI_ISL_858950	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-CED401/2020	EPI_ISL_858977	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-CEC323/2020	EPI_ISL_858979	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FB6152/2021	EPI_ISL_863213	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FBC0AA/2021	EPI_ISL_863241	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-1002F77/2021	EPI_ISL_863273	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-FAA24F/2021	EPI_ISL_864511	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Germany/NW-IMB14646/2020	EPI_ISL_864547	2020-12-16	Europe / Germany / North Rhine-Westphalia	Human	Vero	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1			B.1.177.62	GV
hCoV-19/Germany/NW-IMB14660/2020	EPI_ISL_864548	2020-12-17	Europe / Germany / North Rhine-Westphalia	Human	Vero	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1			B.1.177.62	GV
hCoV-19/Germany/NW-IMB14747/2020	EPI_ISL_864549	2020-12-21	Europe / Germany / North Rhine-Westphalia	Human	Vero	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1			B.1.177.62	GV
hCoV-19/Germany/NW-IMB14752/2020	EPI_ISL_864551	2020-12-21	Europe / Germany / North Rhine-Westphalia	Human	Vero	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1			B.1.177.62	GV
hCoV-19/Germany/NW-IMB14742/2020	EPI_ISL_864552	2020-12-21	Europe / Germany / North Rhine-Westphalia	Human	Vero	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1			B.1.177.62	GV
hCoV-19/Germany/NW-IMB14753/2020	EPI_ISL_864553	2020-12-21	Europe / Germany / North Rhine-Westphalia	Human	Vero	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1			B.1.177.62	GV
hCoV-19/Germany/NW-IMB14682/2020	EPI_ISL_864555	2020-12-17	Europe / Germany / North Rhine-Westphalia	Human	Vero	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1			B.1.177.62	GV
hCoV-19/Germany/NW-IMB14676/2020	EPI_ISL_864556	2020-12-18	Europe / Germany / North Rhine-Westphalia	Human	Vero	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1			B.1.177.62	GV
hCoV-19/Germany/NW-IMB14770/2020	EPI_ISL_864558	2020-12-16	Europe / Germany / North Rhine-Westphalia	Human	Vero	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1			B.1.177.62	GV
hCoV-19/Germany/NW-IMB14657/2020	EPI_ISL_864560	2020-12-17	Europe / Germany / North Rhine-Westphalia	Human	Vero	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1			B.1.177.62	GV
hCoV-19/Germany/NW-IMB14658/2020	EPI_ISL_864561	2020-12-18	Europe / Germany / North Rhine-Westphalia	Human	Vero	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1			B.1.177.62	GV
hCoV-19/Germany/NW-IMB14662/2020	EPI_ISL_864562	2020-12-18	Europe / Germany / North Rhine-Westphalia	Human	Vero	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1			B.1.177.62	GV
hCoV-19/England/PORT-2EEBF6/2021	EPI_ISL_868326	2021-01-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2EEC4E/2021	EPI_ISL_868330	2021-01-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2EEC6C/2021	EPI_ISL_868332	2021-01-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Denmark/DCGC-32507/2021	EPI_ISL_869511	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 12 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32521/2021	EPI_ISL_869525	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32591/2021	EPI_ISL_869595	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32603/2021	EPI_ISL_869607	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32657/2021	EPI_ISL_869661	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32679/2021	EPI_ISL_869683	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32685/2021	EPI_ISL_869689	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33386/2021	EPI_ISL_870396	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33501/2021	EPI_ISL_870511	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33533/2021	EPI_ISL_870543	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33544/2021	EPI_ISL_870554	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 7 nucleotide(s) found at refpos 27794 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 21 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33566/2021	EPI_ISL_870576	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 2 nucleotide(s) found at refpos 9328 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence. NSP4 without BLAST coverage.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33575/2021	EPI_ISL_870585	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 21575 (frameshift confirmed by the submitter).	info	B.1.177	GV
hCoV-19/Denmark/DCGC-33581/2021	EPI_ISL_870591	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33602/2021	EPI_ISL_870612	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33612/2021	EPI_ISL_870622	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33620/2021	EPI_ISL_870630	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33633/2021	EPI_ISL_870643	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33647/2021	EPI_ISL_870657	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33649/2021	EPI_ISL_870659	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33665/2021	EPI_ISL_870675	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-10004D4/2021	EPI_ISL_874015	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FEC84F/2021	EPI_ISL_874022	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FFFDD1/2021	EPI_ISL_874028	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FFFB9B/2021	EPI_ISL_874056	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FFFD77/2021	EPI_ISL_874062	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-F88599/2021	EPI_ISL_875264	2021-01-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1091432/2021	EPI_ISL_877802	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1091942/2021	EPI_ISL_877814	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-109205B/2021	EPI_ISL_877819	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1092817/2021	EPI_ISL_877821	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1092316/2021	EPI_ISL_877847	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1091BC4/2021	EPI_ISL_877970	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1092176/2021	EPI_ISL_877991	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10914D8/2021	EPI_ISL_877997	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-101681B/2021	EPI_ISL_881177	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1016972/2021	EPI_ISL_881186	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-101A56B/2021	EPI_ISL_881195	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-101C2BD/2021	EPI_ISL_881200	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-101A70B/2021	EPI_ISL_881206	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-101AC66/2021	EPI_ISL_881210	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-101A835/2021	EPI_ISL_881234	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-101ADCD/2021	EPI_ISL_881247	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 12 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-10173BF/2021	EPI_ISL_881253	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-F75465/2021	EPI_ISL_882366	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-F73FA2/2021	EPI_ISL_882540	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-109DFDB/2021	EPI_ISL_886071	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10B4C40/2021	EPI_ISL_886086	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-10192ED/2021	EPI_ISL_892030	2021-01-13	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq		Insertion of 9 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/Switzerland/BE-ETHZ-450454/2021	EPI_ISL_899352	2021-01-13	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Netherlands/NB-EMC-564/2020	EPI_ISL_904225	2020-12-19	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Netherlands/UT-RIVM-10128/2021	EPI_ISL_905525	2021-01-05	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/NH-RIVM-10196/2021	EPI_ISL_905628	2021-01-10	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/OV-RIVM-10236/2021	EPI_ISL_905697	2021-01-06	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Norway/0239/2021	EPI_ISL_906826	2021-01-07	Europe / Norway / Innlandet	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/England/ALDP-10B7E56/2021	EPI_ISL_909302	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1121B9B/2021	EPI_ISL_917544	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10F973F/2021	EPI_ISL_917621	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-110ACFF/2021	EPI_ISL_917670	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1121BB9/2021	EPI_ISL_917690	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-110B21A/2021	EPI_ISL_917691	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10F9A72/2021	EPI_ISL_917695	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/BIRM-6EA20/2021	EPI_ISL_918810	2021-01-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/BIRM-6EF4F/2020	EPI_ISL_918858	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6F9C8/2021	EPI_ISL_918921	2021-01-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/BIRM-70F59/2020	EPI_ISL_918942	2020-12-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-712C8/2021	EPI_ISL_918966	2021-01-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-713A7/2020	EPI_ISL_918972	2020-12-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Northern Ireland/NIRE-2366D0/2021	EPI_ISL_921012	2021-01-13	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.58	GV
hCoV-19/Northern Ireland/NIRE-245A69/2020	EPI_ISL_921031	2020-12-30	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Wales/PHWC-4BAA21/2021	EPI_ISL_922361	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BAAC7/2021	EPI_ISL_922370	2021-01-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/PORT-2E0B7C/2021	EPI_ISL_923504	2021	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Denmark/DCGC-35899/2021	EPI_ISL_927040	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	GV
hCoV-19/Denmark/DCGC-35931/2020	EPI_ISL_927072	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36040/2021	EPI_ISL_927181	2021-01-25	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36049/2021	EPI_ISL_927190	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36058/2021	EPI_ISL_927199	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37088/2020	EPI_ISL_928229	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37194/2020	EPI_ISL_928335	2020-11-23	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37209/2021	EPI_ISL_928350	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38395/2021	EPI_ISL_929536	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-38461/2021	EPI_ISL_929602	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38463/2021	EPI_ISL_929604	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38477/2021	EPI_ISL_929618	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38478/2020	EPI_ISL_929619	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38482/2021	EPI_ISL_929623	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-38484/2021	EPI_ISL_929625	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-38493/2021	EPI_ISL_929634	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38497/2020	EPI_ISL_929638	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38506/2020	EPI_ISL_929647	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38538/2021	EPI_ISL_929679	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39358/2021	EPI_ISL_930500	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39378/2021	EPI_ISL_930520	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-1185EAB/2021	EPI_ISL_931836	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1185D08/2021	EPI_ISL_931837	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-116F609/2021	EPI_ISL_931997	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Sweden/21-00150/2021	EPI_ISL_934324	2021-01-08	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions <20x coverage masked with N	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Sweden/21-50334/2021	EPI_ISL_934365	2021-01-04	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions <20x coverage masked with N	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Scotland/QEUH-118A0BF/2021	EPI_ISL_946069	2021-01-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-118A152/2021	EPI_ISL_946070	2021-01-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-1189126/2021	EPI_ISL_946129	2021-01-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-1188242/2021	EPI_ISL_946137	2021-01-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-11713FE/2021	EPI_ISL_947389	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1150638/2021	EPI_ISL_947495	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11503F5/2021	EPI_ISL_947544	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-114F0D4/2021	EPI_ISL_947626	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-114DAAB/2021	EPI_ISL_947633	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-114E8EC/2021	EPI_ISL_947635	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-114DDB1/2021	EPI_ISL_947668	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11506DE/2021	EPI_ISL_947673	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-114C444/2021	EPI_ISL_948808	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-114B06F/2021	EPI_ISL_948833	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-114B0D8/2021	EPI_ISL_948841	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-114B07E/2021	EPI_ISL_948849	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-114B481/2021	EPI_ISL_948882	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-114B788/2021	EPI_ISL_948884	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-114B58E/2021	EPI_ISL_948887	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-114B111/2021	EPI_ISL_948909	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-114B17B/2021	EPI_ISL_948923	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-114B524/2021	EPI_ISL_948926	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-114B964/2021	EPI_ISL_948927	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-114AC11/2021	EPI_ISL_948931	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-1129F4C/2021	EPI_ISL_948945	2021-01-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-1129182/2021	EPI_ISL_948947	2021-01-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-112A1AF/2021	EPI_ISL_948953	2021-01-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-1129173/2021	EPI_ISL_948956	2021-01-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-101576A/2021	EPI_ISL_948996	2021-01-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Wales/PHWC-4C2051/2021	EPI_ISL_952176	2021-01-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C207F/2021	EPI_ISL_952178	2021-01-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-11C5917/2021	EPI_ISL_958047	2021-01-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/Spain/IB-IBV-99016844/2021	EPI_ISL_959442	2021-01-28	Europe / Spain / Balear Islands / Palma de Mallorca	Human	Original			Illumina MiSeq	BWA/IVAR	NS7a_E95stop results in 22.3% truncation of the protein sequence.	info	B.1.177.61	GV
hCoV-19/England/ALDP-11B9CC2/2021	EPI_ISL_964184	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Belgium/ULG-11724/2021	EPI_ISL_965481	2021-01-21	Europe / Belgium / Hainaut	Human	Original			Nanopore MinION	Artic network			B.1.177	GV
hCoV-19/England/MILK-11C14A1/2021	EPI_ISL_971113	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Denmark/DCGC-39698/2021	EPI_ISL_971244	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39712/2021	EPI_ISL_971287	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-40742/2021	EPI_ISL_972419	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.80	GV
hCoV-19/Denmark/DCGC-40793/2021	EPI_ISL_972470	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40801/2021	EPI_ISL_972478	2021-02-01	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-40808/2021	EPI_ISL_972485	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-40819/2021	EPI_ISL_972496	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40827/2021	EPI_ISL_972504	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-40829/2021	EPI_ISL_972506	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40839/2021	EPI_ISL_972516	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40880/2021	EPI_ISL_972557	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40936/2021	EPI_ISL_972613	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41957/2021	EPI_ISL_973784	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/MILK-11EF48F/2021	EPI_ISL_980716	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-121DF0E/2021	EPI_ISL_985825	2021-02-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-121ED03/2021	EPI_ISL_985852	2021-02-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-11CE802/2021	EPI_ISL_989160	2021-01-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11CEDD6/2021	EPI_ISL_989164	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-119AB42/2021	EPI_ISL_989457	2021-01-29	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-1170F46/2021	EPI_ISL_990138	2021-01-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-1197644/2021	EPI_ISL_990408	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1198027/2021	EPI_ISL_990452	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-114D5C8/2021	EPI_ISL_991454	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-115BEAE/2021	EPI_ISL_991776	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10E97E7/2021	EPI_ISL_992752	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Germany/BE-IMB15558/2021	EPI_ISL_996415	2021-02-04	Europe / Germany / Berlin	Human	Original	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/BRIS-25E845/2021	EPI_ISL_996504	2021-01-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-4C5E09/2021	EPI_ISL_1000066	2021-02-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Switzerland/SO-ETHZ-480378/2021	EPI_ISL_1003985	2021-02-01	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Scotland/QEUH-1236E99/2021	EPI_ISL_1019511	2021-02-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-1236F2D/2021	EPI_ISL_1019545	2021-02-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-114CEFB/2021	EPI_ISL_1019604	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 32 nucleotide(s) found at refpos 27535 (frameshift confirmed by the submitter). NS7a without BLAST coverage.	info	B.1.177.5	GV
hCoV-19/Scotland/QEUH-114BEDE/2021	EPI_ISL_1019621	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-114C58D/2021	EPI_ISL_1019626	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-114D05E/2021	EPI_ISL_1019652	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Denmark/DCGC-42750/2021	EPI_ISL_1023028	2021-02-08	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-43643/2021	EPI_ISL_1024021	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-43685/2021	EPI_ISL_1024063	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-43710/2021	EPI_ISL_1024088	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-43715/2021	EPI_ISL_1024093	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.62	GV
hCoV-19/Denmark/DCGC-43928/2021	EPI_ISL_1024306	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-43957/2021	EPI_ISL_1024335	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44952/2021	EPI_ISL_1025330	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44979/2021	EPI_ISL_1025357	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-45276/2020	EPI_ISL_1025654	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-45281/2020	EPI_ISL_1025659	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-UK-Hal-4/2021	EPI_ISL_1039927	2021-02	Europe / Germany / Saxony-Anhalt	Human	Original			Illumina MiniSeq	BWA 0.7.17, bcftools 1.10.2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-UK-Hal-13/2021	EPI_ISL_1039936	2021-02	Europe / Germany / Saxony-Anhalt	Human	Original			Illumina MiniSeq	BWA 0.7.17, bcftools 1.10.2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-UK-Hal-14/2021	EPI_ISL_1039937	2021-02	Europe / Germany / Saxony-Anhalt	Human	Original			Illumina MiniSeq	BWA 0.7.17, bcftools 1.10.2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-UK-Hal-15/2021	EPI_ISL_1039938	2021-02	Europe / Germany / Saxony-Anhalt	Human	Original			Illumina MiniSeq	BWA 0.7.17, bcftools 1.10.2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-UK-Hal-16/2021	EPI_ISL_1039939	2021-02	Europe / Germany / Saxony-Anhalt	Human	Original			Illumina MiniSeq	BWA 0.7.17, bcftools 1.10.2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-UK-Hal-19/2021	EPI_ISL_1039942	2021-02	Europe / Germany / Saxony-Anhalt	Human	Original			Illumina MiniSeq	BWA 0.7.17, bcftools 1.10.2			B.1.177	GV
hCoV-19/Poland/Pomorskie_MWB_121/2021	EPI_ISL_1040947	2021-01-16	Europe / Poland / Pomorskie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime	NS7b_E39stop results in 11.6% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Poland/Pomorskie_MWB_132/2021	EPI_ISL_1040956	2021-01-16	Europe / Poland / Pomorskie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Poland/Pomorskie_MWB_158/2021	EPI_ISL_1040982	2021-01-15	Europe / Poland / Pomorskie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Poland/Pomorskie_MWB_173/2021	EPI_ISL_1040995	2021-01-16	Europe / Poland / Pomorskie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-129A121/2021	EPI_ISL_1043150	2021-02-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-129A72F/2021	EPI_ISL_1043154	2021-02-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-12833F8/2021	EPI_ISL_1044473	2021-02-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1283747/2021	EPI_ISL_1044475	2021-02-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-128346E/2021	EPI_ISL_1044526	2021-02-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-126FBFA/2021	EPI_ISL_1045859	2021-02-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/LOND-1289EB5/2021	EPI_ISL_1048056	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Germany/MV-RKI-I-0719/2021	EPI_ISL_1048306	2021-01-29	Europe / Germany / Mecklenburg-Western Pomerania	Human	Original			Illumina iSeq	Covpipe	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-RKI-N-0163/2020	EPI_ISL_1048307	2020-10-26	Europe / Germany / Berlin	Human	Original			Illumina iSeq	Covpipe	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-RKI-N-0171/2020	EPI_ISL_1048308	2020-11-09	Europe / Germany / Berlin	Human	Original			Illumina iSeq	Covpipe	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BW-RKI-N-0237/2021	EPI_ISL_1048309	2021-01-15	Europe / Germany / Baden-Wurttemberg	Human	Original			Illumina iSeq	Covpipe	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/MV-RKI-I-0717/2021	EPI_ISL_1048310	2021-01-29	Europe / Germany / Mecklenburg-Western Pomerania	Human	Original			Illumina iSeq	Covpipe	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/un-RKI-I-0471/2021	EPI_ISL_1048311	2021-01-20	Europe / Germany	Human	Original			Illumina iSeq	Covpipe	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/NI-RKI-I-0445/2021	EPI_ISL_1048321	2021-01-07	Europe / Germany / Lower Saxony	Human	Original			Illumina iSeq	Covpipe			B.1.177.62	GV
hCoV-19/Germany/NI-RKI-I-0455/2021	EPI_ISL_1048323	2021-01-08	Europe / Germany / Lower Saxony	Human	Original			Illumina iSeq	Covpipe			B.1.177.62	GV
hCoV-19/Germany/NW-RKI-I-0295/2020	EPI_ISL_1048346	2020-12-14	Europe / Germany / North Rhine-Westphalia	Human	Original			Illumina iSeq	Covpipe			B.1.177.62	GV
hCoV-19/Germany/BW-RKI-I-0672/2021	EPI_ISL_1048350	2021-02-01	Europe / Germany / Baden-Wurttemberg	Human	Original			Illumina iSeq	Covpipe			B.1.177.62	GV
hCoV-19/England/OXON-F61ED7/2021	EPI_ISL_1051639	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F61EE6/2021	EPI_ISL_1051640	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/PHWC-4C05DC/2021	EPI_ISL_1051998	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Slovenia/08-030183-MB/2021	EPI_ISL_1056551	2021-01-29	Europe / Slovenia / Pomurska	Human	Original			Illumina Miseq				B.1.177	GV
hCoV-19/Slovenia/08-030238-MB/2021	EPI_ISL_1056552	2021-01-29	Europe / Slovenia / Podravska	Human	Original			Illumina Miseq				B.1.177	GV
hCoV-19/Slovenia/08-030913-MB/2021	EPI_ISL_1056556	2021-01-30	Europe / Slovenia / Podravska	Human	Original			Illumina Miseq				B.1.177	GV
hCoV-19/Wales/ALDP-128396F/2021	EPI_ISL_1057875	2021-02-10	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-12A8C2F/2021	EPI_ISL_1062393	2021-02-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Denmark/DCGC-46613/2021	EPI_ISL_1066123	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46659/2021	EPI_ISL_1066169	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47944/2021	EPI_ISL_1067479	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Scotland/QEUH-98FAB7/2020	EPI_ISL_534447	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-98EEAD/2020	EPI_ISL_540354	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-98F404/2020	EPI_ISL_540362	2020-08-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-98F7DE/2020	EPI_ISL_540367	2020-08-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-993FA2/2020	EPI_ISL_551703	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-99479A/2020	EPI_ISL_552378	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9C447C/2020	EPI_ISL_566900	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9C8CF8/2020	EPI_ISL_567161	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9C7BFC/2020	EPI_ISL_567218	2020-09-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9C7E6C/2020	EPI_ISL_567249	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-98F7ED/2020	EPI_ISL_568456	2020-08-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CC201/2020	EPI_ISL_573092	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9CC4B0/2020	EPI_ISL_573110	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9CC5CC/2020	EPI_ISL_573116	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-9C0003/2020	EPI_ISL_573166	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-9C163D/2020	EPI_ISL_573195	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9CBDD4/2020	EPI_ISL_575709	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CBBF8/2020	EPI_ISL_575720	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CB220/2020	EPI_ISL_575726	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CB3B4/2020	EPI_ISL_575731	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CB3A5/2020	EPI_ISL_575737	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CB035/2020	EPI_ISL_575738	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CBA0A/2020	EPI_ISL_575743	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-974B58/2020	EPI_ISL_575773	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-97352E/2020	EPI_ISL_575782	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9734A9/2020	EPI_ISL_575787	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E9F70/2020	EPI_ISL_580108	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9EA67A/2020	EPI_ISL_580119	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9EA461/2020	EPI_ISL_580146	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9EA64D/2020	EPI_ISL_580147	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9EA16A/2020	EPI_ISL_580151	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9EAE72/2020	EPI_ISL_580209	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E9FE9/2020	EPI_ISL_580226	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9EA63E/2020	EPI_ISL_580235	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9EA188/2020	EPI_ISL_580236	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9EAEAF/2020	EPI_ISL_580266	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E719A/2020	EPI_ISL_580279	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E7394/2020	EPI_ISL_580293	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E70CA/2020	EPI_ISL_580296	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Spain/CB-IBV-98007068/2020	EPI_ISL_582100	2020-09-03	Europe / Spain / Cantabria / Santander	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Sweden/20-08993/2020	EPI_ISL_582775	2020-09-16	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction using torrent suite variantCaller with fill from reference and majority wins			B.1.177	GV
hCoV-19/England/NOTT-114B52/2020	EPI_ISL_584763	2020-10-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/SHEF-CDD71/2020	EPI_ISL_585063	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/ALDP-9FD50E/2020	EPI_ISL_587784	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9FDEC7/2020	EPI_ISL_587799	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F5E65/2020	EPI_ISL_588306	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F5B04/2020	EPI_ISL_588325	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9F19A4/2020	EPI_ISL_589627	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9F194A/2020	EPI_ISL_589628	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9F1C14/2020	EPI_ISL_589645	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 2 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-9B7C38/2020	EPI_ISL_590580	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/CVR4960/2020	EPI_ISL_594724	2020-10-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR4966/2020	EPI_ISL_594730	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5003/2020	EPI_ISL_594742	2020-10-10	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5006/2020	EPI_ISL_594745	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5010/2020	EPI_ISL_594749	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5023/2020	EPI_ISL_594757	2020-10-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5024/2020	EPI_ISL_594758	2020-10-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5050/2020	EPI_ISL_594784	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5062/2020	EPI_ISL_594795	2020-10-10	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5074/2020	EPI_ISL_594807	2020-10-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5081/2020	EPI_ISL_594814	2020-10-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB8224/2020	EPI_ISL_594835	2020-10-10	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8288/2020	EPI_ISL_594839	2020-10-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8293/2020	EPI_ISL_594842	2020-10-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/England/LOND-12626C9/2020	EPI_ISL_594870	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-47E160/2020	EPI_ISL_595414	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47E1D9/2020	EPI_ISL_595421	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47E34C/2020	EPI_ISL_595441	2020-09-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47E43A/2020	EPI_ISL_595455	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47E4EF/2020	EPI_ISL_595463	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47E4FE/2020	EPI_ISL_595464	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47E6CB/2020	EPI_ISL_595488	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47E722/2020	EPI_ISL_595494	2020-09-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-A57CFD/2020	EPI_ISL_597041	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A58D08/2020	EPI_ISL_597057	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A5812A/2020	EPI_ISL_597064	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A57DEB/2020	EPI_ISL_597066	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-A58218/2020	EPI_ISL_597070	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-A58DEA/2020	EPI_ISL_597077	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A57C57/2020	EPI_ISL_597083	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A592F9/2020	EPI_ISL_597093	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A59727/2020	EPI_ISL_597108	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A5810C/2020	EPI_ISL_597130	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A4711F/2020	EPI_ISL_598392	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A46D67/2020	EPI_ISL_598426	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A47F7F/2020	EPI_ISL_598429	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A47258/2020	EPI_ISL_598432	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A4765C/2020	EPI_ISL_598438	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A48169/2020	EPI_ISL_598450	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.65	GV
hCoV-19/England/QEUH-9DD0C7/2020	EPI_ISL_599716	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9DD1D3/2020	EPI_ISL_599740	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DDBF3/2020	EPI_ISL_599745	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9DCFF8/2020	EPI_ISL_599762	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9FFAEF/2020	EPI_ISL_600422	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9FF690/2020	EPI_ISL_600450	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-9D3E7C/2020	EPI_ISL_601745	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-9D4637/2020	EPI_ISL_601775	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9CE7A6/2020	EPI_ISL_602007	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9CE69A/2020	EPI_ISL_602010	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9CF82A/2020	EPI_ISL_602016	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9B75D3/2020	EPI_ISL_602104	2020-09-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9B78CB/2020	EPI_ISL_602107	2020-09-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9B7BE0/2020	EPI_ISL_602115	2020-09-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9B7CCF/2020	EPI_ISL_602124	2020-09-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9B7737/2020	EPI_ISL_602127	2020-09-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A87562/2020	EPI_ISL_605940	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A8634B/2020	EPI_ISL_605949	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A872E3/2020	EPI_ISL_605976	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A86E59/2020	EPI_ISL_605980	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A877F3/2020	EPI_ISL_605982	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A86E1D/2020	EPI_ISL_605983	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A86466/2020	EPI_ISL_605984	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A8717D/2020	EPI_ISL_605994	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7D7B4/2020	EPI_ISL_606584	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-A7A6D8/2020	EPI_ISL_606585	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7A8E1/2020	EPI_ISL_606657	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A704AB/2020	EPI_ISL_607974	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A70238/2020	EPI_ISL_607988	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-A6C6E8/2020	EPI_ISL_607989	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A70089/2020	EPI_ISL_608212	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6C730/2020	EPI_ISL_608217	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6FEFC/2020	EPI_ISL_608222	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-A6C518/2020	EPI_ISL_608236	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6D1D7/2020	EPI_ISL_608247	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6D0BC/2020	EPI_ISL_608296	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A40EC4/2020	EPI_ISL_609511	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A412C7/2020	EPI_ISL_609519	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A42008/2020	EPI_ISL_609533	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A3EE14/2020	EPI_ISL_609560	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A3F244/2020	EPI_ISL_609567	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/CAMC-A3EF99/2020	EPI_ISL_609578	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A8534C/2020	EPI_ISL_610508	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A8491E/2020	EPI_ISL_610515	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A849D2/2020	EPI_ISL_610525	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A85F75/2020	EPI_ISL_610531	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A85CD8/2020	EPI_ISL_610549	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A84BDC/2020	EPI_ISL_610562	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A927B9/2020	EPI_ISL_611115	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AB8D51/2020	EPI_ISL_623825	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AB7CBF/2020	EPI_ISL_623826	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA19C0/2020	EPI_ISL_623862	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AAEF49/2020	EPI_ISL_623865	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA3120/2020	EPI_ISL_623867	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AAEF76/2020	EPI_ISL_623868	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA2BBA/2020	EPI_ISL_623882	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AAEF0D/2020	EPI_ISL_623883	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-AAE565/2020	EPI_ISL_623884	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AADC9E/2020	EPI_ISL_623886	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AAD3A8/2020	EPI_ISL_623895	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA13B3/2020	EPI_ISL_623898	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-AA10CB/2020	EPI_ISL_624414	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA44BD/2020	EPI_ISL_624426	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-8496/2020	EPI_ISL_625737	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-8855/2020	EPI_ISL_625739	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-8970/2020	EPI_ISL_625740	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-8966/2020	EPI_ISL_625741	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Scotland/CVR5241/2020	EPI_ISL_627407	2020-10-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5250/2020	EPI_ISL_627412	2020-10-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5253/2020	EPI_ISL_627415	2020-10-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5254/2020	EPI_ISL_627416	2020-10-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5256/2020	EPI_ISL_627418	2020-10-19	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5259/2020	EPI_ISL_627419	2020-10-19	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5262/2020	EPI_ISL_627421	2020-10-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5266/2020	EPI_ISL_627423	2020-10-18	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/EXET-138D16/2020	EPI_ISL_627442	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/LIVE-1E45A8/2020	EPI_ISL_627448	2020-10-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/MILK-A19565/2020	EPI_ISL_627489	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A4D46B/2020	EPI_ISL_628600	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A4D60B/2020	EPI_ISL_628607	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A6170E/2020	EPI_ISL_628629	2020-10-13	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A6181A/2020	EPI_ISL_628634	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A61838/2020	EPI_ISL_628635	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-ACBADC/2020	EPI_ISL_629218	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AC9634/2020	EPI_ISL_629255	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ACE22C/2020	EPI_ISL_629287	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD0940/2020	EPI_ISL_629903	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD1CA0/2020	EPI_ISL_629905	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AC74E1/2020	EPI_ISL_630209	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_K53stop results in 57.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/MILK-AC9115/2020	EPI_ISL_630248	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/MILK-AC7593/2020	EPI_ISL_630288	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA4CE2/2020	EPI_ISL_630917	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA1C21/2020	EPI_ISL_630922	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-AA265F/2020	EPI_ISL_630930	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA274D/2020	EPI_ISL_630938	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE5104/2020	EPI_ISL_633169	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AEAB7A/2020	EPI_ISL_633189	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AEABA7/2020	EPI_ISL_633192	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE5377/2020	EPI_ISL_633196	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE49A3/2020	EPI_ISL_633210	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE51B9/2020	EPI_ISL_633213	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AEAB5C/2020	EPI_ISL_633224	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE50CB/2020	EPI_ISL_633285	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AEAC0E/2020	EPI_ISL_633295	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AC7E89/2020	EPI_ISL_634500	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD46FA/2020	EPI_ISL_634525	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD5B90/2020	EPI_ISL_634543	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-AD5A75/2020	EPI_ISL_634549	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD194F/2020	EPI_ISL_634553	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD5CE8/2020	EPI_ISL_634576	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD4C61/2020	EPI_ISL_634582	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD4BDD/2020	EPI_ISL_634592	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-4882BB/2020	EPI_ISL_639375	2020-10-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48844C/2020	EPI_ISL_639392	2020-10-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48845B/2020	EPI_ISL_639393	2020-10-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-488813/2020	EPI_ISL_639433	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-488910/2020	EPI_ISL_639444	2020-10-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-488A2C/2020	EPI_ISL_639454	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-488C62/2020	EPI_ISL_639486	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-488C9F/2020	EPI_ISL_639488	2020-10-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B14244/2020	EPI_ISL_641705	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B138CB/2020	EPI_ISL_641718	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B1398C/2020	EPI_ISL_641724	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B12F12/2020	EPI_ISL_641734	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B13AE3/2020	EPI_ISL_641735	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B13500/2020	EPI_ISL_641772	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B145A5/2020	EPI_ISL_641778	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B11B6A/2020	EPI_ISL_642248	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B11BF1/2020	EPI_ISL_642253	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B11D55/2020	EPI_ISL_642256	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B11A4F/2020	EPI_ISL_642263	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-B129AB/2020	EPI_ISL_642264	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B136A3/2020	EPI_ISL_642272	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B12361/2020	EPI_ISL_642288	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B119AC/2020	EPI_ISL_642295	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-B11A5E/2020	EPI_ISL_642296	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-B1271A/2020	EPI_ISL_642299	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B025B9/2020	EPI_ISL_642928	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B0CBF9/2020	EPI_ISL_643522	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B0C625/2020	EPI_ISL_643525	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B0C652/2020	EPI_ISL_643585	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B0B2E6/2020	EPI_ISL_643595	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B3D6FE/2020	EPI_ISL_645264	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B3666E/2020	EPI_ISL_645268	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B371C6/2020	EPI_ISL_645271	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B3714E/2020	EPI_ISL_645286	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B2BB12/2020	EPI_ISL_646480	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B25231/2020	EPI_ISL_646491	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2B4EA/2020	EPI_ISL_646499	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2B875/2020	EPI_ISL_646501	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B26212/2020	EPI_ISL_646502	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B25F58/2020	EPI_ISL_646505	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B25213/2020	EPI_ISL_646506	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B25F67/2020	EPI_ISL_646521	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B25116/2020	EPI_ISL_646529	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B260EB/2020	EPI_ISL_646558	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B26203/2020	EPI_ISL_646564	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B21332/2020	EPI_ISL_647163	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-B02CF0/2020	EPI_ISL_647835	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/QEUH-AE4EB3/2020	EPI_ISL_647899	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD429C/2020	EPI_ISL_649703	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD195E/2020	EPI_ISL_649708	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD1305/2020	EPI_ISL_649714	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD088F/2020	EPI_ISL_649719	2020-10-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AD1596/2020	EPI_ISL_649724	2020-10-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD6652/2020	EPI_ISL_649727	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-B055C5/2020	EPI_ISL_651096	2020-10-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Northern Ireland/NIRE-1091A9/2020	EPI_ISL_651097	2020-10-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.58	GV
hCoV-19/England/NORT-2A0FB8/2020	EPI_ISL_652345	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-2A0FF4/2020	EPI_ISL_652346	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-2A102D/2020	EPI_ISL_652347	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORW-F693F/2020	EPI_ISL_652352	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NOTT-11B441/2020	EPI_ISL_652366	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11B48D/2020	EPI_ISL_652368	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11BECB/2020	EPI_ISL_652391	2020-11-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11BEDA/2020	EPI_ISL_652392	2020-11-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11C11C/2020	EPI_ISL_652398	2020-11-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11C2FB/2020	EPI_ISL_652401	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-B6BA0A/2020	EPI_ISL_654997	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B96A/2020	EPI_ISL_655505	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5E721/2020	EPI_ISL_655507	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5BA1C/2020	EPI_ISL_655509	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B302/2020	EPI_ISL_655516	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-B5B9C4/2020	EPI_ISL_655526	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62E34/2020	EPI_ISL_655538	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B9D3/2020	EPI_ISL_655541	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5AEC6/2020	EPI_ISL_655555	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B89A/2020	EPI_ISL_655569	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B092/2020	EPI_ISL_655570	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B9E2/2020	EPI_ISL_655577	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B9B5/2020	EPI_ISL_655584	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B56835/2020	EPI_ISL_656840	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B56BB4/2020	EPI_ISL_656860	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B52699/2020	EPI_ISL_656863	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B524BD/2020	EPI_ISL_656890	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B524DB/2020	EPI_ISL_656896	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B43491/2020	EPI_ISL_657138	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B436AA/2020	EPI_ISL_657143	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B40063/2020	EPI_ISL_657144	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B3FE7C/2020	EPI_ISL_657162	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B425CC/2020	EPI_ISL_657165	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B400FA/2020	EPI_ISL_657208	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B40670/2020	EPI_ISL_657211	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B42465/2020	EPI_ISL_657230	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B435F8/2020	EPI_ISL_657239	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B43622/2020	EPI_ISL_657253	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B406E9/2020	EPI_ISL_657260	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B42641/2020	EPI_ISL_657271	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B4093B/2020	EPI_ISL_657272	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B43859/2020	EPI_ISL_657279	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B3FF88/2020	EPI_ISL_657286	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B40616/2020	EPI_ISL_657297	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B3F8D8/2020	EPI_ISL_658440	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B3F4C5/2020	EPI_ISL_658444	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B41466/2020	EPI_ISL_658463	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B40F84/2020	EPI_ISL_658468	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B3F410/2020	EPI_ISL_658469	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B40F48/2020	EPI_ISL_658485	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B3F7EA/2020	EPI_ISL_658492	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B3F5B3/2020	EPI_ISL_658517	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-B3F841/2020	EPI_ISL_658526	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B41B07/2020	EPI_ISL_658529	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B3F3E6/2020	EPI_ISL_658533	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B41730/2020	EPI_ISL_658534	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B3FD15/2020	EPI_ISL_658566	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B4141B/2020	EPI_ISL_658575	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B4109F/2020	EPI_ISL_658587	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B416BB/2020	EPI_ISL_658594	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2E8FA/2020	EPI_ISL_659774	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2DA13/2020	EPI_ISL_659822	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2D8EC/2020	EPI_ISL_659866	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2F361/2020	EPI_ISL_659876	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2EAE5/2020	EPI_ISL_659877	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B303C7/2020	EPI_ISL_659879	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B68F59/2020	EPI_ISL_661443	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B699E1/2020	EPI_ISL_661448	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF5EA0/2020	EPI_ISL_663013	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-AF4C01/2020	EPI_ISL_663031	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF69DB/2020	EPI_ISL_663033	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF54CC/2020	EPI_ISL_663035	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF4C98/2020	EPI_ISL_663042	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF407E/2020	EPI_ISL_663054	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-AF3D69/2020	EPI_ISL_663071	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF6249/2020	EPI_ISL_663072	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF55E7/2020	EPI_ISL_663081	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF54F9/2020	EPI_ISL_663089	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF4C6B/2020	EPI_ISL_663101	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/EDB9387/2020	EPI_ISL_665646	2020-11-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		NS8_K53stop results in 57.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/LOND-12513B7/2020	EPI_ISL_665648	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/MILK-A23CAF/2020	EPI_ISL_665652	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7a_E95stop results in 22.3% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/Wales/PHWC-48B1E8/2020	EPI_ISL_666206	2020-11-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48B2A9/2020	EPI_ISL_666216	2020-11-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48B2C7/2020	EPI_ISL_666218	2020-10-31	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48B4C1/2020	EPI_ISL_666243	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48B564/2020	EPI_ISL_666253	2020-10-31	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48B643/2020	EPI_ISL_666264	2020-10-31	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48B7D7/2020	EPI_ISL_666285	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48B82F/2020	EPI_ISL_666288	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48B85C/2020	EPI_ISL_666290	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48B8D4/2020	EPI_ISL_666297	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-BA11E5/2020	EPI_ISL_672758	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BA30E6/2020	EPI_ISL_672778	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BA2F62/2020	EPI_ISL_672834	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BA2EB0/2020	EPI_ISL_672848	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BA2FAE/2020	EPI_ISL_672867	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B9AE24/2020	EPI_ISL_673389	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B99520/2020	EPI_ISL_673398	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B992CF/2020	EPI_ISL_673429	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B9A923/2020	EPI_ISL_673431	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8F7EB/2020	EPI_ISL_674753	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8E4E5/2020	EPI_ISL_674774	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B95CD4/2020	EPI_ISL_675015	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B97337/2020	EPI_ISL_675025	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B96BC7/2020	EPI_ISL_675062	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B95E65/2020	EPI_ISL_675072	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-B96CB5/2020	EPI_ISL_675077	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B9708B/2020	EPI_ISL_675089	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B94710/2020	EPI_ISL_676308	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B694FF/2020	EPI_ISL_676319	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B6941D/2020	EPI_ISL_676331	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B6944A/2020	EPI_ISL_676332	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B6C580/2020	EPI_ISL_676342	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B6C5F9/2020	EPI_ISL_676343	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B66656/2020	EPI_ISL_676346	2020-11-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B67A95/2020	EPI_ISL_676348	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B81321/2020	EPI_ISL_676353	2020-11-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B687AC/2020	EPI_ISL_676359	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B68BBF/2020	EPI_ISL_676364	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B68108/2020	EPI_ISL_676368	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B68117/2020	EPI_ISL_676372	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B69662/2020	EPI_ISL_676379	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/CAMC-B524EA/2020	EPI_ISL_676383	2020-11-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B403D3/2020	EPI_ISL_676384	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B403B5/2020	EPI_ISL_676385	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B40388/2020	EPI_ISL_676386	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B4040D/2020	EPI_ISL_676387	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B403F1/2020	EPI_ISL_676388	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B4033D/2020	EPI_ISL_676389	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B403C4/2020	EPI_ISL_676391	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B4042B/2020	EPI_ISL_676392	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B4035B/2020	EPI_ISL_676393	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B402F4/2020	EPI_ISL_676394	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B2CE36/2020	EPI_ISL_676400	2020-11-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B2CD0C/2020	EPI_ISL_676403	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B2CD66/2020	EPI_ISL_676404	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B2D2FD/2020	EPI_ISL_676405	2020-11-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B31830/2020	EPI_ISL_676406	2020-11-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B31812/2020	EPI_ISL_676409	2020-11-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-B74A59/2020	EPI_ISL_678962	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/ALDP-B74A95/2020	EPI_ISL_678966	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/ALDP-B74AC2/2020	EPI_ISL_678969	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/ALDP-B74B1A/2020	EPI_ISL_678973	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/ALDP-B74B38/2020	EPI_ISL_678975	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/ALDP-B74BFC/2020	EPI_ISL_678986	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/ALDP-B74DF6/2020	EPI_ISL_678992	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB9408/2020	EPI_ISL_680515	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB9775/2020	EPI_ISL_680540	2020-11-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		NS8_K53stop results in 57.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/Scotland/EDB9803/2020	EPI_ISL_680542	2020-11-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB9949/2020	EPI_ISL_680551	2020-11-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB9964/2020	EPI_ISL_680553	2020-11-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB9972/2020	EPI_ISL_680554	2020-11-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/204721133/2020	EPI_ISL_683534	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.58	GV
hCoV-19/England/204721137/2020	EPI_ISL_683535	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.58	GV
hCoV-19/England/204780433/2020	EPI_ISL_683564	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/204780434/2020	EPI_ISL_683565	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/ALDP-BB9E6B/2020	EPI_ISL_701840	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBB300/2020	EPI_ISL_701844	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB503C/2020	EPI_ISL_701884	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-BB934E/2020	EPI_ISL_702401	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBB27C/2020	EPI_ISL_702440	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB9B82/2020	EPI_ISL_702454	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB4DEB/2020	EPI_ISL_702491	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB4A5D/2020	EPI_ISL_702499	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCA474/2020	EPI_ISL_703778	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCA24D/2020	EPI_ISL_703780	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCAB7F/2020	EPI_ISL_703791	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCA2E3/2020	EPI_ISL_703793	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-491862/2020	EPI_ISL_706700	2020-11-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4918BD/2020	EPI_ISL_706705	2020-11-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49196F/2020	EPI_ISL_706716	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4919C9/2020	EPI_ISL_706722	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-491AB7/2020	EPI_ISL_706737	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-491AC6/2020	EPI_ISL_706738	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-491B1E/2020	EPI_ISL_706743	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-491B2D/2020	EPI_ISL_706744	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-491BD2/2020	EPI_ISL_706755	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-491BE1/2020	EPI_ISL_706756	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-BE57C5/2020	EPI_ISL_709826	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BE71A7/2020	EPI_ISL_709828	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BE7013/2020	EPI_ISL_709830	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BE7189/2020	EPI_ISL_709871	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BDCFF6/2020	EPI_ISL_709876	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8C906/2020	EPI_ISL_709893	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B02777/2020	EPI_ISL_709906	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AC9573/2020	EPI_ISL_709924	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BCCD1D/2020	EPI_ISL_710800	2020-11-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BCCC10/2020	EPI_ISL_710802	2020-11-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BCCD0E/2020	EPI_ISL_710804	2020-11-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BCCBD7/2020	EPI_ISL_710810	2020-11-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-BCCD4A/2020	EPI_ISL_710811	2020-11-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BCCD2C/2020	EPI_ISL_710812	2020-11-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BCCD68/2020	EPI_ISL_710813	2020-11-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BCCC7A/2020	EPI_ISL_710818	2020-11-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-BCCBAA/2020	EPI_ISL_710820	2020-11-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/CAMC-BC00C5/2020	EPI_ISL_710824	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BA308C/2020	EPI_ISL_710832	2020-11-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/CAMC-B99B88/2020	EPI_ISL_710835	2020-11-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B7F344/2020	EPI_ISL_710840	2020-11-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B7BF9F/2020	EPI_ISL_710844	2020-11-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B7C0F5/2020	EPI_ISL_710845	2020-11-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B7F308/2020	EPI_ISL_710846	2020-11-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/QEUH-B7C17A/2020	EPI_ISL_710847	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B7F362/2020	EPI_ISL_710848	2020-11-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B7BFDB/2020	EPI_ISL_710849	2020-11-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B7F2DE/2020	EPI_ISL_710851	2020-11-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B7C101/2020	EPI_ISL_710852	2020-11-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B7F2ED/2020	EPI_ISL_710853	2020-11-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B7E433/2020	EPI_ISL_710854	2020-11-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B7F2CF/2020	EPI_ISL_710855	2020-11-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B7F317/2020	EPI_ISL_710857	2020-11-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B7F335/2020	EPI_ISL_710860	2020-11-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Wales/QEUH-B678B9/2020	EPI_ISL_710863	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B630A6/2020	EPI_ISL_710876	2020-11-08	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B49228/2020	EPI_ISL_710889	2020-11-07	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B48845/2020	EPI_ISL_710900	2020-11-07	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B1A27B/2020	EPI_ISL_710915	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B19F93/2020	EPI_ISL_710918	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B1A044/2020	EPI_ISL_710921	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B1B68D/2020	EPI_ISL_710965	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B1A035/2020	EPI_ISL_710970	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B19F66/2020	EPI_ISL_710972	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B1E1A7/2020	EPI_ISL_710973	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B1E259/2020	EPI_ISL_710974	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B1B73F/2020	EPI_ISL_710975	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B1B650/2020	EPI_ISL_710979	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-14039/2020	EPI_ISL_711234	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14048/2020	EPI_ISL_711235	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14056/2020	EPI_ISL_711236	2020-11-30	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14106/2020	EPI_ISL_711237	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14112/2020	EPI_ISL_711238	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14149/2020	EPI_ISL_711239	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14167/2020	EPI_ISL_711240	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14168/2020	EPI_ISL_711241	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14303/2020	EPI_ISL_711243	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14318/2020	EPI_ISL_711244	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14333/2020	EPI_ISL_711245	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14390/2020	EPI_ISL_711246	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14393/2020	EPI_ISL_711247	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14432/2020	EPI_ISL_711249	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14446/2020	EPI_ISL_711250	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14479/2020	EPI_ISL_711252	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14489/2020	EPI_ISL_711253	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14497/2020	EPI_ISL_711254	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14529/2020	EPI_ISL_711255	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14594/2020	EPI_ISL_711256	2020-11-23	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14616/2020	EPI_ISL_711257	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14619/2020	EPI_ISL_711258	2020-11-23	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14646/2020	EPI_ISL_711259	2020-11-23	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14708/2020	EPI_ISL_711262	2020-11-23	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14829/2020	EPI_ISL_711264	2020-11-23	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14833/2020	EPI_ISL_711265	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-C48176/2020	EPI_ISL_718700	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C480D3/2020	EPI_ISL_718711	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C480A6/2020	EPI_ISL_718728	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C47D28/2020	EPI_ISL_718739	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C47E52/2020	EPI_ISL_718747	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C43B31/2020	EPI_ISL_719235	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C4422C/2020	EPI_ISL_719281	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB08C0/2020	EPI_ISL_720222	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/MILK-BB18FC/2020	EPI_ISL_720240	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB1407/2020	EPI_ISL_720247	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB1ECD/2020	EPI_ISL_720274	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB1883/2020	EPI_ISL_720276	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB0408/2020	EPI_ISL_720295	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC84EF/2020	EPI_ISL_721500	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC6830/2020	EPI_ISL_721506	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC8573/2020	EPI_ISL_721508	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC8670/2020	EPI_ISL_721509	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A8B6A7/2020	EPI_ISL_721540	2020-10-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A8C776/2020	EPI_ISL_721541	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Netherlands/OV-EMC-102/2020	EPI_ISL_722822	2020-09-17	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.177	GV
hCoV-19/Netherlands/OV-EMC-94/2020	EPI_ISL_722847	2020-09-08	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20096/2020	EPI_ISL_723274	2020-11-19	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/England/LIVE-DCC531/2020	EPI_ISL_724514	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F1AE6/2020	EPI_ISL_725137	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F3E9D/2020	EPI_ISL_725163	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F3ECA/2020	EPI_ISL_725166	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F3FD6/2020	EPI_ISL_725178	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F3FE5/2020	EPI_ISL_725179	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F4078/2020	EPI_ISL_725184	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F40F0/2020	EPI_ISL_725191	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	G
hCoV-19/England/NORW-F410C/2020	EPI_ISL_725192	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F4148/2020	EPI_ISL_725195	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F4157/2020	EPI_ISL_725196	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-492EE7/2020	EPI_ISL_725805	2020-11-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-492EF6/2020	EPI_ISL_725806	2020-11-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-493129/2020	EPI_ISL_725841	2020-11-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4934F3/2020	EPI_ISL_725898	2020-11-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4956CE/2020	EPI_ISL_726382	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495743/2020	EPI_ISL_726390	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495761/2020	EPI_ISL_726392	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4957F8/2020	EPI_ISL_726400	2020-11-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495804/2020	EPI_ISL_726401	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4959C5/2020	EPI_ISL_726423	2020-11-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495A2C/2020	EPI_ISL_726428	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495AB3/2020	EPI_ISL_726435	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495AC2/2020	EPI_ISL_726436	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495AD1/2020	EPI_ISL_726437	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495B65/2020	EPI_ISL_726446	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495B83/2020	EPI_ISL_726448	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495C53/2020	EPI_ISL_726461	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495C62/2020	EPI_ISL_726462	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495C9F/2020	EPI_ISL_726465	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495CAE/2020	EPI_ISL_726466	2020-11-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495CCC/2020	EPI_ISL_726468	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-495D32/2020	EPI_ISL_726475	2020-11-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-495D50/2020	EPI_ISL_726477	2020-11-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495D6F/2020	EPI_ISL_726478	2020-11-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495D8D/2020	EPI_ISL_726480	2020-11-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495DAB/2020	EPI_ISL_726482	2020-11-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495DC9/2020	EPI_ISL_726484	2020-11-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495E02/2020	EPI_ISL_726488	2020-11-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495E7B/2020	EPI_ISL_726495	2020-11-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-495E8A/2020	EPI_ISL_726496	2020-11-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/PORT-2EAA39/2020	EPI_ISL_727765	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/PORT-2EAA93/2020	EPI_ISL_727767	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/PORT-2EAAA2/2020	EPI_ISL_727768	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/PORT-2EAB27/2020	EPI_ISL_727773	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-A9D88E/2020	EPI_ISL_727791	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A9E137/2020	EPI_ISL_727798	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/England/ALDP-C3CB0E/2020	EPI_ISL_731702	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C4BCFA/2020	EPI_ISL_736567	2020-12-14	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C48D18/2020	EPI_ISL_736579	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C4899C/2020	EPI_ISL_736585	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C489E7/2020	EPI_ISL_736587	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B7A121/2020	EPI_ISL_741084	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49B789/2020	EPI_ISL_742382	2020-12-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Italy/VEN-UniVR-20/2020	EPI_ISL_751341	2020-08-26	Europe / Italy / Veneto / Verona	Human	Original			Illumina NovaSeq 5867	Artic amplicon V3; BWA 0.7.17; Ivar v1.2.2			B.1.177	GV
hCoV-19/Denmark/DCGC-20360/2020	EPI_ISL_758892	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20364/2020	EPI_ISL_758893	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20536/2020	EPI_ISL_758894	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20881/2020	EPI_ISL_758895	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21082/2020	EPI_ISL_758896	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20400/2020	EPI_ISL_758897	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20515/2020	EPI_ISL_758899	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20519/2020	EPI_ISL_758900	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20520/2020	EPI_ISL_758901	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20524/2020	EPI_ISL_758902	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-CBE1F3/2020	EPI_ISL_760261	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C9902E/2020	EPI_ISL_762024	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C92D2E/2020	EPI_ISL_762047	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C934EC/2020	EPI_ISL_762051	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C995D4/2020	EPI_ISL_762059	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C99079/2020	EPI_ISL_762155	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C92D88/2020	EPI_ISL_762157	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C92BD9/2020	EPI_ISL_762162	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C82F85/2020	EPI_ISL_762827	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C7ABB9/2020	EPI_ISL_762867	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-4A3D9B/2020	EPI_ISL_764629	2020-12-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A3FC2/2020	EPI_ISL_764650	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A433E/2020	EPI_ISL_764681	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A4529/2020	EPI_ISL_764704	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A4538/2020	EPI_ISL_764705	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A4565/2020	EPI_ISL_764706	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A45A1/2020	EPI_ISL_764709	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A45B0/2020	EPI_ISL_764710	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A4A48/2020	EPI_ISL_764761	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A4BEB/2020	EPI_ISL_764775	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A64C0/2020	EPI_ISL_765043	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A6563/2020	EPI_ISL_765048	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A6606/2020	EPI_ISL_765053	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A66E8/2020	EPI_ISL_765065	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A66F7/2020	EPI_ISL_765066	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A6A0A/2020	EPI_ISL_765094	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A6A37/2020	EPI_ISL_765095	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/205120686/2020	EPI_ISL_766310	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205121330/2020	EPI_ISL_766395	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/CAMC-C71E40/2020	EPI_ISL_768970	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C71D16/2020	EPI_ISL_768981	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C5CA47/2020	EPI_ISL_769511	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C5BB63/2020	EPI_ISL_769513	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C5D92B/2020	EPI_ISL_769517	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-C4B8D8/2020	EPI_ISL_769567	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C4FDF3/2020	EPI_ISL_769591	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Norway/6731/2020	EPI_ISL_775407	2020-12-06	Europe / Norway / Vestland	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.177.7	GV
hCoV-19/England/ALDP-C8D0E1/2020	EPI_ISL_777043	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C8CCEE/2020	EPI_ISL_777044	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C8C8F9/2020	EPI_ISL_777071	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C65410/2020	EPI_ISL_778377	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CEC156/2020	EPI_ISL_781205	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CECF4D/2020	EPI_ISL_781214	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D06568/2020	EPI_ISL_781233	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D08CCB/2020	EPI_ISL_781238	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-CF8EF6/2020	EPI_ISL_781258	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CEBF99/2020	EPI_ISL_781273	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CECCCE/2020	EPI_ISL_781292	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC93B3/2020	EPI_ISL_781933	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CED173/2020	EPI_ISL_781945	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C3231F/2020	EPI_ISL_782501	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-C335EB/2020	EPI_ISL_782517	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C32AA1/2020	EPI_ISL_782549	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-C31F76/2020	EPI_ISL_782550	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C32B62/2020	EPI_ISL_782570	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C32B26/2020	EPI_ISL_782577	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C3232E/2020	EPI_ISL_782580	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-C32CF6/2020	EPI_ISL_782593	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Netherlands/UT-RIVM-20976/2020	EPI_ISL_790997	2020-12-20	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Czech Republic/NRL_11501/2020	EPI_ISL_792696	2020-11-25	Europe / Czech Republic / Prague	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC-Medaka			B.1.177.8	GV
hCoV-19/Denmark/DCGC-23001/2020	EPI_ISL_793205	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23004/2020	EPI_ISL_793206	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23012/2020	EPI_ISL_793207	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23024/2020	EPI_ISL_793208	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23079/2020	EPI_ISL_793210	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23083/2020	EPI_ISL_793211	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23104/2020	EPI_ISL_793212	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23137/2020	EPI_ISL_793213	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23174/2020	EPI_ISL_793214	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23184/2020	EPI_ISL_793215	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23210/2020	EPI_ISL_793216	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23335/2020	EPI_ISL_793219	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23337/2020	EPI_ISL_793220	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23351/2020	EPI_ISL_793221	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23360/2020	EPI_ISL_793222	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23374/2020	EPI_ISL_793223	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23380/2020	EPI_ISL_793224	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23425/2020	EPI_ISL_793225	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23435/2020	EPI_ISL_793226	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23450/2020	EPI_ISL_793227	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23452/2020	EPI_ISL_793228	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23481/2020	EPI_ISL_793229	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23493/2020	EPI_ISL_793230	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23496/2020	EPI_ISL_793231	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23528/2020	EPI_ISL_793232	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23529/2020	EPI_ISL_793233	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23534/2020	EPI_ISL_793234	2020-12-21	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23575/2020	EPI_ISL_793235	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23601/2020	EPI_ISL_793236	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23610/2020	EPI_ISL_793237	2020-12-21	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23643/2020	EPI_ISL_793239	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23668/2020	EPI_ISL_793240	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23670/2020	EPI_ISL_793241	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23675/2020	EPI_ISL_793242	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23725/2020	EPI_ISL_793243	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23747/2020	EPI_ISL_793244	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23758/2020	EPI_ISL_793245	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23842/2020	EPI_ISL_793247	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23892/2020	EPI_ISL_793248	2020-12-14	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23885/2020	EPI_ISL_793988	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177	GV
hCoV-19/Denmark/DCGC-22927/2020	EPI_ISL_794587	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177	GV
hCoV-19/England/QEUH-D50884/2020	EPI_ISL_798020	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D54DBE/2020	EPI_ISL_798023	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D512C1/2020	EPI_ISL_798099	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D124F3/2020	EPI_ISL_799342	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D1201D/2020	EPI_ISL_799344	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-D21637/2020	EPI_ISL_799354	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.177.8	GV
hCoV-19/England/QEUH-D12147/2020	EPI_ISL_799359	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C18494/2020	EPI_ISL_800800	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C18A0B/2020	EPI_ISL_800801	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C18977/2020	EPI_ISL_800825	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/MILK-C21B48/2020	EPI_ISL_800864	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C22B65/2020	EPI_ISL_800879	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC297D/2020	EPI_ISL_800895	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB1197/2020	EPI_ISL_801203	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB11D3/2020	EPI_ISL_801204	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAFD89/2020	EPI_ISL_801229	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/205240226/2020	EPI_ISL_804362	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205240237/2020	EPI_ISL_804363	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205240242/2020	EPI_ISL_804364	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205261452/2020	EPI_ISL_804368	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/MILK-E72302/2021	EPI_ISL_811549	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/BIRM-64DD6/2020	EPI_ISL_812972	2020-10-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6E361/2020	EPI_ISL_813144	2020-12-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B6053/2020	EPI_ISL_813156	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B6080/2020	EPI_ISL_813158	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A98DA2/2020	EPI_ISL_813194	2020-12-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-4A84A0/2020	EPI_ISL_815010	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A85BC/2020	EPI_ISL_815024	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A87B6/2020	EPI_ISL_815044	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A891A/2020	EPI_ISL_815059	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A8B50/2020	EPI_ISL_815080	2020-12-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-27199/2020	EPI_ISL_818001	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NSP11 without BLAST coverage.	warn	B.1.177.80	GV
hCoV-19/England/ALDP-E285E7/2021	EPI_ISL_821002	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-E2F39B/2020	EPI_ISL_821617	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Northern Ireland/CAMC-A41D3F/2020	EPI_ISL_822313	2020-10-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-4AF56A/2020	EPI_ISL_822348	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AC442/2020	EPI_ISL_823555	2020-12-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AC8EC/2020	EPI_ISL_823609	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AC8FB/2020	EPI_ISL_823610	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AC952/2020	EPI_ISL_823613	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4ACA8C/2020	EPI_ISL_823625	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4ACC77/2020	EPI_ISL_823645	2020-12-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4ACD29/2020	EPI_ISL_823651	2020-12-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4ACDB0/2020	EPI_ISL_823654	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4ACF8D/2020	EPI_ISL_823671	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AD001/2020	EPI_ISL_823676	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Germany/NI-ChVir21963/2021	EPI_ISL_824985	2021-01-05	Europe / Germany / Lower Saxony	Human	Original			Illumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/NI-ChVir21964/2021	EPI_ISL_824986	2021-01-05	Europe / Germany / Lower Saxony	Human	Original			Illumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/SN-RKI-Z-0033/2020	EPI_ISL_825166	2020-12-21	Europe / Germany / Saxony	Human	Original			Nanopore MinION, Amplicon		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/USA/MI-UM-10036921818/2020	EPI_ISL_826452	2020-11-12	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.177	GV
hCoV-19/England/ALDP-AA0800/2020	EPI_ISL_826490	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA55B9/2020	EPI_ISL_826492	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA081F/2020	EPI_ISL_826497	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Iceland/3346/2021	EPI_ISL_827038	2021-01-03	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.177.8	GV
hCoV-19/Sweden/20-53006/2020	EPI_ISL_831976	2020-09-28	Europe / Sweden / Orebro	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with fill from reference and majority wins			B.1.177	GV
hCoV-19/Sweden/20-53820/2020	EPI_ISL_831987	2020-12-14	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with fill from reference and majority wins			B.1.177.80	GV
hCoV-19/England/ALDP-F4E66F/2021	EPI_ISL_834197	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-F4F08E/2021	EPI_ISL_834198	2021-01-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-EE5E18/2021	EPI_ISL_834902	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-EE208E/2021	EPI_ISL_834969	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-EE6E62/2021	EPI_ISL_834970	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-E812C7/2021	EPI_ISL_835635	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-E8755F/2021	EPI_ISL_836802	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-E92919/2021	EPI_ISL_836844	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-E95DED/2021	EPI_ISL_836864	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-E92CA7/2021	EPI_ISL_836874	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.177.8	GV
hCoV-19/England/ALDP-E880C6/2021	EPI_ISL_836890	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-E976A4/2021	EPI_ISL_836893	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-E874CB/2021	EPI_ISL_836935	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/205040519/2020	EPI_ISL_837199	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205241121/2020	EPI_ISL_837208	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/LIVE-DCED55/2020	EPI_ISL_838499	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina	unknown			B.1.177	GV
hCoV-19/England/OXON-F3ED6D/2020	EPI_ISL_840195	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F3EEA6/2020	EPI_ISL_840199	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-29858/2020	EPI_ISL_843905	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29193/2021	EPI_ISL_843925	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (FRAMESHIFT confirmed by submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29620/2020	EPI_ISL_843937	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (FRAMESHIFT confirmed by submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29922/2020	EPI_ISL_843969	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29933/2020	EPI_ISL_843980	2020-12-28	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29937/2020	EPI_ISL_843984	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-F81439/2021	EPI_ISL_846217	2021-01-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-F830CA/2021	EPI_ISL_846232	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-31552/2021	EPI_ISL_855967	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31553/2021	EPI_ISL_855969	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Scotland/QEUH-EFF2C4/2021	EPI_ISL_858159	2021-01-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-EFF2A6/2021	EPI_ISL_858165	2021-01-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-EFD1AB/2021	EPI_ISL_858167	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-EFF297/2021	EPI_ISL_858169	2021-01-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-EFD24E/2021	EPI_ISL_858177	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-EFB92D/2021	EPI_ISL_858184	2021-01-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-EF4669/2021	EPI_ISL_858245	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-EF455D/2021	EPI_ISL_858254	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-EF3961/2021	EPI_ISL_858256	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Wales/ALDP-CF14FB/2020	EPI_ISL_858909	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-CC91D7/2020	EPI_ISL_858910	2020-12-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-CEFD04/2020	EPI_ISL_858918	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-CC9456/2020	EPI_ISL_858919	2020-12-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C4B6ED/2020	EPI_ISL_859470	2020-12-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-C4B79F/2020	EPI_ISL_859472	2020-12-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C4B9A8/2020	EPI_ISL_859478	2020-12-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C4B98A/2020	EPI_ISL_859480	2020-12-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-C32DE4/2020	EPI_ISL_859486	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-C33509/2020	EPI_ISL_859488	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-C31D30/2020	EPI_ISL_859491	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C33439/2020	EPI_ISL_859494	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-C3294A/2020	EPI_ISL_859496	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-C31B09/2020	EPI_ISL_859501	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-C334B1/2020	EPI_ISL_859503	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C31BFA/2020	EPI_ISL_859509	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C334EE/2020	EPI_ISL_859510	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-C3340C/2020	EPI_ISL_859516	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C31CBB/2020	EPI_ISL_859524	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-C32977/2020	EPI_ISL_859529	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-C186AD/2020	EPI_ISL_859541	2020-12-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C186DA/2020	EPI_ISL_859546	2020-12-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C18898/2020	EPI_ISL_859548	2020-12-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C1843A/2020	EPI_ISL_859549	2020-12-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Germany/BE-ChVir21646/2020	EPI_ISL_862145	2020-12-24	Europe / Germany / Berlin	Human	Original			Illumina MiSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-ChVir22201/2021	EPI_ISL_862146	2021-01-14	Europe / Germany / Berlin	Human	Original			Illumina MiSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/SH-ChVir22169/2021	EPI_ISL_862147	2021-01-11	Europe / Germany / Schleswig-Holstein	Human	Original			Illumina MiSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/NI-ChVir22197/2021	EPI_ISL_862165	2021-01-13	Europe / Germany / Lower Saxony	Human	Original			Illumina MiSeq	bowtie2			B.1.177.62	GV
hCoV-19/Germany/NI-ChVir22200/2021	EPI_ISL_862167	2021-01-13	Europe / Germany / Lower Saxony	Human	Original			Illumina MiSeq	bowtie2			B.1.177.62	GV
hCoV-19/Germany/NI-ChVir22202/2021	EPI_ISL_862168	2021-01-13	Europe / Germany / Lower Saxony	Human	Original			Illumina MiSeq	bowtie2			B.1.177.62	GV
hCoV-19/Germany/NI-ChVir22203/2021	EPI_ISL_862169	2021-01-13	Europe / Germany / Lower Saxony	Human	Original			Illumina MiSeq	bowtie2			B.1.177.62	GV
hCoV-19/Germany/NI-ChVir22209/2021	EPI_ISL_862171	2021-01-13	Europe / Germany / Lower Saxony	Human	Original			Illumina MiSeq	bowtie2			B.1.177.62	GV
hCoV-19/England/QEUH-100350B/2021	EPI_ISL_863435	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-1002CF8/2021	EPI_ISL_863472	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1003F3A/2021	EPI_ISL_864010	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1006061/2021	EPI_ISL_864027	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1005FFC/2021	EPI_ISL_864148	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1005FB0/2021	EPI_ISL_864171	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMB-A9A0A7/2021	EPI_ISL_864749	2021-01-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/LIVE-DDCF4F/2020	EPI_ISL_865395	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DDCF5E/2020	EPI_ISL_865396	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-2252A3/2021	EPI_ISL_866633	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-225443/2021	EPI_ISL_866656	2021-01-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BA827/2021	EPI_ISL_867911	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-4BA872/2021	EPI_ISL_867916	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-4BA890/2021	EPI_ISL_867918	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-4BA924/2021	EPI_ISL_867927	2021-01-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-34125/2021	EPI_ISL_871135	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34155/2021	EPI_ISL_871165	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34168/2021	EPI_ISL_871178	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-FFFD86/2021	EPI_ISL_874107	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FFFCF2/2021	EPI_ISL_874108	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-100003A/2021	EPI_ISL_874162	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FEC645/2021	EPI_ISL_874173	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1000085/2021	EPI_ISL_874177	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Poland/6838615223_diag1_gx1/2020	EPI_ISL_876026	2020-12-22	Europe / Poland / warminsko-mazurskie	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.177.8	GV
hCoV-19/England/ALDP-1064D5B/2021	EPI_ISL_878602	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10658D1/2021	EPI_ISL_878607	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1065482/2021	EPI_ISL_878670	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1064A72/2021	EPI_ISL_878678	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10647F3/2021	EPI_ISL_878691	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1064F82/2021	EPI_ISL_878699	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-104A1E6/2021	EPI_ISL_879047	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-101B870/2021	EPI_ISL_879936	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-101B254/2021	EPI_ISL_879955	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-101AC75/2021	EPI_ISL_880947	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1019F40/2021	EPI_ISL_880953	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10B668C/2021	EPI_ISL_885745	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10B57B7/2021	EPI_ISL_885780	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-109DADA/2021	EPI_ISL_886134	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Belgium/rega-1502/2020	EPI_ISL_888752	2020-12-12	Europe / Belgium / Sorinnes	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177	GV
hCoV-19/Belgium/rega-1656/2021	EPI_ISL_890304	2021-01-03	Europe / Belgium / Sint-Amandsberg	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177.62	GV
hCoV-19/England/ALDP-10B78D0/2021	EPI_ISL_891625	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-10338/2021	EPI_ISL_905034	2021-01-02	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/England/ALDP-10EB071/2021	EPI_ISL_907636	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-10EF0C8/2021	EPI_ISL_907653	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10EAFB1/2021	EPI_ISL_907690	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10EAD5D/2021	EPI_ISL_907692	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10F4567/2021	EPI_ISL_907694	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Sweden/21-00097/2020	EPI_ISL_913479	2020-11-13	Europe / Sweden / Stockholm	Human	Original			Ion Torrent Genexus System, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with fill from reference and majority wins			B.1.177.80	GV
hCoV-19/England/ALDP-100F9D6/2021	EPI_ISL_917016	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10F9984/2021	EPI_ISL_917758	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1121C6B/2021	EPI_ISL_917762	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-110B1A4/2021	EPI_ISL_917768	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-110B8CD/2021	EPI_ISL_917799	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/LIVE-DE98CC/2021	EPI_ISL_919622	2021-01-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/LIVE-DEB55A/2021	EPI_ISL_919638	2021-01-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/SHEF-10D321C/2020	EPI_ISL_924316	2020-12-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 12 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/Denmark/DCGC-35619/2021	EPI_ISL_926760	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-35687/2021	EPI_ISL_926828	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-35817/2021	EPI_ISL_926958	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-35833/2021	EPI_ISL_926974	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-35836/2021	EPI_ISL_926977	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-35843/2021	EPI_ISL_926984	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-35966/2021	EPI_ISL_927107	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-35975/2021	EPI_ISL_927116	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36009/2021	EPI_ISL_927150	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37267/2021	EPI_ISL_928408	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37284/2021	EPI_ISL_928425	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37317/2021	EPI_ISL_928458	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37867/2021	EPI_ISL_929008	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37891/2021	EPI_ISL_929032	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37910/2021	EPI_ISL_929051	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37917/2021	EPI_ISL_929058	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-37926/2021	EPI_ISL_929067	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38045/2021	EPI_ISL_929186	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-38567/2021	EPI_ISL_929708	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38605/2020	EPI_ISL_929746	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38646/2021	EPI_ISL_929788	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38648/2020	EPI_ISL_929790	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38864/2021	EPI_ISL_930006	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38882/2021	EPI_ISL_930024	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39052/2021	EPI_ISL_930194	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Lithuania/ID2809/2020	EPI_ISL_933970	2020-12-06	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			B.1.177	GV
hCoV-19/England/ALDP-115CE61/2021	EPI_ISL_937620	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-116FFD1/2021	EPI_ISL_938942	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-118A125/2021	EPI_ISL_945935	2021-01-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-118A082/2021	EPI_ISL_945956	2021-01-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-118A0EC/2021	EPI_ISL_945970	2021-01-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-1188233/2021	EPI_ISL_946250	2021-01-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-1189153/2021	EPI_ISL_946253	2021-01-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-114E758/2021	EPI_ISL_947575	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-116F3C6/2021	EPI_ISL_948190	2021-01-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-114B76A/2021	EPI_ISL_948898	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMB-A9FC44/2021	EPI_ISL_949479	2021	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-1B85463/2020	EPI_ISL_950438	2020-12-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-1B8564F/2020	EPI_ISL_950456	2020-12-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-4BFBDE/2021	EPI_ISL_951761	2021-01-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BFBFC/2021	EPI_ISL_951763	2021-01-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BFC08/2021	EPI_ISL_951764	2021-01-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BFCDB/2021	EPI_ISL_951776	2021-01-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BFD6F/2021	EPI_ISL_951785	2021-01-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BFDE7/2020	EPI_ISL_951793	2020-12-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C0633/2021	EPI_ISL_951912	2021-01-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-41577/2021	EPI_ISL_973254	2021-01-25	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41582/2021	EPI_ISL_973259	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-41587/2021	EPI_ISL_973264	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41985/2021	EPI_ISL_973831	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/England/CAMC-11E789A/2021	EPI_ISL_980475	2021-02-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/CAMC-11B526A/2021	EPI_ISL_987876	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11CE3B6/2021	EPI_ISL_989332	2021-01-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11974D1/2021	EPI_ISL_990358	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1198652/2021	EPI_ISL_990368	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-118303E/2021	EPI_ISL_991093	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1182A31/2021	EPI_ISL_991125	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-115C432/2021	EPI_ISL_991634	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-115CB4C/2021	EPI_ISL_991667	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10EA3A6/2021	EPI_ISL_992282	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-10E8DB9/2021	EPI_ISL_992963	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10E7D14/2021	EPI_ISL_992989	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-4C49DC/2021	EPI_ISL_999803	2021-02-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C6B5C/2021	EPI_ISL_1000160	2021-02-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-125DE14/2021	EPI_ISL_1019272	2021-02-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-114BE92/2021	EPI_ISL_1019644	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-114BFDB/2021	EPI_ISL_1019682	2021-01-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Denmark/DCGC-42660/2021	EPI_ISL_1022938	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-42662/2021	EPI_ISL_1022940	2021-02-08	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.86	GV
hCoV-19/Denmark/DCGC-44723/2021	EPI_ISL_1025101	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44725/2021	EPI_ISL_1025103	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44769/2021	EPI_ISL_1025147	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44771/2021	EPI_ISL_1025149	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-45063/2021	EPI_ISL_1025441	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-45073/2021	EPI_ISL_1025451	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/MILK-125F6ED/2021	EPI_ISL_1033648	2021-02-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1289046/2021	EPI_ISL_1044588	2021-02-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-12895ED/2021	EPI_ISL_1044667	2021-02-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ARCH-REACT0001736/2020	EPI_ISL_1046919	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ARCH-REACT0002725/2020	EPI_ISL_1046931	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/BIRM-7001A/2021	EPI_ISL_1046981	2021-02-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/BIRM-70065/2021	EPI_ISL_1046984	2021-02-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6928/2021	EPI_ISL_1050180	2021-02-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6939/2021	EPI_ISL_1050191	2021-02-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/NORW-228352/2021	EPI_ISL_1051444	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-228589/2021	EPI_ISL_1051450	2021-01-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-228932/2021	EPI_ISL_1051456	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-228C2A/2021	EPI_ISL_1051465	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-228F21/2021	EPI_ISL_1051475	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-228F8B/2021	EPI_ISL_1051479	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-2291DF/2021	EPI_ISL_1051487	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-2292CD/2021	EPI_ISL_1051493	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-229597/2020	EPI_ISL_1051498	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F6335E/2021	EPI_ISL_1051721	2021-01-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F638D7/2021	EPI_ISL_1051747	2021-01-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/OXON-F63A59/2021	EPI_ISL_1051752	2021-02-01	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-4C849B/2021	EPI_ISL_1052799	2021-02-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Spain/IB-IBV-99019898/2021	EPI_ISL_1056615	2021-02-10	Europe / Spain / Balear Islands / Palma de Mallorca	Human	Original			Illumina MiSeq	BWA/IVAR	NS7a_E95stop results in 22.3% truncation of the protein sequence.	info	B.1.177.61	GV
hCoV-19/Italy/TAA-IGA-1900478851/2021	EPI_ISL_1063472	2021-02-08	Europe / Italy / Trentino Alto Adige	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	GV
hCoV-19/Italy/TAA-IGA-1900475995/2021	EPI_ISL_1063484	2021-02-07	Europe / Italy / Trentino Alto Adige	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000				B.1.177	GV
hCoV-19/Sweden/21-51315/2021	EPI_ISL_1064707	2021-02-15	Europe / Sweden / Halland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N			B.1.177	GV
hCoV-19/Denmark/DCGC-47699/2021	EPI_ISL_1067234	2021-02-15	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47708/2020	EPI_ISL_1067243	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47721/2020	EPI_ISL_1067256	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47723/2020	EPI_ISL_1067258	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47736/2020	EPI_ISL_1067271	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47740/2021	EPI_ISL_1067275	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47785/2020	EPI_ISL_1067320	2020-11-16	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.8	GV
hCoV-19/England/RAND-129048C/2021	EPI_ISL_1070944	2021-02-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-96549B/2020	EPI_ISL_531006	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-965871/2020	EPI_ISL_531045	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-98F49B/2020	EPI_ISL_539975	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-990075/2020	EPI_ISL_539990	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-98FCC0/2020	EPI_ISL_539994	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/CVR4175/2020	EPI_ISL_540852	2020-08-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB7748/2020	EPI_ISL_540886	2020-09-10	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB7762/2020	EPI_ISL_540893	2020-09-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/MILK-9A82FC/2020	EPI_ISL_550247	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9C8FFF/2020	EPI_ISL_567002	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9C81EA/2020	EPI_ISL_567067	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/QEUH-9C8047/2020	EPI_ISL_567108	2020-09-11	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-99813E/2020	EPI_ISL_568390	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-98F2FB/2020	EPI_ISL_568445	2020-08-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BCAA2/2020	EPI_ISL_573047	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9BCAC0/2020	EPI_ISL_573049	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9BCAFD/2020	EPI_ISL_573050	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9BCBDC/2020	EPI_ISL_573061	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9BCBFA/2020	EPI_ISL_573063	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16CDEC/2020	EPI_ISL_574170	2020-09-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16CE52/2020	EPI_ISL_574176	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16CECB/2020	EPI_ISL_574181	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16D176/2020	EPI_ISL_574207	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16D501/2020	EPI_ISL_574247	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16D57A/2020	EPI_ISL_574252	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9CB8F1/2020	EPI_ISL_575507	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CB484/2020	EPI_ISL_575541	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CBC22/2020	EPI_ISL_575544	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CB7F4/2020	EPI_ISL_575545	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CB958/2020	EPI_ISL_575550	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CB994/2020	EPI_ISL_575554	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CBDE3/2020	EPI_ISL_575575	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CBA28/2020	EPI_ISL_575595	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CBCC8/2020	EPI_ISL_575603	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CB2E4/2020	EPI_ISL_575610	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CB31E/2020	EPI_ISL_575617	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CB0F9/2020	EPI_ISL_575623	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CB5CD/2020	EPI_ISL_575629	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CBC04/2020	EPI_ISL_575637	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CBBCB/2020	EPI_ISL_575643	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CB396/2020	EPI_ISL_575657	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CAD8A/2020	EPI_ISL_575658	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CC08F/2020	EPI_ISL_575671	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CAE69/2020	EPI_ISL_575680	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CBF47/2020	EPI_ISL_575695	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CB25D/2020	EPI_ISL_575697	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9D9FCE/2020	EPI_ISL_576833	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9D9FDD/2020	EPI_ISL_576834	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9DA033/2020	EPI_ISL_576838	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-9DFCB2/2020	EPI_ISL_576931	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9EA003/2020	EPI_ISL_580013	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9EAE81/2020	EPI_ISL_580021	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9EA65C/2020	EPI_ISL_580025	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E9EDD/2020	EPI_ISL_580032	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.177	GV
hCoV-19/England/ALDP-9E9ECE/2020	EPI_ISL_580043	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9EA698/2020	EPI_ISL_580044	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E9FAD/2020	EPI_ISL_580049	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9EA382/2020	EPI_ISL_580053	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9EAAAB/2020	EPI_ISL_580072	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9EA48F/2020	EPI_ISL_580077	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E9E55/2020	EPI_ISL_580128	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9EAF33/2020	EPI_ISL_580167	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E9E0A/2020	EPI_ISL_580179	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-9E2AEF/2020	EPI_ISL_581325	2020-09-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9E3134/2020	EPI_ISL_581331	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9E2EF2/2020	EPI_ISL_581345	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/SHEF-C70C9/2020	EPI_ISL_585028	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-47D626/2020	EPI_ISL_586169	2020-10-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47D653/2020	EPI_ISL_586172	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47D732/2020	EPI_ISL_586185	2020-10-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47D802/2020	EPI_ISL_586196	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47D84E/2020	EPI_ISL_586199	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47D9A5/2020	EPI_ISL_586218	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47D9D2/2020	EPI_ISL_586221	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47DA2A/2020	EPI_ISL_586226	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A1E23C/2020	EPI_ISL_587496	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A1DA35/2020	EPI_ISL_587502	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A1DB05/2020	EPI_ISL_587524	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A1FCD3/2020	EPI_ISL_587620	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A21096/2020	EPI_ISL_587628	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A20747/2020	EPI_ISL_587656	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A22499/2020	EPI_ISL_587678	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F62D1/2020	EPI_ISL_588886	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F8460/2020	EPI_ISL_588946	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F5955/2020	EPI_ISL_588952	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F62B3/2020	EPI_ISL_588973	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-9EC863/2020	EPI_ISL_594623	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-9EC890/2020	EPI_ISL_594626	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/CVR4899/2020	EPI_ISL_594666	2020-10-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4903/2020	EPI_ISL_594670	2020-10-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4907/2020	EPI_ISL_594674	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4911/2020	EPI_ISL_594677	2020-10-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4913/2020	EPI_ISL_594679	2020-10-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4918/2020	EPI_ISL_594684	2020-10-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4923/2020	EPI_ISL_594689	2020-10-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR4928/2020	EPI_ISL_594694	2020-10-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR4942/2020	EPI_ISL_594706	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4947/2020	EPI_ISL_594711	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5039/2020	EPI_ISL_594773	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5040/2020	EPI_ISL_594774	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A3153A/2020	EPI_ISL_595900	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A48F6F/2020	EPI_ISL_595940	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A48FAB/2020	EPI_ISL_595941	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A4906B/2020	EPI_ISL_595951	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A492DE/2020	EPI_ISL_595957	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A49423/2020	EPI_ISL_595960	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4AAB7/2020	EPI_ISL_595969	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4C52D/2020	EPI_ISL_595974	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/QEUH-A4C5B4/2020	EPI_ISL_595982	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A4C693/2020	EPI_ISL_595988	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4C6FD/2020	EPI_ISL_595992	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4C754/2020	EPI_ISL_595998	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/CAMC-A58E05/2020	EPI_ISL_597006	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A5943F/2020	EPI_ISL_597010	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A58D26/2020	EPI_ISL_597011	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A58AD4/2020	EPI_ISL_597016	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A524CD/2020	EPI_ISL_598132	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A47CC3/2020	EPI_ISL_598253	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A4716A/2020	EPI_ISL_598254	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A46D2B/2020	EPI_ISL_598264	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A47328/2020	EPI_ISL_598276	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A4714C/2020	EPI_ISL_598336	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A0B7F7/2020	EPI_ISL_599466	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-A0BDD7/2020	EPI_ISL_599473	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DE04E/2020	EPI_ISL_599511	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9DD795/2020	EPI_ISL_599521	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9DD698/2020	EPI_ISL_599540	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9DD1A6/2020	EPI_ISL_599548	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DD504/2020	EPI_ISL_599658	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DD522/2020	EPI_ISL_599676	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DD4DA/2020	EPI_ISL_599683	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F7D66/2020	EPI_ISL_600918	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9F7DC0/2020	EPI_ISL_600924	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9E51C9/2020	EPI_ISL_600949	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9E3ED3/2020	EPI_ISL_600953	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9E4F1B/2020	EPI_ISL_600959	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9E46CB/2020	EPI_ISL_600972	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9E5387/2020	EPI_ISL_600973	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9E4B17/2020	EPI_ISL_600975	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9E4810/2020	EPI_ISL_600980	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9E487A/2020	EPI_ISL_600982	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9E5378/2020	EPI_ISL_600988	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9E42C7/2020	EPI_ISL_600990	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-9C985D/2020	EPI_ISL_602034	2020-09-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9C93B6/2020	EPI_ISL_602041	2020-09-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9B54BA/2020	EPI_ISL_602046	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9B4EF9/2020	EPI_ISL_602047	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9B4AE6/2020	EPI_ISL_602068	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9B4EDB/2020	EPI_ISL_602070	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9B5450/2020	EPI_ISL_602071	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9B4E44/2020	EPI_ISL_602073	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9B4F05/2020	EPI_ISL_602079	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A86C9B/2020	EPI_ISL_605955	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A701C2/2020	EPI_ISL_608005	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-A6CF65/2020	EPI_ISL_608006	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6D81E/2020	EPI_ISL_608052	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6CDB6/2020	EPI_ISL_608062	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6C624/2020	EPI_ISL_608070	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6C5BE/2020	EPI_ISL_608073	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6FADA/2020	EPI_ISL_608085	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6CE3B/2020	EPI_ISL_608090	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A707EE/2020	EPI_ISL_608138	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-A6C8C4/2020	EPI_ISL_608154	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6C3E1/2020	EPI_ISL_608161	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6CEE0/2020	EPI_ISL_608177	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6CED1/2020	EPI_ISL_608178	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6D31D/2020	EPI_ISL_608190	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6C7C7/2020	EPI_ISL_608199	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A41DD5/2020	EPI_ISL_609322	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A41397/2020	EPI_ISL_609329	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A41F48/2020	EPI_ISL_609332	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A40D12/2020	EPI_ISL_609341	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A41DA8/2020	EPI_ISL_609373	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A41379/2020	EPI_ISL_609376	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A41072/2020	EPI_ISL_609383	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A4143A/2020	EPI_ISL_609386	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A413D3/2020	EPI_ISL_609429	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A42017/2020	EPI_ISL_609430	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A41740/2020	EPI_ISL_609453	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A4127C/2020	EPI_ISL_609464	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A41C32/2020	EPI_ISL_609468	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A41BBD/2020	EPI_ISL_609479	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A85634/2020	EPI_ISL_610368	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A858A7/2020	EPI_ISL_610370	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A859A4/2020	EPI_ISL_610373	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A8524F/2020	EPI_ISL_610379	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-A8592C/2020	EPI_ISL_610392	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A85573/2020	EPI_ISL_610397	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A85C7E/2020	EPI_ISL_610399	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A859D1/2020	EPI_ISL_610415	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A85A65/2020	EPI_ISL_610467	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-A85300/2020	EPI_ISL_610495	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A85B17/2020	EPI_ISL_610497	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-A84B81/2020	EPI_ISL_610499	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-480550/2020	EPI_ISL_612901	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4805BA/2020	EPI_ISL_612905	2020-10-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48072D/2020	EPI_ISL_612923	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-480866/2020	EPI_ISL_612941	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-2858/2020	EPI_ISL_616686	2020-08-17	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/England/CAMC-AB114D/2020	EPI_ISL_623640	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AB7D16/2020	EPI_ISL_623669	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_G254stop results in 8.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/CAMC-AB18C0/2020	EPI_ISL_623683	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AB222B/2020	EPI_ISL_623703	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/MILK-AB7B1C/2020	EPI_ISL_623739	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_K53stop results in 57.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/CAMC-AB14AE/2020	EPI_ISL_623742	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AB7DE9/2020	EPI_ISL_623748	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AB8D7F/2020	EPI_ISL_623752	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Wales/ALDP-AA4981/2020	EPI_ISL_624913	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA2BD8/2020	EPI_ISL_624933	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA3876/2020	EPI_ISL_624937	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA52C1/2020	EPI_ISL_624939	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA20BB/2020	EPI_ISL_624955	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-AA1140/2020	EPI_ISL_624975	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A6603B/2020	EPI_ISL_627314	2020-10-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/CVR4759/2020	EPI_ISL_627340	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/CVR4815/2020	EPI_ISL_627358	2020-09-21	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5094/2020	EPI_ISL_627370	2020-10-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5095/2020	EPI_ISL_627371	2020-10-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5096/2020	EPI_ISL_627372	2020-10-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5113/2020	EPI_ISL_627377	2020-10-19	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5178/2020	EPI_ISL_627380	2020-10-19	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5185/2020	EPI_ISL_627382	2020-10-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5190/2020	EPI_ISL_627384	2020-10-19	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4B7EC/2020	EPI_ISL_628481	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4B807/2020	EPI_ISL_628482	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A4B88F/2020	EPI_ISL_628486	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A4B89E/2020	EPI_ISL_628487	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4B8E9/2020	EPI_ISL_628490	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4B8F8/2020	EPI_ISL_628491	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4B904/2020	EPI_ISL_628492	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4B922/2020	EPI_ISL_628494	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A4B9B9/2020	EPI_ISL_628499	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A4B9E6/2020	EPI_ISL_628500	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4BA10/2020	EPI_ISL_628503	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4BA7A/2020	EPI_ISL_628507	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/QEUH-A4BB2C/2020	EPI_ISL_628510	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A4BBC2/2020	EPI_ISL_628513	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A4BC29/2020	EPI_ISL_628518	2020-10-06	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A4C262/2020	EPI_ISL_628556	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4C29F/2020	EPI_ISL_628558	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A4C94F/2020	EPI_ISL_628580	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A4C9F4/2020	EPI_ISL_628586	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A4CC28/2020	EPI_ISL_628589	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A4D45C/2020	EPI_ISL_628599	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A61D48/2020	EPI_ISL_628650	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A63BA6/2020	EPI_ISL_628664	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A63C1C/2020	EPI_ISL_628667	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A63EE9/2020	EPI_ISL_628675	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A64334/2020	EPI_ISL_628689	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-AD1DBC/2020	EPI_ISL_629806	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD2647/2020	EPI_ISL_629818	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD1EB9/2020	EPI_ISL_629824	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD0649/2020	EPI_ISL_629826	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD2F3D/2020	EPI_ISL_629830	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD1842/2020	EPI_ISL_629851	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD2EB8/2020	EPI_ISL_629852	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD2331/2020	EPI_ISL_629858	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD04B8/2020	EPI_ISL_629865	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-AD2ED6/2020	EPI_ISL_629897	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD29A8/2020	EPI_ISL_629906	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD3AE0/2020	EPI_ISL_629973	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD1F7A/2020	EPI_ISL_629982	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA4FE9/2020	EPI_ISL_630808	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA2701/2020	EPI_ISL_630814	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA4FAD/2020	EPI_ISL_630820	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AAE723/2020	EPI_ISL_630833	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA4022/2020	EPI_ISL_630857	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA2A71/2020	EPI_ISL_630868	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA4D1C/2020	EPI_ISL_630901	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.177	GV
hCoV-19/England/ALDP-AA50E5/2020	EPI_ISL_630905	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AC5D8E/2020	EPI_ISL_630983	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AAF4EF/2020	EPI_ISL_630997	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AEAB98/2020	EPI_ISL_633116	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AEAB4D/2020	EPI_ISL_633141	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE52F2/2020	EPI_ISL_633145	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE4CF5/2020	EPI_ISL_633175	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AEABC5/2020	EPI_ISL_633187	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ACC4FB/2020	EPI_ISL_634345	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AC7B55/2020	EPI_ISL_634354	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AC786D/2020	EPI_ISL_634364	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-A780DC/2020	EPI_ISL_638037	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/Wales/PHWC-486E40/2020	EPI_ISL_639137	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-486E5F/2020	EPI_ISL_639138	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-486F10/2020	EPI_ISL_639148	2020-10-31	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-486FA7/2020	EPI_ISL_639155	2020-10-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-486FC5/2020	EPI_ISL_639156	2020-10-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-487058/2020	EPI_ISL_639160	2020-10-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-487076/2020	EPI_ISL_639161	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-487182/2020	EPI_ISL_639169	2020-10-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48729E/2020	EPI_ISL_639178	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4872F8/2020	EPI_ISL_639181	2020	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48737D/2020	EPI_ISL_639186	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48745C/2020	EPI_ISL_639196	2020-10-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-487559/2020	EPI_ISL_639210	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4875FF/2020	EPI_ISL_639218	2020-10-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-487744/2020	EPI_ISL_639231	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-487805/2020	EPI_ISL_639243	2020-10-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4878E7/2020	EPI_ISL_639251	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4879D5/2020	EPI_ISL_639261	2020-10-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-487F00/2020	EPI_ISL_639324	2020-10-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-487F97/2020	EPI_ISL_639331	2020-10-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48800C/2020	EPI_ISL_639338	2020-10-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4880A2/2020	EPI_ISL_639347	2020-10-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B140E0/2020	EPI_ISL_641617	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B10688/2020	EPI_ISL_641643	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B13861/2020	EPI_ISL_641650	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-B0F7F2/2020	EPI_ISL_641660	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B142CC/2020	EPI_ISL_641663	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B140B3/2020	EPI_ISL_641665	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B13A01/2020	EPI_ISL_641671	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B12F7C/2020	EPI_ISL_641686	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B02012/2020	EPI_ISL_642817	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B0273B/2020	EPI_ISL_642835	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B06263/2020	EPI_ISL_642839	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B02BB7/2020	EPI_ISL_642847	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-B02BF3/2020	EPI_ISL_642848	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-B02795/2020	EPI_ISL_642859	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B01D49/2020	EPI_ISL_642886	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B02AD8/2020	EPI_ISL_642887	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B02A50/2020	EPI_ISL_642930	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B01FE9/2020	EPI_ISL_642956	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B06193/2020	EPI_ISL_642966	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B029DB/2020	EPI_ISL_642993	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-B02786/2020	EPI_ISL_642995	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B06324/2020	EPI_ISL_642997	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B31F1D/2020	EPI_ISL_646301	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B23EF3/2020	EPI_ISL_646305	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B23C26/2020	EPI_ISL_646313	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B31D6E/2020	EPI_ISL_646317	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2E441/2020	EPI_ISL_646321	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B31A76/2020	EPI_ISL_646337	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B23E20/2020	EPI_ISL_646343	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24065/2020	EPI_ISL_646345	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B23EC6/2020	EPI_ISL_646350	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B31997/2020	EPI_ISL_646352	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B310A1/2020	EPI_ISL_646364	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B23B56/2020	EPI_ISL_646369	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B31A94/2020	EPI_ISL_646381	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2DE44/2020	EPI_ISL_646391	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2E4C9/2020	EPI_ISL_646394	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B23EB7/2020	EPI_ISL_646402	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B31CBC/2020	EPI_ISL_646404	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2DE80/2020	EPI_ISL_646424	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2E07A/2020	EPI_ISL_646436	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B23E6C/2020	EPI_ISL_646448	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2CA41/2020	EPI_ISL_646453	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B26036/2020	EPI_ISL_646454	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2C99F/2020	EPI_ISL_646473	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1A536/2020	EPI_ISL_647615	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B20DAE/2020	EPI_ISL_647661	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B20C83/2020	EPI_ISL_647671	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B212DB/2020	EPI_ISL_647685	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/CAMC-B20DEA/2020	EPI_ISL_647692	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-B1AA82/2020	EPI_ISL_647693	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B210E0/2020	EPI_ISL_647706	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B20A2F/2020	EPI_ISL_647717	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B20DCC/2020	EPI_ISL_647719	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B20F11/2020	EPI_ISL_647721	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B20A3E/2020	EPI_ISL_647731	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B20AA7/2020	EPI_ISL_647739	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1A457/2020	EPI_ISL_647741	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B20807/2020	EPI_ISL_647761	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B210D1/2020	EPI_ISL_647775	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B21244/2020	EPI_ISL_647778	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B20C65/2020	EPI_ISL_647785	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B20D53/2020	EPI_ISL_647790	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B205F1/2020	EPI_ISL_647793	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B1FDFD/2020	EPI_ISL_647795	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/LIVE-DB651C/2020	EPI_ISL_652101	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DB652B/2020	EPI_ISL_652102	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-ACFA9C/2020	EPI_ISL_652119	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-ACFAAB/2020	EPI_ISL_652120	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-ACFC4B/2020	EPI_ISL_652129	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B05AA8/2020	EPI_ISL_652217	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B06B2C/2020	EPI_ISL_652262	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B06BB3/2020	EPI_ISL_652264	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B06C65/2020	EPI_ISL_652269	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B391E2/2020	EPI_ISL_652296	2020-11-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.58	GV
hCoV-19/Northern Ireland/NIRE-1090BB/2020	EPI_ISL_652312	2020-10-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Northern Ireland/NIRE-1090F7/2020	EPI_ISL_652314	2020-10-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Northern Ireland/NIRE-1091C7/2020	EPI_ISL_652320	2020-10-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B69608/2020	EPI_ISL_654973	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B66753/2020	EPI_ISL_654975	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6AD11/2020	EPI_ISL_654980	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6C386/2020	EPI_ISL_654995	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B432C4/2020	EPI_ISL_657031	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B42535/2020	EPI_ISL_657038	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B407E6/2020	EPI_ISL_657040	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B426BA/2020	EPI_ISL_657049	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B40546/2020	EPI_ISL_657052	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B425F9/2020	EPI_ISL_657074	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B43710/2020	EPI_ISL_657076	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B424B0/2020	EPI_ISL_657092	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B55BB5/2020	EPI_ISL_658301	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B51858/2020	EPI_ISL_658327	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B51B40/2020	EPI_ISL_658331	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B5A51C/2020	EPI_ISL_658339	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B55E25/2020	EPI_ISL_658344	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B55CA3/2020	EPI_ISL_658374	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B51867/2020	EPI_ISL_658383	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B545B8/2020	EPI_ISL_658390	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B3F805/2020	EPI_ISL_658419	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B41B52/2020	EPI_ISL_658434	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B34105/2020	EPI_ISL_659620	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B34008/2020	EPI_ISL_659624	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B348A6/2020	EPI_ISL_659659	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B34985/2020	EPI_ISL_659672	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B34017/2020	EPI_ISL_659706	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B3416F/2020	EPI_ISL_659716	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B34202/2020	EPI_ISL_659726	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2E960/2020	EPI_ISL_659754	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2CEDC/2020	EPI_ISL_659767	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2CD75/2020	EPI_ISL_659781	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7FF5F/2020	EPI_ISL_661936	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7F3EA/2020	EPI_ISL_661942	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B82311/2020	EPI_ISL_661955	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B686CD/2020	EPI_ISL_661972	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B68D31/2020	EPI_ISL_661973	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B75162/2020	EPI_ISL_661974	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B74998/2020	EPI_ISL_661978	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/C200044464/2020	EPI_ISL_666756	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/C200044468/2020	EPI_ISL_666757	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/C200044470/2020	EPI_ISL_666758	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/C200044472/2020	EPI_ISL_666759	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/C200044475/2020	EPI_ISL_666760	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/C200044478/2020	EPI_ISL_666761	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/C200044479/2020	EPI_ISL_666762	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/C200044480/2020	EPI_ISL_666763	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/C200044483/2020	EPI_ISL_666764	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/C200044487/2020	EPI_ISL_666765	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/C200044492/2020	EPI_ISL_666766	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/MILK-B85DF2/2020	EPI_ISL_673908	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B862B6/2020	EPI_ISL_673911	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8640B/2020	EPI_ISL_673944	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B85E3B/2020	EPI_ISL_673951	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8E597/2020	EPI_ISL_673966	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B85E0E/2020	EPI_ISL_673978	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8E7A0/2020	EPI_ISL_673991	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B95FBD/2020	EPI_ISL_676108	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B943EF/2020	EPI_ISL_676134	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B95F80/2020	EPI_ISL_676173	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B96031/2020	EPI_ISL_676180	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B960AA/2020	EPI_ISL_676204	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B96B6D/2020	EPI_ISL_676217	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B94E48/2020	EPI_ISL_676226	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B948C2/2020	EPI_ISL_676244	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B969EB/2020	EPI_ISL_676287	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B9664E/2020	EPI_ISL_676296	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5D0BE/2020	EPI_ISL_678853	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/ALDP-B5D3E2/2020	EPI_ISL_678895	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/ALDP-B5D3F1/2020	EPI_ISL_678896	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/ALDP-B748C8/2020	EPI_ISL_678954	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/ALDP-BB9BEC/2020	EPI_ISL_702502	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBAD9A/2020	EPI_ISL_702521	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBB40D/2020	EPI_ISL_702530	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBB24F/2020	EPI_ISL_702576	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBABCD/2020	EPI_ISL_702581	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBA5ED/2020	EPI_ISL_702603	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBAD30/2020	EPI_ISL_702630	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB362D/2020	EPI_ISL_702634	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB8E4E/2020	EPI_ISL_702660	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB52EB/2020	EPI_ISL_702688	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB8E8A/2020	EPI_ISL_702696	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BC4B84/2020	EPI_ISL_703819	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BCC7A6/2020	EPI_ISL_703835	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BCB947/2020	EPI_ISL_703836	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BC3E04/2020	EPI_ISL_703852	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BCB965/2020	EPI_ISL_703854	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BC4BB1/2020	EPI_ISL_703857	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BCB9DE/2020	EPI_ISL_703949	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BC35D2/2020	EPI_ISL_703994	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B3A06C/2020	EPI_ISL_706014	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3A2C0/2020	EPI_ISL_706015	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3A767/2020	EPI_ISL_706033	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/MILK-B3B6E1/2020	EPI_ISL_706079	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3BF9B/2020	EPI_ISL_706110	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3C0B5/2020	EPI_ISL_706118	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3C158/2020	EPI_ISL_706122	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3C695/2020	EPI_ISL_706152	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3C853/2020	EPI_ISL_706162	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3C932/2020	EPI_ISL_706169	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/ALDP-B1E295/2020	EPI_ISL_710944	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-B1E1E3/2020	EPI_ISL_710954	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-14942/2020	EPI_ISL_713273	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-14992/2020	EPI_ISL_713275	2020-11-23	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-15012/2020	EPI_ISL_713276	2020-11-23	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-15078/2020	EPI_ISL_713277	2020-11-23	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-15079/2020	EPI_ISL_713278	2020-11-23	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-15082/2020	EPI_ISL_713279	2020-11-23	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-15126/2020	EPI_ISL_713280	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-15138/2020	EPI_ISL_713281	2020-11-23	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-15163/2020	EPI_ISL_713282	2020-11-23	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-15167/2020	EPI_ISL_713283	2020-11-23	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-15292/2020	EPI_ISL_713285	2020-11-23	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-15329/2020	EPI_ISL_713286	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-15579/2020	EPI_ISL_713289	2020-11-23	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/NW-HHU-414/2020	EPI_ISL_718088	2020-11-11	Europe / Germany / North Rhine-Westphalia	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.177.62	GV
hCoV-19/Germany/NW-HHU-416/2020	EPI_ISL_718090	2020-11-11	Europe / Germany / North Rhine-Westphalia	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.177.62	GV
hCoV-19/Germany/NW-HHU-419/2020	EPI_ISL_718093	2020-11-11	Europe / Germany / North Rhine-Westphalia	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.177	GV
hCoV-19/England/CAMC-C3F60A/2020	EPI_ISL_719334	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C43EDE/2020	EPI_ISL_719344	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C43EB0/2020	EPI_ISL_719366	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C43551/2020	EPI_ISL_719472	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB2442/2020	EPI_ISL_720314	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB1012/2020	EPI_ISL_720315	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB1847/2020	EPI_ISL_720320	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/MILK-BB1D48/2020	EPI_ISL_720349	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB0CA6/2020	EPI_ISL_720353	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAFCC8/2020	EPI_ISL_720372	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB0E19/2020	EPI_ISL_720379	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BABA86/2020	EPI_ISL_720392	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB0DC1/2020	EPI_ISL_720429	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAC399/2020	EPI_ISL_720430	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/MILK-BB0E55/2020	EPI_ISL_720440	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-BB1AD8/2020	EPI_ISL_720444	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAB8D7/2020	EPI_ISL_720451	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB0013/2020	EPI_ISL_720481	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB0BD6/2020	EPI_ISL_720482	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB0C88/2020	EPI_ISL_720486	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B7B630/2020	EPI_ISL_724018	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-B7B66D/2020	EPI_ISL_724021	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-B7B69A/2020	EPI_ISL_724024	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-B7BD86/2020	EPI_ISL_724057	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-B7BD95/2020	EPI_ISL_724058	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F447C/2020	EPI_ISL_725220	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F5226/2020	EPI_ISL_725233	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F5262/2020	EPI_ISL_725236	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F5271/2020	EPI_ISL_725237	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F529F/2020	EPI_ISL_725238	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F52AE/2020	EPI_ISL_725239	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F52BD/2020	EPI_ISL_725240	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F538D/2020	EPI_ISL_725248	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F53E7/2020	EPI_ISL_725253	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F5402/2020	EPI_ISL_725255	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F553C/2020	EPI_ISL_725269	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F55F0/2020	EPI_ISL_725276	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F59E5/2020	EPI_ISL_725285	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F5A88/2020	EPI_ISL_725292	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49601A/2020	EPI_ISL_726519	2020-11-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-496205/2020	EPI_ISL_726547	2020-11-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49635D/2020	EPI_ISL_726567	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4965DF/2020	EPI_ISL_726606	2020-11-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-496645/2020	EPI_ISL_726613	2020-11-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-496654/2020	EPI_ISL_726614	2020-11-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-496681/2020	EPI_ISL_726617	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4966FA/2020	EPI_ISL_726624	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49692E/2020	EPI_ISL_726658	2020-11-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-496AD0/2020	EPI_ISL_726684	2020-11-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B7D962/2020	EPI_ISL_727835	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B7D971/2020	EPI_ISL_727836	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B7E318/2020	EPI_ISL_727855	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/SHEF-10D1A16/2020	EPI_ISL_727947	2020-12-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/ALDP-C39F32/2020	EPI_ISL_731000	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3DB3A/2020	EPI_ISL_731007	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-C3C52E/2020	EPI_ISL_731009	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C39F05/2020	EPI_ISL_731040	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3D0A4/2020	EPI_ISL_731051	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3A49C/2020	EPI_ISL_731096	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3D4B7/2020	EPI_ISL_731097	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C39E08/2020	EPI_ISL_731110	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3C791/2020	EPI_ISL_731155	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3DB85/2020	EPI_ISL_731173	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3D0C2/2020	EPI_ISL_731174	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3A283/2020	EPI_ISL_731181	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3B941/2020	EPI_ISL_731193	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3CA7A/2020	EPI_ISL_731195	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C264A2/2020	EPI_ISL_733614	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C2FB1D/2020	EPI_ISL_733617	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C2C943/2020	EPI_ISL_733726	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C2D3F9/2020	EPI_ISL_733732	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C233F3/2020	EPI_ISL_733754	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C2FC74/2020	EPI_ISL_733771	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C2CFD8/2020	EPI_ISL_733784	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C2F9D7/2020	EPI_ISL_733796	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B751EA/2020	EPI_ISL_740899	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B75205/2020	EPI_ISL_740900	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B75469/2020	EPI_ISL_740904	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B75539/2020	EPI_ISL_740912	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B75EA7/2020	EPI_ISL_740946	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B75EC5/2020	EPI_ISL_740948	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMB-1BD04D/2020	EPI_ISL_740957	2020-12-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-49E470/2020	EPI_ISL_743005	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49E74A/2020	EPI_ISL_743041	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49E962/2020	EPI_ISL_743072	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49EC2D/2020	EPI_ISL_743105	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49EC69/2020	EPI_ISL_743107	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49F293/2020	EPI_ISL_743189	2020-12-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-17749/2020	EPI_ISL_749296	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17764/2020	EPI_ISL_749297	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17779/2020	EPI_ISL_749298	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17780/2020	EPI_ISL_749299	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17783/2020	EPI_ISL_749300	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17801/2020	EPI_ISL_749301	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17803/2020	EPI_ISL_749302	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17820/2020	EPI_ISL_749303	2020-12-14	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17843/2020	EPI_ISL_749304	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17876/2020	EPI_ISL_749305	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17917/2020	EPI_ISL_749306	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17932/2020	EPI_ISL_749307	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17959/2020	EPI_ISL_749308	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17996/2020	EPI_ISL_749309	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18036/2020	EPI_ISL_749310	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18087/2020	EPI_ISL_749311	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	GV
hCoV-19/Denmark/DCGC-18095/2020	EPI_ISL_749312	2020-12-14	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18119/2020	EPI_ISL_749313	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18126/2020	EPI_ISL_749314	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18131/2020	EPI_ISL_749315	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18143/2020	EPI_ISL_749316	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18149/2020	EPI_ISL_749317	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18161/2020	EPI_ISL_749318	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18230/2020	EPI_ISL_749319	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18605/2020	EPI_ISL_749343	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18626/2020	EPI_ISL_749344	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18688/2020	EPI_ISL_749347	2020-12-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18700/2020	EPI_ISL_749348	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18706/2020	EPI_ISL_749349	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18708/2020	EPI_ISL_749350	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18730/2020	EPI_ISL_749351	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18731/2020	EPI_ISL_749352	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18740/2020	EPI_ISL_749353	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18747/2020	EPI_ISL_749354	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-16785/2020	EPI_ISL_750301	2020-12-14	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-16814/2020	EPI_ISL_750302	2020-12-14	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-16820/2020	EPI_ISL_750303	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-16845/2020	EPI_ISL_750304	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-16846/2020	EPI_ISL_750305	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-16873/2020	EPI_ISL_750308	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-16886/2020	EPI_ISL_750309	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-16908/2020	EPI_ISL_750310	2020-12-14	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-16920/2020	EPI_ISL_750311	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-16930/2020	EPI_ISL_750312	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-16940/2020	EPI_ISL_750315	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-16943/2020	EPI_ISL_750316	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-16994/2020	EPI_ISL_750317	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17010/2020	EPI_ISL_750319	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17022/2020	EPI_ISL_750320	2020-12-14	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17029/2020	EPI_ISL_750321	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17031/2020	EPI_ISL_750322	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17032/2020	EPI_ISL_750323	2020-12-14	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17038/2020	EPI_ISL_750324	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17049/2020	EPI_ISL_750325	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17089/2020	EPI_ISL_750327	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17109/2020	EPI_ISL_750328	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17113/2020	EPI_ISL_750329	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17125/2020	EPI_ISL_750330	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17131/2020	EPI_ISL_750331	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17142/2020	EPI_ISL_750332	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17145/2020	EPI_ISL_750333	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17163/2020	EPI_ISL_750334	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17166/2020	EPI_ISL_750335	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17172/2020	EPI_ISL_750336	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17176/2020	EPI_ISL_750337	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17188/2020	EPI_ISL_750338	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17192/2020	EPI_ISL_750339	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17197/2020	EPI_ISL_750340	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17231/2020	EPI_ISL_750341	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17240/2020	EPI_ISL_750342	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17249/2020	EPI_ISL_750343	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17260/2020	EPI_ISL_750344	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-C8962F/2020	EPI_ISL_756378	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C8AC2C/2020	EPI_ISL_756408	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-C88F52/2020	EPI_ISL_756471	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-22528/2020	EPI_ISL_757616	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177	GV
hCoV-19/Denmark/DCGC-20527/2020	EPI_ISL_758903	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20539/2020	EPI_ISL_758904	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20543/2020	EPI_ISL_758905	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20600/2020	EPI_ISL_758906	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20613/2020	EPI_ISL_758907	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20620/2020	EPI_ISL_758908	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20630/2020	EPI_ISL_758909	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20631/2020	EPI_ISL_758910	2020-12-21	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20632/2020	EPI_ISL_758911	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20680/2020	EPI_ISL_758912	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20690/2020	EPI_ISL_758913	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20741/2020	EPI_ISL_758914	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20758/2020	EPI_ISL_758915	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20770/2020	EPI_ISL_758916	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20771/2020	EPI_ISL_758917	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20806/2020	EPI_ISL_758918	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20820/2020	EPI_ISL_758919	2020-12-21	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20834/2020	EPI_ISL_758920	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20872/2020	EPI_ISL_758921	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20874/2020	EPI_ISL_758922	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20876/2020	EPI_ISL_758923	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20886/2020	EPI_ISL_758924	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20899/2020	EPI_ISL_758925	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20925/2020	EPI_ISL_758926	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20941/2020	EPI_ISL_758927	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20967/2020	EPI_ISL_758928	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20973/2020	EPI_ISL_758929	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21003/2020	EPI_ISL_758930	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21004/2020	EPI_ISL_758931	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21011/2020	EPI_ISL_758932	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21051/2020	EPI_ISL_758933	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21074/2020	EPI_ISL_758934	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21143/2020	EPI_ISL_758935	2020-12-21	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21149/2020	EPI_ISL_758936	2020-12-21	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21212/2020	EPI_ISL_758937	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21254/2020	EPI_ISL_758938	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21295/2020	EPI_ISL_758939	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21297/2020	EPI_ISL_758940	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21318/2020	EPI_ISL_758941	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21323/2020	EPI_ISL_758942	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/MILK-CA95FF/2020	EPI_ISL_762214	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-CA98BA/2020	EPI_ISL_762233	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-CA9D51/2020	EPI_ISL_762272	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-4A4F76/2020	EPI_ISL_764803	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A4F85/2020	EPI_ISL_764804	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A5D3F/2020	EPI_ISL_764971	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-CB5AB5/2020	EPI_ISL_767104	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-CB6A4B/2020	EPI_ISL_767106	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C5A029/2020	EPI_ISL_767130	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-C49931/2020	EPI_ISL_767141	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C4995F/2020	EPI_ISL_767147	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C39925/2020	EPI_ISL_767157	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C3ADEC/2020	EPI_ISL_767159	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C39BA7/2020	EPI_ISL_767163	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C39D29/2020	EPI_ISL_767171	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C39776/2020	EPI_ISL_767193	2020-12-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C53415/2020	EPI_ISL_769602	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C5017B/2020	EPI_ISL_769610	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C4B850/2020	EPI_ISL_769614	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C4B920/2020	EPI_ISL_769617	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C4B911/2020	EPI_ISL_769625	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C4B841/2020	EPI_ISL_769652	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-C4B735/2020	EPI_ISL_769687	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C4B87E/2020	EPI_ISL_769689	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C4FD20/2020	EPI_ISL_769710	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C4B89C/2020	EPI_ISL_769753	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C4FE1E/2020	EPI_ISL_769786	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C4B8BA/2020	EPI_ISL_769794	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 6 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/Germany/NW-HHU-463/2020	EPI_ISL_770697	2020-12-11	Europe / Germany / North Rhine-Westphalia	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.177.62	GV
hCoV-19/Germany/NW-HHU-465/2020	EPI_ISL_770699	2020-12-11	Europe / Germany / North Rhine-Westphalia	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.177	GV
hCoV-19/Germany/NW-HHU-492/2020	EPI_ISL_770741	2020-12-03	Europe / Germany / North Rhine-Westphalia	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 4 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Germany/NW-HHU-496/2020	EPI_ISL_770745	2020-12-03	Europe / Germany / North Rhine-Westphalia	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.177.62	GV
hCoV-19/Sweden/20-53779/2020	EPI_ISL_775583	2020-12-14	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with fill from reference and majority wins			B.1.177.80	GV
hCoV-19/Spain/MD-IBV-99012454/2020	EPI_ISL_780084	2020-11-19	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/England/ALDP-CEB49A/2020	EPI_ISL_781400	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CEC3BA/2020	EPI_ISL_781451	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-CEB46D/2020	EPI_ISL_781456	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C328A7/2020	EPI_ISL_782605	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	G
hCoV-19/England/QEUH-C32CAB/2020	EPI_ISL_782619	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C31FD0/2020	EPI_ISL_782651	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-C33484/2020	EPI_ISL_782667	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C32B71/2020	EPI_ISL_782683	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C33606/2020	EPI_ISL_782733	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/CAMC-C26615/2020	EPI_ISL_782763	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/New Zealand/21CV0009/2021	EPI_ISL_794614	2021-01-01	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.177	GV
hCoV-19/New Zealand/21CV0034/2021	EPI_ISL_794626	2021-01-04	Oceania / New Zealand / Counties Manukau	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.177	GV
hCoV-19/Denmark/DCGC-25076/2020	EPI_ISL_795909	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177	GV
hCoV-19/England/ALDP-D442A3/2020	EPI_ISL_798119	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D42C4D/2020	EPI_ISL_798127	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D51443/2020	EPI_ISL_798187	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-D538FA/2020	EPI_ISL_798188	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-D50990/2020	EPI_ISL_798198	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D513CE/2020	EPI_ISL_798262	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-D42BC8/2020	EPI_ISL_798282	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D54D81/2020	EPI_ISL_798291	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D459E9/2020	EPI_ISL_798292	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D54EAC/2020	EPI_ISL_798293	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D12499/2020	EPI_ISL_799450	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D227E8/2020	EPI_ISL_799496	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D23082/2020	EPI_ISL_799505	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D215C1/2020	EPI_ISL_799562	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-4A8EDF/2020	EPI_ISL_815116	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A9023/2020	EPI_ISL_815134	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A918A/2020	EPI_ISL_815147	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A92D2/2020	EPI_ISL_815162	2020-12-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A9418/2020	EPI_ISL_815174	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A9621/2020	EPI_ISL_815192	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A9867/2020	EPI_ISL_815218	2020-12-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A9ACB/2020	EPI_ISL_815233	2020-12-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A9BB9/2020	EPI_ISL_815241	2020-12-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/SHEF-10D4DDE/2020	EPI_ISL_816574	2020-11-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Denmark/DCGC-26980/2020	EPI_ISL_817882	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NSP11 without BLAST coverage.	warn	B.1.177.80	GV
hCoV-19/Denmark/DCGC-27001/2020	EPI_ISL_817897	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NSP11 without BLAST coverage.	warn	B.1.177.80	GV
hCoV-19/Denmark/DCGC-27019/2020	EPI_ISL_817905	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NSP11 without BLAST coverage.	warn	B.1.177.80	GV
hCoV-19/England/ALDP-E302F4/2021	EPI_ISL_821009	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-E371E1/2021	EPI_ISL_821063	2021-01-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-E303C4/2021	EPI_ISL_821065	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-E30397/2021	EPI_ISL_821079	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-E2BD55/2021	EPI_ISL_821081	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-E2F595/2021	EPI_ISL_821147	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-E30959/2021	EPI_ISL_821196	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/PHWC-4AF922/2020	EPI_ISL_822349	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AF940/2020	EPI_ISL_822355	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AE2A0/2020	EPI_ISL_822410	2020-12-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AE4E6/2020	EPI_ISL_822479	2020-12-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AEAE4/2020	EPI_ISL_822484	2020-12-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AC864/2020	EPI_ISL_823602	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AC873/2020	EPI_ISL_823603	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AD06B/2020	EPI_ISL_823679	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AD089/2020	EPI_ISL_823681	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AD0D4/2020	EPI_ISL_823685	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AD4F6/2020	EPI_ISL_823728	2020-12-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4ADCEF/2020	EPI_ISL_823780	2020-12-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4ADE43/2020	EPI_ISL_823790	2020-12-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4ADEBC/2020	EPI_ISL_823795	2020-12-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4ADEE9/2020	EPI_ISL_823797	2020-12-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Germany/HH-ChVir21712/2020	EPI_ISL_824921	2020-12-29	Europe / Germany / Hamburg	Human	Original			Illumina NextSeq	bowtie2	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/Iceland/6100/2020	EPI_ISL_829779	2020-12-19	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Switzerland/BL-42481120/2020	EPI_ISL_830749	2020-10-12	Europe / Switzerland / Basel-Land / Allschwil	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.177	GV
hCoV-19/England/ALDP-EF13DE/2021	EPI_ISL_834399	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-EF13FC/2021	EPI_ISL_834421	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-EF03C0/2021	EPI_ISL_834454	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-EB3693/2021	EPI_ISL_835667	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-E864CC/2021	EPI_ISL_835668	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-E812E5/2021	EPI_ISL_835699	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-E87F9D/2021	EPI_ISL_836903	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/205221650/2020	EPI_ISL_836988	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/NOTT-2483C5/2020	EPI_ISL_840151	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/OXON-F3EF58/2020	EPI_ISL_840204	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F41B5E/2020	EPI_ISL_840254	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B5DC3/2021	EPI_ISL_841420	2021-01-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-F81C9B/2021	EPI_ISL_846310	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-F81F92/2021	EPI_ISL_846375	2021-01-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-F82580/2021	EPI_ISL_846411	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-F82508/2021	EPI_ISL_846412	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-F82D1F/2021	EPI_ISL_846430	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-F82FEC/2021	EPI_ISL_846454	2021-01-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-F8225C/2021	EPI_ISL_846475	2021-01-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-E963DB/2021	EPI_ISL_858283	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-E95EDB/2021	EPI_ISL_858297	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-E96380/2021	EPI_ISL_858299	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-E96B97/2021	EPI_ISL_858336	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-E96CEF/2021	EPI_ISL_858364	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-E95D56/2021	EPI_ISL_858371	2021-01-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-E982FA/2021	EPI_ISL_858374	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-E97228/2021	EPI_ISL_858377	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-E972FB/2021	EPI_ISL_858378	2021-01-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-E96BA6/2021	EPI_ISL_858404	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-C6AB25/2020	EPI_ISL_858408	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C63FC6/2020	EPI_ISL_858412	2020-12-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-C6AB43/2020	EPI_ISL_858418	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-C63FD5/2020	EPI_ISL_858420	2020-12-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-E49CBE/2021	EPI_ISL_858436	2021-01-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-E49C09/2021	EPI_ISL_858456	2021-01-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-E49216/2021	EPI_ISL_858483	2021-01-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-E49146/2021	EPI_ISL_858498	2021-01-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/210160526/2021	EPI_ISL_860680	2021-01-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/210291734/2021	EPI_ISL_860697	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/210291824/2021	EPI_ISL_860708	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/ALDP-1004F66/2021	EPI_ISL_864107	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1004458/2021	EPI_ISL_864110	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1003BDC/2021	EPI_ISL_864199	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/LIVE-DDCFD6/2020	EPI_ISL_865401	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DDD7A0/2020	EPI_ISL_865425	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DE23FF/2021	EPI_ISL_865467	2021-01-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/LOND-1288AC1/2020	EPI_ISL_865510	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-22620C/2021	EPI_ISL_866773	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Germany/BE-ChVir22280/2021	EPI_ISL_869119	2021-01-15	Europe / Germany / Berlin	Human	Original			Illumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/SH-ChVir22531/2021	EPI_ISL_869120	2021-01-16	Europe / Germany / Schleswig-Holstein	Human	Original			Illumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/SH-ChVir22534/2021	EPI_ISL_869121	2021-01-16	Europe / Germany / Schleswig-Holstein	Human	Original			Illumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/SH-ChVir22539/2021	EPI_ISL_869122	2021-01-16	Europe / Germany / Schleswig-Holstein	Human	Original			Illumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33007/2021	EPI_ISL_870011	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33068/2021	EPI_ISL_870073	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34221/2021	EPI_ISL_871231	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-34227/2021	EPI_ISL_871237	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34234/2021	EPI_ISL_871244	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34275/2021	EPI_ISL_871285	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-34302/2021	EPI_ISL_871312	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34332/2021	EPI_ISL_871343	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34354/2021	EPI_ISL_871365	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34363/2021	EPI_ISL_871374	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34365/2021	EPI_ISL_871376	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34400/2021	EPI_ISL_871411	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34432/2021	EPI_ISL_871443	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-FFFF53/2021	EPI_ISL_873982	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FEC79D/2021	EPI_ISL_873984	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FEC38A/2021	EPI_ISL_873988	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1000489/2021	EPI_ISL_873992	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FB5162/2021	EPI_ISL_882016	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FAF796/2021	EPI_ISL_882018	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FAF778/2021	EPI_ISL_882042	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FB519F/2021	EPI_ISL_882079	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FB5566/2021	EPI_ISL_882082	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FAF8DF/2021	EPI_ISL_882113	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10B4F83/2021	EPI_ISL_885955	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-109DE83/2021	EPI_ISL_885963	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Czech Republic/IAB20_016_120/2020	EPI_ISL_889427	2020-10-05	Europe / Czech Republic / Olomouc	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, reference mapping			B.1.177.8	GV
hCoV-19/England/ALDP-10E272A/2021	EPI_ISL_907700	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10E248D/2021	EPI_ISL_907728	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10E50A4/2021	EPI_ISL_907806	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Germany/SH-ChVir22771/2021	EPI_ISL_912238	2021-01-15	Europe / Germany / Schleswig-Holstein	Human	Original			MiSeq	Bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/SH-ChVir22775/2021	EPI_ISL_912241	2021-01-16	Europe / Germany / Schleswig-Holstein	Human	Original			MiSeq	Bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-ChVir23058/2021	EPI_ISL_912267	2021-01-24	Europe / Germany / Berlin	Human	Original			MiSeq	Bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-10F9377/2021	EPI_ISL_917210	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Germany/BE-IMB15401/2021	EPI_ISL_918431	2021-01-28	Europe / Germany / Berlin	Human	Original	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1			B.1.177	GV
hCoV-19/Germany/BE-IMB15402/2021	EPI_ISL_918432	2021-01-28	Europe / Germany / Berlin	Human	Original	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-IMB15403/2021	EPI_ISL_918433	2021-01-28	Europe / Germany / Berlin	Human	Original	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/LOND-1289495/2021	EPI_ISL_919833	2021-01-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LOND-12894C2/2021	EPI_ISL_919836	2021-01-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LOND-E506B/2020	EPI_ISL_920854	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BD815/2021	EPI_ISL_923020	2021-01-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BDCBF/2021	EPI_ISL_923092	2021-01-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BDD61/2021	EPI_ISL_923103	2021-01-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/SHEF-CBFD7/2020	EPI_ISL_924425	2020-10-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Denmark/DCGC-35776/2021	EPI_ISL_926917	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-38033/2021	EPI_ISL_929174	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38057/2021	EPI_ISL_929198	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38062/2021	EPI_ISL_929203	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38154/2021	EPI_ISL_929295	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39009/2020	EPI_ISL_930151	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	GV
hCoV-19/Denmark/DCGC-39042/2021	EPI_ISL_930184	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39085/2020	EPI_ISL_930227	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39126/2021	EPI_ISL_930268	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/England/QEUH-114ADD2/2021	EPI_ISL_932732	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Netherlands/ZH-RIVM-11300/2021	EPI_ISL_943530	2021-01-23	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/ZH-RIVM-11301/2021	EPI_ISL_943531	2021-01-23	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/ZH-RIVM-11369/2021	EPI_ISL_943543	2021-01-20	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/ZH-RIVM-11370/2021	EPI_ISL_943544	2021-01-20	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/ZH-RIVM-11371/2021	EPI_ISL_943545	2021-01-23	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/ZH-RIVM-11372/2021	EPI_ISL_943546	2021-01-19	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Scotland/QEUH-116F33F/2021	EPI_ISL_948406	2021-01-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/LIVE-DF0E57/2021	EPI_ISL_949684	2021-01-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORW-22169C/2021	EPI_ISL_950551	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-2216BA/2020	EPI_ISL_950553	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F4A5C/2020	EPI_ISL_950595	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NOTT-24D23C/2021	EPI_ISL_950697	2021-02-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-24D3B1/2020	EPI_ISL_950708	2020-12-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-4BFFE1/2021	EPI_ISL_951820	2021-01-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C0B8F/2021	EPI_ISL_951976	2021-01-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-1196F86/2021	EPI_ISL_959070	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1196065/2021	EPI_ISL_959072	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-119F3DC/2021	EPI_ISL_963815	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-119F512/2021	EPI_ISL_963960	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11B2AFC/2021	EPI_ISL_963961	2021-01-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-119F381/2021	EPI_ISL_963977	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Norway/1437/2021	EPI_ISL_965005	2021-01-19	Europe / Norway / Rogaland	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Norway/1444/2021	EPI_ISL_965006	2021-01-18	Europe / Norway / Rogaland	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Norway/1449/2021	EPI_ISL_965007	2021-01-19	Europe / Norway / Rogaland	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/England/ALDP-11C67EF/2021	EPI_ISL_969911	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-39510/2021	EPI_ISL_970906	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40431/2021	EPI_ISL_972108	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-40451/2021	EPI_ISL_972128	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40472/2021	EPI_ISL_972149	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.86	GV
hCoV-19/Denmark/DCGC-41484/2021	EPI_ISL_973161	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41725/2021	EPI_ISL_973402	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-41750/2021	EPI_ISL_973427	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-41788/2021	EPI_ISL_973465	2021-02-01	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/England/CAMC-1234B76/2021	EPI_ISL_986733	2021-02-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1183775/2021	EPI_ISL_991012	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-118661B/2021	EPI_ISL_991260	2021-01-25	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-BC93F0/2020	EPI_ISL_991320	2020-11-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-BC8C41/2020	EPI_ISL_991325	2020-11-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-BCAF0A/2020	EPI_ISL_991348	2020-11-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-10EF8FD/2021	EPI_ISL_992324	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10EE542/2021	EPI_ISL_992611	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/EDB14621/2020	EPI_ISL_997114	2020-12-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB14859/2021	EPI_ISL_997164	2021-01-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Wales/PHWC-4C420E/2021	EPI_ISL_999704	2021-01-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-4C42C2/2021	EPI_ISL_999714	2021-01-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C4383/2021	EPI_ISL_999724	2021-01-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-4C458D/2021	EPI_ISL_999750	2021-01-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Switzerland/SZ-ETHZ-450570/2021	EPI_ISL_1002542	2021-01-08	Europe / Switzerland / Schwyz	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177	GV
hCoV-19/Switzerland/VS-ETHZ-450728/2021	EPI_ISL_1002555	2021-01-08	Europe / Switzerland / Valais	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Switzerland/SO-ETHZ-471222/2021	EPI_ISL_1003824	2021-01-28	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Switzerland/SO-ETHZ-480182/2021	EPI_ISL_1003891	2021-01-30	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Switzerland/SO-ETHZ-480181/2021	EPI_ISL_1003893	2021-01-30	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Austria/CeMM2094/2021	EPI_ISL_1008385	2021-01-07	Europe / Austria / Vienna / Wien-Stadt / Wien	Human	Original	Swab		Illumina NovaSeq	bwa			B.1.177	GV
hCoV-19/Sweden/21-20022/2021	EPI_ISL_1008408	2021-01-11	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N			B.1.177.80	GV
hCoV-19/Sweden/21-20412/2020	EPI_ISL_1008434	2020-12-27	Europe / Sweden / Uppsala	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N			B.1.177.80	GV
hCoV-19/Sweden/21-50569/2021	EPI_ISL_1008457	2021-01-20	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Australia/NSW-R0017/2021	EPI_ISL_1010702	2021-01-28	Oceania / Australia / New South Wales / Sydney	Human	Original			Oxford Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/ZE-RIVM-11636/2021	EPI_ISL_1014284	2021-01-21	Europe / Netherlands / Zeeland	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-125DDDB/2021	EPI_ISL_1019045	2021-02-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/Denmark/DCGC-42454/2021	EPI_ISL_1022732	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-42495/2021	EPI_ISL_1022773	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44747/2021	EPI_ISL_1025125	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44840/2021	EPI_ISL_1025218	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44842/2021	EPI_ISL_1025220	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44848/2021	EPI_ISL_1025226	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-UK-Hal-1/2021	EPI_ISL_1034761	2021-02	Europe / Germany / Saxony-Anhalt	Human	Original			Illumina MiniSeq	BWA 0.7.17, bcftools 1.10.2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-UK-Hal-2/2021	EPI_ISL_1034762	2021-02	Europe / Germany / Saxony-Anhalt	Human	Original			Illumina MiniSeq	BWA 0.7.17, bcftools 1.10.2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Switzerland/AG-UZH-IMV-3ba3ce2e/2021	EPI_ISL_1039808	2021-01-21	Europe / Switzerland / Aargau	Human	Original			Illumina	SMALT, 15% ambiguity threshold			B.1.177.62	GV
hCoV-19/England/ALDP-12A00C1/2021	EPI_ISL_1043047	2021-02-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1198EF0/2021	EPI_ISL_1044054	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-128940E/2021	EPI_ISL_1044414	2021-02-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1289A93/2021	EPI_ISL_1044415	2021-02-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/NORT-1B86FF8/2021	EPI_ISL_1051214	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORT-1B8706D/2021	EPI_ISL_1051218	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-2296C1/2021	EPI_ISL_1051510	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-2297CE/2021	EPI_ISL_1051516	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-2298DA/2020	EPI_ISL_1051517	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-2298E9/2021	EPI_ISL_1051518	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F524D7/2021	EPI_ISL_1051595	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Wales/PHWC-4C72B0/2021	EPI_ISL_1052527	2021-01-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/PHWC-4C7784/2021	EPI_ISL_1052599	2021-02-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/ALDP-1198A1A/2021	EPI_ISL_1057732	2021-01-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Northern Ireland/RAND-1267B2F/2021	EPI_ISL_1057768	2021-02-03	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/Scotland/QEUH-126971A/2021	EPI_ISL_1063201	2021-02-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Northern Ireland/RAND-12683DB/2021	EPI_ISL_1063214	2021-02-03	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/Scotland/QEUH-1269729/2021	EPI_ISL_1063243	2021-02-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Northern Ireland/RAND-12879A7/2021	EPI_ISL_1063293	2021-02-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/Sweden/21-51003/2021	EPI_ISL_1064551	2021-01-27	Europe / Sweden / Kalmar	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N	NS7b_E39stop results in 11.6% truncation of the protein sequence. NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Sweden/21-50668/2021	EPI_ISL_1064552	2021-01-27	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Sweden/21-20593/2020	EPI_ISL_1064553	2020-12-10	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Sweden/21-51193/2021	EPI_ISL_1064554	2021-02-10	Europe / Sweden / Halland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N	NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/Denmark/DCGC-46342/2020	EPI_ISL_1065852	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46344/2021	EPI_ISL_1065854	2021-02-15	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46349/2021	EPI_ISL_1065859	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/MILK-12B5375/2021	EPI_ISL_1069658	2021-02-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-13439/2021	EPI_ISL_1089836	2021-01-26	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/ZH-RIVM-13809/2021	EPI_ISL_1089898	2021-02-03	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/ZH-RIVM-13821/2021	EPI_ISL_1089899	2021-02-03	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/England/QEUH-99806E/2020	EPI_ISL_537162	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9980AA/2020	EPI_ISL_537182	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/CVR3982/2020	EPI_ISL_540779	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR3987/2020	EPI_ISL_540784	2020-08-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR3989/2020	EPI_ISL_540786	2020-09-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR3999/2020	EPI_ISL_540796	2020-09-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/MILK-99D11B/2020	EPI_ISL_549825	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9AA6A3/2020	EPI_ISL_550851	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9760EE/2020	EPI_ISL_552733	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-975EB8/2020	EPI_ISL_552767	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CD67D/2020	EPI_ISL_566306	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CCFDD/2020	EPI_ISL_566327	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CDEA2/2020	EPI_ISL_566337	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CD051/2020	EPI_ISL_566343	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CCFFB/2020	EPI_ISL_566345	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CD5DA/2020	EPI_ISL_566361	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CDDE1/2020	EPI_ISL_566369	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CD09D/2020	EPI_ISL_566393	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9C5C64/2020	EPI_ISL_567655	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9C51CF/2020	EPI_ISL_567661	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9B8930/2020	EPI_ISL_568225	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9B8D61/2020	EPI_ISL_568228	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9B8A4C/2020	EPI_ISL_568241	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9B8226/2020	EPI_ISL_568242	2020-09-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9B9C63/2020	EPI_ISL_568256	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9B9DAC/2020	EPI_ISL_568258	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9B8ED7/2020	EPI_ISL_568260	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9B82DB/2020	EPI_ISL_568262	2020-09-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9B8D25/2020	EPI_ISL_568283	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9B8B0D/2020	EPI_ISL_568285	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9B8271/2020	EPI_ISL_568287	2020-09-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9B9D24/2020	EPI_ISL_568288	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/PHWC-16C72A/2020	EPI_ISL_574086	2020-09-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16C739/2020	EPI_ISL_574087	2020-09-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16C7EE/2020	EPI_ISL_574096	2020-09-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16C8CD/2020	EPI_ISL_574107	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-9DA84A/2020	EPI_ISL_575390	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9DAA80/2020	EPI_ISL_575391	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DA7D4/2020	EPI_ISL_575393	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CB82E/2020	EPI_ISL_575409	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CAF48/2020	EPI_ISL_575418	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CA9A4/2020	EPI_ISL_575428	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CBD2F/2020	EPI_ISL_575434	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CAD3F/2020	EPI_ISL_575450	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CCC9A/2020	EPI_ISL_575452	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CBA19/2020	EPI_ISL_575462	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CAACF/2020	EPI_ISL_575469	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CBBDA/2020	EPI_ISL_575488	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CC09E/2020	EPI_ISL_575491	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9D919B/2020	EPI_ISL_576705	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9D91AA/2020	EPI_ISL_576706	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9D94ED/2020	EPI_ISL_576734	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9D959F/2020	EPI_ISL_576741	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/ALDP-9D9896/2020	EPI_ISL_576765	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9D990C/2020	EPI_ISL_576771	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9D9966/2020	EPI_ISL_576777	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9D9975/2020	EPI_ISL_576778	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9D9E3A/2020	EPI_ISL_576821	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9DA0E8/2020	EPI_ISL_576845	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9DA14F/2020	EPI_ISL_576851	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9EA70E/2020	EPI_ISL_580091	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E9F61/2020	EPI_ISL_580096	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9EA504/2020	EPI_ISL_580099	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E6A90/2020	EPI_ISL_580623	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9EE852/2020	EPI_ISL_580652	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.65	GV
hCoV-19/Wales/MILK-9E2126/2020	EPI_ISL_581259	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E98EE/2020	EPI_ISL_584262	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-16F8BB/2020	EPI_ISL_586033	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16F8CA/2020	EPI_ISL_586034	2020-10-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47CD22/2020	EPI_ISL_586040	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47CF77/2020	EPI_ISL_586076	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47D0DD/2020	EPI_ISL_586097	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47D0EC/2020	EPI_ISL_586098	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47D107/2020	EPI_ISL_586100	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47D459/2020	EPI_ISL_586144	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A1DAAE/2020	EPI_ISL_587377	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A1DA9F/2020	EPI_ISL_587384	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A1E59D/2020	EPI_ISL_587394	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A1EFDB/2020	EPI_ISL_587471	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F54FA/2020	EPI_ISL_588691	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F3492/2020	EPI_ISL_588708	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F327A/2020	EPI_ISL_588710	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F333B/2020	EPI_ISL_588721	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F9098/2020	EPI_ISL_588734	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F904D/2020	EPI_ISL_588737	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F5797/2020	EPI_ISL_588752	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F6295/2020	EPI_ISL_588786	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F92DE/2020	EPI_ISL_588808	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F63FC/2020	EPI_ISL_588809	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F6277/2020	EPI_ISL_589004	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F956C/2020	EPI_ISL_589061	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9CFACA/2020	EPI_ISL_590013	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9CF58D/2020	EPI_ISL_590018	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9CEC89/2020	EPI_ISL_590043	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9CEF80/2020	EPI_ISL_590049	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9CEF71/2020	EPI_ISL_590059	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9CF3CF/2020	EPI_ISL_590074	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-9CE74C/2020	EPI_ISL_590085	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/BIRM-6577D/2020	EPI_ISL_594580	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A02936/2020	EPI_ISL_595843	2020-09-28	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/QEUH-A02972/2020	EPI_ISL_595844	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A31127/2020	EPI_ISL_595867	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A313B8/2020	EPI_ISL_595884	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A314C4/2020	EPI_ISL_595895	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/SHEF-C477C/2020	EPI_ISL_596197	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/ALDP-A510E8/2020	EPI_ISL_597577	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A51446/2020	EPI_ISL_598017	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-A51543/2020	EPI_ISL_598026	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A51CB7/2020	EPI_ISL_598041	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A52797/2020	EPI_ISL_598068	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A5159E/2020	EPI_ISL_598070	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A511A9/2020	EPI_ISL_598111	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A52409/2020	EPI_ISL_598117	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A1E0AB/2020	EPI_ISL_598888	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A2163A/2020	EPI_ISL_598891	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A1EE56/2020	EPI_ISL_598896	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1EA70/2020	EPI_ISL_598897	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A0B88B/2020	EPI_ISL_599353	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-A0B047/2020	EPI_ISL_599370	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A0BD04/2020	EPI_ISL_599379	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-A0BBCE/2020	EPI_ISL_599388	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A0B91F/2020	EPI_ISL_599393	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A0BC43/2020	EPI_ISL_599409	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A0C37A/2020	EPI_ISL_599416	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A0B557/2020	EPI_ISL_599426	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A0BCBC/2020	EPI_ISL_599429	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A0B79D/2020	EPI_ISL_599449	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-A0BBDD/2020	EPI_ISL_599453	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F392A/2020	EPI_ISL_600800	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F2D2F/2020	EPI_ISL_600805	2020-09-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9F2E95/2020	EPI_ISL_600817	2020-09-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9F3D79/2020	EPI_ISL_600821	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F84AC/2020	EPI_ISL_600829	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9F59DD/2020	EPI_ISL_600830	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F6875/2020	EPI_ISL_600836	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F612F/2020	EPI_ISL_600837	2020-09-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9F858B/2020	EPI_ISL_600839	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9F682A/2020	EPI_ISL_600854	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F855E/2020	EPI_ISL_600859	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9F84E8/2020	EPI_ISL_600860	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9F8DED/2020	EPI_ISL_600866	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9F61C5/2020	EPI_ISL_600875	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9F9405/2020	EPI_ISL_600886	2020-09-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9F9951/2020	EPI_ISL_600893	2020-09-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9F7407/2020	EPI_ISL_600902	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DE6A6/2020	EPI_ISL_601217	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DEA8C/2020	EPI_ISL_601220	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9DEAF5/2020	EPI_ISL_601228	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-9DA91A/2020	EPI_ISL_601259	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-9E0902/2020	EPI_ISL_601273	2020-09-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A865CD/2020	EPI_ISL_606021	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A86CD7/2020	EPI_ISL_606045	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A87957/2020	EPI_ISL_606048	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A87447/2020	EPI_ISL_606059	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7C5AC/2020	EPI_ISL_607403	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7C81C/2020	EPI_ISL_607419	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7B76B/2020	EPI_ISL_607429	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6D34A/2020	EPI_ISL_608011	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6CE0E/2020	EPI_ISL_608014	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6CBCB/2020	EPI_ISL_608016	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6C34B/2020	EPI_ISL_608028	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A701A4/2020	EPI_ISL_608034	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-A68567/2020	EPI_ISL_608684	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A6B29A/2020	EPI_ISL_608737	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A69BA0/2020	EPI_ISL_608746	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/CAMC-A570F1/2020	EPI_ISL_609200	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/CAMC-A57352/2020	EPI_ISL_609203	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-A4FEE3/2020	EPI_ISL_609213	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-A52991/2020	EPI_ISL_609218	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-A47E63/2020	EPI_ISL_609221	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-A47D84/2020	EPI_ISL_609231	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-A477FF/2020	EPI_ISL_609236	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-A46E46/2020	EPI_ISL_609239	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-A4774A/2020	EPI_ISL_609248	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-A4748F/2020	EPI_ISL_609269	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A85E5A/2020	EPI_ISL_610293	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A8550A/2020	EPI_ISL_610295	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A84CE8/2020	EPI_ISL_610338	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A85449/2020	EPI_ISL_610346	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-47FDA7/2020	EPI_ISL_612809	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47FE0E/2020	EPI_ISL_612814	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-480004/2020	EPI_ISL_612842	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-480392/2020	EPI_ISL_612879	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-480417/2020	EPI_ISL_612885	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-480523/2020	EPI_ISL_612898	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48220C/2020	EPI_ISL_613204	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-482257/2020	EPI_ISL_613207	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-482460/2020	EPI_ISL_613220	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48255E/2020	EPI_ISL_613228	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-482794/2020	EPI_ISL_613241	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4827FE/2020	EPI_ISL_613245	2020-10-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4829E9/2020	EPI_ISL_613258	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-482A13/2020	EPI_ISL_613260	2020-10-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-482AD7/2020	EPI_ISL_613266	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-ABB802/2020	EPI_ISL_623517	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AAFE5A/2020	EPI_ISL_623527	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-ABBA84/2020	EPI_ISL_623542	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AB13CF/2020	EPI_ISL_623576	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A95D4B/2020	EPI_ISL_624809	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A95FAF/2020	EPI_ISL_624810	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A960D8/2020	EPI_ISL_624838	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A946E7/2020	EPI_ISL_624847	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A95EFD/2020	EPI_ISL_624851	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A95D87/2020	EPI_ISL_624854	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A960BA/2020	EPI_ISL_624872	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA221F/2020	EPI_ISL_624960	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA07D6/2020	EPI_ISL_624991	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA5777/2020	EPI_ISL_624998	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-AA0A64/2020	EPI_ISL_625202	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA17F3/2020	EPI_ISL_625211	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA0AEC/2020	EPI_ISL_625223	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA21A9/2020	EPI_ISL_625239	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-A85133/2020	EPI_ISL_625274	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-A85106/2020	EPI_ISL_625276	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/CAMC-A82E20/2020	EPI_ISL_625283	2020-10-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/CAMC-A8237C/2020	EPI_ISL_625284	2020-10-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/CAMC-A824E2/2020	EPI_ISL_625285	2020-10-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/NORW-F16E2/2020	EPI_ISL_627080	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/NORW-F1BF2/2020	EPI_ISL_627081	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Wales/PHWC-483502/2020	EPI_ISL_627829	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48372A/2020	EPI_ISL_627852	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A328E5/2020	EPI_ISL_628365	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A3291F/2020	EPI_ISL_628367	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A3341D/2020	EPI_ISL_628378	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A33635/2020	EPI_ISL_628397	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A33671/2020	EPI_ISL_628399	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A33680/2020	EPI_ISL_628400	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-A336EA/2020	EPI_ISL_628404	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A498BE/2020	EPI_ISL_628436	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A4998E/2020	EPI_ISL_628442	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A499BB/2020	EPI_ISL_628443	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4AE7F/2020	EPI_ISL_628457	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/QEUH-A4AF03/2020	EPI_ISL_628460	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A4AF4F/2020	EPI_ISL_628461	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4B315/2020	EPI_ISL_628465	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4B324/2020	EPI_ISL_628466	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A4B6B2/2020	EPI_ISL_628471	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A4B728/2020	EPI_ISL_628474	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A4B737/2020	EPI_ISL_628475	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4B773/2020	EPI_ISL_628477	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A4B782/2020	EPI_ISL_628478	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4B7BF/2020	EPI_ISL_628479	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/MILK-AC8204/2020	EPI_ISL_629700	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-ACEFF8/2020	EPI_ISL_629721	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ACE2B3/2020	EPI_ISL_629722	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD3AFF/2020	EPI_ISL_629758	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD1EE6/2020	EPI_ISL_629771	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD21FB/2020	EPI_ISL_629776	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD2771/2020	EPI_ISL_629785	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD06B2/2020	EPI_ISL_629791	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD2E30/2020	EPI_ISL_629796	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD300C/2020	EPI_ISL_629799	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A66D9E/2020	EPI_ISL_630680	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AAE6AE/2020	EPI_ISL_630719	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA30E7/2020	EPI_ISL_630727	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA4CF1/2020	EPI_ISL_630747	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA315D/2020	EPI_ISL_630752	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA507C/2020	EPI_ISL_630753	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA2622/2020	EPI_ISL_630776	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA4EEC/2020	EPI_ISL_630785	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE1E98/2020	EPI_ISL_633634	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE2732/2020	EPI_ISL_633651	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE2FB2/2020	EPI_ISL_633656	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD669E/2020	EPI_ISL_634211	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD5082/2020	EPI_ISL_634215	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD23F5/2020	EPI_ISL_634217	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD2BFD/2020	EPI_ISL_634218	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD525F/2020	EPI_ISL_634240	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ACCEC0/2020	EPI_ISL_634272	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AC7B64/2020	EPI_ISL_634299	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/NORT-2A600A/2020	EPI_ISL_638580	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11A0F3/2020	EPI_ISL_638590	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11A952/2020	EPI_ISL_638598	2020-11-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-486226/2020	EPI_ISL_639021	2020-10-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48639C/2020	EPI_ISL_639036	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4863AB/2020	EPI_ISL_639037	2020-10-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48655A/2020	EPI_ISL_639054	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4866B1/2020	EPI_ISL_639068	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4866C0/2020	EPI_ISL_639069	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-486754/2020	EPI_ISL_639075	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-486B58/2020	EPI_ISL_639113	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-486BA3/2020	EPI_ISL_639114	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-486BEF/2020	EPI_ISL_639117	2020-10-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-486D25/2020	EPI_ISL_639127	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-486D43/2020	EPI_ISL_639128	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B124F5/2020	EPI_ISL_642670	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-B12B87/2020	EPI_ISL_642688	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B12E8E/2020	EPI_ISL_642690	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-B12E33/2020	EPI_ISL_642697	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B12510/2020	EPI_ISL_642710	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B12EF7/2020	EPI_ISL_642759	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-B02DB1/2020	EPI_ISL_642770	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A8C7B2/2020	EPI_ISL_643080	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD1C0A/2020	EPI_ISL_643992	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AD4A76/2020	EPI_ISL_643994	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-B1A114/2020	EPI_ISL_645608	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1B984/2020	EPI_ISL_645638	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-B23D9C/2020	EPI_ISL_646208	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B32028/2020	EPI_ISL_646209	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24038/2020	EPI_ISL_646215	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B23BCF/2020	EPI_ISL_646231	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B23B65/2020	EPI_ISL_646242	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B23E7B/2020	EPI_ISL_646252	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2E11D/2020	EPI_ISL_646253	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B32125/2020	EPI_ISL_646255	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-B31B28/2020	EPI_ISL_646273	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B32091/2020	EPI_ISL_646274	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2DDA1/2020	EPI_ISL_646284	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B23B92/2020	EPI_ISL_646935	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B243D5/2020	EPI_ISL_646938	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B249B5/2020	EPI_ISL_646945	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24C16/2020	EPI_ISL_646965	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-B24180/2020	EPI_ISL_646971	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2DC77/2020	EPI_ISL_646977	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B1FEAF/2020	EPI_ISL_647509	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1A9C1/2020	EPI_ISL_647535	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B20F02/2020	EPI_ISL_647544	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B20CB0/2020	EPI_ISL_647559	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B1FF8E/2020	EPI_ISL_647561	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B20AC5/2020	EPI_ISL_647563	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1A493/2020	EPI_ISL_647591	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B2098C/2020	EPI_ISL_647593	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B48283/2020	EPI_ISL_649202	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B483BD/2020	EPI_ISL_649224	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B503C1/2020	EPI_ISL_649228	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B490B5/2020	EPI_ISL_649256	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B49167/2020	EPI_ISL_649285	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/EDB8208/2020	EPI_ISL_651520	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/Scotland/EDB8660/2020	EPI_ISL_651521	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/Scotland/EDB8661/2020	EPI_ISL_651522	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/Scotland/EDB9056/2020	EPI_ISL_651523	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/Scotland/EDB9175/2020	EPI_ISL_651524	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/Scotland/EDB8826/2020	EPI_ISL_652006	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8836/2020	EPI_ISL_652008	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8881/2020	EPI_ISL_652015	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8897/2020	EPI_ISL_652018	2020-10-28	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8898/2020	EPI_ISL_652019	2020-10-28	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8968/2020	EPI_ISL_652025	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8972/2020	EPI_ISL_652027	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8990/2020	EPI_ISL_652029	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB9006/2020	EPI_ISL_652032	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB9014/2020	EPI_ISL_652033	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB9206/2020	EPI_ISL_652049	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB9231/2020	EPI_ISL_652051	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB9257/2020	EPI_ISL_652055	2020-11-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/LIVE-DB40B3/2020	EPI_ISL_652078	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DB40C2/2020	EPI_ISL_652079	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DB41B0/2020	EPI_ISL_652081	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DB601B/2020	EPI_ISL_652089	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DB6039/2020	EPI_ISL_652090	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DB6057/2020	EPI_ISL_652091	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DB6093/2020	EPI_ISL_652092	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DB60C0/2020	EPI_ISL_652093	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DB644C/2020	EPI_ISL_652097	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DB645B/2020	EPI_ISL_652098	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B05783/2020	EPI_ISL_652197	2020-10-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-AAB5FF/2020	EPI_ISL_652800	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AAB629/2020	EPI_ISL_652802	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-AAB7DB/2020	EPI_ISL_652814	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-AAB841/2020	EPI_ISL_652817	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/QEUH-AAC646/2020	EPI_ISL_652863	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-AACA0E/2020	EPI_ISL_652885	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AACA3B/2020	EPI_ISL_652886	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AACA68/2020	EPI_ISL_652888	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-AACB38/2020	EPI_ISL_652897	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/QEUH-B65DBC/2020	EPI_ISL_655083	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6951A/2020	EPI_ISL_655093	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B65E8C/2020	EPI_ISL_655973	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-B5CED3/2020	EPI_ISL_655974	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46B5D/2020	EPI_ISL_655978	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B45B6D/2020	EPI_ISL_655980	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-B468CF/2020	EPI_ISL_655981	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46971/2020	EPI_ISL_655984	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B4616A/2020	EPI_ISL_655988	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62809/2020	EPI_ISL_656384	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B625F3/2020	EPI_ISL_656385	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-B63B69/2020	EPI_ISL_656388	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B634D7/2020	EPI_ISL_656389	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 8 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-B63826/2020	EPI_ISL_656392	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B63844/2020	EPI_ISL_656394	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B5A2D9/2020	EPI_ISL_658213	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B5464C/2020	EPI_ISL_658218	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B5A50D/2020	EPI_ISL_658241	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B55C94/2020	EPI_ISL_658251	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B51885/2020	EPI_ISL_658252	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B5A37C/2020	EPI_ISL_658261	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B549BC/2020	EPI_ISL_658263	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B55C85/2020	EPI_ISL_658265	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B51A9E/2020	EPI_ISL_658275	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B51A70/2020	EPI_ISL_658276	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B546B5/2020	EPI_ISL_658279	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/CAMC-B5183A/2020	EPI_ISL_658285	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B517D3/2020	EPI_ISL_658287	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B5612B/2020	EPI_ISL_658288	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-B5A549/2020	EPI_ISL_658294	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-B3881B/2020	EPI_ISL_658927	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B38392/2020	EPI_ISL_658937	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B393FB/2020	EPI_ISL_658944	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B3824A/2020	EPI_ISL_658954	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B34B52/2020	EPI_ISL_659535	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B343B4/2020	EPI_ISL_659538	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B35702/2020	EPI_ISL_659539	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B34B9E/2020	EPI_ISL_659581	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B340AE/2020	EPI_ISL_659584	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7F3F9/2020	EPI_ISL_661816	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7E406/2020	EPI_ISL_661831	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B7FF31/2020	EPI_ISL_661859	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B8284F/2020	EPI_ISL_661865	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7FEE9/2020	EPI_ISL_661868	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7F06B/2020	EPI_ISL_661878	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B825EE/2020	EPI_ISL_661888	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B7400C/2020	EPI_ISL_662208	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B75135/2020	EPI_ISL_662209	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6746A/2020	EPI_ISL_662220	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B752D8/2020	EPI_ISL_662237	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B749C5/2020	EPI_ISL_662240	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B7526F/2020	EPI_ISL_662245	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B737EA/2020	EPI_ISL_664859	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B7398A/2020	EPI_ISL_664863	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B73999/2020	EPI_ISL_664864	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B73BDF/2020	EPI_ISL_664871	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B73BFD/2020	EPI_ISL_664872	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B73C36/2020	EPI_ISL_664875	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B73C45/2020	EPI_ISL_664876	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B73C54/2020	EPI_ISL_664877	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B73D33/2020	EPI_ISL_664885	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B73DAC/2020	EPI_ISL_664888	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B7EE35/2020	EPI_ISL_667959	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B81628/2020	EPI_ISL_667992	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7C12F/2020	EPI_ISL_668386	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/MILK-B94938/2020	EPI_ISL_673821	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B9AED9/2020	EPI_ISL_673849	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B9947E/2020	EPI_ISL_673852	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B994E7/2020	EPI_ISL_673864	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B84C8D/2020	EPI_ISL_674160	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B85466/2020	EPI_ISL_674172	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B88524/2020	EPI_ISL_674178	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8C423/2020	EPI_ISL_674184	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B84C23/2020	EPI_ISL_674197	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B83F85/2020	EPI_ISL_674199	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B84AFC/2020	EPI_ISL_674201	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8C380/2020	EPI_ISL_674205	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B88463/2020	EPI_ISL_674210	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B84379/2020	EPI_ISL_674211	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8830C/2020	EPI_ISL_674212	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B850F9/2020	EPI_ISL_674223	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8C432/2020	EPI_ISL_674225	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B9274F/2020	EPI_ISL_675491	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-B92466/2020	EPI_ISL_675494	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B89F16/2020	EPI_ISL_675507	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B83091/2020	EPI_ISL_675526	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B82EE3/2020	EPI_ISL_675532	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B89E19/2020	EPI_ISL_675533	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B830DD/2020	EPI_ISL_675534	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B89D1C/2020	EPI_ISL_675542	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B894DB/2020	EPI_ISL_676003	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B9674B/2020	EPI_ISL_676016	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B965D8/2020	EPI_ISL_676019	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B96927/2020	EPI_ISL_676051	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B965BA/2020	EPI_ISL_676056	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B9680C/2020	EPI_ISL_676069	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B9440A/2020	EPI_ISL_676087	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B96796/2020	EPI_ISL_676139	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B94EB1/2020	EPI_ISL_676147	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/204541203/2020	EPI_ISL_678669	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/204541206/2020	EPI_ISL_678670	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/204700489/2020	EPI_ISL_678706	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/BIRM-6A06E/2020	EPI_ISL_679016	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6A15C/2020	EPI_ISL_679025	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6A6F3/2020	EPI_ISL_679073	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6A72D/2020	EPI_ISL_679076	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6A74B/2020	EPI_ISL_679078	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6A75A/2020	EPI_ISL_679079	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6A81B/2020	EPI_ISL_679089	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/NOTT-1185D8/2020	EPI_ISL_679926	2020-10-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11A1E1/2020	EPI_ISL_679932	2020-11-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11F322/2020	EPI_ISL_679962	2020-11-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-B2BF43/2020	EPI_ISL_680039	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-B2C05E/2020	EPI_ISL_680048	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-B2C06D/2020	EPI_ISL_680049	2020-11-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-B2C188/2020	EPI_ISL_680064	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-B2CFCA/2020	EPI_ISL_680093	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-B2CFF7/2020	EPI_ISL_680095	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-48EA08/2020	EPI_ISL_680947	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48EABD/2020	EPI_ISL_680958	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48EBBA/2020	EPI_ISL_680973	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-BAA3B9/2020	EPI_ISL_681351	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAB44C/2020	EPI_ISL_681356	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BA9E31/2020	EPI_ISL_681380	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAA1EC/2020	EPI_ISL_681389	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BA99D6/2020	EPI_ISL_681391	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-BAAC09/2020	EPI_ISL_681392	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Spain/IB-IBV-99010780/2020	EPI_ISL_691671	2020-10-06	Europe / Spain / Balear Islands / Palma de Mallorca	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Spain/IB-IBV-99010788/2020	EPI_ISL_691676	2020-10-17	Europe / Spain / Balear Islands / Palma de Mallorca	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/England/ALDP-BB2891/2020	EPI_ISL_702704	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-BB8C08/2020	EPI_ISL_702767	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCABAC/2020	EPI_ISL_703294	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/LIVE-DC478E/2020	EPI_ISL_705905	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/MILK-B3D148/2020	EPI_ISL_706223	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3D816/2020	EPI_ISL_706238	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3E165/2020	EPI_ISL_706263	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3E174/2020	EPI_ISL_706264	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-BE9011/2020	EPI_ISL_708845	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/MILK-BEE4B6/2020	EPI_ISL_708848	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BE8E09/2020	EPI_ISL_708866	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BE9530/2020	EPI_ISL_708870	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BE8F51/2020	EPI_ISL_708892	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BE911E/2020	EPI_ISL_708894	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BEB088/2020	EPI_ISL_708910	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-BE8EAF/2020	EPI_ISL_708917	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-BEB440/2020	EPI_ISL_708922	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-BEB48C/2020	EPI_ISL_708933	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C06086/2020	EPI_ISL_709437	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C06D70/2020	EPI_ISL_709445	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C0645D/2020	EPI_ISL_709461	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-C16496/2020	EPI_ISL_709464	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-C0602C/2020	EPI_ISL_709468	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-C0655A/2020	EPI_ISL_709471	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C1494E/2020	EPI_ISL_709472	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C06244/2020	EPI_ISL_709479	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-14445/2020	EPI_ISL_711772	2020-11-30	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177	GV
hCoV-19/England/CAMC-C3FBED/2020	EPI_ISL_719500	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C4406E/2020	EPI_ISL_719540	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C441A7/2020	EPI_ISL_719551	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C443DE/2020	EPI_ISL_719576	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB0A24/2020	EPI_ISL_720504	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB1DB1/2020	EPI_ISL_720509	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BABF4B/2020	EPI_ISL_720520	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/MILK-BB0E37/2020	EPI_ISL_720534	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-BB1D2A/2020	EPI_ISL_720573	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAFCAA/2020	EPI_ISL_720579	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB0E46/2020	EPI_ISL_720582	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-BB1A8D/2020	EPI_ISL_720589	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B9E1DC/2020	EPI_ISL_721131	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BA2D1D/2020	EPI_ISL_721136	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-B9FAFE/2020	EPI_ISL_721142	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BA3541/2020	EPI_ISL_721152	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B76073/2020	EPI_ISL_723728	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B76161/2020	EPI_ISL_723739	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B762AA/2020	EPI_ISL_723750	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B7635C/2020	EPI_ISL_723758	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B76477/2020	EPI_ISL_723763	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B764E0/2020	EPI_ISL_723765	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B76723/2020	EPI_ISL_723776	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B7676F/2020	EPI_ISL_723778	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B769B4/2020	EPI_ISL_723792	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B769E1/2020	EPI_ISL_723795	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B76A39/2020	EPI_ISL_723798	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-B7BC3E/2020	EPI_ISL_724043	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-BBB7B9/2020	EPI_ISL_724067	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMC-BBB977/2020	EPI_ISL_724073	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMC-BBB9FF/2020	EPI_ISL_724078	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMC-BBC044/2020	EPI_ISL_724120	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMC-BBC34B/2020	EPI_ISL_724125	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-BBC6E8/2020	EPI_ISL_724174	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-496B37/2020	EPI_ISL_726690	2020-11-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-496C07/2020	EPI_ISL_726702	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-496CAD/2020	EPI_ISL_726711	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-496D40/2020	EPI_ISL_726721	2020-11-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-496D8C/2020	EPI_ISL_726725	2020-11-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-496E01/2020	EPI_ISL_726733	2020-11-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-496E10/2020	EPI_ISL_726734	2020-11-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-496E3E/2020	EPI_ISL_726735	2020-11-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-496EA7/2020	EPI_ISL_726742	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-496F0E/2020	EPI_ISL_726748	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4970BF/2020	EPI_ISL_726775	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-497231/2020	EPI_ISL_726799	2020-11-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-498E69/2020	EPI_ISL_727220	2020-11-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-498F57/2020	EPI_ISL_727233	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-498FA2/2020	EPI_ISL_727238	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/Wales/PHWC-499017/2020	EPI_ISL_727245	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4990F9/2020	EPI_ISL_727257	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-499132/2020	EPI_ISL_727260	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-499141/2020	EPI_ISL_727261	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-499150/2020	EPI_ISL_727262	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4991C9/2020	EPI_ISL_727269	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4991E7/2020	EPI_ISL_727271	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4992B7/2020	EPI_ISL_727283	2020-12-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-C3DEF5/2020	EPI_ISL_730878	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3B668/2020	EPI_ISL_730885	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3DBC1/2020	EPI_ISL_730886	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3DEC8/2020	EPI_ISL_730893	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-C3A371/2020	EPI_ISL_731204	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-C3C4D6/2020	EPI_ISL_731211	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3B853/2020	EPI_ISL_731249	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3A6F0/2020	EPI_ISL_731268	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3AD55/2020	EPI_ISL_731278	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C31662/2020	EPI_ISL_731295	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C2329C/2020	EPI_ISL_733807	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C2FC0B/2020	EPI_ISL_733825	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C2CE44/2020	EPI_ISL_733853	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C2D405/2020	EPI_ISL_733862	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C2FB2C/2020	EPI_ISL_733872	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C617C0/2020	EPI_ISL_735701	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C61FB9/2020	EPI_ISL_735764	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C6165A/2020	EPI_ISL_735769	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C5801C/2020	EPI_ISL_736010	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-C588E7/2020	EPI_ISL_736011	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C58911/2020	EPI_ISL_736013	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C5BD12/2020	EPI_ISL_736059	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C57E5F/2020	EPI_ISL_736061	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C57D9E/2020	EPI_ISL_736074	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C58717/2020	EPI_ISL_736106	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-C586FC/2020	EPI_ISL_736164	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/NORW-222E93/2020	EPI_ISL_741541	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49DCD3/2020	EPI_ISL_742896	2020-11-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49F3DC/2020	EPI_ISL_743209	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49F406/2020	EPI_ISL_743212	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49F5C7/2020	EPI_ISL_743238	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49F80A/2020	EPI_ISL_743273	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-19763/2020	EPI_ISL_747769	2020-12-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177	GV
hCoV-19/Denmark/DCGC-20212/2020	EPI_ISL_748052	2020-11-30	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177	GV
hCoV-19/Denmark/DCGC-20354/2020	EPI_ISL_748134	2020-09-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.8	GV
hCoV-19/Denmark/DCGC-18250/2020	EPI_ISL_749320	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18291/2020	EPI_ISL_749321	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18292/2020	EPI_ISL_749322	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18313/2020	EPI_ISL_749323	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18328/2020	EPI_ISL_749324	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18374/2020	EPI_ISL_749325	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18383/2020	EPI_ISL_749326	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18384/2020	EPI_ISL_749327	2020-12-07	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18392/2020	EPI_ISL_749328	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18416/2020	EPI_ISL_749329	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18420/2020	EPI_ISL_749330	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18456/2020	EPI_ISL_749331	2020-12-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18467/2020	EPI_ISL_749332	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18480/2020	EPI_ISL_749333	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18496/2020	EPI_ISL_749335	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18499/2020	EPI_ISL_749336	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18554/2020	EPI_ISL_749338	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18564/2020	EPI_ISL_749339	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18594/2020	EPI_ISL_749341	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18603/2020	EPI_ISL_749342	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-18635/2020	EPI_ISL_749346	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17272/2020	EPI_ISL_750345	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17387/2020	EPI_ISL_750346	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17396/2020	EPI_ISL_750347	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17403/2020	EPI_ISL_750348	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17404/2020	EPI_ISL_750349	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17407/2020	EPI_ISL_750350	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17408/2020	EPI_ISL_750351	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17424/2020	EPI_ISL_750352	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17436/2020	EPI_ISL_750353	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17466/2020	EPI_ISL_750355	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17489/2020	EPI_ISL_750356	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17499/2020	EPI_ISL_750357	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17512/2020	EPI_ISL_750358	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17517/2020	EPI_ISL_750359	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17551/2020	EPI_ISL_750360	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17610/2020	EPI_ISL_750361	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17623/2020	EPI_ISL_750362	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17640/2020	EPI_ISL_750364	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-17741/2020	EPI_ISL_750367	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Scotland/QEUH-C4BC54/2020	EPI_ISL_757104	2020-12-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Stretches of NNNs (4.71% of overall sequence).		B.1.177.5	GV
hCoV-19/Scotland/QEUH-C30FD1/2020	EPI_ISL_757122	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177	GV
hCoV-19/Scotland/QEUH-C30C8F/2020	EPI_ISL_757124	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177	GV
hCoV-19/Scotland/QEUH-C30F86/2020	EPI_ISL_757126	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177	GV
hCoV-19/Scotland/QEUH-C30CAD/2020	EPI_ISL_757128	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.5	GV
hCoV-19/Scotland/QEUH-C30D31/2020	EPI_ISL_757129	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.8	GV
hCoV-19/Scotland/QEUH-C33651/2020	EPI_ISL_757137	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.09%.		B.1.177	GV
hCoV-19/Denmark/DCGC-21374/2020	EPI_ISL_757896	2020-12-21	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21382/2020	EPI_ISL_757897	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-21429/2020	EPI_ISL_757899	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/QEUH-CC2921/2020	EPI_ISL_760741	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC3DBB/2020	EPI_ISL_760751	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CBE472/2020	EPI_ISL_760752	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-CB4263/2020	EPI_ISL_761027	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CB31D0/2020	EPI_ISL_761043	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB42BE/2020	EPI_ISL_761060	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C1E8A1/2020	EPI_ISL_761074	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB4D26/2020	EPI_ISL_761084	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB403C/2020	EPI_ISL_761111	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-CA513B/2020	EPI_ISL_762327	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMB-1BC8A0/2020	EPI_ISL_764287	2020-11-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1BCB01/2020	EPI_ISL_764293	2020-12-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1BCB4D/2020	EPI_ISL_764295	2020-12-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1BCC95/2020	EPI_ISL_764298	2020-12-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1BCCB3/2020	EPI_ISL_764299	2020-12-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-4A57D7/2020	EPI_ISL_764922	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A6062/2020	EPI_ISL_764994	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/ALDP-C3C4F4/2020	EPI_ISL_767217	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C3BBF0/2020	EPI_ISL_767231	2020-12-11	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C230DE/2020	EPI_ISL_767241	2020-12-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C22FE1/2020	EPI_ISL_767242	2020-12-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C22F96/2020	EPI_ISL_767247	2020-12-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/Wales/ALDP-C22F87/2020	EPI_ISL_767248	2020-12-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C3A7DF/2020	EPI_ISL_767258	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C3A6B4/2020	EPI_ISL_767259	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C3A6C3/2020	EPI_ISL_767261	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-C3CFE4/2020	EPI_ISL_767277	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C3BF03/2020	EPI_ISL_767282	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C3BEE8/2020	EPI_ISL_767286	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C3D02C/2020	EPI_ISL_767289	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-C04DBE/2020	EPI_ISL_767298	2020-12-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C6FEBE/2020	EPI_ISL_769112	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C4BBDF/2020	EPI_ISL_769802	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C53424/2020	EPI_ISL_769808	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/CAMC-C987C0/2020	EPI_ISL_777511	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CEB8AD/2020	EPI_ISL_781475	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CECFE3/2020	EPI_ISL_781502	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D06647/2020	EPI_ISL_781504	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-CC93A4/2020	EPI_ISL_782062	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CF1419/2020	EPI_ISL_782082	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-CC8ED1/2020	EPI_ISL_782084	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CED1CE/2020	EPI_ISL_782085	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D0BFA1/2020	EPI_ISL_782093	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C25CC9/2020	EPI_ISL_782872	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C26132/2020	EPI_ISL_782877	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B78FED/2020	EPI_ISL_783406	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-23063/2020	EPI_ISL_793508	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177	GV
hCoV-19/Denmark/DCGC-25389/2020	EPI_ISL_794871	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-D9FCE7/2020	EPI_ISL_797022	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D41525/2020	EPI_ISL_798384	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D14FC3/2020	EPI_ISL_799605	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D1F4D8/2020	EPI_ISL_799616	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CE20CC/2020	EPI_ISL_799638	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CE21D8/2020	EPI_ISL_799665	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D18E1D/2020	EPI_ISL_799707	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D1AC5D/2020	EPI_ISL_799709	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/205390566/2020	EPI_ISL_811095	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205390634/2020	EPI_ISL_811100	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/OXON-F43F32/2020	EPI_ISL_819816	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-E30995/2021	EPI_ISL_821204	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-E319B2/2021	EPI_ISL_821246	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-E3517A/2021	EPI_ISL_821268	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-4AEB3C/2020	EPI_ISL_822506	2020-12-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AEC75/2020	EPI_ISL_822518	2020-12-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AE5F2/2020	EPI_ISL_822531	2020-12-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AEE06/2020	EPI_ISL_822563	2020-12-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AEFD6/2020	EPI_ISL_822590	2020-12-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AD414/2020	EPI_ISL_823715	2020-12-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4ADF5F/2020	EPI_ISL_823803	2020-12-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/USA/NY-NYCPHL-001705/2020	EPI_ISL_823851	2020-12-09	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-EE1FCE/2021	EPI_ISL_835106	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-EE2033/2021	EPI_ISL_835126	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ECBC4B/2021	EPI_ISL_836381	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ECBECD/2021	EPI_ISL_836405	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMB-A9B8BD/2021	EPI_ISL_838000	2021-01-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A9B99C/2021	EPI_ISL_838008	2021-01-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A9BCA2/2021	EPI_ISL_838031	2021-01-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A9BDEB/2021	EPI_ISL_838040	2021-01-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A9BE9D/2021	EPI_ISL_838042	2021-01-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR6034/2020	EPI_ISL_838055	2020-11-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6035/2020	EPI_ISL_838056	2020-11-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6041/2020	EPI_ISL_838058	2020-11-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6089/2020	EPI_ISL_838070	2020-11-28	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR6174/2020	EPI_ISL_838073	2020-11-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		Insertion of 1 nucleotides when compared to the reference sequence.	info	B.1.177.5	GV
hCoV-19/Scotland/CVR6177/2020	EPI_ISL_838076	2020-12-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6179/2020	EPI_ISL_838078	2020-12-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6181/2020	EPI_ISL_838080	2020-12-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6188/2020	EPI_ISL_838087	2020-12-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		Gap of 19 nucleotide(s) found at refpos 27568 (FRAMESHIFT confirmed by the submitter). NS7a without BLAST coverage. NSP11 without BLAST coverage.	info	B.1.177.5	GV
hCoV-19/Scotland/CVR6193/2020	EPI_ISL_838092	2020-12-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		Gap of 8 nucleotide(s) found at refpos 27386 (FRAMESHIFT confirmed by the submitter). NSP11 without BLAST coverage.	info	B.1.177.8	GV
hCoV-19/England/OXON-F4510D/2020	EPI_ISL_840319	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-29530/2021	EPI_ISL_843577	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29534/2021	EPI_ISL_843581	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Czech Republic/NRL_12030/2020	EPI_ISL_850667	2020-12-15	Europe / Czech Republic / Ústí nad Labem	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC-Medaka	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/USA/NY-NYCPHL-002137/2021	EPI_ISL_857201	2021-01-04	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Scotland/QEUH-E5023A/2021	EPI_ISL_858503	2021-01-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-E501F1/2021	EPI_ISL_858507	2021-01-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-E4D018/2021	EPI_ISL_858510	2021-01-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-E509BD/2021	EPI_ISL_858519	2021-01-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-E4D009/2021	EPI_ISL_858526	2021-01-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-E4D036/2021	EPI_ISL_858538	2021-01-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-E509EA/2021	EPI_ISL_858555	2021-01-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-E4D090/2021	EPI_ISL_858569	2021-01-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-D94480/2021	EPI_ISL_858587	2021-01-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-D8C816/2020	EPI_ISL_858590	2020-12-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-D9AD61/2021	EPI_ISL_858592	2021-01-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-D9AD9E/2021	EPI_ISL_858598	2021-01-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Wales/ALDP-C8BA30/2020	EPI_ISL_859006	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C8BA8B/2020	EPI_ISL_859009	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C8E7BE/2020	EPI_ISL_859013	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-C8E7AF/2020	EPI_ISL_859017	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-C8C48C/2020	EPI_ISL_859024	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-CADDE4/2020	EPI_ISL_859100	2020-12-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-CAD616/2020	EPI_ISL_859108	2020-12-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-FBB4BE/2021	EPI_ISL_863019	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FBC031/2021	EPI_ISL_863088	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-4B8EEB/2021	EPI_ISL_867542	2021-01-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-4B8EFA/2021	EPI_ISL_867543	2021-01-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-4B8FCA/2021	EPI_ISL_867556	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B9248/2021	EPI_ISL_867594	2021-01-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-4B9275/2021	EPI_ISL_867595	2021-01-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/TFCI-26FF053/2020	EPI_ISL_868877	2020-12-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.58	GV
hCoV-19/Denmark/DCGC-33177/2021	EPI_ISL_870182	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33181/2021	EPI_ISL_870186	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33226/2021	EPI_ISL_870231	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34463/2020	EPI_ISL_871474	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34473/2020	EPI_ISL_871484	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34484/2020	EPI_ISL_871495	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34507/2020	EPI_ISL_871518	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34528/2020	EPI_ISL_871539	2020-12-28	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34539/2020	EPI_ISL_871550	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34549/2020	EPI_ISL_871560	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34555/2020	EPI_ISL_871566	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 34 nucleotide(s) found at refpos 18633 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence. NSP14 without BLAST coverage.	info	B.1.177.86	GV
hCoV-19/England/MILK-102E31F/2021	EPI_ISL_873312	2021-01-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-1003E3D/2021	EPI_ISL_874613	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-1005150/2021	EPI_ISL_874626	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1005123/2021	EPI_ISL_874720	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1008409/2021	EPI_ISL_874722	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10069FD/2021	EPI_ISL_874729	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-1037252/2021	EPI_ISL_878876	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1036E31/2021	EPI_ISL_878985	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-10637F4/2021	EPI_ISL_879587	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-10637E5/2021	EPI_ISL_879599	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1030BC7/2021	EPI_ISL_880508	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1031346/2021	EPI_ISL_880523	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FA2669/2021	EPI_ISL_881833	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FA2F9B/2021	EPI_ISL_881872	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FA2E9E/2021	EPI_ISL_881892	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FB4DE7/2021	EPI_ISL_882134	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FAF49F/2021	EPI_ISL_882155	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FB5126/2021	EPI_ISL_882157	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FAF81B/2021	EPI_ISL_882168	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-FB5724/2021	EPI_ISL_882179	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FB4989/2021	EPI_ISL_882229	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10B78B2/2021	EPI_ISL_891838	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Belgium/rega-1779/2021	EPI_ISL_894210	2021-01-11	Europe / Belgium / Jumet	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.177	GV
hCoV-19/Switzerland/AG-ETHZ-440205/2021	EPI_ISL_899062	2021-01-04	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Switzerland/BL-ETHZ-440390/2021	EPI_ISL_899063	2021-01-07	Europe / Switzerland / Basel-Landschaft	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/QEUH-10F7B53/2021	EPI_ISL_907232	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-10F7ADE/2021	EPI_ISL_907245	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-10F86D9/2021	EPI_ISL_907296	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10DE3B4/2021	EPI_ISL_908550	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC9BDA/2020	EPI_ISL_915710	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC8E4B/2020	EPI_ISL_915731	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC677F/2020	EPI_ISL_916004	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC6A49/2020	EPI_ISL_916013	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC6C07/2020	EPI_ISL_916017	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-BCAD79/2020	EPI_ISL_916029	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCAD97/2020	EPI_ISL_916031	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-BCACE5/2020	EPI_ISL_916043	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC6B55/2020	EPI_ISL_916044	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC725F/2020	EPI_ISL_916048	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC7073/2020	EPI_ISL_916050	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC6A94/2020	EPI_ISL_916051	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11216D6/2021	EPI_ISL_917304	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10F9E0D/2021	EPI_ISL_917369	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/BIRM-6C8CE/2020	EPI_ISL_918600	2020-12-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6C8FB/2020	EPI_ISL_918602	2020-12-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6CB6B/2020	EPI_ISL_918608	2020-12-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6CB7A/2020	EPI_ISL_918609	2020-12-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/England/BIRM-6CDB0/2020	EPI_ISL_918630	2020-12-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6CDDE/2020	EPI_ISL_918632	2020-12-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6CEBD/2020	EPI_ISL_918640	2020-12-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6CECC/2020	EPI_ISL_918641	2020-12-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6CFBA/2020	EPI_ISL_918648	2020-12-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6CFE7/2020	EPI_ISL_918649	2020-12-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6D098/2020	EPI_ISL_918654	2020-12-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6D1B3/2020	EPI_ISL_918664	2020-11-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6D1D1/2020	EPI_ISL_918666	2020-11-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6D326/2020	EPI_ISL_918674	2020-11-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6D39F/2020	EPI_ISL_918677	2020-11-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6D3CC/2020	EPI_ISL_918679	2020-11-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6D405/2020	EPI_ISL_918682	2020-11-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6D56C/2021	EPI_ISL_918696	2021-01-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR6643/2021	EPI_ISL_919217	2021-01-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6652/2021	EPI_ISL_919224	2021-01-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6697/2020	EPI_ISL_919256	2020-12-25	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6699/2020	EPI_ISL_919257	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6700/2020	EPI_ISL_919258	2020-12-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6746/2021	EPI_ISL_919282	2021-01-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Wales/PHWC-4BCC47/2021	EPI_ISL_922845	2021-01-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BCCA1/2021	EPI_ISL_922851	2021-01-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BCDDB/2021	EPI_ISL_922867	2021-01-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BDFD4/2021	EPI_ISL_923140	2021-01-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BE02B/2021	EPI_ISL_923145	2021-01-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BE164/2021	EPI_ISL_923165	2021-01-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BE313/2021	EPI_ISL_923192	2021-01-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BE43E/2021	EPI_ISL_923209	2021-01-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/SHEF-10D3FE8/2021	EPI_ISL_924333	2021-01-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Denmark/DCGC-35250/2021	EPI_ISL_926390	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-36560/2021	EPI_ISL_927701	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36572/2021	EPI_ISL_927713	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36871/2020	EPI_ISL_928012	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36916/2021	EPI_ISL_928057	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38164/2021	EPI_ISL_929305	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38179/2021	EPI_ISL_929320	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38189/2021	EPI_ISL_929330	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38190/2021	EPI_ISL_929331	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	GV
hCoV-19/Denmark/DCGC-38206/2021	EPI_ISL_929347	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39171/2021	EPI_ISL_930313	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39173/2021	EPI_ISL_930315	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39188/2021	EPI_ISL_930330	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39198/2021	EPI_ISL_930340	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39225/2021	EPI_ISL_930367	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-118643F/2021	EPI_ISL_931619	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1185DBD/2021	EPI_ISL_931666	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-116F742/2021	EPI_ISL_932234	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1181B7B/2021	EPI_ISL_932246	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-112AB47/2021	EPI_ISL_932255	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-1129191/2021	EPI_ISL_932282	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-115E0E1/2021	EPI_ISL_937658	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-115CF9B/2021	EPI_ISL_937778	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-115DB5A/2021	EPI_ISL_937790	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-115D04C/2021	EPI_ISL_937833	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-119C427/2021	EPI_ISL_945517	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-119C8EF/2021	EPI_ISL_945560	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-119C946/2021	EPI_ISL_945564	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-119550D/2021	EPI_ISL_947101	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11454F0/2021	EPI_ISL_948504	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1145487/2021	EPI_ISL_948516	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-1015032/2021	EPI_ISL_949028	2021-01-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-1016198/2021	EPI_ISL_949029	2021-01-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-1014B41/2021	EPI_ISL_949039	2021-01-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-1015D0E/2021	EPI_ISL_949041	2021-01-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-10160D7/2021	EPI_ISL_949063	2021-01-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-1014ACC/2021	EPI_ISL_949065	2021-01-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/CVR6825/2021	EPI_ISL_949621	2021-01-28	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB13742/2021	EPI_ISL_949637	2021-01-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB14035/2021	EPI_ISL_949639	2021-01-18	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/OXON-F448AF/2020	EPI_ISL_950784	2020-12-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/OXON-F44942/2020	EPI_ISL_950786	2020-12-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F44CD0/2020	EPI_ISL_950803	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/OXON-F44D46/2020	EPI_ISL_950804	2020-12-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/OXON-F450F1/2020	EPI_ISL_950822	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F455D4/2020	EPI_ISL_950841	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Northern Ireland/OXON-F5300F/2021	EPI_ISL_951350	2021-01-07	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Wales/PHWC-4C07C7/2021	EPI_ISL_951934	2021-01-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-1196A67/2021	EPI_ISL_959173	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11D5291/2021	EPI_ISL_964700	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11D654C/2021	EPI_ISL_964753	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-11D62EB/2021	EPI_ISL_964778	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11BE595/2021	EPI_ISL_969592	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-40332/2021	EPI_ISL_972009	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40333/2021	EPI_ISL_972010	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40357/2021	EPI_ISL_972034	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40358/2021	EPI_ISL_972035	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40389/2021	EPI_ISL_972066	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40422/2021	EPI_ISL_972099	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41690/2021	EPI_ISL_973367	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-41714/2021	EPI_ISL_973391	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/MILK-11EF49E/2021	EPI_ISL_980568	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-11785C4/2021	EPI_ISL_987463	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1201DB8/2021	EPI_ISL_988701	2021-02-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1201705/2021	EPI_ISL_988723	2021-02-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-11872F8/2021	EPI_ISL_990008	2021-01-25	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-1183C1C/2021	EPI_ISL_991144	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-BC6DAA/2020	EPI_ISL_991342	2020-11-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10EE120/2021	EPI_ISL_992482	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1093BC2/2021	EPI_ISL_993292	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Finland/HEL-8-20/2021	EPI_ISL_995875	2021-01-11	Europe / Finland / Uusimaa	Human	Original			Illumina Miseq	BWA-MEM			B.1.177.62	GV
hCoV-19/England/EXET-144E14/2020	EPI_ISL_997319	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/EXET-144E8D/2021	EPI_ISL_997323	2021-01-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/EXET-144ED8/2021	EPI_ISL_997327	2021-01-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/EXET-144EF6/2021	EPI_ISL_997328	2021-01-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/EXET-144F02/2021	EPI_ISL_997329	2021-01-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-4C5364/2021	EPI_ISL_999929	2021-02-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C59AE/2021	EPI_ISL_999986	2021-01-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Switzerland/SZ-ETHZ-480315/2021	EPI_ISL_1002206	2021-02-01	Europe / Switzerland / Schwyz	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.62	GV
hCoV-19/Switzerland/SZ-ETHZ-480410/2021	EPI_ISL_1002207	2021-02-01	Europe / Switzerland / Schwyz	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.62	GV
hCoV-19/Switzerland/ZH-ETHZ-480805/2021	EPI_ISL_1002395	2021-01-05	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Switzerland/SG-ETHZ-470109/2021	EPI_ISL_1003501	2021-01-22	Europe / Switzerland / St Gallen	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Switzerland/SG-ETHZ-470112/2021	EPI_ISL_1003502	2021-01-22	Europe / Switzerland / St Gallen	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Switzerland/SH-ETHZ-470486/2021	EPI_ISL_1003507	2021-01-22	Europe / Switzerland / Schaffhausen	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Switzerland/ZH-ETHZ-470474/2021	EPI_ISL_1003549	2021-01-22	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Switzerland/SH-ETHZ-470630/2021	EPI_ISL_1003560	2021-01-23	Europe / Switzerland / Schaffhausen	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Switzerland/SH-ETHZ-470631/2021	EPI_ISL_1003561	2021-01-23	Europe / Switzerland / Schaffhausen	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Sweden/21-50681/2021	EPI_ISL_1008502	2021-01-25	Europe / Sweden / Halland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N			B.1.177	GV
hCoV-19/Sweden/21-20566/2021	EPI_ISL_1008592	2021-01-27	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-125EA5B/2021	EPI_ISL_1019168	2021-02-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-42600/2021	EPI_ISL_1022878	2021-02-08	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44629/2021	EPI_ISL_1025007	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44639/2021	EPI_ISL_1025017	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44641/2021	EPI_ISL_1025019	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44652/2021	EPI_ISL_1025030	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44669/2021	EPI_ISL_1025047	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44680/2021	EPI_ISL_1025058	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44688/2021	EPI_ISL_1025066	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44693/2021	EPI_ISL_1025071	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44694/2021	EPI_ISL_1025072	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44700/2021	EPI_ISL_1025078	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44705/2021	EPI_ISL_1025083	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44711/2021	EPI_ISL_1025089	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44714/2021	EPI_ISL_1025092	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD538/2021	EPI_ISL_1034818	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD543/2021	EPI_ISL_1034819	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD552/2021	EPI_ISL_1034820	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD609/2021	EPI_ISL_1034821	2021-02-03	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD613/2021	EPI_ISL_1034822	2021-02-03	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD614/2021	EPI_ISL_1034823	2021-02-03	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD615/2021	EPI_ISL_1034824	2021-02-03	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD616/2021	EPI_ISL_1034825	2021-02-03	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD617/2021	EPI_ISL_1034826	2021-02-03	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD619/2021	EPI_ISL_1034827	2021-02-03	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD620/2021	EPI_ISL_1034828	2021-02-03	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD621/2021	EPI_ISL_1034829	2021-02-03	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD643/2021	EPI_ISL_1034830	2021-02-05	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD654/2021	EPI_ISL_1034831	2021-02-08	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD658/2021	EPI_ISL_1034832	2021-02-08	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD665/2021	EPI_ISL_1034833	2021-02-08	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD667/2021	EPI_ISL_1034834	2021-02-08	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD681/2021	EPI_ISL_1034835	2021-02-09	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD690/2021	EPI_ISL_1034836	2021	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD691/2021	EPI_ISL_1034837	2021	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD694/2021	EPI_ISL_1034838	2021	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD696/2021	EPI_ISL_1034839	2021	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD699/2021	EPI_ISL_1034840	2021-02-12	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD700/2021	EPI_ISL_1034841	2021-02-12	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD702/2021	EPI_ISL_1034842	2021-02-12	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD736/2021	EPI_ISL_1034843	2021-02-12	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD742/2021	EPI_ISL_1034844	2021-02-12	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD743/2021	EPI_ISL_1034845	2021-02-12	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD748/2021	EPI_ISL_1034846	2021-02-12	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD753/2021	EPI_ISL_1034847	2021-02-15	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-1199633/2021	EPI_ISL_1044143	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11999C1/2021	EPI_ISL_1044172	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-4C7960/2021	EPI_ISL_1052626	2021-02-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/PORT-2EFA34/2021	EPI_ISL_1053943	2021-02-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Northern Ireland/RAND-12879F2/2021	EPI_ISL_1063322	2021-02-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Northern Ireland/RAND-1287901/2021	EPI_ISL_1063347	2021-02-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/Denmark/DCGC-46312/2021	EPI_ISL_1065822	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46464/2021	EPI_ISL_1065974	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Netherlands/ZH-RIVM-13641/2021	EPI_ISL_1089955	2021-02-07	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/England/QEUH-99053A/2020	EPI_ISL_530362	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-96E0F8/2020	EPI_ISL_530473	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-962F60/2020	EPI_ISL_531582	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Northern Ireland/QEUH-961FCB/2020	EPI_ISL_531654	2020-08-10	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-962FAC/2020	EPI_ISL_531771	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/CVR4015/2020	EPI_ISL_535114	2020-08-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4052/2020	EPI_ISL_535146	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4069/2020	EPI_ISL_535160	2020-08-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/MILK-99C5A7/2020	EPI_ISL_550755	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-16A856/2020	EPI_ISL_560113	2020-09-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16ACC3/2020	EPI_ISL_560183	2020-09-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16AFAC/2020	EPI_ISL_560229	2020-09-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16B11E/2020	EPI_ISL_560246	2020-09-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16B275/2020	EPI_ISL_560266	2020-09-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9CDC7B/2020	EPI_ISL_566228	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CD17C/2020	EPI_ISL_566230	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-9CCF0A/2020	EPI_ISL_566238	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CD22E/2020	EPI_ISL_566270	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9CA8D4/2020	EPI_ISL_567515	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9C5F01/2020	EPI_ISL_567581	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9C5781/2020	EPI_ISL_567600	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9C5EF5/2020	EPI_ISL_567606	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9C4BC2/2020	EPI_ISL_567614	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9C5851/2020	EPI_ISL_567730	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_G38stop results in 69.4% truncation of the protein sequence.	info	B.1.177.5	GV
hCoV-19/England/ALDP-9C52EA/2020	EPI_ISL_567750	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/NOTT-113801/2020	EPI_ISL_573433	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/ALDP-9E6535/2020	EPI_ISL_580501	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-9EC669/2020	EPI_ISL_580511	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E7024/2020	EPI_ISL_580535	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-9EC21A/2020	EPI_ISL_580536	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E6A72/2020	EPI_ISL_580546	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E66BA/2020	EPI_ISL_580568	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E6C6D/2020	EPI_ISL_580572	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E6289/2020	EPI_ISL_580588	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-9F0662/2020	EPI_ISL_580700	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E973C/2020	EPI_ISL_584242	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB7880/2020	EPI_ISL_585433	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB7891/2020	EPI_ISL_585441	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB8241/2020	EPI_ISL_585492	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-9E34B3/2020	EPI_ISL_585504	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-9E35DE/2020	EPI_ISL_585509	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9E393C/2020	EPI_ISL_585529	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A00B9C/2020	EPI_ISL_585555	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A00BAB/2020	EPI_ISL_585556	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A00BBA/2020	EPI_ISL_585557	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A00BD8/2020	EPI_ISL_585558	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/ALDP-A2E002/2020	EPI_ISL_586719	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2DB3F/2020	EPI_ISL_586724	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2DE36/2020	EPI_ISL_586732	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2DC78/2020	EPI_ISL_586747	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2DE63/2020	EPI_ISL_586767	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2D4BC/2020	EPI_ISL_586771	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2D30A/2020	EPI_ISL_586793	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2DB5D/2020	EPI_ISL_586797	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2D980/2020	EPI_ISL_586824	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2E169/2020	EPI_ISL_586827	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2D100/2020	EPI_ISL_586838	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2E424/2020	EPI_ISL_586845	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-A2D892/2020	EPI_ISL_586848	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2DC4B/2020	EPI_ISL_586863	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2E1B4/2020	EPI_ISL_586895	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2D443/2020	EPI_ISL_586898	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_K53stop results in 57.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-9CF24A/2020	EPI_ISL_590091	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A4D067/2020	EPI_ISL_596083	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A4D243/2020	EPI_ISL_596104	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A4D29E/2020	EPI_ISL_596106	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/QEUH-A63380/2020	EPI_ISL_596117	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A63678/2020	EPI_ISL_596129	2020-10-12	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A63687/2020	EPI_ISL_596130	2020-10-12	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A636B4/2020	EPI_ISL_596133	2020-10-12	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A636C3/2020	EPI_ISL_596134	2020-10-10	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/QEUH-A636E1/2020	EPI_ISL_596135	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.58	GV
hCoV-19/Scotland/QEUH-A6371B/2020	EPI_ISL_596137	2020-10-12	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A63766/2020	EPI_ISL_596142	2020-10-12	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A637B1/2020	EPI_ISL_596146	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A637C0/2020	EPI_ISL_596147	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A637FD/2020	EPI_ISL_596150	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A6398E/2020	EPI_ISL_596171	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A63B1F/2020	EPI_ISL_596181	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A63B4C/2020	EPI_ISL_596184	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/CAMC-A57C1B/2020	EPI_ISL_597414	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A5E4B2/2020	EPI_ISL_597423	2020-10-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-A5DD5E/2020	EPI_ISL_597434	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A5E036/2020	EPI_ISL_597439	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A57149/2020	EPI_ISL_597441	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A5DDE5/2020	EPI_ISL_597455	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A57765/2020	EPI_ISL_597480	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A5E26D/2020	EPI_ISL_597485	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A578DB/2020	EPI_ISL_597490	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A576FF/2020	EPI_ISL_597494	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A5E34C/2020	EPI_ISL_597496	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A5E379/2020	EPI_ISL_597509	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A5E203/2020	EPI_ISL_597514	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A5DDC7/2020	EPI_ISL_597518	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A50896/2020	EPI_ISL_597527	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A456B8/2020	EPI_ISL_598748	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A45E56/2020	EPI_ISL_598761	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A45937/2020	EPI_ISL_598785	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-A44E39/2020	EPI_ISL_598789	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A460B9/2020	EPI_ISL_598813	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-A2D57D/2020	EPI_ISL_598825	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A1E3EE/2020	EPI_ISL_598840	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1E445/2020	EPI_ISL_598841	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A214F4/2020	EPI_ISL_598853	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A2199B/2020	EPI_ISL_598859	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A21922/2020	EPI_ISL_598867	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1E9FB/2020	EPI_ISL_598870	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A2155B/2020	EPI_ISL_598871	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1E6F4/2020	EPI_ISL_598877	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A1E0C9/2020	EPI_ISL_598878	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1E0BA/2020	EPI_ISL_598880	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DAD69/2020	EPI_ISL_601103	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DCAD9/2020	EPI_ISL_601117	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9DAEEE/2020	EPI_ISL_601120	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9DC9FA/2020	EPI_ISL_601121	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9DCE73/2020	EPI_ISL_601122	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9DAB9C/2020	EPI_ISL_601123	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DB005/2020	EPI_ISL_601128	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DC514/2020	EPI_ISL_601130	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DACB7/2020	EPI_ISL_601131	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DC505/2020	EPI_ISL_601140	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DC471/2020	EPI_ISL_601157	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DC3DE/2020	EPI_ISL_601160	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DCDEF/2020	EPI_ISL_601165	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9DC480/2020	EPI_ISL_601166	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DAB50/2020	EPI_ISL_601167	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9DC82A/2020	EPI_ISL_601177	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9DAD5A/2020	EPI_ISL_601179	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DE7A3/2020	EPI_ISL_601189	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9DEDCF/2020	EPI_ISL_601198	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A87993/2020	EPI_ISL_606006	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A86C5F/2020	EPI_ISL_606008	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A8766F/2020	EPI_ISL_606010	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A8632D/2020	EPI_ISL_606054	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A86E86/2020	EPI_ISL_606066	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A879B1/2020	EPI_ISL_606068	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A87C5E/2020	EPI_ISL_606074	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A86C7D/2020	EPI_ISL_606075	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A87D6A/2020	EPI_ISL_606086	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A86624/2020	EPI_ISL_606089	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6E358/2020	EPI_ISL_607222	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6D632/2020	EPI_ISL_607254	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6D993/2020	EPI_ISL_607255	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6F1F3/2020	EPI_ISL_607272	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-A6CC22/2020	EPI_ISL_607286	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7C9DD/2020	EPI_ISL_607386	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7BFAF/2020	EPI_ISL_607394	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-A67F5B/2020	EPI_ISL_608520	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68FC3/2020	EPI_ISL_608526	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A656FE/2020	EPI_ISL_608568	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68813/2020	EPI_ISL_608579	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A681BE/2020	EPI_ISL_608586	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A67ED6/2020	EPI_ISL_608593	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6838B/2020	EPI_ISL_608605	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A67F4C/2020	EPI_ISL_608614	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68576/2020	EPI_ISL_608617	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A684D3/2020	EPI_ISL_608630	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A64B69/2020	EPI_ISL_608645	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A6551F/2020	EPI_ISL_608650	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A65184/2020	EPI_ISL_608664	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A67F79/2020	EPI_ISL_608674	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/204180614/2020	EPI_ISL_609857	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/204200592/2020	EPI_ISL_609883	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/204200600/2020	EPI_ISL_609884	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/CAMC-A82E8A/2020	EPI_ISL_610846	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A819B7/2020	EPI_ISL_610864	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A82734/2020	EPI_ISL_610884	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A80CDD/2020	EPI_ISL_610886	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A81E4F/2020	EPI_ISL_610887	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A822AC/2020	EPI_ISL_610890	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A81DD9/2020	EPI_ISL_610917	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A92BDB/2020	EPI_ISL_610923	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A93949/2020	EPI_ISL_610933	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A93D01/2020	EPI_ISL_610936	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A9268F/2020	EPI_ISL_610949	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A936AC/2020	EPI_ISL_610982	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A9483C/2020	EPI_ISL_610996	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-48173B/2020	EPI_ISL_613102	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48174A/2020	EPI_ISL_613103	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4817E0/2020	EPI_ISL_613112	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-481944/2020	EPI_ISL_613126	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-481953/2020	EPI_ISL_613127	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-481AD8/2020	EPI_ISL_613143	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-481B11/2020	EPI_ISL_613146	2020-10-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-481BA8/2020	EPI_ISL_613152	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-481D0C/2020	EPI_ISL_613165	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-481E18/2020	EPI_ISL_613175	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-481E54/2020	EPI_ISL_613179	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-481E63/2020	EPI_ISL_613180	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-482011/2020	EPI_ISL_613193	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48205D/2020	EPI_ISL_613196	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-AA3F80/2020	EPI_ISL_625105	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA226A/2020	EPI_ISL_625118	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA1641/2020	EPI_ISL_625141	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA1DF1/2020	EPI_ISL_625154	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA117D/2020	EPI_ISL_625197	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/NOTT-118FDA/2020	EPI_ISL_627700	2020-10-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-119003/2020	EPI_ISL_627702	2020-10-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11909A/2020	EPI_ISL_627705	2020-10-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-1190C7/2020	EPI_ISL_627707	2020-10-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11949E/2020	EPI_ISL_627708	2020-11-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-1199BD/2020	EPI_ISL_627717	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-119A14/2020	EPI_ISL_627719	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-119B4E/2020	EPI_ISL_627726	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/NOTT-119E81/2020	EPI_ISL_627728	2020-11-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-119EDC/2020	EPI_ISL_627729	2020-11-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-482F41/2020	EPI_ISL_627759	2020-10-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4830E3/2020	EPI_ISL_627780	2020-10-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-AC5D51/2020	EPI_ISL_631012	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AAF9E0/2020	EPI_ISL_631055	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ABC2D6/2020	EPI_ISL_631058	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AAF986/2020	EPI_ISL_631069	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ABBEC4/2020	EPI_ISL_631079	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-AE284E/2020	EPI_ISL_633506	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE25A1/2020	EPI_ISL_633512	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE1EC5/2020	EPI_ISL_633527	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE3115/2020	EPI_ISL_633535	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE2547/2020	EPI_ISL_633538	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE286C/2020	EPI_ISL_633550	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE277E/2020	EPI_ISL_633564	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE2DC7/2020	EPI_ISL_633604	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-AE2EF1/2020	EPI_ISL_633619	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE25FC/2020	EPI_ISL_633692	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD1BC1/2020	EPI_ISL_633694	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD1587/2020	EPI_ISL_633698	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/CAMC-AB2030/2020	EPI_ISL_634812	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-9DFAB8/2020	EPI_ISL_638441	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/LIVE-DAF710/2020	EPI_ISL_638451	2020-10-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/LIVE-DAF8C2/2020	EPI_ISL_638452	2020-10-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/MILK-A23A78/2020	EPI_ISL_638456	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/MILK-A7E012/2020	EPI_ISL_638482	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B024CB/2020	EPI_ISL_643042	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-A8B328/2020	EPI_ISL_643045	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B3757F/2020	EPI_ISL_645500	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B372F0/2020	EPI_ISL_645528	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1E2B3/2020	EPI_ISL_645548	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1A19C/2020	EPI_ISL_645551	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1BFFB/2020	EPI_ISL_645553	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1CE0C/2020	EPI_ISL_645561	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1BF64/2020	EPI_ISL_645581	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1C4FB/2020	EPI_ISL_645586	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1BF91/2020	EPI_ISL_645596	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1B2E3/2020	EPI_ISL_645673	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1B19B/2020	EPI_ISL_645678	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B19EF0/2020	EPI_ISL_645696	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B248C7/2020	EPI_ISL_646801	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B23831/2020	EPI_ISL_646802	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24A67/2020	EPI_ISL_646822	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24A85/2020	EPI_ISL_646827	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B242AB/2020	EPI_ISL_646833	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24672/2020	EPI_ISL_646838	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B236CE/2020	EPI_ISL_646839	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B2437B/2020	EPI_ISL_646849	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B23664/2020	EPI_ISL_646855	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-B244E1/2020	EPI_ISL_646890	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24566/2020	EPI_ISL_646903	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B2487C/2020	EPI_ISL_646907	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B23B0B/2020	EPI_ISL_646979	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AA0071/2020	EPI_ISL_652704	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-AAA930/2020	EPI_ISL_652720	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/QEUH-AAABEF/2020	EPI_ISL_652732	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-AAAF6B/2020	EPI_ISL_652758	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-AAAF89/2020	EPI_ISL_652760	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-AAAF98/2020	EPI_ISL_652761	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-AAAFA7/2020	EPI_ISL_652762	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-AAAFB6/2020	EPI_ISL_652763	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-AAB00D/2020	EPI_ISL_652765	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-AAB0B2/2020	EPI_ISL_652769	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-AAB0D0/2020	EPI_ISL_652771	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-AAB0FE/2020	EPI_ISL_652772	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-AAB155/2020	EPI_ISL_652775	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AAB173/2020	EPI_ISL_652776	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-AAB252/2020	EPI_ISL_652779	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-AAB559/2020	EPI_ISL_652797	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/QEUH-B69FA3/2020	EPI_ISL_655016	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-B6BA28/2020	EPI_ISL_655019	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B66735/2020	EPI_ISL_655023	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6BE1D/2020	EPI_ISL_655024	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46D1B/2020	EPI_ISL_656201	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B45A33/2020	EPI_ISL_656202	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46179/2020	EPI_ISL_656205	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B460B8/2020	EPI_ISL_656206	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-B47345/2020	EPI_ISL_656211	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B45A8E/2020	EPI_ISL_656213	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B45D3A/2020	EPI_ISL_656226	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46BA8/2020	EPI_ISL_656227	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B464F8/2020	EPI_ISL_656248	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B45F8F/2020	EPI_ISL_656250	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46795/2020	EPI_ISL_656252	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B45B9A/2020	EPI_ISL_656265	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46373/2020	EPI_ISL_656271	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B4658C/2020	EPI_ISL_656272	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46276/2020	EPI_ISL_656276	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B45BC7/2020	EPI_ISL_656284	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B461E2/2020	EPI_ISL_656290	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B45D67/2020	EPI_ISL_656293	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46847/2020	EPI_ISL_656299	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B4605E/2020	EPI_ISL_656304	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46285/2020	EPI_ISL_656313	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46003/2020	EPI_ISL_656315	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B45D58/2020	EPI_ISL_656324	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B468DE/2020	EPI_ISL_656333	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B466C5/2020	EPI_ISL_656334	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62A6D/2020	EPI_ISL_656368	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B629CA/2020	EPI_ISL_656369	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B63A02/2020	EPI_ISL_656370	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62A12/2020	EPI_ISL_656371	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B564F5/2020	EPI_ISL_657515	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B52E73/2020	EPI_ISL_657541	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B556B4/2020	EPI_ISL_657542	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B563CB/2020	EPI_ISL_657570	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B5560F/2020	EPI_ISL_657584	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-B555D5/2020	EPI_ISL_657591	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B53012/2020	EPI_ISL_657592	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B5315B/2020	EPI_ISL_657634	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B5648C/2020	EPI_ISL_657636	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B5620A/2020	EPI_ISL_657642	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B55AD6/2020	EPI_ISL_657651	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B53319/2020	EPI_ISL_657659	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B52EEC/2020	EPI_ISL_657668	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B55933/2020	EPI_ISL_657682	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B564C8/2020	EPI_ISL_657688	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B52796/2020	EPI_ISL_657697	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B38884/2020	EPI_ISL_658814	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B39434/2020	EPI_ISL_658818	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B38453/2020	EPI_ISL_658823	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B3956E/2020	EPI_ISL_658879	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B37DB3/2020	EPI_ISL_658900	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B37DA4/2020	EPI_ISL_658905	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-B38D0D/2020	EPI_ISL_658966	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B38C88/2020	EPI_ISL_658982	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B38ABB/2020	EPI_ISL_658988	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6892E/2020	EPI_ISL_662016	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B75126/2020	EPI_ISL_662019	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B68EB6/2020	EPI_ISL_662037	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B68742/2020	EPI_ISL_662073	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B749D4/2020	EPI_ISL_662074	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B69231/2020	EPI_ISL_662076	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B68074/2020	EPI_ISL_662082	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B68092/2020	EPI_ISL_662089	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B68645/2020	EPI_ISL_662104	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6919E/2020	EPI_ISL_662125	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B68E3E/2020	EPI_ISL_662127	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B68DF5/2020	EPI_ISL_662134	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B7519F/2020	EPI_ISL_662145	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B73FF1/2020	EPI_ISL_662151	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B69204/2020	EPI_ISL_662158	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B746BF/2020	EPI_ISL_662176	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B75153/2020	EPI_ISL_662178	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B7396C/2020	EPI_ISL_664741	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/CAMC-B78114/2020	EPI_ISL_668200	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7FDBF/2020	EPI_ISL_668206	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B77889/2020	EPI_ISL_668212	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7C013/2020	EPI_ISL_668223	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7E460/2020	EPI_ISL_668235	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B823C6/2020	EPI_ISL_668242	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7F371/2020	EPI_ISL_668243	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-B80683/2020	EPI_ISL_668266	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7F99D/2020	EPI_ISL_668273	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B7782F/2020	EPI_ISL_668299	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-10367/2020	EPI_ISL_669549	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-10497/2020	EPI_ISL_669550	2020-11-02	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-10614/2020	EPI_ISL_669551	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-10811/2020	EPI_ISL_669552	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-11098/2020	EPI_ISL_669553	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-11138/2020	EPI_ISL_669554	2020-11-02	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-11189/2020	EPI_ISL_669555	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-11208/2020	EPI_ISL_669556	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-11526/2020	EPI_ISL_670529	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-11798/2020	EPI_ISL_670530	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/MILK-B865BD/2020	EPI_ISL_674013	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B86544/2020	EPI_ISL_674028	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B86650/2020	EPI_ISL_674036	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8D316/2020	EPI_ISL_674113	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8D352/2020	EPI_ISL_674114	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B84731/2020	EPI_ISL_675327	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B846AD/2020	EPI_ISL_675330	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B8469E/2020	EPI_ISL_675339	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8F350/2020	EPI_ISL_675340	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B845A0/2020	EPI_ISL_675348	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B8384E/2020	EPI_ISL_675350	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B84652/2020	EPI_ISL_675378	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B845EC/2020	EPI_ISL_675395	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B83AEE/2020	EPI_ISL_675415	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8EF4E/2020	EPI_ISL_675439	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B8377E/2020	EPI_ISL_675473	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B831CB/2020	EPI_ISL_675479	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B854B1/2020	EPI_ISL_675489	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B74EB7/2020	EPI_ISL_679002	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-48FBF5/2020	EPI_ISL_681202	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48FE56/2020	EPI_ISL_681238	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48FEB0/2020	EPI_ISL_681244	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48FF71/2020	EPI_ISL_681255	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48FFBD/2020	EPI_ISL_681259	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-BB9E7A/2020	EPI_ISL_702013	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-BBB018/2020	EPI_ISL_702021	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BD21EB/2020	EPI_ISL_702025	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BD4617/2020	EPI_ISL_702064	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BD46AE/2020	EPI_ISL_702129	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCAA36/2020	EPI_ISL_703318	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BC46B0/2020	EPI_ISL_703325	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCABBB/2020	EPI_ISL_703342	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCA69C/2020	EPI_ISL_703347	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BC41FB/2020	EPI_ISL_703355	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCAA72/2020	EPI_ISL_703418	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCA6D8/2020	EPI_ISL_703437	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BC450E/2020	EPI_ISL_703444	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCA08F/2020	EPI_ISL_703493	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BCCABC/2020	EPI_ISL_704645	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BBFFBD/2020	EPI_ISL_704702	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC1F9A/2020	EPI_ISL_704743	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC0E70/2020	EPI_ISL_704756	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC0C94/2020	EPI_ISL_704769	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC0F04/2020	EPI_ISL_704774	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC0C58/2020	EPI_ISL_704781	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC09BB/2020	EPI_ISL_704782	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/LOND-126475B/2020	EPI_ISL_705971	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-A919B4/2020	EPI_ISL_705999	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-C060A4/2020	EPI_ISL_709501	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C06217/2020	EPI_ISL_709507	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C14683/2020	EPI_ISL_709524	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C1460B/2020	EPI_ISL_709558	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BDC5D6/2020	EPI_ISL_709579	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BDC9BC/2020	EPI_ISL_709596	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-BC83C4/2020	EPI_ISL_721198	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-BC84C1/2020	EPI_ISL_721233	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC7D30/2020	EPI_ISL_721235	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC83A6/2020	EPI_ISL_721236	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-BC7A39/2020	EPI_ISL_721239	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC877D/2020	EPI_ISL_721266	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC7B18/2020	EPI_ISL_721283	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B76E1F/2020	EPI_ISL_723817	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/ALDP-B76E4C/2020	EPI_ISL_723820	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/ALDP-B76E5B/2020	EPI_ISL_723821	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B76EB5/2020	EPI_ISL_723823	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/ALDP-B76F2B/2020	EPI_ISL_723829	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B76F58/2020	EPI_ISL_723831	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B77054/2020	EPI_ISL_723840	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B7735B/2020	EPI_ISL_723848	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMB-1BC1D2/2020	EPI_ISL_723856	2020-11-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/CAMB-1BC345/2020	EPI_ISL_723864	2020-11-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1BC4AC/2020	EPI_ISL_723877	2020-11-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/Wales/PHWC-493F6B/2020	EPI_ISL_726045	2020-11-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-494076/2020	EPI_ISL_726061	2020-11-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4940D0/2020	EPI_ISL_726066	2020-11-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-494128/2020	EPI_ISL_726071	2020-11-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4942BC/2020	EPI_ISL_726095	2020-11-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49443E/2020	EPI_ISL_726115	2020-11-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-499439/2020	EPI_ISL_727304	2020-12-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49975E/2020	EPI_ISL_727350	2020-12-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49976D/2020	EPI_ISL_727351	2020-12-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4997B8/2020	EPI_ISL_727356	2020-12-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-499897/2020	EPI_ISL_727370	2020-12-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49992B/2020	EPI_ISL_727378	2020-12-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49993A/2020	EPI_ISL_727379	2020-12-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-499949/2020	EPI_ISL_727380	2020-12-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-499A91/2020	EPI_ISL_727397	2020-12-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-499B34/2020	EPI_ISL_727405	2020-12-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-499B52/2020	EPI_ISL_727406	2020-12-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-499BAD/2020	EPI_ISL_727411	2020-11-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-499E4A/2020	EPI_ISL_727453	2020-11-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20458/2020	EPI_ISL_728674	2020-11-20	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20459/2020	EPI_ISL_728675	2020-11-20	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20461/2020	EPI_ISL_728676	2020-11-19	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20462/2020	EPI_ISL_728677	2020-11-19	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20463/2020	EPI_ISL_728678	2020-11-18	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20464/2020	EPI_ISL_728679	2020-11-17	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20465/2020	EPI_ISL_728680	2020-11-16	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20466/2020	EPI_ISL_728681	2020-11-17	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20467/2020	EPI_ISL_728682	2020-11-15	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20468/2020	EPI_ISL_728683	2020-11-15	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20469/2020	EPI_ISL_728684	2020-11-19	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20470/2020	EPI_ISL_728685	2020-11-20	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20471/2020	EPI_ISL_728686	2020-11-14	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20493/2020	EPI_ISL_728708	2020-11-24	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20494/2020	EPI_ISL_728709	2020-11-23	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20495/2020	EPI_ISL_728710	2020-11-21	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20496/2020	EPI_ISL_728711	2020-11-21	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20497/2020	EPI_ISL_728712	2020-11-20	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20498/2020	EPI_ISL_728713	2020-11-19	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20499/2020	EPI_ISL_728714	2020-11-19	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20500/2020	EPI_ISL_728715	2020-11-18	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20501/2020	EPI_ISL_728716	2020-11-18	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20502/2020	EPI_ISL_728717	2020-11-18	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20503/2020	EPI_ISL_728718	2020-11-17	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20504/2020	EPI_ISL_728719	2020-11-17	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20505/2020	EPI_ISL_728720	2020-11-17	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20508/2020	EPI_ISL_728723	2020-11-16	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20509/2020	EPI_ISL_728724	2020-11-16	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20510/2020	EPI_ISL_728725	2020-11-14	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20512/2020	EPI_ISL_728727	2020-11-20	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20513/2020	EPI_ISL_728728	2020-11-11	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20529/2020	EPI_ISL_728744	2020-12-04	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20533/2020	EPI_ISL_728748	2020-11-23	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20534/2020	EPI_ISL_728749	2020-11-21	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20536/2020	EPI_ISL_728751	2020-11-22	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20537/2020	EPI_ISL_728752	2020-11-21	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20538/2020	EPI_ISL_728753	2020-11-17	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20539/2020	EPI_ISL_728754	2020-11-17	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20542/2020	EPI_ISL_728757	2020-11-23	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/England/QEUH-C30DE6/2020	EPI_ISL_730910	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3B5A7/2020	EPI_ISL_730915	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3D095/2020	EPI_ISL_730940	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3CF6C/2020	EPI_ISL_730941	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3DAD3/2020	EPI_ISL_730949	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/MILK-C61EBC/2020	EPI_ISL_735833	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C62167/2020	EPI_ISL_735855	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C61854/2020	EPI_ISL_735858	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	GV
hCoV-19/England/QEUH-C5BCBB/2020	EPI_ISL_735894	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/NOTT-119DB1/2020	EPI_ISL_741609	2020-11-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/PORT-2F6047/2020	EPI_ISL_741730	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2F6065/2020	EPI_ISL_741732	2020-12-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2F6074/2020	EPI_ISL_741733	2020-12-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2F6092/2020	EPI_ISL_741734	2020-12-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2F60CF/2020	EPI_ISL_741737	2020-12-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2F6135/2020	EPI_ISL_741742	2020-11-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2F6153/2020	EPI_ISL_741744	2020-11-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2F61AE/2020	EPI_ISL_741747	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2F61BD/2020	EPI_ISL_741748	2020-12-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2F61EA/2020	EPI_ISL_741749	2020-12-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2F6214/2020	EPI_ISL_741751	2020-12-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Wales/PHWC-49DDEF/2020	EPI_ISL_742913	2020-12-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49DE0A/2020	EPI_ISL_742915	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49DE73/2020	EPI_ISL_742921	2020-12-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49DE82/2020	EPI_ISL_742922	2020-12-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49DF34/2020	EPI_ISL_742932	2020-12-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49E0A9/2020	EPI_ISL_742950	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49E0B8/2020	EPI_ISL_742951	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49E0F4/2020	EPI_ISL_742954	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49E14C/2020	EPI_ISL_742959	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49E197/2020	EPI_ISL_742963	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49E267/2020	EPI_ISL_742975	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49E2B2/2020	EPI_ISL_742980	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49E2C1/2020	EPI_ISL_742981	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49E2EF/2020	EPI_ISL_742983	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49E3DD/2020	EPI_ISL_742997	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-17575/2020	EPI_ISL_751077	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177	GV
hCoV-19/Scotland/QEUH-C30CF8/2020	EPI_ISL_757133	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.8	GV
hCoV-19/Scotland/QEUH-C3309F/2020	EPI_ISL_757145	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.5	GV
hCoV-19/Scotland/QEUH-C3378B/2020	EPI_ISL_757147	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Stretches of NNNs (1.34% of overall sequence). Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.06%.		B.1.177.8	GV
hCoV-19/Scotland/QEUH-C339C1/2020	EPI_ISL_757149	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Stretches of NNNs (1.81% of overall sequence).		B.1.177.5	GV
hCoV-19/Scotland/QEUH-C339D0/2020	EPI_ISL_757152	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Stretches of NNNs (1.81% of overall sequence).		B.1.177.5	GV
hCoV-19/Scotland/QEUH-C339EF/2020	EPI_ISL_757164	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Stretches of NNNs (1.81% of overall sequence). Gap of 49 nucleotides when compared to the reference sequence.		B.1.177.5	GV
hCoV-19/Scotland/QEUH-C33CAA/2020	EPI_ISL_757172	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Stretches of NNNs (1.94% of overall sequence).		B.1.177.5	GV
hCoV-19/Scotland/QEUH-C330BD/2020	EPI_ISL_757178	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.08%.		B.1.177.8	GV
hCoV-19/Scotland/QEUH-C33958/2020	EPI_ISL_757184	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Stretches of NNNs (1.41% of overall sequence). Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.06%.		B.1.177.5	GV
hCoV-19/Scotland/QEUH-BA0D4C/2020	EPI_ISL_757187	2020-11-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_K68stop results in 44.6% truncation of the protein sequence. NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.08%.		B.1.177.5	GV
hCoV-19/Scotland/QEUH-BA0A27/2020	EPI_ISL_757189	2020-11-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_K68stop results in 44.6% truncation of the protein sequence. NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.08%.		B.1.177.5	GV
hCoV-19/Scotland/QEUH-BA165F/2020	EPI_ISL_757195	2020-11-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.8	GV
hCoV-19/Scotland/QEUH-B9E646/2020	EPI_ISL_757197	2020-11-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Long stretches of NNNs (6.30% of overall sequence).		B.1.177.5	GV
hCoV-19/Scotland/QEUH-B9E5D0/2020	EPI_ISL_757204	2020-11-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Long stretches of NNNs (5.13% of overall sequence).		B.1.177.8	GV
hCoV-19/Scotland/QEUH-BA140A/2020	EPI_ISL_757207	2020-11-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_K68stop results in 44.6% truncation of the protein sequence. NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.09%.		B.1.177.5	GV
hCoV-19/Scotland/QEUH-BA1473/2020	EPI_ISL_757211	2020-11-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.5	GV
hCoV-19/Scotland/QEUH-BA14BF/2020	EPI_ISL_757219	2020-11-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177	GV
hCoV-19/Scotland/QEUH-BA1464/2020	EPI_ISL_757221	2020-11-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.8	GV
hCoV-19/Scotland/QEUH-B9E682/2020	EPI_ISL_757224	2020-11-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Long stretches of NNNs (6.64% of overall sequence). Gap of 1 nucleotide(s) found at refpos 28254 (FRAMESHIFT not confirmed by the submitter). Gap of 20 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.8	GV
hCoV-19/Scotland/QEUH-C30E3E/2020	EPI_ISL_757230	2020-12-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.8	GV
hCoV-19/Scotland/QEUH-C01BA8/2020	EPI_ISL_757232	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177	GV
hCoV-19/Scotland/QEUH-C0113D/2020	EPI_ISL_757235	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.8	GV
hCoV-19/Scotland/QEUH-C01D84/2020	EPI_ISL_757236	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.5	GV
hCoV-19/Scotland/QEUH-C01B99/2020	EPI_ISL_757238	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177	GV
hCoV-19/Scotland/QEUH-C01DB1/2020	EPI_ISL_757240	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.5	GV
hCoV-19/Scotland/QEUH-C01DEE/2020	EPI_ISL_757247	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.5	GV
hCoV-19/Scotland/QEUH-C01DA2/2020	EPI_ISL_757248	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.5	GV
hCoV-19/Scotland/QEUH-C01B4E/2020	EPI_ISL_757254	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.8	GV
hCoV-19/Scotland/QEUH-C01470/2020	EPI_ISL_757255	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177	GV
hCoV-19/Scotland/QEUH-C01B5D/2020	EPI_ISL_757256	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177	GV
hCoV-19/Scotland/QEUH-C01B11/2020	EPI_ISL_757260	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.5	GV
hCoV-19/Scotland/QEUH-C014BC/2020	EPI_ISL_757262	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177	GV
hCoV-19/Scotland/QEUH-C0115B/2020	EPI_ISL_757263	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.5	GV
hCoV-19/Scotland/QEUH-C01179/2020	EPI_ISL_757264	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.5	GV
hCoV-19/Scotland/QEUH-C011B5/2020	EPI_ISL_757267	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.5	GV
hCoV-19/Scotland/QEUH-C0116A/2020	EPI_ISL_757272	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.177.8	GV
hCoV-19/Denmark/DCGC-22152/2020	EPI_ISL_758589	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177	GV
hCoV-19/England/QEUH-CC39A8/2020	EPI_ISL_760704	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CC0808/2020	EPI_ISL_760728	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CBF5BA/2020	EPI_ISL_760738	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC2C82/2020	EPI_ISL_760787	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB3D18/2020	EPI_ISL_760838	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CABE01/2020	EPI_ISL_760849	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-CB4227/2020	EPI_ISL_760867	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Germany/TH-RKI-NP-0048/2020	EPI_ISL_763003	2020-12-11	Europe / Germany / Thuringia	Human	Original		unknown	Nanopore MinION	ARTIC pipeline	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/NW-RKI-NP-0003/2020	EPI_ISL_763029	2020-11-27	Europe / Germany / North Rhine-Westphalia	Human	Original		unknown	Nanopore MinION	ARTIC pipeline			B.1.177.62	GV
hCoV-19/Germany/HE-RKI-NP-0008/2020	EPI_ISL_763034	2020-12-01	Europe / Germany / Hesse	Human	Original		unknown	Nanopore MinION	ARTIC pipeline	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Germany/HE-RKI-NP-0004/2020	EPI_ISL_763035	2020-11-30	Europe / Germany / Hesse	Human	Original		unknown	Nanopore MinION	ARTIC pipeline	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BW-RKI-NP-0071/2020	EPI_ISL_763039	2020-12-14	Europe / Germany / Baden-Wurttemberg	Human	Original		unknown	Nanopore MinION	ARTIC pipeline	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BW-RKI-NP-0039/2020	EPI_ISL_763044	2020-12-09	Europe / Germany / Baden-Wurttemberg	Human	Original		unknown	Nanopore MinION	ARTIC pipeline			B.1.177	GV
hCoV-19/Germany/BB-RKI-NP-0038/2020	EPI_ISL_763059	2020-12-10	Europe / Germany / Brandenburg	Human	Original		unknown	Nanopore MinION	ARTIC pipeline	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BB-RKI-NP-0035/2020	EPI_ISL_763061	2020-12-09	Europe / Germany / Brandenburg	Human	Original		unknown	Nanopore MinION	ARTIC pipeline	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/CAMB-1BCCC2/2020	EPI_ISL_764300	2020-12-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A97CD3/2020	EPI_ISL_764329	2020-12-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A98434/2020	EPI_ISL_764344	2020-12-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A9857D/2020	EPI_ISL_764350	2020-12-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A985B9/2020	EPI_ISL_764351	2020-12-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A98768/2020	EPI_ISL_764355	2020-12-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB11097/2020	EPI_ISL_764360	2020-11-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/England/EXET-13ED7A/2020	EPI_ISL_764375	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/EXET-13F3D1/2020	EPI_ISL_764381	2020-12-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Northern Ireland/NIRE-234E43/2020	EPI_ISL_764399	2020-10-23	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/CAMC-C75538/2020	EPI_ISL_769128	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C71FE3/2020	EPI_ISL_769159	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C5BBAF/2020	EPI_ISL_769254	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C60D92/2020	EPI_ISL_769256	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C5BC15/2020	EPI_ISL_769291	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC968D/2020	EPI_ISL_782101	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-CF1288/2020	EPI_ISL_782102	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC96F6/2020	EPI_ISL_782115	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-CED340/2020	EPI_ISL_782149	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.5	GV
hCoV-19/England/ALDP-CEC97C/2020	EPI_ISL_782165	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CCDC78/2020	EPI_ISL_782210	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CEC2F9/2020	EPI_ISL_782211	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CDF4A8/2020	EPI_ISL_782216	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CDE9E6/2020	EPI_ISL_782222	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CECFF2/2020	EPI_ISL_782271	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B77F48/2020	EPI_ISL_783464	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B781D8/2020	EPI_ISL_783468	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B77BEA/2020	EPI_ISL_783470	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B77E1E/2020	EPI_ISL_783491	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B78B34/2020	EPI_ISL_783492	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Netherlands/FR-RIVM-20554/2020	EPI_ISL_790641	2020-12-15	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/OV-RIVM-20616/2020	EPI_ISL_790695	2020-11-20	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Denmark/DCGC-24798/2020	EPI_ISL_795414	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide found at refpos 11083 (Frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-DA76FD/2020	EPI_ISL_796796	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-DA27B3/2020	EPI_ISL_796820	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-D9FB62/2020	EPI_ISL_796841	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-DA77BE/2020	EPI_ISL_796874	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D53AA9/2020	EPI_ISL_799014	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-D51FF7/2020	EPI_ISL_799082	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/CAMC-D0DB32/2020	EPI_ISL_800419	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-D118F8/2020	EPI_ISL_800425	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	GV
hCoV-19/England/CAMC-D114C7/2020	EPI_ISL_800429	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-D0FD58/2020	EPI_ISL_800437	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-CE22E4/2020	EPI_ISL_800457	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CE131F/2020	EPI_ISL_800526	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/CAMC-D11A89/2020	EPI_ISL_800537	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-D0F3FC/2020	EPI_ISL_800541	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-E4E67F/2021	EPI_ISL_811254	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-E4CE5B/2021	EPI_ISL_811257	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-E46B2D/2021	EPI_ISL_811270	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-E4B5C0/2021	EPI_ISL_811272	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-E4E642/2021	EPI_ISL_811273	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-26545/2021	EPI_ISL_817333	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26555/2021	EPI_ISL_817334	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26564/2021	EPI_ISL_817335	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26669/2020	EPI_ISL_817337	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26671/2020	EPI_ISL_817338	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26700/2020	EPI_ISL_817339	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26704/2020	EPI_ISL_817340	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26790/2020	EPI_ISL_817342	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26796/2020	EPI_ISL_817343	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26818/2020	EPI_ISL_817344	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26829/2020	EPI_ISL_817345	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26849/2020	EPI_ISL_817346	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26864/2020	EPI_ISL_817347	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26956/2020	EPI_ISL_817348	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27050/2020	EPI_ISL_817349	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27051/2020	EPI_ISL_817350	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27075/2020	EPI_ISL_817351	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27102/2020	EPI_ISL_817352	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27220/2020	EPI_ISL_817353	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27226/2020	EPI_ISL_817354	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27274/2020	EPI_ISL_817355	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27314/2020	EPI_ISL_817356	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27336/2020	EPI_ISL_817357	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27369/2020	EPI_ISL_817358	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25691/2021	EPI_ISL_818589	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NSP11 without BLAST coverage.	warn	B.1.177.80	GV
hCoV-19/Denmark/DCGC-25983/2021	EPI_ISL_818645	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NSP11 without BLAST coverage.	warn	B.1.177.80	GV
hCoV-19/England/MILK-EBB552/2021	EPI_ISL_820864	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-4A9D3B/2020	EPI_ISL_823177	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A9D77/2020	EPI_ISL_823180	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A9E0B/2020	EPI_ISL_823187	2020-12-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A9F08/2020	EPI_ISL_823194	2020-12-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A9FAE/2020	EPI_ISL_823201	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A9FEA/2020	EPI_ISL_823203	2020-12-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A9FF9/2020	EPI_ISL_823204	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AA013/2020	EPI_ISL_823205	2020-12-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AA022/2020	EPI_ISL_823206	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AA05F/2020	EPI_ISL_823208	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AA0AA/2020	EPI_ISL_823213	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AA15C/2020	EPI_ISL_823217	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AA189/2020	EPI_ISL_823218	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AA1A7/2020	EPI_ISL_823220	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AA1C5/2020	EPI_ISL_823222	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AA1E3/2020	EPI_ISL_823223	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AA23B/2020	EPI_ISL_823226	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AA408/2020	EPI_ISL_823245	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AA471/2020	EPI_ISL_823250	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AA778/2020	EPI_ISL_823277	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AA787/2020	EPI_ISL_823278	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Iceland/4312/2020	EPI_ISL_828005	2020-10-08	Europe / Iceland / Reykjavik	Human	Original			Illumina Miseq	MPileup			B.1.177	GV
hCoV-19/England/ALDP-EE9184/2021	EPI_ISL_835070	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-EE6E26/2021	EPI_ISL_835072	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-EE1C6D/2021	EPI_ISL_835088	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-EFC2C7/2021	EPI_ISL_835160	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-EFD32D/2021	EPI_ISL_835200	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-EF985F/2021	EPI_ISL_835269	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-EDE52C/2021	EPI_ISL_836519	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMB-A9A836/2020	EPI_ISL_837891	2020-12-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-4B40BC/2021	EPI_ISL_841059	2021-01-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-29482/2021	EPI_ISL_843529	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29496/2021	EPI_ISL_843543	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29499/2021	EPI_ISL_843546	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29512/2021	EPI_ISL_843559	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29515/2021	EPI_ISL_843562	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29556/2021	EPI_ISL_843603	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29569/2020	EPI_ISL_843616	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29606/2020	EPI_ISL_843653	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29619/2020	EPI_ISL_843666	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29621/2020	EPI_ISL_843668	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30865/2021	EPI_ISL_847239	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30888/2021	EPI_ISL_847240	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-30951/2021	EPI_ISL_847241	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31022/2021	EPI_ISL_847242	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31030/2021	EPI_ISL_847243	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31082/2021	EPI_ISL_847244	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31091/2021	EPI_ISL_847245	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31093/2021	EPI_ISL_847246	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31101/2021	EPI_ISL_847247	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/SH-ChVir21759/2020	EPI_ISL_849806	2020-12-25	Europe / Germany / Schleswig-Holstein	Human	Original			NextSeq	Bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/SH-ChVir21760/2020	EPI_ISL_849807	2020-12-25	Europe / Germany / Schleswig-Holstein	Human	Original			NextSeq	Bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/HE-ChVir21762/2020	EPI_ISL_849809	2020-12-24	Europe / Germany / Hesse	Human	Original			NextSeq	Bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/SH-ChVir21764/2020	EPI_ISL_849811	2020-12-24	Europe / Germany / Schleswig-Holstein	Human	Original			NextSeq	Bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/SH-ChVir21765/2020	EPI_ISL_849812	2020-12-25	Europe / Germany / Schleswig-Holstein	Human	Original			NextSeq	Bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/SH-ChVir21768/2020	EPI_ISL_849815	2020-12-25	Europe / Germany / Schleswig-Holstein	Human	Original			NextSeq	Bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31238/2021	EPI_ISL_855618	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31246/2021	EPI_ISL_855626	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31291/2021	EPI_ISL_855671	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31316/2021	EPI_ISL_855696	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31318/2021	EPI_ISL_855698	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Wales/ALDP-CB397E/2020	EPI_ISL_859043	2020-12-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-CAD564/2020	EPI_ISL_859048	2020-12-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 17 nucleotides when compared to the reference sequence.	info	B.1.177.5	GV
hCoV-19/Scotland/QEUH-CAD546/2020	EPI_ISL_859057	2020-12-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-CB3941/2020	EPI_ISL_859061	2020-12-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-CAB609/2020	EPI_ISL_859077	2020-12-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-CAD968/2020	EPI_ISL_859112	2020-12-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-CADB71/2020	EPI_ISL_859118	2020-12-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-CB4B2C/2020	EPI_ISL_859126	2020-12-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-CAD7F5/2020	EPI_ISL_859139	2020-12-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-CC74EF/2020	EPI_ISL_859155	2020-12-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-CC5A85/2020	EPI_ISL_859157	2020-12-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-CC460A/2020	EPI_ISL_859158	2020-12-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-CC3164/2020	EPI_ISL_859164	2020-12-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-CC4628/2020	EPI_ISL_859168	2020-12-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-CC7519/2020	EPI_ISL_859172	2020-12-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-CC7528/2020	EPI_ISL_859174	2020-12-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-CC7573/2020	EPI_ISL_859175	2020-12-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-CC7546/2020	EPI_ISL_859180	2020-12-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-CC4619/2020	EPI_ISL_859184	2020-12-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-CC7555/2020	EPI_ISL_859200	2020-12-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Germany/NW-HHU-580/2020	EPI_ISL_861518	2020-12-16	Europe / Germany / North Rhine-Westphalia	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.177	GV
hCoV-19/Germany/NW-HHU-582/2020	EPI_ISL_861520	2020-12-16	Europe / Germany / North Rhine-Westphalia	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.177.62	GV
hCoV-19/Germany/NW-HHU-586/2020	EPI_ISL_861524	2020-12-16	Europe / Germany / North Rhine-Westphalia	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.177.62	GV
hCoV-19/Scotland/CVR6522/2021	EPI_ISL_865025	2021-01-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6537/2021	EPI_ISL_865038	2021-01-10	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6545/2021	EPI_ISL_865041	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6546/2021	EPI_ISL_865042	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6548/2021	EPI_ISL_865044	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6565/2021	EPI_ISL_865056	2021-01-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6566/2021	EPI_ISL_865057	2021-01-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB10857/2020	EPI_ISL_865069	2020-12-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB10861/2020	EPI_ISL_865071	2020-12-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB11257/2020	EPI_ISL_865072	2020-12-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB12155/2021	EPI_ISL_865075	2021-01-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB12205/2020	EPI_ISL_865083	2020-12-28	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB12212/2020	EPI_ISL_865087	2020-12-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB12214/2020	EPI_ISL_865088	2020-12-28	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/LOND-E48BF/2020	EPI_ISL_866334	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/LOND-E4907/2020	EPI_ISL_866339	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/LOND-E4934/2020	EPI_ISL_866342	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/LOND-E4943/2020	EPI_ISL_866343	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/LOND-E4952/2020	EPI_ISL_866344	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Northern Ireland/NIRE-235D63/2021	EPI_ISL_866353	2021-01-04	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.58	GV
hCoV-19/Northern Ireland/NIRE-236148/2021	EPI_ISL_866394	2021-01-09	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.58	GV
hCoV-19/Wales/PHWC-4B8C87/2021	EPI_ISL_867512	2021-01-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B8D1B/2021	EPI_ISL_867520	2021-01-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-4B92EE/2021	EPI_ISL_867602	2021-01-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B9952/2021	EPI_ISL_867699	2021-01-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/TFCI-26FF35A/2020	EPI_ISL_868914	2020-12-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/MILK-102DF85/2021	EPI_ISL_873519	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-10095AB/2021	EPI_ISL_874670	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1009004/2021	EPI_ISL_874685	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-100A7C2/2021	EPI_ISL_874758	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1005606/2021	EPI_ISL_874764	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10083FD/2021	EPI_ISL_874772	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-10090AA/2021	EPI_ISL_874801	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1005220/2021	EPI_ISL_874817	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1008AE9/2021	EPI_ISL_874819	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1006ABE/2021	EPI_ISL_874820	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-1064AEB/2021	EPI_ISL_878332	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1035BE0/2021	EPI_ISL_879616	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-102FA37/2021	EPI_ISL_880637	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FA2BC4/2021	EPI_ISL_881811	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FA2502/2021	EPI_ISL_881815	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FA22ED/2021	EPI_ISL_881817	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FA2599/2021	EPI_ISL_881922	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FA2C67/2021	EPI_ISL_881936	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FA35B6/2021	EPI_ISL_881937	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FA2229/2021	EPI_ISL_881940	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FA35E3/2021	EPI_ISL_881942	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FA2960/2021	EPI_ISL_881947	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FA355C/2021	EPI_ISL_881953	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FB5988/2021	EPI_ISL_881965	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1090A22/2021	EPI_ISL_885328	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-109011E/2021	EPI_ISL_885335	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-1090794/2021	EPI_ISL_885434	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1090864/2021	EPI_ISL_885449	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1090FC9/2021	EPI_ISL_885482	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10B7120/2021	EPI_ISL_891342	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Netherlands/FR-RIVM-10298/2021	EPI_ISL_904989	2021-01-07	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/England/ALDP-10E2380/2021	EPI_ISL_908510	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-10C1572/2021	EPI_ISL_908630	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Ireland/LS-NVRL-83IRL33516/2021	EPI_ISL_909942	2021-01-12	Europe / Ireland / Laois	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177.58	GV
hCoV-19/Germany/SH-ChVir21724/2020	EPI_ISL_909964	2020-12-21	Europe / Germany / Schleswig-Holstein	Human	Original			Illumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/SH-ChVir21725/2020	EPI_ISL_909965	2020-12-21	Europe / Germany / Schleswig-Holstein	Human	Original			Illumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/SH-ChVir21726/2020	EPI_ISL_909966	2020-12-22	Europe / Germany / Schleswig-Holstein	Human	Original			Illumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/SH-ChVir21454/2020	EPI_ISL_909984	2020-12-17	Europe / Germany / Schleswig-Holstein	Human	Original			Illumina NextSeq	bowtie2			B.1.177.62	GV
hCoV-19/Germany/SH-ChVir21455/2020	EPI_ISL_909985	2020-12-16	Europe / Germany / Schleswig-Holstein	Human	Original			Illumina NextSeq	bowtie2			B.1.177.62	GV
hCoV-19/Spain/CE-ISCIII-210083/2021	EPI_ISL_913058	2021-01-05	Europe / Spain / Ceuta	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.177.63	GV
hCoV-19/England/ALDP-BC95CD/2020	EPI_ISL_915627	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC9457/2020	EPI_ISL_915634	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC98E2/2020	EPI_ISL_915676	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC927B/2020	EPI_ISL_915685	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC8B53/2020	EPI_ISL_915686	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC9080/2020	EPI_ISL_915690	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-BC9633/2020	EPI_ISL_915692	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC818E/2020	EPI_ISL_915742	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC817F/2020	EPI_ISL_915743	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC828B/2020	EPI_ISL_915756	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCAC9A/2020	EPI_ISL_915814	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC6CAD/2020	EPI_ISL_915819	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCACC7/2020	EPI_ISL_915820	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC6A2B/2020	EPI_ISL_915821	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC82A9/2020	EPI_ISL_915833	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC6E4D/2020	EPI_ISL_915835	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC7DC7/2020	EPI_ISL_915843	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCB121/2020	EPI_ISL_915848	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-10BA002/2021	EPI_ISL_918014	2021-01-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-10B9DEE/2021	EPI_ISL_918017	2021-01-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-109C15E/2021	EPI_ISL_918030	2021-01-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-109C0CA/2021	EPI_ISL_918034	2021-01-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-10BAB5C/2021	EPI_ISL_918058	2021-01-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-100385D/2021	EPI_ISL_918068	2021-01-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-100386C/2021	EPI_ISL_918072	2021-01-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-10033D4/2021	EPI_ISL_918077	2021-01-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-100383F/2021	EPI_ISL_918079	2021-01-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-1003626/2021	EPI_ISL_918082	2021-01-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/EDB13767/2020	EPI_ISL_919347	2020-11-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB13768/2020	EPI_ISL_919348	2020-11-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB13769/2020	EPI_ISL_919349	2020-12-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB13772/2020	EPI_ISL_919352	2020-12-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB13773/2020	EPI_ISL_919353	2020-12-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB13774/2020	EPI_ISL_919354	2020-12-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB13775/2020	EPI_ISL_919355	2020-12-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB13777/2020	EPI_ISL_919356	2020-12-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB13778/2020	EPI_ISL_919357	2020-12-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB13779/2020	EPI_ISL_919358	2020-12-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB13781/2020	EPI_ISL_919359	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB13782/2020	EPI_ISL_919360	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB13783/2020	EPI_ISL_919361	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB13786/2020	EPI_ISL_919363	2020-12-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB13787/2020	EPI_ISL_919364	2020-12-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB13788/2020	EPI_ISL_919365	2020-12-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB13789/2020	EPI_ISL_919366	2020-12-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/England/NORT-28E30F/2020	EPI_ISL_921688	2020-12-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-28E40C/2020	EPI_ISL_921696	2020-12-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-4BD068/2021	EPI_ISL_922903	2021-01-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BD077/2021	EPI_ISL_922904	2021-01-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BD0A4/2021	EPI_ISL_922907	2021-01-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BD0B3/2021	EPI_ISL_922908	2021-01-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BD0C2/2021	EPI_ISL_922909	2021-01-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BD0E0/2021	EPI_ISL_922911	2021-01-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BD208/2021	EPI_ISL_922929	2021-01-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BD226/2021	EPI_ISL_922931	2021-01-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BD2F9/2021	EPI_ISL_922944	2021-01-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BD341/2021	EPI_ISL_922949	2021-01-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BD350/2021	EPI_ISL_922950	2021-01-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BD3AB/2021	EPI_ISL_922955	2021-01-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BD3D8/2021	EPI_ISL_922958	2021-01-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BD411/2021	EPI_ISL_922962	2021-01-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-35204/2021	EPI_ISL_926344	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-35277/2021	EPI_ISL_926417	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-35346/2020	EPI_ISL_926487	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-35348/2021	EPI_ISL_926489	2021-01-25	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36542/2021	EPI_ISL_927683	2021-01-25	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36553/2021	EPI_ISL_927694	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-36554/2020	EPI_ISL_927695	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36630/2020	EPI_ISL_927771	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36642/2021	EPI_ISL_927783	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36646/2020	EPI_ISL_927787	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36683/2020	EPI_ISL_927824	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37806/2021	EPI_ISL_928947	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-116F9E2/2021	EPI_ISL_932199	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-112951D/2021	EPI_ISL_932389	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1143AF0/2021	EPI_ISL_939604	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-119CB13/2021	EPI_ISL_945689	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-119C7B5/2021	EPI_ISL_945690	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11954E2/2021	EPI_ISL_946939	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-118B3D3/2021	EPI_ISL_946960	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/Scotland/QEUH-1015ADA/2021	EPI_ISL_949001	2021-01-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 15 nucleotides when compared to the reference sequence.	info	B.1.177.5	GV
hCoV-19/England/LOND-E4D56/2021	EPI_ISL_950126	2021-01-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/LOND-E4E26/2020	EPI_ISL_950138	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F587F6/2021	EPI_ISL_951488	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-11963E4/2021	EPI_ISL_958953	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1196CE9/2021	EPI_ISL_958993	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-11A0A5B/2021	EPI_ISL_963477	2021-01-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11D611B/2021	EPI_ISL_964678	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11BE586/2021	EPI_ISL_969483	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-11BD62A/2021	EPI_ISL_969544	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11BEC27/2021	EPI_ISL_969550	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/Denmark/DCGC-40136/2021	EPI_ISL_971813	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-40192/2021	EPI_ISL_971869	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40223/2021	EPI_ISL_971900	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40270/2021	EPI_ISL_971947	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-40282/2021	EPI_ISL_971959	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40305/2021	EPI_ISL_971982	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40322/2021	EPI_ISL_971999	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/MILK-11EBD79/2021	EPI_ISL_986063	2021-02-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/Scotland/QEUH-119A31D/2021	EPI_ISL_989921	2021-01-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-119B73E/2021	EPI_ISL_989961	2021-01-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-119B9A1/2021	EPI_ISL_989965	2021-01-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-119B8FF/2021	EPI_ISL_989980	2021-01-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C54AF4/2020	EPI_ISL_989985	2020-12-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-F3813A/2020	EPI_ISL_989989	2020-12-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-F3801F/2020	EPI_ISL_989990	2020-11-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-F382FB/2020	EPI_ISL_989992	2020-12-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-BE6032/2020	EPI_ISL_989993	2020-11-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-F387A1/2020	EPI_ISL_989994	2020-12-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C574C6/2020	EPI_ISL_989997	2020-12-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-1182A13/2021	EPI_ISL_990948	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10681F1/2021	EPI_ISL_994407	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1068249/2021	EPI_ISL_994456	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-108FCC6/2021	EPI_ISL_994620	2021-01-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Northern Ireland/NIRE-236B68/2021	EPI_ISL_998153	2021-01-13	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.58	GV
hCoV-19/Northern Ireland/NIRE-2374A8/2021	EPI_ISL_998173	2021-01-17	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/OXON-F5EA8E/2021	EPI_ISL_999323	2021-01-27	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Switzerland/SG-ETHZ-470115/2021	EPI_ISL_1003499	2021-01-22	Europe / Switzerland / St Gallen	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Switzerland/ZH-ETHZ-440416/2021	EPI_ISL_1004678	2021-01-01	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Austria/CeMM2807/2020	EPI_ISL_1008148	2020-12-30	Europe / Austria / Burgenland	Human	Original	Swab		Illumina NovaSeq	bwa	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Austria/CeMM2816/2020	EPI_ISL_1008157	2020-12-30	Europe / Austria / Burgenland	Human	Original	Swab		Illumina NovaSeq	bwa			B.1.177	GV
hCoV-19/Austria/CeMM2061/2020	EPI_ISL_1008357	2020-12-29	Europe / Austria / Styria	Human	Original	Swab		Illumina NovaSeq	bwa	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	GV
hCoV-19/England/ALDP-125C20A/2021	EPI_ISL_1011846	2021-02-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-125C13A/2021	EPI_ISL_1011937	2021-02-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-125C11C/2021	EPI_ISL_1011947	2021-02-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-109BE67/2021	EPI_ISL_1020001	2021-01-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Denmark/DCGC-42337/2021	EPI_ISL_1022615	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-42363/2021	EPI_ISL_1022641	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-42392/2021	EPI_ISL_1022670	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-42397/2021	EPI_ISL_1022675	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-42399/2021	EPI_ISL_1022677	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-43554/2021	EPI_ISL_1023932	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44630/2021	EPI_ISL_1025008	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-12A0744/2021	EPI_ISL_1042903	2021-02-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-128F0F5/2021	EPI_ISL_1045133	2021-02-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Northern Ireland/RAND-11ED533/2021	EPI_ISL_1046440	2021-01-30	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/LCST-24DC917/2020	EPI_ISL_1047947	2020-12-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-1B85EA1/2021	EPI_ISL_1051054	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORT-1B862B3/2021	EPI_ISL_1051097	2021-01-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/PHWC-4C55E6/2021	EPI_ISL_1052304	2021-02-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/PHWC-4C5C0F/2021	EPI_ISL_1052320	2021-02-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/PHWC-4C5F60/2021	EPI_ISL_1052343	2021-02-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/PHWC-4C62C0/2021	EPI_ISL_1052383	2021-02-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/PHWC-4C65D6/2021	EPI_ISL_1052395	2021-02-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/PHWC-4C6A22/2021	EPI_ISL_1052438	2021-02-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/PHWC-4C6B98/2021	EPI_ISL_1052448	2021-02-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C6FAB/2021	EPI_ISL_1052484	2021-01-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C7001/2021	EPI_ISL_1052490	2021-01-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C705C/2021	EPI_ISL_1052495	2021-01-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C70A7/2021	EPI_ISL_1052498	2021-02-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Switzerland/TG-ETHZ-490652/2021	EPI_ISL_1059762	2021-02-08	Europe / Switzerland / Thurgau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Scotland/QEUH-129E600/2021	EPI_ISL_1063071	2021-02-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Denmark/DCGC-46163/2021	EPI_ISL_1065673	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46259/2020	EPI_ISL_1065769	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46263/2021	EPI_ISL_1065773	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46390/2021	EPI_ISL_1065900	2021-02-15	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47377/2020	EPI_ISL_1066912	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47425/2021	EPI_ISL_1066960	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/RAND-12BF478/2021	EPI_ISL_1070159	2021-02-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Northern Ireland/QEUH-96B8D5/2020	EPI_ISL_531387	2020-08-16	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9933F1/2020	EPI_ISL_551950	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-992D9A/2020	EPI_ISL_551981	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9AD02A/2020	EPI_ISL_560015	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-9AD1CD/2020	EPI_ISL_560021	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9AF18F/2020	EPI_ISL_560031	2020-09-03	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9B0BD8/2020	EPI_ISL_560036	2020-09-03	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-9B0BE7/2020	EPI_ISL_560037	2020-09-03	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-9B0E48/2020	EPI_ISL_560046	2020-09-03	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-9B0F72/2020	EPI_ISL_560053	2020-09-03	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-16AB5D/2020	EPI_ISL_560160	2020-09-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9CDC99/2020	EPI_ISL_566111	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CE111/2020	EPI_ISL_566116	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CDDF0/2020	EPI_ISL_566140	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9CD060/2020	EPI_ISL_566181	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9CA661/2020	EPI_ISL_567338	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9C9B36/2020	EPI_ISL_567352	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9C9565/2020	EPI_ISL_567381	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-9CA036/2020	EPI_ISL_567399	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9C9DA9/2020	EPI_ISL_567402	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9CA3E2/2020	EPI_ISL_567419	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9CA7C8/2020	EPI_ISL_567441	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9CA5A0/2020	EPI_ISL_567450	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9CA27C/2020	EPI_ISL_567452	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/NORT-2A494D/2020	EPI_ISL_573390	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/MILK-974A1F/2020	EPI_ISL_575918	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-97637C/2020	EPI_ISL_575947	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-97487F/2020	EPI_ISL_575953	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/MILK-9C3A4E/2020	EPI_ISL_575987	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9C7CCC/2020	EPI_ISL_575996	2020-09-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Netherlands/ZH-EMC-606/2020	EPI_ISL_578034	2020-09-18	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.177	GV
hCoV-19/England/ALDP-9E7446/2020	EPI_ISL_580311	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E72F1/2020	EPI_ISL_580330	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E6E3A/2020	EPI_ISL_580334	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E716D/2020	EPI_ISL_580335	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E6869/2020	EPI_ISL_580348	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E6B7F/2020	EPI_ISL_580351	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E6DB5/2020	EPI_ISL_580363	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E6C03/2020	EPI_ISL_580370	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E626B/2020	EPI_ISL_580378	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E6E2B/2020	EPI_ISL_580380	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-9EC11D/2020	EPI_ISL_580385	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E74DD/2020	EPI_ISL_580386	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E6F82/2020	EPI_ISL_580387	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E6ADC/2020	EPI_ISL_580392	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-9EC335/2020	EPI_ISL_580393	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E6887/2020	EPI_ISL_580395	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E72B5/2020	EPI_ISL_580399	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-9EC70C/2020	EPI_ISL_580400	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E61D7/2020	EPI_ISL_580415	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E6544/2020	EPI_ISL_580424	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E7376/2020	EPI_ISL_580439	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E732B/2020	EPI_ISL_580446	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E722E/2020	EPI_ISL_580448	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E6B15/2020	EPI_ISL_580451	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E6C5E/2020	EPI_ISL_580458	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E6E76/2020	EPI_ISL_580468	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E6A63/2020	EPI_ISL_580475	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/CVR4621/2020	EPI_ISL_585422	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB7866/2020	EPI_ISL_585426	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB7879/2020	EPI_ISL_585432	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/ALDP-A2DB99/2020	EPI_ISL_586574	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2DCA5/2020	EPI_ISL_586575	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2E2DF/2020	EPI_ISL_586610	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2E13C/2020	EPI_ISL_586624	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2D276/2020	EPI_ISL_586639	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-A2D531/2020	EPI_ISL_586660	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2E04E/2020	EPI_ISL_586665	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2E06C/2020	EPI_ISL_586681	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2D4F8/2020	EPI_ISL_586694	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2E11E/2020	EPI_ISL_586699	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9FCA97/2020	EPI_ISL_587900	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9FDB84/2020	EPI_ISL_587904	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9FDE5E/2020	EPI_ISL_587922	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9FD39B/2020	EPI_ISL_587942	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9FD9F3/2020	EPI_ISL_587991	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9EF772/2020	EPI_ISL_594937	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/MILK-9EFB49/2020	EPI_ISL_594983	2020-09-23	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/MILK-A17DC9/2020	EPI_ISL_594988	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A4C806/2020	EPI_ISL_596003	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4C824/2020	EPI_ISL_596004	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4C842/2020	EPI_ISL_596006	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4C860/2020	EPI_ISL_596008	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/QEUH-A4CAC4/2020	EPI_ISL_596017	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A4CC73/2020	EPI_ISL_596038	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A4CCFB/2020	EPI_ISL_596045	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A4CD07/2020	EPI_ISL_596046	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A4CD34/2020	EPI_ISL_596049	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A4CD43/2020	EPI_ISL_596050	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina		NS8_K53stop results in 57.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-A4CD8F/2020	EPI_ISL_596053	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A4CEC8/2020	EPI_ISL_596063	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/CAMC-A594E4/2020	EPI_ISL_597188	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A58AA7/2020	EPI_ISL_597192	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A5E2D6/2020	EPI_ISL_597280	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A5E133/2020	EPI_ISL_597281	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A577B0/2020	EPI_ISL_597293	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A5E5EC/2020	EPI_ISL_597312	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A5DEA6/2020	EPI_ISL_597330	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A5E5BF/2020	EPI_ISL_597339	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A5DE79/2020	EPI_ISL_597356	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A5DF94/2020	EPI_ISL_597359	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A5E142/2020	EPI_ISL_597370	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A570E2/2020	EPI_ISL_597397	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A47908/2020	EPI_ISL_598490	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A45991/2020	EPI_ISL_598611	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-A44C6C/2020	EPI_ISL_598655	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A06817/2020	EPI_ISL_599881	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A06176/2020	EPI_ISL_599932	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A06A6C/2020	EPI_ISL_599941	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A05B1F/2020	EPI_ISL_599958	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-A05414/2020	EPI_ISL_599977	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-A05836/2020	EPI_ISL_599982	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A06783/2020	EPI_ISL_599987	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9E4A65/2020	EPI_ISL_601013	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9E42D6/2020	EPI_ISL_601036	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9E43D3/2020	EPI_ISL_601038	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9E4582/2020	EPI_ISL_601039	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9E517E/2020	EPI_ISL_601040	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9E3F1C/2020	EPI_ISL_601046	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9E52D5/2020	EPI_ISL_601062	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9E41E8/2020	EPI_ISL_601064	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9E434C/2020	EPI_ISL_601075	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9E4D5D/2020	EPI_ISL_601081	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9E486B/2020	EPI_ISL_601089	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9E4EF0/2020	EPI_ISL_601091	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9E4722/2020	EPI_ISL_601092	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Switzerland/BE-ETHZ-310520/2020	EPI_ISL_603588	2020-10-08	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-A6FD1D/2020	EPI_ISL_607104	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6E349/2020	EPI_ISL_607107	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6E297/2020	EPI_ISL_607110	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6E570/2020	EPI_ISL_607127	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6D9B1/2020	EPI_ISL_607171	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6EEEE/2020	EPI_ISL_607172	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-A6E33A/2020	EPI_ISL_607173	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6EE66/2020	EPI_ISL_607180	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6CADD/2020	EPI_ISL_607197	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7B40A/2020	EPI_ISL_607296	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-A6C4FD/2020	EPI_ISL_608328	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68172/2020	EPI_ISL_608419	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68E8A/2020	EPI_ISL_608435	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A687CB/2020	EPI_ISL_608438	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68242/2020	EPI_ISL_608454	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A67E30/2020	EPI_ISL_608474	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68F96/2020	EPI_ISL_608481	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68154/2020	EPI_ISL_608489	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A688AA/2020	EPI_ISL_608496	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A685B2/2020	EPI_ISL_608499	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6879E/2020	EPI_ISL_608503	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A3E9E6/2020	EPI_ISL_609702	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A3E421/2020	EPI_ISL_609723	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A3F851/2020	EPI_ISL_609734	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A3F9E5/2020	EPI_ISL_609735	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A3F6DF/2020	EPI_ISL_609745	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A3F860/2020	EPI_ISL_609763	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A3E412/2020	EPI_ISL_609771	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A3F55A/2020	EPI_ISL_609772	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A3EBB3/2020	EPI_ISL_609781	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A3EAB6/2020	EPI_ISL_609788	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A82488/2020	EPI_ISL_610707	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A82E7B/2020	EPI_ISL_610708	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A82127/2020	EPI_ISL_610729	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A821AF/2020	EPI_ISL_610736	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A820A2/2020	EPI_ISL_610738	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A81D8E/2020	EPI_ISL_610752	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A81D9D/2020	EPI_ISL_610760	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A81F1F/2020	EPI_ISL_610781	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A81717/2020	EPI_ISL_610789	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A81058/2020	EPI_ISL_610791	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A8229D/2020	EPI_ISL_610829	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-480DFE/2020	EPI_ISL_613005	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-480F16/2020	EPI_ISL_613015	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-480FDA/2020	EPI_ISL_613024	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-480FE9/2020	EPI_ISL_613025	2020-10-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48106D/2020	EPI_ISL_613030	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-481249/2020	EPI_ISL_613047	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-481294/2020	EPI_ISL_613051	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-481337/2020	EPI_ISL_613056	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-481531/2020	EPI_ISL_613082	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48157D/2020	EPI_ISL_613086	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48164D/2020	EPI_ISL_613096	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48166B/2020	EPI_ISL_613097	2020-10-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4816A7/2020	EPI_ISL_613099	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-8256/2020	EPI_ISL_616956	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-AA2E75/2020	EPI_ISL_623958	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA36D6/2020	EPI_ISL_623965	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA17C6/2020	EPI_ISL_625004	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA093A/2020	EPI_ISL_625007	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-AA115F/2020	EPI_ISL_625008	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA32D2/2020	EPI_ISL_625009	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA5461/2020	EPI_ISL_625012	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA5470/2020	EPI_ISL_625044	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-AA178A/2020	EPI_ISL_625050	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA11B9/2020	EPI_ISL_625063	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA49DC/2020	EPI_ISL_625076	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA54AD/2020	EPI_ISL_625081	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-A6A4B3/2020	EPI_ISL_627508	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Northern Ireland/NIRE-108B8E/2020	EPI_ISL_627541	2020-10-09	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/NORW-F0346/2020	EPI_ISL_627580	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F14BB/2020	EPI_ISL_627597	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F161F/2020	EPI_ISL_627608	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F1C0E/2020	EPI_ISL_627623	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/NORW-F1CD1/2020	EPI_ISL_627630	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F1D0B/2020	EPI_ISL_627632	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F1D47/2020	EPI_ISL_627633	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F1DCF/2020	EPI_ISL_627637	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F1FAB/2020	EPI_ISL_627645	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NOTT-117876/2020	EPI_ISL_627671	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-117B8C/2020	EPI_ISL_627672	2020-10-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-117E38/2020	EPI_ISL_627673	2020-10-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-118620/2020	EPI_ISL_627677	2020-10-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11863F/2020	EPI_ISL_627678	2020-10-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-118699/2020	EPI_ISL_627680	2020-10-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-1186A8/2020	EPI_ISL_627681	2020-10-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-1186B7/2020	EPI_ISL_627682	2020-10-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11881B/2020	EPI_ISL_627684	2020-10-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-118A8E/2020	EPI_ISL_627688	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-118ABB/2020	EPI_ISL_627691	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-118D76/2020	EPI_ISL_627695	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-118E73/2020	EPI_ISL_627698	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-118E82/2020	EPI_ISL_627699	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMC-AEABB6/2020	EPI_ISL_633390	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AEAC4A/2020	EPI_ISL_633408	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE1C9E/2020	EPI_ISL_633414	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-AE28E4/2020	EPI_ISL_633416	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE1EB6/2020	EPI_ISL_633417	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE27C9/2020	EPI_ISL_633459	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE2D5E/2020	EPI_ISL_633461	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE2BBE/2020	EPI_ISL_633470	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE1E7A/2020	EPI_ISL_633471	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE28C6/2020	EPI_ISL_633473	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE2046/2020	EPI_ISL_633485	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE22B9/2020	EPI_ISL_633491	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE1DF5/2020	EPI_ISL_633572	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE25DE/2020	EPI_ISL_633579	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD16EE/2020	EPI_ISL_634603	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD1F10/2020	EPI_ISL_634703	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-AD103B/2020	EPI_ISL_634720	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD4672/2020	EPI_ISL_634722	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/QEUH-AD3DC9/2020	EPI_ISL_634738	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/QEUH-AD1790/2020	EPI_ISL_634745	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/QEUH-AD261A/2020	EPI_ISL_634750	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-AA1BCA/2020	EPI_ISL_634781	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E775C/2020	EPI_ISL_638215	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/ALDP-9E776B/2020	EPI_ISL_638216	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/ALDP-9E832A/2020	EPI_ISL_638244	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/ALDP-9E8348/2020	EPI_ISL_638246	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/ALDP-9E87A6/2020	EPI_ISL_638256	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B708F/2020	EPI_ISL_638300	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B76AB/2020	EPI_ISL_638327	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-488DAB/2020	EPI_ISL_639501	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-488F2D/2020	EPI_ISL_639517	2020-10-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4890A1/2020	EPI_ISL_639532	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48928D/2020	EPI_ISL_639556	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48941E/2020	EPI_ISL_639574	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-489478/2020	EPI_ISL_639578	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-489618/2020	EPI_ISL_639596	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-489742/2020	EPI_ISL_639611	2020-10-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48978E/2020	EPI_ISL_639615	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4897E8/2020	EPI_ISL_639620	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B145B4/2020	EPI_ISL_641809	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B139AA/2020	EPI_ISL_641818	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B13D62/2020	EPI_ISL_641836	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-B13DBD/2020	EPI_ISL_641839	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B14271/2020	EPI_ISL_641849	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B0F859/2020	EPI_ISL_641856	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B141B0/2020	EPI_ISL_641868	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B13816/2020	EPI_ISL_641885	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B14262/2020	EPI_ISL_641904	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B0E025/2020	EPI_ISL_641934	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B0E0DA/2020	EPI_ISL_641948	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B0F40A/2020	EPI_ISL_641952	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B0E0AD/2020	EPI_ISL_641954	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B0FB9C/2020	EPI_ISL_641961	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B0DD89/2020	EPI_ISL_641999	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD0306/2020	EPI_ISL_644040	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD0421/2020	EPI_ISL_644041	2020-10-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD02DC/2020	EPI_ISL_644051	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/MILK-ACE927/2020	EPI_ISL_644075	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AB7754/2020	EPI_ISL_644087	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AAE802/2020	EPI_ISL_644094	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AAE7C9/2020	EPI_ISL_644101	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-AA29ED/2020	EPI_ISL_644105	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AAE680/2020	EPI_ISL_644112	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B372E1/2020	EPI_ISL_645381	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B3730C/2020	EPI_ISL_645387	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B3EC91/2020	EPI_ISL_645418	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B374FA/2020	EPI_ISL_645420	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B36789/2020	EPI_ISL_645431	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B36965/2020	EPI_ISL_645435	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B374EB/2020	EPI_ISL_645460	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1CE66/2020	EPI_ISL_645544	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24DAA/2020	EPI_ISL_646603	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24E89/2020	EPI_ISL_646710	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2B49F/2020	EPI_ISL_646729	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2B82A/2020	EPI_ISL_646730	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B2636A/2020	EPI_ISL_646737	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B25F76/2020	EPI_ISL_646743	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24E01/2020	EPI_ISL_646749	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24E2F/2020	EPI_ISL_646753	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-B2B3A1/2020	EPI_ISL_646766	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2B505/2020	EPI_ISL_646774	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2B5BA/2020	EPI_ISL_646781	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2C935/2020	EPI_ISL_646783	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2B73C/2020	EPI_ISL_646785	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24B82/2020	EPI_ISL_646793	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B2489A/2020	EPI_ISL_646797	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B248F4/2020	EPI_ISL_646873	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-489F68/2020	EPI_ISL_652508	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48A222/2020	EPI_ISL_652537	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48A2AA/2020	EPI_ISL_652540	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48A43B/2020	EPI_ISL_652554	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48A459/2020	EPI_ISL_652555	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48A617/2020	EPI_ISL_652576	2020-10-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48A644/2020	EPI_ISL_652579	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48A671/2020	EPI_ISL_652582	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48A6AE/2020	EPI_ISL_652585	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48A732/2020	EPI_ISL_652594	2020-10-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48A78D/2020	EPI_ISL_652598	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48A94B/2020	EPI_ISL_652616	2020-10-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/PORT-2F5F5A/2020	EPI_ISL_652624	2020-10-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2F5F69/2020	EPI_ISL_652625	2020-10-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2F5F87/2020	EPI_ISL_652626	2020-10-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/QEUH-A9BFF4/2020	EPI_ISL_652627	2020-10-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A9C37F/2020	EPI_ISL_652633	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A9C412/2020	EPI_ISL_652641	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/England/QEUH-A9CF4E/2020	EPI_ISL_652648	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A9D0D1/2020	EPI_ISL_652652	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A9D138/2020	EPI_ISL_652656	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A9D174/2020	EPI_ISL_652660	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A9DF98/2020	EPI_ISL_652671	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/204441503/2020	EPI_ISL_653974	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/204462379/2020	EPI_ISL_653983	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/ALDP-B45ACA/2020	EPI_ISL_656028	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-B462A3/2020	EPI_ISL_656034	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46DB1/2020	EPI_ISL_656036	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B45FDA/2020	EPI_ISL_656037	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B4606D/2020	EPI_ISL_656039	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46B02/2020	EPI_ISL_656040	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46C2D/2020	EPI_ISL_656043	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B4609A/2020	EPI_ISL_656046	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B472FD/2020	EPI_ISL_656047	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B461A6/2020	EPI_ISL_656061	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46BB7/2020	EPI_ISL_656078	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46030/2020	EPI_ISL_656085	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46D75/2020	EPI_ISL_656093	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46F24/2020	EPI_ISL_656103	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B469CC/2020	EPI_ISL_656114	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46C3C/2020	EPI_ISL_656123	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46892/2020	EPI_ISL_656124	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B4630A/2020	EPI_ISL_656126	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46346/2020	EPI_ISL_656127	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B45DEF/2020	EPI_ISL_656130	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B47020/2020	EPI_ISL_656135	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46D2A/2020	EPI_ISL_656150	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46AF6/2020	EPI_ISL_656155	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B4608B/2020	EPI_ISL_656169	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B460A9/2020	EPI_ISL_656171	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46CF0/2020	EPI_ISL_656179	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B45E28/2020	EPI_ISL_656187	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46258/2020	EPI_ISL_656189	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B55A9A/2020	EPI_ISL_657367	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B55678/2020	EPI_ISL_657381	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B55836/2020	EPI_ISL_657401	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B52884/2020	EPI_ISL_657407	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B55827/2020	EPI_ISL_657417	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B55AF4/2020	EPI_ISL_657429	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B52DB2/2020	EPI_ISL_657431	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B55845/2020	EPI_ISL_657441	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B5562D/2020	EPI_ISL_657459	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B55739/2020	EPI_ISL_657491	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B5313D/2020	EPI_ISL_657498	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B5280C/2020	EPI_ISL_657524	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B410EA/2020	EPI_ISL_658684	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B3F4B6/2020	EPI_ISL_658701	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B410DB/2020	EPI_ISL_658702	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B411AB/2020	EPI_ISL_658711	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B3FCAF/2020	EPI_ISL_658714	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B40F39/2020	EPI_ISL_658715	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B3F8F6/2020	EPI_ISL_658725	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B3F5E0/2020	EPI_ISL_658727	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/MILK-B38972/2020	EPI_ISL_658747	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B38D1C/2020	EPI_ISL_658783	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B395AA/2020	EPI_ISL_658847	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B7439A/2020	EPI_ISL_662013	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/LOND-1250D14/2020	EPI_ISL_665801	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/NORW-F5129/2020	EPI_ISL_665885	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F5675/2020	EPI_ISL_665889	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F5824/2020	EPI_ISL_665894	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/NOTT-11CF03/2020	EPI_ISL_665908	2020-11-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11D4D6/2020	EPI_ISL_665934	2020-11-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11D8BC/2020	EPI_ISL_665944	2020-11-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/PORT-2EA2C8/2020	EPI_ISL_665951	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/PORT-2EA3B6/2020	EPI_ISL_665952	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-A9BFC7/2020	EPI_ISL_665977	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-A9C8E9/2020	EPI_ISL_665979	2020-10-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-A9F7AD/2020	EPI_ISL_665985	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-A9FF1E/2020	EPI_ISL_665997	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-B80F5B/2020	EPI_ISL_668028	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B80F2E/2020	EPI_ISL_668062	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B80F97/2020	EPI_ISL_668073	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B7B08D/2020	EPI_ISL_668090	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B81664/2020	EPI_ISL_668093	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B80F1F/2020	EPI_ISL_668102	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B80E6D/2020	EPI_ISL_668107	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B80E5E/2020	EPI_ISL_668113	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7EBA7/2020	EPI_ISL_668120	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7EB2F/2020	EPI_ISL_668121	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-B7E415/2020	EPI_ISL_668135	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B821EA/2020	EPI_ISL_668196	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-10068/2020	EPI_ISL_669376	2020-11-09	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.80	GV
hCoV-19/England/MILK-B8D20A/2020	EPI_ISL_674091	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8E52E/2020	EPI_ISL_674095	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8D53E/2020	EPI_ISL_674099	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B849A4/2020	EPI_ISL_675161	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B846BC/2020	EPI_ISL_675202	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B83A39/2020	EPI_ISL_675203	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B8468F/2020	EPI_ISL_675204	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8F00E/2020	EPI_ISL_675241	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B845CE/2020	EPI_ISL_675248	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-B84625/2020	EPI_ISL_675255	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B82CF8/2020	EPI_ISL_675265	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B8479B/2020	EPI_ISL_675269	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-B8F226/2020	EPI_ISL_675276	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B83EA6/2020	EPI_ISL_675278	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B846CB/2020	EPI_ISL_675291	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B838A8/2020	EPI_ISL_675300	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8F305/2020	EPI_ISL_675308	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B84643/2020	EPI_ISL_675316	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B8378D/2020	EPI_ISL_675321	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-48EDF0/2020	EPI_ISL_681008	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48EF90/2020	EPI_ISL_681028	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48EFDC/2020	EPI_ISL_681032	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48F278/2020	EPI_ISL_681066	2020-11-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48F2B4/2020	EPI_ISL_681070	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.7	GV
hCoV-19/Wales/PHWC-48F2F0/2020	EPI_ISL_681074	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48F357/2020	EPI_ISL_681079	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48F3C0/2020	EPI_ISL_681086	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48F3DF/2020	EPI_ISL_681087	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48F409/2020	EPI_ISL_681090	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48F67C/2020	EPI_ISL_681121	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48F797/2020	EPI_ISL_681136	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48F7A6/2020	EPI_ISL_681137	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48F8C1/2020	EPI_ISL_681154	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48FA07/2020	EPI_ISL_681173	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48FBAA/2020	EPI_ISL_681197	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-12199/2020	EPI_ISL_682380	2020-11-16	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-12280/2020	EPI_ISL_682461	2020-11-16	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/CAMC-BD146B/2020	EPI_ISL_702147	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BD16A1/2020	EPI_ISL_702215	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BD1692/2020	EPI_ISL_702224	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BD21DC/2020	EPI_ISL_702241	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BD14F2/2020	EPI_ISL_702273	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCA3B3/2020	EPI_ISL_703531	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCA034/2020	EPI_ISL_703536	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCA19B/2020	EPI_ISL_703563	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCA6BA/2020	EPI_ISL_703588	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCA966/2020	EPI_ISL_703594	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC0942/2020	EPI_ISL_704810	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC0818/2020	EPI_ISL_704824	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC01C2/2020	EPI_ISL_704859	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/LIVE-DC19B8/2020	EPI_ISL_704903	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/MILK-BDC5C7/2020	EPI_ISL_709605	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BDC679/2020	EPI_ISL_709618	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BDBA8D/2020	EPI_ISL_709623	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BDB795/2020	EPI_ISL_709629	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BDC72B/2020	EPI_ISL_709662	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BDC4AC/2020	EPI_ISL_709696	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BDB7D1/2020	EPI_ISL_709700	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BDC749/2020	EPI_ISL_709711	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BDC5E5/2020	EPI_ISL_709770	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BDB786/2020	EPI_ISL_709774	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-BE95E5/2020	EPI_ISL_710617	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BEB1D0/2020	EPI_ISL_710619	2020-12-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-BEB185/2020	EPI_ISL_710627	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-BEB1FE/2020	EPI_ISL_710629	2020-12-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Wales/ALDP-BE8E18/2020	EPI_ISL_710638	2020-12-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BEAE8F/2020	EPI_ISL_710641	2020-12-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-BEB1EF/2020	EPI_ISL_710642	2020-12-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-BEAF5F/2020	EPI_ISL_710643	2020-12-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-BEAF31/2020	EPI_ISL_710644	2020-12-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-BEB04C/2020	EPI_ISL_710646	2020-12-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-C148D8/2020	EPI_ISL_710657	2020-12-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-C14C90/2020	EPI_ISL_710659	2020-12-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-C067FA/2020	EPI_ISL_710661	2020-12-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-C1691F/2020	EPI_ISL_710664	2020-12-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C14DF7/2020	EPI_ISL_710670	2020-12-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-C14911/2020	EPI_ISL_710672	2020-12-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-C14823/2020	EPI_ISL_710674	2020-12-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-C14CFA/2020	EPI_ISL_710678	2020-12-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C14C81/2020	EPI_ISL_710684	2020-12-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C148E7/2020	EPI_ISL_710685	2020-12-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-C148AB/2020	EPI_ISL_710687	2020-12-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-C1489C/2020	EPI_ISL_710688	2020-12-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-C148BA/2020	EPI_ISL_710696	2020-12-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-BBA310/2020	EPI_ISL_710725	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-BB94D2/2020	EPI_ISL_710734	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-BB9830/2020	EPI_ISL_710735	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-BB9DB9/2020	EPI_ISL_710736	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-BCAB15/2020	EPI_ISL_710747	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BC4656/2020	EPI_ISL_710748	2020-11-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-BCAAEB/2020	EPI_ISL_710749	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BC397C/2020	EPI_ISL_710757	2020-11-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-BC38CA/2020	EPI_ISL_710760	2020-11-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BCC393/2020	EPI_ISL_710763	2020-11-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BC3833/2020	EPI_ISL_710766	2020-11-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-BCC32A/2020	EPI_ISL_710770	2020-11-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BCC2F0/2020	EPI_ISL_710775	2020-11-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BCC25A/2020	EPI_ISL_710776	2020-11-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BCBEEE/2020	EPI_ISL_710778	2020-11-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-BCC357/2020	EPI_ISL_710779	2020-11-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BCC366/2020	EPI_ISL_710783	2020-11-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BCC348/2020	EPI_ISL_710784	2020-11-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BCBF36/2020	EPI_ISL_710788	2020-11-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-BCC3B1/2020	EPI_ISL_710789	2020-11-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BCBF27/2020	EPI_ISL_710790	2020-11-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-BCCCD4/2020	EPI_ISL_710797	2020-11-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-16064/2020	EPI_ISL_714265	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-16080/2020	EPI_ISL_714266	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-16129/2020	EPI_ISL_714267	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-16317/2020	EPI_ISL_714268	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-16695/2020	EPI_ISL_714269	2020-11-02	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/CAMC-C3E638/2020	EPI_ISL_719001	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C3EFC4/2020	EPI_ISL_719040	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C436D6/2020	EPI_ISL_719054	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C40E2C/2020	EPI_ISL_719091	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/CAMC-C437F1/2020	EPI_ISL_719126	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C41298/2020	EPI_ISL_719154	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB1425/2020	EPI_ISL_720024	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB08DF/2020	EPI_ISL_720039	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB1355/2020	EPI_ISL_720063	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB148F/2020	EPI_ISL_720073	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB0505/2020	EPI_ISL_720074	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC7A93/2020	EPI_ISL_721300	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-BC7A1B/2020	EPI_ISL_721301	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC65B1/2020	EPI_ISL_721307	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC795A/2020	EPI_ISL_721314	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC8591/2020	EPI_ISL_721316	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC67BB/2020	EPI_ISL_721326	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC7D5E/2020	EPI_ISL_721327	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC794B/2020	EPI_ISL_721347	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-BC7CAC/2020	EPI_ISL_721349	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC64E1/2020	EPI_ISL_721370	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC6654/2020	EPI_ISL_721376	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC89E0/2020	EPI_ISL_721380	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC7AFD/2020	EPI_ISL_721388	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC686D/2020	EPI_ISL_721403	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC793C/2020	EPI_ISL_721409	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC777E/2020	EPI_ISL_721424	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC7A84/2020	EPI_ISL_721428	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-BC628D/2020	EPI_ISL_721442	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-BC626F/2020	EPI_ISL_721444	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC7C06/2020	EPI_ISL_721463	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC8643/2020	EPI_ISL_721467	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Netherlands/ZH-EMC-1011/2020	EPI_ISL_722605	2020-11-01	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.177	GV
hCoV-19/Netherlands/GE-EMC-410/2020	EPI_ISL_722621	2020-11-12	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.177	GV
hCoV-19/Netherlands/GE-EMC-414/2020	EPI_ISL_722643	2020-11-15	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1BCFF6/2020	EPI_ISL_723920	2020-12-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/CAMB-A97866/2020	EPI_ISL_723928	2020-12-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A978C0/2020	EPI_ISL_723932	2020-12-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A97972/2020	EPI_ISL_723939	2020-12-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A979DC/2020	EPI_ISL_723944	2020-12-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMC-B7B111/2020	EPI_ISL_723983	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/CAMC-B7B14E/2020	EPI_ISL_723985	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-B7B1D5/2020	EPI_ISL_723992	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-B7B20F/2020	EPI_ISL_723994	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4945E0/2020	EPI_ISL_726141	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4946B0/2020	EPI_ISL_726154	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-494841/2020	EPI_ISL_726175	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4948C9/2020	EPI_ISL_726183	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-494920/2020	EPI_ISL_726189	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-494999/2020	EPI_ISL_726196	2020-11-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4949E4/2020	EPI_ISL_726201	2020-11-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4949F3/2020	EPI_ISL_726202	2020-11-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-494A0F/2020	EPI_ISL_726203	2020-11-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-494A78/2020	EPI_ISL_726209	2020-11-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-499EB3/2020	EPI_ISL_727460	2020-11-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49A016/2020	EPI_ISL_727482	2020-11-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.65	GV
hCoV-19/Wales/PHWC-49A1B9/2020	EPI_ISL_727506	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49A22F/2020	EPI_ISL_727513	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49A298/2020	EPI_ISL_727520	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/Wales/PHWC-49A2F2/2020	EPI_ISL_727526	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49A33B/2020	EPI_ISL_727530	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49A580/2020	EPI_ISL_727565	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49A5BD/2020	EPI_ISL_727568	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49A5EA/2020	EPI_ISL_727571	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49A66F/2020	EPI_ISL_727578	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49A6C9/2020	EPI_ISL_727583	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49A6F6/2020	EPI_ISL_727586	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49A78A/2020	EPI_ISL_727594	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-20535/2020	EPI_ISL_728750	2020-11-22	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/England/ALDP-C58780/2020	EPI_ISL_735916	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C5B85D/2020	EPI_ISL_735920	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C5A01A/2020	EPI_ISL_735925	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C5852C/2020	EPI_ISL_735926	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C58207/2020	EPI_ISL_735950	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C58F2E/2020	EPI_ISL_735975	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/PORT-2EE622/2020	EPI_ISL_741717	2020-11-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2EE631/2020	EPI_ISL_741718	2020-11-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2EE67D/2020	EPI_ISL_741721	2020-11-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/England/PORT-2EE69B/2020	EPI_ISL_741723	2020-11-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2EE6AA/2020	EPI_ISL_741724	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2EE6C8/2020	EPI_ISL_741726	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2F62AB/2020	EPI_ISL_741756	2020-11-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2F62E7/2020	EPI_ISL_741758	2020-11-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/PORT-2F6302/2020	EPI_ISL_741759	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/QEUH-B7C49F/2020	EPI_ISL_741779	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B7C5C9/2020	EPI_ISL_741789	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B7C5D8/2020	EPI_ISL_741790	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B7C963/2020	EPI_ISL_741804	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B7CC97/2020	EPI_ISL_741820	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B7CF16/2020	EPI_ISL_741832	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B7CF61/2020	EPI_ISL_741833	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B7D100/2020	EPI_ISL_741848	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B7D11F/2020	EPI_ISL_741849	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B7D892/2020	EPI_ISL_741888	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B7DB02/2020	EPI_ISL_741897	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A2CCC/2020	EPI_ISL_744004	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A2CDB/2020	EPI_ISL_744005	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A2DD8/2020	EPI_ISL_744018	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A2DE7/2020	EPI_ISL_744019	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A2F87/2020	EPI_ISL_744038	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A3038/2020	EPI_ISL_744043	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A3117/2020	EPI_ISL_744055	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A319F/2020	EPI_ISL_744063	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A32D8/2020	EPI_ISL_744083	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A3302/2020	EPI_ISL_744086	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Germany/BE-ChVir-D1929-7417/2020	EPI_ISL_753781	2020-10-09	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-ChVir-D1931-8262/2020	EPI_ISL_753782	2020-10-08	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-ChVir-D1933-8292/2020	EPI_ISL_753783	2020-10-08	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-ChVir-D1934-8278/2020	EPI_ISL_753784	2020-10-11	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-ChVir-D1936-8209/2020	EPI_ISL_753785	2020-09-24	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-ChVir-D1938-8233/2020	EPI_ISL_753786	2020-09-28	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-ChVir-D1939-8206/2020	EPI_ISL_753787	2020-09-26	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-ChVir-D1946-8235/2020	EPI_ISL_753788	2020-10-01	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-ChVir-D1955-8202/2020	EPI_ISL_753789	2020-10-11	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-ChVir-D2001-8219/2020	EPI_ISL_753790	2020-10-19	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-ChVir-D2009-8236/2020	EPI_ISL_753791	2020-10-15	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-ChVir-D2014-8229/2020	EPI_ISL_753792	2020-10-14	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-ChVir-D2029-8271/2020	EPI_ISL_753793	2020-10-15	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-ChVir-D2032-8244/2020	EPI_ISL_753794	2020-10-12	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-ChVir-W2118-4404/2020	EPI_ISL_753795	2020-10-12	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/NW-ChVir-D2005-8224/2020	EPI_ISL_753796	2020-10-19	Europe / Germany / North Rhine-Westphalia	Human	Original			llumina NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/205141162/2020	EPI_ISL_756136	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/QEUH-CADA1A/2020	EPI_ISL_760907	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB3D45/2020	EPI_ISL_760925	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB4746/2020	EPI_ISL_760933	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CAD9C2/2020	EPI_ISL_760999	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Netherlands/ZH-EMC-1193/2020	EPI_ISL_763266	2020-12-21	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Northern Ireland/NIRE-2351FE/2020	EPI_ISL_764417	2020-10-16	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-221113/2020	EPI_ISL_764446	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-22115F/2020	EPI_ISL_764447	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-2211C8/2020	EPI_ISL_764449	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-2211E6/2020	EPI_ISL_764450	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-22122F/2020	EPI_ISL_764452	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-22124D/2020	EPI_ISL_764454	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-221975/2020	EPI_ISL_764457	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-2219A2/2020	EPI_ISL_764458	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-221A36/2020	EPI_ISL_764462	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-221C12/2020	EPI_ISL_764470	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-221C4F/2020	EPI_ISL_764471	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-221C5E/2020	EPI_ISL_764472	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-221D5B/2020	EPI_ISL_764474	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-221DD3/2020	EPI_ISL_764475	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-221E94/2020	EPI_ISL_764478	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-221F55/2020	EPI_ISL_764482	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-22232B/2020	EPI_ISL_764486	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-2223FE/2020	EPI_ISL_764488	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NOTT-121846/2020	EPI_ISL_764510	2020-12-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-121851/2020	EPI_ISL_764512	2020-12-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/OXON-F4024B/2020	EPI_ISL_764531	2020-12-15	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/OXON-F40D77/2020	EPI_ISL_764551	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F40EFC/2020	EPI_ISL_764554	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/OXON-F41295/2020	EPI_ISL_764563	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-C5D563/2020	EPI_ISL_769273	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C5D5FA/2020	EPI_ISL_769276	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C5BC06/2020	EPI_ISL_769316	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C5B9E1/2020	EPI_ISL_769334	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Norway/7021/2020	EPI_ISL_775275	2020-12-18	Europe / Norway / Oslo	Human	Original	Nasopharyngeal aspirate		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/CAMC-CB7A95/2020	EPI_ISL_777780	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-CB7910/2020	EPI_ISL_777800	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-CB7B0B/2020	EPI_ISL_777878	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CCCABB/2020	EPI_ISL_782228	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CDEAB6/2020	EPI_ISL_782238	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CDEAF2/2020	EPI_ISL_782298	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CEC9D6/2020	EPI_ISL_782352	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-CEBAC5/2020	EPI_ISL_782361	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CDE360/2020	EPI_ISL_782379	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Netherlands/FR-RIVM-20862/2020	EPI_ISL_790831	2020-12-21	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/GR-RIVM-20836/2020	EPI_ISL_790891	2020-12-15	Europe / Netherlands / Groningen	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Denmark/DCGC-22669/2020	EPI_ISL_794353	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22733/2020	EPI_ISL_794357	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22735/2020	EPI_ISL_794358	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22742/2020	EPI_ISL_794360	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22771/2020	EPI_ISL_794361	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22780/2020	EPI_ISL_794363	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22789/2020	EPI_ISL_794364	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22808/2020	EPI_ISL_794365	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22846/2020	EPI_ISL_794366	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22853/2020	EPI_ISL_794367	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24605/2020	EPI_ISL_795639	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NSP11 without BLAST coverage.	warn	B.1.177.80	GV
hCoV-19/England/ALDP-DA7781/2020	EPI_ISL_796850	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D9F1AC/2020	EPI_ISL_796860	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-DA6C92/2020	EPI_ISL_796990	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-DA02F0/2020	EPI_ISL_796995	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D44540/2020	EPI_ISL_799106	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-D539D9/2020	EPI_ISL_799134	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-D53A4F/2020	EPI_ISL_799151	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-D44980/2020	EPI_ISL_799154	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D51E09/2020	EPI_ISL_799192	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D45A7D/2020	EPI_ISL_799235	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D45BB6/2020	EPI_ISL_799252	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-D44908/2020	EPI_ISL_799278	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C1C393/2020	EPI_ISL_800609	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C22AA4/2020	EPI_ISL_800617	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C1834C/2020	EPI_ISL_800625	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C1BACC/2020	EPI_ISL_800626	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C22B83/2020	EPI_ISL_800636	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C18537/2020	EPI_ISL_800643	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C21B66/2020	EPI_ISL_800650	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C184B2/2020	EPI_ISL_800656	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C22D50/2020	EPI_ISL_800661	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C18995/2020	EPI_ISL_800705	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C18388/2020	EPI_ISL_800722	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C18D11/2020	EPI_ISL_800723	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C183F1/2020	EPI_ISL_800728	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-E4D8A7/2021	EPI_ISL_811370	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-E4E6CA/2021	EPI_ISL_811426	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/PORT-2E8BA1/2020	EPI_ISL_816166	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/PORT-2E8D23/2020	EPI_ISL_816184	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Denmark/DCGC-26609/2020	EPI_ISL_817411	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 7 nucleotide(s) found at refpos 27794 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 21 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27349/2020	EPI_ISL_817412	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 7 nucleotide(s) found at refpos 27794 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 21 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-DCB848/2020	EPI_ISL_822126	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-DB1B2E/2021	EPI_ISL_822141	2021-01-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-DB18EB/2021	EPI_ISL_822193	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-4AA918/2020	EPI_ISL_823294	2020-12-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AADD0/2020	EPI_ISL_823340	2020-12-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AAFF8/2020	EPI_ISL_823362	2020-12-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AB1B5/2020	EPI_ISL_823373	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AB1C4/2020	EPI_ISL_823374	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AB258/2020	EPI_ISL_823381	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AB2B2/2020	EPI_ISL_823383	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AB346/2020	EPI_ISL_823389	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AB355/2020	EPI_ISL_823390	2020-12-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AB373/2020	EPI_ISL_823392	2020-12-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AB382/2020	EPI_ISL_823393	2020-12-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AB391/2020	EPI_ISL_823394	2020-12-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AB407/2020	EPI_ISL_823398	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4AB72C/2020	EPI_ISL_823419	2020-12-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4ABC0F/2020	EPI_ISL_823467	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4ABD93/2020	EPI_ISL_823481	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4ABDA2/2020	EPI_ISL_823482	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4ABE81/2020	EPI_ISL_823490	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Germany/SH-ChVir21110/2020	EPI_ISL_824748	2020-12-03	Europe / Germany / Schleswig-Holstein	Human	Original			NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/SH-ChVir21115/2020	EPI_ISL_824753	2020-12-03	Europe / Germany / Schleswig-Holstein	Human	Original			NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/SH-ChVir21120/2020	EPI_ISL_824757	2020-12-04	Europe / Germany / Schleswig-Holstein	Human	Original			NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/SH-ChVir21121/2020	EPI_ISL_824758	2020-12-04	Europe / Germany / Schleswig-Holstein	Human	Original			NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-F4A52A/2021	EPI_ISL_834039	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-F4A41E/2021	EPI_ISL_834055	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-F4BAEE/2021	EPI_ISL_834059	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-F4879F/2021	EPI_ISL_834076	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-F5171B/2021	EPI_ISL_834078	2021-01-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-F5403B/2021	EPI_ISL_834129	2021-01-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-EFBA48/2021	EPI_ISL_835284	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-EF9B29/2021	EPI_ISL_835343	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMB-A9B64A/2021	EPI_ISL_837984	2021-01-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A9B668/2021	EPI_ISL_837985	2021-01-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-4B515E/2021	EPI_ISL_841287	2021-01-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B5288/2021	EPI_ISL_841299	2021-01-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-29622/2020	EPI_ISL_843669	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29667/2020	EPI_ISL_843714	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29686/2020	EPI_ISL_843733	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29694/2020	EPI_ISL_843741	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7a_Q90stop results in 26.4% truncation of the protein sequence. NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29696/2020	EPI_ISL_843743	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29713/2020	EPI_ISL_843760	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29715/2020	EPI_ISL_843762	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29718/2020	EPI_ISL_843765	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29727/2020	EPI_ISL_843774	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31268/2021	EPI_ISL_855648	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31336/2021	EPI_ISL_855716	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31345/2021	EPI_ISL_855725	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Wales/ALDP-F82052/2021	EPI_ISL_858001	2021-01-08	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-F6B7C3/2021	EPI_ISL_858014	2021-01-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-F5AE95/2021	EPI_ISL_858019	2021-01-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-F5AE3B/2021	EPI_ISL_858030	2021-01-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-F69AF9/2021	EPI_ISL_858033	2021-01-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-F6833B/2021	EPI_ISL_858034	2021-01-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-F493A9/2021	EPI_ISL_858106	2021-01-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-CBF8B1/2020	EPI_ISL_859239	2020-12-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-CC39B7/2020	EPI_ISL_859256	2020-12-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-CC39C6/2020	EPI_ISL_859268	2020-12-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/QEUH-CC3191/2020	EPI_ISL_859270	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-CC2262/2020	EPI_ISL_859280	2020-12-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-CBFA24/2020	EPI_ISL_859283	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-CC25C3/2020	EPI_ISL_859295	2020-12-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Wales/ALDP-CBF1B6/2020	EPI_ISL_859302	2020-12-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-CC09BA/2020	EPI_ISL_859308	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-CBFA06/2020	EPI_ISL_859314	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-CC2EAA/2020	EPI_ISL_859316	2020-12-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-C932D3/2020	EPI_ISL_859321	2020-12-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-C9331C/2020	EPI_ISL_859322	2020-12-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-C9325B/2020	EPI_ISL_859324	2020-12-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-C9326A/2020	EPI_ISL_859325	2020-12-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-CB5DCB/2020	EPI_ISL_859334	2020-12-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-CB594F/2020	EPI_ISL_859349	2020-12-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-CB5E04/2020	EPI_ISL_859363	2020-12-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-CB43BB/2020	EPI_ISL_859417	2020-12-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/Wales/ALDP-C88365/2020	EPI_ISL_859428	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-C8B1D1/2020	EPI_ISL_859445	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-C8B5E4/2020	EPI_ISL_859455	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C4B708/2020	EPI_ISL_859463	2020-12-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-C4B97B/2020	EPI_ISL_859466	2020-12-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Norway/7225/2020	EPI_ISL_860214	2020-12-23	Europe / Norway / Agder	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Norway/0050/2021	EPI_ISL_860215	2021-01-04	Europe / Norway / Oslo	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Norway/0436/2021	EPI_ISL_860272	2021-01-04	Europe / Norway / Viken	Human	original	nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Norway/0438/2021	EPI_ISL_860273	2021-01-06	Europe / Norway / Viken	Human	original	nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Norway/0437/2021	EPI_ISL_860279	2021-01-07	Europe / Norway / Viken	Human	original	nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Norway/0094/2021	EPI_ISL_860294	2021-01-06	Europe / Norway / Oslo	Human	original	saliva		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Germany/BB-RKI-NP-0011/2021	EPI_ISL_860314	2021-01-05	Europe / Germany / Brandenburg	Human	Original		unknown	Nanopore MinION	ARTIC pipeline	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/HE-RKI-NP-0012/2021	EPI_ISL_860315	2021-01-05	Europe / Germany / Hesse	Human	Original		unknown	Nanopore MinION	ARTIC pipeline	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-FB5C8F/2021	EPI_ISL_862920	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FB6CBB/2021	EPI_ISL_862957	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FB5EA7/2021	EPI_ISL_862964	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/EDB12908/2021	EPI_ISL_865111	2021-01-10	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB12917/2021	EPI_ISL_865117	2021-01-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB12925/2021	EPI_ISL_865125	2021-01-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB12929/2021	EPI_ISL_865129	2021-01-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB13078/2021	EPI_ISL_865132	2021-01-10	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB13079/2021	EPI_ISL_865133	2021-01-10	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB13080/2021	EPI_ISL_865134	2021-01-10	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB9627/2020	EPI_ISL_865162	2020-11-10	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/LIVE-DD8408/2020	EPI_ISL_865230	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DD873C/2020	EPI_ISL_865263	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORT-1B8B8BC/2020	EPI_ISL_866450	2020-12-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-4B99BC/2021	EPI_ISL_867704	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B99CB/2021	EPI_ISL_867705	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B99DA/2021	EPI_ISL_867706	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B9AF5/2021	EPI_ISL_867723	2021-01-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B9BF2/2021	EPI_ISL_867737	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B9C0E/2021	EPI_ISL_867738	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B9C1D/2021	EPI_ISL_867739	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B9C2C/2021	EPI_ISL_867740	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B9C3B/2021	EPI_ISL_867741	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BA6A5/2021	EPI_ISL_867890	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-33997/2021	EPI_ISL_871007	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/MILK-102E063/2021	EPI_ISL_873555	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 23 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-10031AD/2021	EPI_ISL_874898	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10055CD/2021	EPI_ISL_874959	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1009013/2021	EPI_ISL_874962	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-106523D/2021	EPI_ISL_878490	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Germany/ST-MD249/2020	EPI_ISL_884287	2020-12-31	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-10B5C12/2021	EPI_ISL_885504	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10B57A8/2021	EPI_ISL_885520	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10B5F73/2021	EPI_ISL_885561	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10B6482/2021	EPI_ISL_885562	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10B68D1/2021	EPI_ISL_885612	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Israel/CVL-942ngs/2020	EPI_ISL_889151	2020-12-31	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-10B9FBB/2021	EPI_ISL_891440	2021-01-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-10A102C/2021	EPI_ISL_891486	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Slovakia/UKBA-1013/2020	EPI_ISL_903992	2020-12-22	Europe / Slovakia / Trenčín	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC 2000bp	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-10EAF75/2021	EPI_ISL_907414	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10F651A/2021	EPI_ISL_907446	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-10BF805/2021	EPI_ISL_908754	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-10BF0C1/2021	EPI_ISL_908782	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Sweden/21-00159/2020	EPI_ISL_913280	2020-12-28	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with fill from reference and majority wins	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Sweden/21-50080/2021	EPI_ISL_913281	2021-01-03	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with fill from reference and majority wins	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-BCAF46/2020	EPI_ISL_915761	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC7EF1/2020	EPI_ISL_915769	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCADE2/2020	EPI_ISL_915861	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC7F0D/2020	EPI_ISL_915869	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCB0CA/2020	EPI_ISL_915871	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC6E98/2020	EPI_ISL_915890	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCB07F/2020	EPI_ISL_915909	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC6D9B/2020	EPI_ISL_915911	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCAC8B/2020	EPI_ISL_915925	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC6900/2020	EPI_ISL_915937	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC8045/2020	EPI_ISL_915943	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-BC80AF/2020	EPI_ISL_915949	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC8388/2020	EPI_ISL_915951	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCB060/2020	EPI_ISL_915962	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-1003750/2021	EPI_ISL_918100	2021-01-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-10036AE/2021	EPI_ISL_918116	2021-01-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-1003741/2021	EPI_ISL_918117	2021-01-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/LIVE-DD9513/2021	EPI_ISL_919463	2021-01-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/LOND-132555B/2020	EPI_ISL_920486	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.58	GV
hCoV-19/England/NORT-28E5FA/2020	EPI_ISL_921717	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-28E6BB/2020	EPI_ISL_921725	2020-12-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-28EA64/2020	EPI_ISL_921758	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-28ED2F/2020	EPI_ISL_921781	2020-12-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORW-22133B/2020	EPI_ISL_921793	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-221377/2020	EPI_ISL_921796	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-221386/2020	EPI_ISL_921797	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-221720/2020	EPI_ISL_921837	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-35264/2020	EPI_ISL_926404	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-35266/2021	EPI_ISL_926406	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-35381/2021	EPI_ISL_926522	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-35440/2021	EPI_ISL_926581	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-35450/2021	EPI_ISL_926591	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-35473/2021	EPI_ISL_926614	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-35586/2020	EPI_ISL_926727	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36585/2021	EPI_ISL_927726	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-36726/2021	EPI_ISL_927867	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-36729/2021	EPI_ISL_927870	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-36751/2021	EPI_ISL_927892	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36798/2021	EPI_ISL_927939	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36799/2021	EPI_ISL_927940	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Switzerland/BL-UHB-42502139/2020	EPI_ISL_931129	2020-10-24	Europe / Switzerland / Basel-Stadt / Basel	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	In-house pipelIne COVGAP			B.1.177	GV
hCoV-19/England/QEUH-11291DD/2021	EPI_ISL_932416	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-112DCF6/2021	EPI_ISL_932460	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-112B232/2021	EPI_ISL_932554	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-116ADDC/2021	EPI_ISL_938708	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Netherlands/FR-RIVM-11099/2021	EPI_ISL_943270	2021-01-20	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/FR-RIVM-11104/2021	EPI_ISL_943275	2021-01-13	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Scotland/QEUH-118A240/2021	EPI_ISL_945725	2021-01-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-118A26E/2021	EPI_ISL_945806	2021-01-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-118A091/2021	EPI_ISL_945815	2021-01-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/NORT-1B7B5A9/2021	EPI_ISL_950242	2021	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORT-1B7B65B/2021	EPI_ISL_950250	2021-01-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BE6A1/2021	EPI_ISL_951524	2021-01-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BE6B0/2021	EPI_ISL_951525	2021-01-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BE8D8/2021	EPI_ISL_951546	2021-01-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	G
hCoV-19/Wales/PHWC-4BED51/2021	EPI_ISL_951575	2021-01-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-103248E/2021	EPI_ISL_952859	2021-01-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-11B6867/2021	EPI_ISL_957708	2021-01-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-11B6858/2021	EPI_ISL_957729	2021-01-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/MILK-11D2DFD/2021	EPI_ISL_957803	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11D5352/2021	EPI_ISL_964802	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11D60A5/2021	EPI_ISL_964833	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11D5228/2021	EPI_ISL_964849	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Norway/1452/2021	EPI_ISL_964961	2021-01-19	Europe / Norway / Rogaland	Human	original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/England/ALDP-11BD5E1/2021	EPI_ISL_969881	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-39464/2021	EPI_ISL_970854	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39477/2021	EPI_ISL_970869	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41330/2021	EPI_ISL_973007	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41350/2021	EPI_ISL_973027	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41354/2021	EPI_ISL_973031	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41374/2021	EPI_ISL_973051	2021-01-25	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41408/2021	EPI_ISL_973085	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41418/2021	EPI_ISL_973095	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/MILK-11F1AB5/2021	EPI_ISL_980026	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-120CCFC/2021	EPI_ISL_986376	2021-02-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-12017C9/2021	EPI_ISL_988927	2021-02-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1201C7F/2021	EPI_ISL_988933	2021-02-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-12018C6/2021	EPI_ISL_988971	2021-02-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-110BD91/2021	EPI_ISL_992012	2021-01-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10EAA92/2021	EPI_ISL_992125	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-10F105A/2021	EPI_ISL_992140	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10EA3E2/2021	EPI_ISL_992209	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-10E9BBE/2021	EPI_ISL_992221	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-109EE0A/2021	EPI_ISL_993465	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Finland/HEL-13-203/2021	EPI_ISL_995975	2021-01-20	Europe / Finland / Uusimaa	Human	Original			Illumina Miseq	BWA-MEM	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Scotland/EDB13737/2021	EPI_ISL_997079	2021-01-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		NS8_Y111stop results in 9.1% truncation of the protein sequence.	info	B.1.177.5	GV
hCoV-19/Northern Ireland/NIRE-237E8C/2020	EPI_ISL_998205	2020-12-17	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.58	GV
hCoV-19/England/OXON-F61253/2021	EPI_ISL_999504	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C3278/2021	EPI_ISL_999526	2021-02-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C390A/2021	EPI_ISL_999603	2021-02-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C3CA7/2021	EPI_ISL_999634	2021-01-31	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C3E47/2021	EPI_ISL_999655	2021-01-31	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C3EB0/2021	EPI_ISL_999659	2021-01-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Switzerland/SZ-ETHZ-460971/2021	EPI_ISL_1003189	2021-01-18	Europe / Switzerland / Schwyz	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Switzerland/ZH-ETHZ-440463/2021	EPI_ISL_1004705	2021-01-01	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177	GV
hCoV-19/England/CAMC-1254A91/2021	EPI_ISL_1005768	2021-02-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Denmark/DCGC-44508/2021	EPI_ISL_1024886	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44517/2021	EPI_ISL_1024895	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44570/2021	EPI_ISL_1024948	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44590/2021	EPI_ISL_1024968	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44595/2021	EPI_ISL_1024973	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/CAMC-1271120/2021	EPI_ISL_1033288	2021-02-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Netherlands/UT-RIVM-12573/2021	EPI_ISL_1035510	2021-01-28	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/OV-RIVM-13037/2021	EPI_ISL_1035569	2021-02-03	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/OV-RIVM-12882/2021	EPI_ISL_1035581	2021-01-09	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Norway/6886/2020	EPI_ISL_1040148	2020-12-12	Europe / Norway / Oslo	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Norway/0980/2021	EPI_ISL_1040151	2021-01-11	Europe / Norway / Vestlandet	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Wales/PHWC-4CB823/2021	EPI_ISL_1053432	2021-02-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4CC154/2021	EPI_ISL_1053533	2021-01-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/SHEF-10D7351/2021	EPI_ISL_1054704	2021-01-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Denmark/DCGC-45968/2021	EPI_ISL_1065478	2021-02-08	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47203/2020	EPI_ISL_1066716	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47210/2021	EPI_ISL_1066723	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/QEUH-12B74DA/2021	EPI_ISL_1071578	2021-02-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Northern Ireland/QEUH-96AAB2/2020	EPI_ISL_531428	2020-08-17	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9A4481/2020	EPI_ISL_540173	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9A4445/2020	EPI_ISL_540183	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-9A4472/2020	EPI_ISL_540187	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-96FE75/2020	EPI_ISL_540264	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-99DF4E/2020	EPI_ISL_550543	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-9907DA/2020	EPI_ISL_551884	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-995395/2020	EPI_ISL_552254	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-993898/2020	EPI_ISL_552257	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9C3334/2020	EPI_ISL_566804	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9C40C3/2020	EPI_ISL_566821	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9C448B/2020	EPI_ISL_566855	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9C446D/2020	EPI_ISL_566869	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-16BB4D/2020	EPI_ISL_573945	2020-09-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16BC4A/2020	EPI_ISL_573956	2020-09-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16BDDE/2020	EPI_ISL_573974	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-9735E2/2020	EPI_ISL_575830	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-97337F/2020	EPI_ISL_575832	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9730D2/2020	EPI_ISL_575846	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9735C4/2020	EPI_ISL_575888	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9C9D03/2020	EPI_ISL_576083	2020-09-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9CA34C/2020	EPI_ISL_576085	2020-09-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9C9653/2020	EPI_ISL_576086	2020-09-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9C9680/2020	EPI_ISL_576087	2020-09-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Wales/PHWC-16D96F/2020	EPI_ISL_577470	2020-09-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16D97E/2020	EPI_ISL_577471	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16DA99/2020	EPI_ISL_577485	2020-09-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16DAD5/2020	EPI_ISL_577488	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16DB78/2020	EPI_ISL_577498	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16DB96/2020	EPI_ISL_577500	2020-09-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16DC57/2020	EPI_ISL_577512	2020-09-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16DD18/2020	EPI_ISL_577524	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORT-2A4F87/2020	EPI_ISL_584682	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-2A5232/2020	EPI_ISL_584686	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4402/2020	EPI_ISL_585276	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR4403/2020	EPI_ISL_585277	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4407/2020	EPI_ISL_585281	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4410/2020	EPI_ISL_585284	2020-09-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4412/2020	EPI_ISL_585286	2020-09-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4413/2020	EPI_ISL_585287	2020-09-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4417/2020	EPI_ISL_585291	2020-09-18	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR4419/2020	EPI_ISL_585293	2020-09-18	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Wales/PHWC-16F095/2020	EPI_ISL_585908	2020-10-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16F165/2020	EPI_ISL_585920	2020-09-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16F280/2020	EPI_ISL_585938	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16F2DB/2020	EPI_ISL_585943	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16F39C/2020	EPI_ISL_585955	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16F3F6/2020	EPI_ISL_585961	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16F61B/2020	EPI_ISL_585995	2020-10-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-A2DDC0/2020	EPI_ISL_586589	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2DEAF/2020	EPI_ISL_586598	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9FC842/2020	EPI_ISL_587820	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9FD4B6/2020	EPI_ISL_587822	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9FD0C1/2020	EPI_ISL_587831	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9FCA5B/2020	EPI_ISL_587867	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9FCCDD/2020	EPI_ISL_587868	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9FA6C2/2020	EPI_ISL_588113	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9FA64A/2020	EPI_ISL_588149	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9FB02D/2020	EPI_ISL_588153	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9FAC84/2020	EPI_ISL_588176	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9FADFA/2020	EPI_ISL_588189	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9FAAF3/2020	EPI_ISL_588194	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E5CF5/2020	EPI_ISL_589437	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E592B/2020	EPI_ISL_589466	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E593A/2020	EPI_ISL_589478	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E5D10/2020	EPI_ISL_589491	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E577C/2020	EPI_ISL_589503	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E58D3/2020	EPI_ISL_589508	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E58C4/2020	EPI_ISL_589509	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9B4DB0/2020	EPI_ISL_590409	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-9B4C2C/2020	EPI_ISL_590416	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/NOTT-115FA0/2020	EPI_ISL_595300	2020-10-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-116060/2020	EPI_ISL_595302	2020-10-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11621F/2020	EPI_ISL_595312	2020-10-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-116349/2020	EPI_ISL_595315	2020-10-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-116C11/2020	EPI_ISL_595323	2020-10-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-116EEE/2020	EPI_ISL_595325	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-47DF49/2020	EPI_ISL_595383	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47DFB2/2020	EPI_ISL_595390	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-47E054/2020	EPI_ISL_595397	2020-09-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-A5910B/2020	EPI_ISL_597203	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A5849A/2020	EPI_ISL_597209	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A58500/2020	EPI_ISL_597225	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A57729/2020	EPI_ISL_597239	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A5E045/2020	EPI_ISL_597249	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A5E0FA/2020	EPI_ISL_597263	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A57079/2020	EPI_ISL_597266	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A572EC/2020	EPI_ISL_597274	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A5DFD0/2020	EPI_ISL_597276	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A5268B/2020	EPI_ISL_597932	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A5206F/2020	EPI_ISL_597943	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A52630/2020	EPI_ISL_597944	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A5133A/2020	EPI_ISL_597961	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A513D0/2020	EPI_ISL_597968	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A5271F/2020	EPI_ISL_597986	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A517C5/2020	EPI_ISL_597992	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A45E47/2020	EPI_ISL_598534	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A466A8/2020	EPI_ISL_598585	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-A05827/2020	EPI_ISL_599847	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A06738/2020	EPI_ISL_599861	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A06A4E/2020	EPI_ISL_599891	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9FF42D/2020	EPI_ISL_600286	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9FF7F7/2020	EPI_ISL_600300	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-A00288/2020	EPI_ISL_600309	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A00394/2020	EPI_ISL_600316	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9FF85E/2020	EPI_ISL_600335	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A003FE/2020	EPI_ISL_600339	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-9FF92E/2020	EPI_ISL_600352	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9FF86D/2020	EPI_ISL_600362	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-A003EF/2020	EPI_ISL_600371	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9FFD8C/2020	EPI_ISL_600385	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9D50FC/2020	EPI_ISL_601614	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-9D3BC0/2020	EPI_ISL_601646	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7AEC1/2020	EPI_ISL_606487	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7AF37/2020	EPI_ISL_606511	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/MILK-A7D2C2/2020	EPI_ISL_606569	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6F2A5/2020	EPI_ISL_607009	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6E2C4/2020	EPI_ISL_607014	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6FD86/2020	EPI_ISL_607040	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6EBC9/2020	EPI_ISL_607052	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6F919/2020	EPI_ISL_607064	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-A6FCE3/2020	EPI_ISL_607082	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6F894/2020	EPI_ISL_607086	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A70748/2020	EPI_ISL_607790	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6DA45/2020	EPI_ISL_607809	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A7058A/2020	EPI_ISL_607813	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6E051/2020	EPI_ISL_607820	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6FA34/2020	EPI_ISL_607832	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6FA61/2020	EPI_ISL_607839	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6F9CE/2020	EPI_ISL_607844	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A704C9/2020	EPI_ISL_607846	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6E82C/2020	EPI_ISL_607849	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A70511/2020	EPI_ISL_607853	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6DAFA/2020	EPI_ISL_607878	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6CD3E/2020	EPI_ISL_608323	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-A6C90D/2020	EPI_ISL_608345	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68CEA/2020	EPI_ISL_608356	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68F1E/2020	EPI_ISL_608362	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68E11/2020	EPI_ISL_608364	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68804/2020	EPI_ISL_608365	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A64AE4/2020	EPI_ISL_608370	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68E7B/2020	EPI_ISL_608375	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A684A6/2020	EPI_ISL_608380	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A3F7FA/2020	EPI_ISL_609629	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A3F842/2020	EPI_ISL_609650	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A3E70A/2020	EPI_ISL_609652	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A3E649/2020	EPI_ISL_609691	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A84A66/2020	EPI_ISL_610600	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A84E1F/2020	EPI_ISL_610620	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A82576/2020	EPI_ISL_610638	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/CAMC-A821BE/2020	EPI_ISL_610651	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A8196C/2020	EPI_ISL_610655	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A82FF0/2020	EPI_ISL_610670	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A81AC3/2020	EPI_ISL_610684	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-A83038/2020	EPI_ISL_610685	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A92889/2020	EPI_ISL_611000	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A935AF/2020	EPI_ISL_611009	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A935EB/2020	EPI_ISL_611016	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A93660/2020	EPI_ISL_611023	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A92CF6/2020	EPI_ISL_611028	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A9385B/2020	EPI_ISL_611029	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A93958/2020	EPI_ISL_611046	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A94007/2020	EPI_ISL_611049	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A93A82/2020	EPI_ISL_611079	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/CVR4662/2020	EPI_ISL_612300	2020-09-28	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4680/2020	EPI_ISL_612308	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4681/2020	EPI_ISL_612309	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR4688/2020	EPI_ISL_612310	2020-09-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR4689/2020	EPI_ISL_612311	2020-09-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4690/2020	EPI_ISL_612312	2020-09-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8298/2020	EPI_ISL_612317	2020-10-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8329/2020	EPI_ISL_612323	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB8330/2020	EPI_ISL_612324	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB8334/2020	EPI_ISL_612326	2020-10-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB8341/2020	EPI_ISL_612329	2020-10-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB8345/2020	EPI_ISL_612333	2020-10-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB8348/2020	EPI_ISL_612336	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB8349/2020	EPI_ISL_612337	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB8351/2020	EPI_ISL_612339	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB8368/2020	EPI_ISL_612344	2020-10-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB8381/2020	EPI_ISL_612350	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8382/2020	EPI_ISL_612351	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8431/2020	EPI_ISL_612357	2020-10-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8443/2020	EPI_ISL_612362	2020-10-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB8451/2020	EPI_ISL_612363	2020-10-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8459/2020	EPI_ISL_612367	2020-10-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8476/2020	EPI_ISL_612369	2020-10-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8487/2020	EPI_ISL_612371	2020-10-18	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB8491/2020	EPI_ISL_612373	2020-10-19	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/204281813/2020	EPI_ISL_613599	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/Denmark/DCGC-8027/2020	EPI_ISL_617139	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Denmark/DCGC-7644/2020	EPI_ISL_618514	2020-10-19	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/England/ALDP-AA2EB1/2020	EPI_ISL_623900	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA2ACC/2020	EPI_ISL_623902	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AADD7D/2020	EPI_ISL_623903	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA56C5/2020	EPI_ISL_623905	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA5276/2020	EPI_ISL_623906	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA2AF9/2020	EPI_ISL_623927	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA51D3/2020	EPI_ISL_623948	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AAE583/2020	EPI_ISL_623986	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-AA2EDF/2020	EPI_ISL_623987	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AADC52/2020	EPI_ISL_623994	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA1C8B/2020	EPI_ISL_624302	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA1D6A/2020	EPI_ISL_624308	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA463F/2020	EPI_ISL_624328	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA23B2/2020	EPI_ISL_624330	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA208E/2020	EPI_ISL_624332	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA4462/2020	EPI_ISL_624337	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA4C00/2020	EPI_ISL_624347	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA46B7/2020	EPI_ISL_624348	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA1ADC/2020	EPI_ISL_624351	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA3ACB/2020	EPI_ISL_624357	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA1CC7/2020	EPI_ISL_624363	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-AA109E/2020	EPI_ISL_624367	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA1CA9/2020	EPI_ISL_624369	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA2015/2020	EPI_ISL_624391	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA1FCE/2020	EPI_ISL_624395	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ACBEFE/2020	EPI_ISL_629118	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AC9519/2020	EPI_ISL_629149	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AC9652/2020	EPI_ISL_629159	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AC92B8/2020	EPI_ISL_629185	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ACCB6F/2020	EPI_ISL_629195	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AC93D3/2020	EPI_ISL_630101	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-ACDB6E/2020	EPI_ISL_630131	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ACD111/2020	EPI_ISL_630159	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Netherlands/GE-EMC-348/2020	EPI_ISL_632764	2020-10-27	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.177	GV
hCoV-19/England/QEUH-AE4A46/2020	EPI_ISL_633332	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AE5007/2020	EPI_ISL_633358	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD4171/2020	EPI_ISL_634602	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD3FC3/2020	EPI_ISL_634616	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD58D5/2020	EPI_ISL_634626	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD41DB/2020	EPI_ISL_634631	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD104A/2020	EPI_ISL_634636	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD5B54/2020	EPI_ISL_634639	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-AD5A84/2020	EPI_ISL_634641	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-AD4C52/2020	EPI_ISL_634658	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD1736/2020	EPI_ISL_634666	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD5B81/2020	EPI_ISL_634671	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-AD46AF/2020	EPI_ISL_634676	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD3F78/2020	EPI_ISL_634692	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD437B/2020	EPI_ISL_634698	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9AE3D5/2020	EPI_ISL_638904	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9AE43C/2020	EPI_ISL_638907	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-9D32BC/2020	EPI_ISL_638912	2020-09-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-9D32CB/2020	EPI_ISL_638913	2020-09-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9F4F36/2020	EPI_ISL_638918	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9F4F45/2020	EPI_ISL_638919	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9F52C3/2020	EPI_ISL_638923	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-9F52E1/2020	EPI_ISL_638925	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A3682D/2020	EPI_ISL_638929	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4B227/2020	EPI_ISL_638936	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A4B4D6/2020	EPI_ISL_638941	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A4B4F4/2020	EPI_ISL_638942	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A7783F/2020	EPI_ISL_638944	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A78063/2020	EPI_ISL_638952	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A781AC/2020	EPI_ISL_638959	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A781D9/2020	EPI_ISL_638960	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A781E8/2020	EPI_ISL_638961	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A781F7/2020	EPI_ISL_638962	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A78397/2020	EPI_ISL_638972	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A78458/2020	EPI_ISL_638973	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A78476/2020	EPI_ISL_638974	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A78652/2020	EPI_ISL_638981	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A786AD/2020	EPI_ISL_638984	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A79044/2020	EPI_ISL_638989	2020-10-13	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A7933C/2020	EPI_ISL_638990	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A793C3/2020	EPI_ISL_638994	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A793D2/2020	EPI_ISL_638995	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A7940C/2020	EPI_ISL_638997	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-488CCC/2020	EPI_ISL_639491	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-488D50/2020	EPI_ISL_639497	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B0DD2F/2020	EPI_ISL_642105	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B0E122/2020	EPI_ISL_642109	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B0F30D/2020	EPI_ISL_642131	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B0E0F8/2020	EPI_ISL_642136	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B0FC3F/2020	EPI_ISL_642180	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B0B107/2020	EPI_ISL_643408	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B0854A/2020	EPI_ISL_643465	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B0AED4/2020	EPI_ISL_643492	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B0AD8C/2020	EPI_ISL_643497	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AD6388/2020	EPI_ISL_644001	2020-10-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AD2AD2/2020	EPI_ISL_644010	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AD02AF/2020	EPI_ISL_644012	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AD2665/2020	EPI_ISL_644016	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AD2B1B/2020	EPI_ISL_644018	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AD06D0/2020	EPI_ISL_644031	2020-10-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AD4B82/2020	EPI_ISL_644034	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD4B91/2020	EPI_ISL_644035	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AD1D52/2020	EPI_ISL_644038	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B375AC/2020	EPI_ISL_645315	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B3F128/2020	EPI_ISL_645368	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B260CD/2020	EPI_ISL_646614	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B2619D/2020	EPI_ISL_646616	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24FE0/2020	EPI_ISL_646635	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2C980/2020	EPI_ISL_646637	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24F2C/2020	EPI_ISL_646653	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B250DD/2020	EPI_ISL_646660	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2BB03/2020	EPI_ISL_646669	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2B611/2020	EPI_ISL_646672	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2B796/2020	EPI_ISL_646677	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B261CA/2020	EPI_ISL_646686	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B243E4/2020	EPI_ISL_647007	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24AA3/2020	EPI_ISL_647018	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B23A3B/2020	EPI_ISL_647029	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24C8F/2020	EPI_ISL_647034	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24C25/2020	EPI_ISL_647037	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B2385F/2020	EPI_ISL_647040	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B23628/2020	EPI_ISL_647041	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B2486D/2020	EPI_ISL_647042	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B24144/2020	EPI_ISL_647089	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/QEUH-AE4BE9/2020	EPI_ISL_647910	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/QEUH-AE515F/2020	EPI_ISL_647920	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/QEUH-AD4153/2020	EPI_ISL_647943	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/QEUH-AD2823/2020	EPI_ISL_647946	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/QEUH-AD5D9A/2020	EPI_ISL_647951	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/QEUH-AD14C6/2020	EPI_ISL_647956	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B1059A/2020	EPI_ISL_649600	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B13315/2020	EPI_ISL_649605	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B135A6/2020	EPI_ISL_649608	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B108EC/2020	EPI_ISL_649620	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B10A8C/2020	EPI_ISL_649621	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B07499/2020	EPI_ISL_649633	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AE1DB9/2020	EPI_ISL_649637	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AE2F85/2020	EPI_ISL_649639	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AE1D7D/2020	EPI_ISL_649640	2020-10-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AE2EA6/2020	EPI_ISL_649643	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AE2662/2020	EPI_ISL_649644	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AE28F3/2020	EPI_ISL_649646	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AE2750/2020	EPI_ISL_649653	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AE2E79/2020	EPI_ISL_649654	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AE2125/2020	EPI_ISL_649656	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AE1F86/2020	EPI_ISL_649658	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AE278D/2020	EPI_ISL_649659	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AE4B07/2020	EPI_ISL_649661	2020-10-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AE5456/2020	EPI_ISL_649662	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AE5113/2020	EPI_ISL_649668	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AE4BCB/2020	EPI_ISL_649669	2020-10-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD101D/2020	EPI_ISL_649671	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AD0F7B/2020	EPI_ISL_649673	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AD5477/2020	EPI_ISL_649679	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AD5714/2020	EPI_ISL_649680	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD5BCD/2020	EPI_ISL_649681	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AD435D/2020	EPI_ISL_649682	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD1684/2020	EPI_ISL_649683	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/Scotland/QEUH-AD56CC/2020	EPI_ISL_649689	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD150F/2020	EPI_ISL_649691	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AD5B36/2020	EPI_ISL_649695	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AD18F7/2020	EPI_ISL_649698	2020-10-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AD146C/2020	EPI_ISL_649699	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/Scotland/CVR5605/2020	EPI_ISL_651864	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5620/2020	EPI_ISL_651870	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5622/2020	EPI_ISL_651872	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5677/2020	EPI_ISL_651901	2020-11-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5679/2020	EPI_ISL_651902	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5682/2020	EPI_ISL_651905	2020-11-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5688/2020	EPI_ISL_651910	2020-11-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5694/2020	EPI_ISL_651915	2020-11-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5701/2020	EPI_ISL_651920	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5702/2020	EPI_ISL_651921	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5706/2020	EPI_ISL_651924	2020-11-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5707/2020	EPI_ISL_651925	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5708/2020	EPI_ISL_651926	2020-11-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5711/2020	EPI_ISL_651928	2020-11-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5716/2020	EPI_ISL_651930	2020-11-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5721/2020	EPI_ISL_651934	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5728/2020	EPI_ISL_651938	2020-11-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5729/2020	EPI_ISL_651939	2020-11-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5731/2020	EPI_ISL_651941	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5733/2020	EPI_ISL_651943	2020-11-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5736/2020	EPI_ISL_651945	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5738/2020	EPI_ISL_651946	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5741/2020	EPI_ISL_651948	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5743/2020	EPI_ISL_651949	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5747/2020	EPI_ISL_651953	2020-11-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5749/2020	EPI_ISL_651954	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5750/2020	EPI_ISL_651955	2020-10-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB8583/2020	EPI_ISL_651964	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8584/2020	EPI_ISL_651965	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB8586/2020	EPI_ISL_651967	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8587/2020	EPI_ISL_651968	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8588/2020	EPI_ISL_651969	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8592/2020	EPI_ISL_651972	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB8774/2020	EPI_ISL_651994	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8776/2020	EPI_ISL_651995	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB8783/2020	EPI_ISL_651996	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Wales/PHWC-489E3E/2020	EPI_ISL_652497	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B5E6E8/2020	EPI_ISL_655405	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5BA0D/2020	EPI_ISL_655410	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B45A/2020	EPI_ISL_655456	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-B5B9A6/2020	EPI_ISL_655460	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5AF2D/2020	EPI_ISL_655463	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B86D/2020	EPI_ISL_655467	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5BBCE/2020	EPI_ISL_655468	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62CEF/2020	EPI_ISL_655470	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B126/2020	EPI_ISL_655473	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62F8C/2020	EPI_ISL_655476	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62DDD/2020	EPI_ISL_655490	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62D46/2020	EPI_ISL_655492	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62FE6/2020	EPI_ISL_655494	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B9F1/2020	EPI_ISL_655499	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46935/2020	EPI_ISL_656005	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B467A4/2020	EPI_ISL_656006	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46953/2020	EPI_ISL_656009	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B45D49/2020	EPI_ISL_656011	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46294/2020	EPI_ISL_656012	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B46425/2020	EPI_ISL_656017	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B5671A/2020	EPI_ISL_656705	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B537B3/2020	EPI_ISL_656714	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B540C6/2020	EPI_ISL_656721	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B56A20/2020	EPI_ISL_656728	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B535E6/2020	EPI_ISL_656734	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B5230B/2020	EPI_ISL_656735	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B5413C/2020	EPI_ISL_656737	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B536C5/2020	EPI_ISL_656742	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B56808/2020	EPI_ISL_656745	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B52611/2020	EPI_ISL_656758	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B56BC3/2020	EPI_ISL_656779	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B54099/2020	EPI_ISL_656794	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B4365F/2020	EPI_ISL_657306	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B427E4/2020	EPI_ISL_657309	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B43358/2020	EPI_ISL_657330	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B434A0/2020	EPI_ISL_657346	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B3F3AA/2020	EPI_ISL_658606	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B3FDAC/2020	EPI_ISL_658616	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B41642/2020	EPI_ISL_658619	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B3FA4B/2020	EPI_ISL_658623	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B4179A/2020	EPI_ISL_658627	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B3F7DB/2020	EPI_ISL_658629	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B4127B/2020	EPI_ISL_658631	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B3F243/2020	EPI_ISL_658640	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B3F270/2020	EPI_ISL_658643	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B41071/2020	EPI_ISL_658662	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B4140C/2020	EPI_ISL_658664	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B4167F/2020	EPI_ISL_658669	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B41615/2020	EPI_ISL_658675	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B3A57C/2020	EPI_ISL_659009	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B387A5/2020	EPI_ISL_659012	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B38D67/2020	EPI_ISL_659051	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.177	GV
hCoV-19/England/MILK-B38AF7/2020	EPI_ISL_659060	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B393DD/2020	EPI_ISL_659064	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B38787/2020	EPI_ISL_659069	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B37D2C/2020	EPI_ISL_659077	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B30BA1/2020	EPI_ISL_659915	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B2DF41/2020	EPI_ISL_659920	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-B2DF6F/2020	EPI_ISL_659928	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B303B8/2020	EPI_ISL_659934	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2EAF4/2020	EPI_ISL_659947	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2EB79/2020	EPI_ISL_659957	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2D8DD/2020	EPI_ISL_659959	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2DEDB/2020	EPI_ISL_659962	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B2EB97/2020	EPI_ISL_660011	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B2CCF0/2020	EPI_ISL_660028	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B2D66A/2020	EPI_ISL_660049	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B2CC78/2020	EPI_ISL_660056	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Sweden/20-53262/2020	EPI_ISL_661290	2020-10-21	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.177.80	GV
hCoV-19/Sweden/20-53290/2020	EPI_ISL_661294	2020-11-02	Europe / Sweden / Sormland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.177.80	GV
hCoV-19/England/QEUH-B67084/2020	EPI_ISL_661314	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B692F5/2020	EPI_ISL_661341	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-B66577/2020	EPI_ISL_661342	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B684A5/2020	EPI_ISL_661352	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B697E7/2020	EPI_ISL_661355	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B676BF/2020	EPI_ISL_661360	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B67BCF/2020	EPI_ISL_661382	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B69B54/2020	EPI_ISL_661390	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 5 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-B68496/2020	EPI_ISL_661392	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B66629/2020	EPI_ISL_661399	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B736CF/2020	EPI_ISL_662610	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-B736FC/2020	EPI_ISL_662621	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5BE98/2020	EPI_ISL_662624	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B482A1/2020	EPI_ISL_662649	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-AF2605/2020	EPI_ISL_662656	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF0036/2020	EPI_ISL_662682	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-AF573C/2020	EPI_ISL_663129	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF4C5C/2020	EPI_ISL_663130	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF4982/2020	EPI_ISL_663141	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF69EA/2020	EPI_ISL_663155	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF6917/2020	EPI_ISL_663157	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-AF5462/2020	EPI_ISL_663164	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF4A07/2020	EPI_ISL_663176	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF4C89/2020	EPI_ISL_663192	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AF6610/2020	EPI_ISL_663194	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/Scotland/EDB9320/2020	EPI_ISL_665790	2020-11-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/Scotland/EDB9321/2020	EPI_ISL_665791	2020-11-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/Scotland/QEUH-AF1484/2020	EPI_ISL_666105	2020-10-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Wales/PHWC-48AB63/2020	EPI_ISL_666126	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48AC7F/2020	EPI_ISL_666141	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48ACAC/2020	EPI_ISL_666143	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48AD12/2020	EPI_ISL_666149	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48ADD6/2020	EPI_ISL_666159	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48B0BE/2020	EPI_ISL_666192	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48B0EB/2020	EPI_ISL_666193	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48B115/2020	EPI_ISL_666195	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-BA265E/2020	EPI_ISL_672900	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BA3435/2020	EPI_ISL_672904	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B0993E/2020	EPI_ISL_672912	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B09A68/2020	EPI_ISL_672935	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B09752/2020	EPI_ISL_672946	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B09637/2020	EPI_ISL_672960	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B091FA/2020	EPI_ISL_672968	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B99502/2020	EPI_ISL_673281	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B99890/2020	EPI_ISL_673282	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/CAMC-B9A8CC/2020	EPI_ISL_673289	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B99511/2020	EPI_ISL_673301	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B98F7E/2020	EPI_ISL_673308	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B9B02D/2020	EPI_ISL_673310	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B98F8D/2020	EPI_ISL_673315	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B99775/2020	EPI_ISL_673330	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B9A2DD/2020	EPI_ISL_673333	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B9A48C/2020	EPI_ISL_673362	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B992A1/2020	EPI_ISL_673378	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B99757/2020	EPI_ISL_673388	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8E0D2/2020	EPI_ISL_674600	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B808BA/2020	EPI_ISL_674613	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8ED35/2020	EPI_ISL_674617	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8F912/2020	EPI_ISL_674632	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8E139/2020	EPI_ISL_674641	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-B8E12A/2020	EPI_ISL_674668	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7D62F/2020	EPI_ISL_674678	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8EAF2/2020	EPI_ISL_674680	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8FA2E/2020	EPI_ISL_674688	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/MILK-B8DC0C/2020	EPI_ISL_674695	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_Q70stop results in 74.9% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-B83C51/2020	EPI_ISL_675152	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8F01D/2020	EPI_ISL_675153	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B8424F/2020	EPI_ISL_675176	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B84616/2020	EPI_ISL_675181	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B83A48/2020	EPI_ISL_675196	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8C7A2/2020	EPI_ISL_675911	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B85A46/2020	EPI_ISL_675925	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8CA5E/2020	EPI_ISL_675927	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B84BDB/2020	EPI_ISL_675942	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B8485C/2020	EPI_ISL_675962	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B89611/2020	EPI_ISL_675981	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B317CA/2020	EPI_ISL_676418	2020-11-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B3187C/2020	EPI_ISL_676420	2020-11-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B319B5/2020	EPI_ISL_676424	2020-11-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B31821/2020	EPI_ISL_676426	2020-11-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B31803/2020	EPI_ISL_676428	2020-11-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B2DCFF/2020	EPI_ISL_676439	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B2ED64/2020	EPI_ISL_676440	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AEFF5B/2020	EPI_ISL_676443	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AEFED6/2020	EPI_ISL_676447	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AEFEA9/2020	EPI_ISL_676451	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AEFE6D/2020	EPI_ISL_676453	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AF2869/2020	EPI_ISL_676456	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AEFEB8/2020	EPI_ISL_676457	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AF52D1/2020	EPI_ISL_676469	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AF614C/2020	EPI_ISL_676474	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AF4B04/2020	EPI_ISL_676477	2020-10-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AF51B6/2020	EPI_ISL_676478	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AF6179/2020	EPI_ISL_676480	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AF4E1A/2020	EPI_ISL_676481	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-AF6197/2020	EPI_ISL_676483	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Northern Ireland/NIRE-234502/2020	EPI_ISL_680400	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.58	GV
hCoV-19/Scotland/CVR5870/2020	EPI_ISL_680449	2020-11-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR6008/2020	EPI_ISL_680453	2020-11-24	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6022/2020	EPI_ISL_680459	2020-11-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB10050/2020	EPI_ISL_680463	2020-11-19	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB10083/2020	EPI_ISL_680466	2020-11-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		NS8_K53stop results in 57.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/Scotland/EDB10089/2020	EPI_ISL_680467	2020-11-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		NS8_K53stop results in 57.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/Scotland/EDB10104/2020	EPI_ISL_680469	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB10105/2020	EPI_ISL_680470	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB10107/2020	EPI_ISL_680471	2020-10-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB10110/2020	EPI_ISL_680472	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB10111/2020	EPI_ISL_680473	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB10112/2020	EPI_ISL_680474	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB10114/2020	EPI_ISL_680475	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB10115/2020	EPI_ISL_680476	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB10116/2020	EPI_ISL_680477	2020-10-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB10117/2020	EPI_ISL_680478	2020-10-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB10119/2020	EPI_ISL_680480	2020-10-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB10164/2020	EPI_ISL_680490	2020-11-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/204961136/2020	EPI_ISL_700691	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/ALDP-BBAFFE/2020	EPI_ISL_701903	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBAFC1/2020	EPI_ISL_701909	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBB32E/2020	EPI_ISL_701915	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBAF0D/2020	EPI_ISL_701916	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBA037/2020	EPI_ISL_701931	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBAC42/2020	EPI_ISL_701934	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBA055/2020	EPI_ISL_701938	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBB063/2020	EPI_ISL_701939	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBB045/2020	EPI_ISL_701957	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBA3F2/2020	EPI_ISL_701990	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BD1683/2020	EPI_ISL_702320	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BD23B8/2020	EPI_ISL_702325	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BD1B2A/2020	EPI_ISL_702334	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BBA9F0/2020	EPI_ISL_702372	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BC4322/2020	EPI_ISL_703640	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BC447A/2020	EPI_ISL_703685	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCA5F9/2020	EPI_ISL_703691	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-BC3DF8/2020	EPI_ISL_704138	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BCB640/2020	EPI_ISL_704144	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-BC3CEC/2020	EPI_ISL_704154	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BCB4CE/2020	EPI_ISL_704185	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BC4AC3/2020	EPI_ISL_704189	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-BC37BE/2020	EPI_ISL_704192	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BCE513/2020	EPI_ISL_704212	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-BCE531/2020	EPI_ISL_704251	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/LIVE-DC19C7/2020	EPI_ISL_704905	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/CAMC-BC0317/2020	EPI_ISL_704935	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC0DDD/2020	EPI_ISL_704938	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BC1C48/2020	EPI_ISL_704949	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-B5DA38/2020	EPI_ISL_705533	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B7C9A/2020	EPI_ISL_705537	2020-10-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B7CA9/2020	EPI_ISL_705538	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B7CC7/2020	EPI_ISL_705540	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B7CE5/2020	EPI_ISL_705542	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1BC98F/2020	EPI_ISL_705553	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-491D81/2020	EPI_ISL_706776	2020-11-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-491DAF/2020	EPI_ISL_706778	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-491DBE/2020	EPI_ISL_706779	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49202D/2020	EPI_ISL_706809	2020-11-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4920B4/2020	EPI_ISL_706816	2020-11-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4923F7/2020	EPI_ISL_706844	2020-11-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4924D6/2020	EPI_ISL_706851	2020-11-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/PORT-2E9CBC/2020	EPI_ISL_706876	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/ALDP-C497FB/2020	EPI_ISL_718761	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C47DBF/2020	EPI_ISL_718769	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C47CD0/2020	EPI_ISL_718847	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C43964/2020	EPI_ISL_719165	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB00C8/2020	EPI_ISL_720165	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BB1337/2020	EPI_ISL_720168	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC67CA/2020	EPI_ISL_721482	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC776F/2020	EPI_ISL_721485	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC67F7/2020	EPI_ISL_721493	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC7B81/2020	EPI_ISL_721497	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-49351E/2020	EPI_ISL_725900	2020-11-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49354B/2020	EPI_ISL_725903	2020-11-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4935B4/2020	EPI_ISL_725910	2020-11-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-493675/2020	EPI_ISL_725921	2020-11-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4938AC/2020	EPI_ISL_725952	2020-11-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4938F7/2020	EPI_ISL_725956	2020-11-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-493903/2020	EPI_ISL_725957	2020-11-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4939C7/2020	EPI_ISL_725967	2020-11-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-493A5B/2020	EPI_ISL_725976	2020-11-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-493A79/2020	EPI_ISL_725978	2020-11-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-493A88/2020	EPI_ISL_725979	2020-11-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-493AD3/2020	EPI_ISL_725984	2020-11-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-493C19/2020	EPI_ISL_725999	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4951BE/2020	EPI_ISL_726309	2020-11-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49536D/2020	EPI_ISL_726333	2020-11-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49543D/2020	EPI_ISL_726346	2020-11-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4955D0/2020	EPI_ISL_726369	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49A8B4/2020	EPI_ISL_727612	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/Wales/PHWC-49AA09/2020	EPI_ISL_727631	2020-12-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49ADB5/2020	EPI_ISL_727686	2020-12-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49AE3A/2020	EPI_ISL_727694	2020-12-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Germany/SH-ChVir20806/2020	EPI_ISL_729416	2020-12-02	Europe / Germany / Schleswig-Holstein	Human	Original			NextSeq	bowtie2	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-C3D10B/2020	EPI_ISL_731718	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3D54B/2020	EPI_ISL_731720	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3BDFA/2020	EPI_ISL_731748	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3CFC6/2020	EPI_ISL_731762	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3BC48/2020	EPI_ISL_731772	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3D147/2020	EPI_ISL_731779	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3D29F/2020	EPI_ISL_731780	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-C3BDDC/2020	EPI_ISL_731784	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-C3B246/2020	EPI_ISL_731788	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3DAC4/2020	EPI_ISL_731818	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3D2AE/2020	EPI_ISL_731826	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-C33A37/2020	EPI_ISL_734001	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C344B0/2020	EPI_ISL_734021	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C34438/2020	EPI_ISL_734027	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C3424D/2020	EPI_ISL_734044	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-C33EC2/2020	EPI_ISL_734056	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C34289/2020	EPI_ISL_734070	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C33C9B/2020	EPI_ISL_734079	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C33949/2020	EPI_ISL_734096	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C48D72/2020	EPI_ISL_736600	2020-12-10	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C489F6/2020	EPI_ISL_736614	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C4861D/2020	EPI_ISL_736615	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C4BD7F/2020	EPI_ISL_736627	2020-12-14	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-C48307/2020	EPI_ISL_736642	2020-12-11	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	GV
hCoV-19/England/QEUH-C4BDCA/2020	EPI_ISL_736646	2020-12-14	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C4848C/2020	EPI_ISL_736664	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C48DDC/2020	EPI_ISL_736670	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C48659/2020	EPI_ISL_736687	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/CAMC-B7AB41/2020	EPI_ISL_741163	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-B7B524/2020	EPI_ISL_741177	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B7DDDF/2020	EPI_ISL_741921	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/QEUH-B7DEAF/2020	EPI_ISL_741924	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/QEUH-B7DEEB/2020	EPI_ISL_741925	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina		NS8_K53stop results in 57.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/Wales/PHWC-49BC11/2020	EPI_ISL_742446	2020-12-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49BFEB/2020	EPI_ISL_742493	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A16ED/2020	EPI_ISL_743713	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A1735/2020	EPI_ISL_743717	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A1A69/2020	EPI_ISL_743767	2020-12-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A1B57/2020	EPI_ISL_743782	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A1B84/2020	EPI_ISL_743785	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A1BA2/2020	EPI_ISL_743786	2020-12-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A1C09/2020	EPI_ISL_743790	2020-12-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A1C54/2020	EPI_ISL_743795	2020-12-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A2145/2020	EPI_ISL_743850	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A2172/2020	EPI_ISL_743853	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A2181/2020	EPI_ISL_743854	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-22432/2020	EPI_ISL_757452	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22473/2020	EPI_ISL_757453	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22512/2020	EPI_ISL_757454	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22541/2020	EPI_ISL_757455	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22556/2020	EPI_ISL_757456	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22562/2020	EPI_ISL_757457	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22581/2020	EPI_ISL_757458	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22591/2020	EPI_ISL_757459	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22619/2020	EPI_ISL_757460	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-22630/2020	EPI_ISL_757461	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/QEUH-CC778C/2020	EPI_ISL_760280	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-CC7A56/2020	EPI_ISL_760302	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CBE21E/2020	EPI_ISL_760341	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CBF4EA/2020	EPI_ISL_760358	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-CC08EA/2020	EPI_ISL_760370	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC2BFE/2020	EPI_ISL_760379	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-CA7254/2020	EPI_ISL_761636	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-CA663B/2020	EPI_ISL_761660	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB661A/2020	EPI_ISL_761675	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-CB6AA5/2020	EPI_ISL_761678	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB5095/2020	EPI_ISL_761685	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB60C1/2020	EPI_ISL_761687	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB5842/2020	EPI_ISL_761693	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C7A6A9/2020	EPI_ISL_762914	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C890C7/2020	EPI_ISL_762975	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C8B292/2020	EPI_ISL_762977	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C7FB4B/2020	EPI_ISL_762984	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-4A3BCE/2020	EPI_ISL_764605	2020-12-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A3BDD/2020	EPI_ISL_764606	2020-12-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-4A3C8F/2020	EPI_ISL_764614	2020-12-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A3CBC/2020	EPI_ISL_764616	2020-12-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A3CE9/2020	EPI_ISL_764619	2020-12-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A3CF8/2020	EPI_ISL_764620	2020-12-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A3D04/2020	EPI_ISL_764621	2020-12-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A6C13/2020	EPI_ISL_765109	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A6C22/2020	EPI_ISL_765110	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/PORT-2D56C4/2020	EPI_ISL_765126	2020-12-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/PORT-2EE7C5/2020	EPI_ISL_765148	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/205140703/2020	EPI_ISL_766401	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205161120/2020	EPI_ISL_766430	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205181819/2020	EPI_ISL_766478	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/QEUH-C5D91C/2020	EPI_ISL_769421	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C5B987/2020	EPI_ISL_769422	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C8EA6A/2020	EPI_ISL_777144	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C8EA5B/2020	EPI_ISL_777170	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-CB8BCE/2020	EPI_ISL_777919	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-CB8B28/2020	EPI_ISL_777925	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C645B4/2020	EPI_ISL_778421	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C6448A/2020	EPI_ISL_778423	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C6CC02/2020	EPI_ISL_778425	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C6F786/2020	EPI_ISL_778429	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C645A5/2020	EPI_ISL_778465	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C6CC11/2020	EPI_ISL_778474	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CDEAD4/2020	EPI_ISL_782403	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CDEAC5/2020	EPI_ISL_782433	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CDEB59/2020	EPI_ISL_782447	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CDF499/2020	EPI_ISL_782476	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C3228B/2020	EPI_ISL_782482	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C32115/2020	EPI_ISL_782492	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-23961/2020	EPI_ISL_792766	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23964/2020	EPI_ISL_792767	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-23997/2020	EPI_ISL_792768	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24022/2020	EPI_ISL_792769	2020-12-14	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24026/2020	EPI_ISL_792770	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24056/2020	EPI_ISL_792771	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24064/2020	EPI_ISL_792772	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24066/2020	EPI_ISL_792773	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24087/2020	EPI_ISL_792774	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24100/2020	EPI_ISL_792775	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24104/2020	EPI_ISL_792776	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24123/2020	EPI_ISL_792777	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24134/2020	EPI_ISL_792779	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/CAMC-DED303/2020	EPI_ISL_797622	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D4084B/2020	EPI_ISL_798888	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-D40429/2020	EPI_ISL_798898	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-D369BE/2020	EPI_ISL_798900	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D407F3/2020	EPI_ISL_798928	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D403D1/2020	EPI_ISL_798951	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D4040B/2020	EPI_ISL_798963	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D402E3/2020	EPI_ISL_798964	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-D406BA/2020	EPI_ISL_798984	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D51EAF/2020	EPI_ISL_799286	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CE29A3/2020	EPI_ISL_800013	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B80B84/2020	EPI_ISL_801331	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B80BDF/2020	EPI_ISL_801335	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B80B57/2020	EPI_ISL_801364	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B80191/2020	EPI_ISL_801377	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/Japan/IC-0643/2020	EPI_ISL_803944	2020-12-05	Asia / Japan	Human	Original			Illumina iSeq	SKESA v. 2.3.0			B.1.177	GV
hCoV-19/England/CAMB-A9998F/2020	EPI_ISL_813302	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A99A13/2020	EPI_ISL_813308	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A99B5C/2020	EPI_ISL_813318	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A99BB6/2020	EPI_ISL_813322	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A99BD4/2020	EPI_ISL_813324	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A99C68/2020	EPI_ISL_813329	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A99D65/2020	EPI_ISL_813336	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A99DB0/2020	EPI_ISL_813337	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A9A03E/2020	EPI_ISL_813355	2020-12-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/EXET-136422/2020	EPI_ISL_813359	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/EXET-136950/2020	EPI_ISL_813365	2020-12-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR6331/2020	EPI_ISL_814590	2020-12-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/Scotland/CVR6332/2020	EPI_ISL_814591	2020-12-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/Scotland/CVR6333/2020	EPI_ISL_814592	2020-12-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/Scotland/CVR6334/2020	EPI_ISL_814593	2020-12-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/Scotland/CVR6249/2020	EPI_ISL_814628	2020-12-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6250/2020	EPI_ISL_814629	2020-12-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6252/2020	EPI_ISL_814631	2020-12-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6264/2020	EPI_ISL_814636	2020-12-18	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6267/2020	EPI_ISL_814638	2020-12-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6273/2020	EPI_ISL_814642	2020-12-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR6285/2020	EPI_ISL_814649	2020-12-19	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6288/2020	EPI_ISL_814651	2020-12-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6293/2020	EPI_ISL_814655	2020-12-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6308/2020	EPI_ISL_814659	2020-12-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Wales/PHWC-493E31/2020	EPI_ISL_814695	2020-11-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/PORT-2EE965/2020	EPI_ISL_816208	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Denmark/DCGC-26558/2021	EPI_ISL_817532	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26932/2020	EPI_ISL_817533	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27030/2020	EPI_ISL_817534	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-27134/2020	EPI_ISL_817535	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/NORW-223D86/2021	EPI_ISL_819442	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-223DB3/2021	EPI_ISL_819443	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LOND-E2417/2020	EPI_ISL_819463	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/LOND-E27C3/2020	EPI_ISL_819492	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/NOTT-122063/2020	EPI_ISL_820428	2020-12-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMC-DE556F/2020	EPI_ISL_821712	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Iceland/4299/2021	EPI_ISL_827992	2021-01-05	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Spain/MD-IBV-99013298/2020	EPI_ISL_831181	2020-10-01	Europe / Spain / Madrid / Madrid	Human	Original			IonTorrent				B.1.177	GV
hCoV-19/England/ALDP-F46E50/2021	EPI_ISL_834085	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/205341074/2020	EPI_ISL_837226	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205390547/2020	EPI_ISL_837234	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/210100207/2020	EPI_ISL_837238	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/210100171/2021	EPI_ISL_837240	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/LIVE-DD383E/2020	EPI_ISL_838615	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina	unknown			B.1.177	GV
hCoV-19/Wales/PHWC-4B4F46/2021	EPI_ISL_841257	2021-01-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/LOND-12886CD/2020	EPI_ISL_843120	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LOND-12886DC/2020	EPI_ISL_843121	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-29812/2020	EPI_ISL_843859	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29850/2020	EPI_ISL_843897	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31465/2021	EPI_ISL_855845	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31509/2021	EPI_ISL_855889	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-31987/2021	EPI_ISL_856403	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32019/2021	EPI_ISL_856435	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32067/2021	EPI_ISL_856483	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32074/2021	EPI_ISL_856490	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32077/2021	EPI_ISL_856493	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32116/2021	EPI_ISL_856532	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Wales/ALDP-F531B1/2021	EPI_ISL_858069	2021-01-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-F53148/2021	EPI_ISL_858086	2021-01-04	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-CB595E/2020	EPI_ISL_859377	2020-12-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-CB4351/2020	EPI_ISL_859396	2020-12-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/210320739/2021	EPI_ISL_862256	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	GV
hCoV-19/England/210291780/2021	EPI_ISL_862262	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/210291783/2021	EPI_ISL_862263	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/CAMB-A9C3D9/2020	EPI_ISL_864843	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-A9C6FE/2020	EPI_ISL_864886	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/OXON-F4BF76/2021	EPI_ISL_867151	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F4BFC1/2021	EPI_ISL_867152	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BA64B/2021	EPI_ISL_867884	2021-01-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-32710/2021	EPI_ISL_869714	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32744/2021	EPI_ISL_869748	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32746/2021	EPI_ISL_869750	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32782/2021	EPI_ISL_869786	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33694/2021	EPI_ISL_870704	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33703/2021	EPI_ISL_870713	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33716/2021	EPI_ISL_870726	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33717/2021	EPI_ISL_870727	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33720/2021	EPI_ISL_870730	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33730/2021	EPI_ISL_870740	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33767/2021	EPI_ISL_870777	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33785/2021	EPI_ISL_870795	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34023/2021	EPI_ISL_871033	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34032/2021	EPI_ISL_871042	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34063/2021	EPI_ISL_871073	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34078/2021	EPI_ISL_871088	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34087/2021	EPI_ISL_871097	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-FEC78E/2021	EPI_ISL_874204	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10003E6/2021	EPI_ISL_874213	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10001FB/2021	EPI_ISL_874223	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FFFF80/2021	EPI_ISL_874247	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FC10C0/2021	EPI_ISL_874266	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1065A62/2021	EPI_ISL_878533	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1036E04/2021	EPI_ISL_879091	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1068434/2021	EPI_ISL_879099	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1068443/2021	EPI_ISL_879118	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1068DFD/2021	EPI_ISL_879173	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-101BEE7/2021	EPI_ISL_879814	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-101B2EB/2021	EPI_ISL_879821	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-101BE14/2021	EPI_ISL_880062	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-103072D/2021	EPI_ISL_880134	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1013F28/2021	EPI_ISL_881454	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10B5D3D/2021	EPI_ISL_885644	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Switzerland/AG-SNRCI-32950124/2021	EPI_ISL_897688	2021-01-12	Europe / Switzerland / Aargau	Human	Original			Illumina NovaSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Netherlands/NH-EMC-102/2021	EPI_ISL_904580	2021-01-11	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore				B.1.177	GV
hCoV-19/Netherlands/NH-EMC-97/2021	EPI_ISL_904581	2021-01-11	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore				B.1.177	GV
hCoV-19/Netherlands/NH-EMC-99/2021	EPI_ISL_904590	2021-01-12	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore				B.1.177	GV
hCoV-19/Netherlands/NH-EMC-100/2021	EPI_ISL_904596	2021-01-13	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore				B.1.177	GV
hCoV-19/England/ALDP-10EAF84/2021	EPI_ISL_907505	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-10EF06E/2021	EPI_ISL_907531	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC68F4/2020	EPI_ISL_915982	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCB0AC/2020	EPI_ISL_915999	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-10F8712/2021	EPI_ISL_916506	2021-01-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-10F8721/2021	EPI_ISL_916537	2021-01-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-10F824E/2021	EPI_ISL_916562	2021-01-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-1067CE2/2021	EPI_ISL_917881	2021-01-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-106756F/2021	EPI_ISL_917918	2021-01-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Northern Ireland/NIRE-245EF4/2021	EPI_ISL_921082	2021-01-04	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Northern Ireland/NIRE-245F00/2021	EPI_ISL_921083	2021-01-04	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Northern Ireland/NIRE-245F2E/2021	EPI_ISL_921084	2021-01-04	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Northern Ireland/NIRE-246172/2021	EPI_ISL_921099	2021-01-04	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.58	GV
hCoV-19/Northern Ireland/NIRE-2461DC/2021	EPI_ISL_921104	2021-01-04	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.58	GV
hCoV-19/Northern Ireland/NIRE-246224/2021	EPI_ISL_921107	2021-01-03	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.58	GV
hCoV-19/Northern Ireland/NIRE-246233/2021	EPI_ISL_921108	2021-01-04	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.58	GV
hCoV-19/Northern Ireland/NIRE-24644C/2021	EPI_ISL_921124	2021-01-04	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/NORT-1B7350B/2020	EPI_ISL_921144	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-22141A/2020	EPI_ISL_921806	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-2214FC/2020	EPI_ISL_921816	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 14 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/NORW-221517/2020	EPI_ISL_921818	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-221562/2020	EPI_ISL_921823	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-2215AE/2020	EPI_ISL_921826	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-2215EA/2020	EPI_ISL_921827	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-2218A5/2020	EPI_ISL_921848	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BB352/2021	EPI_ISL_922481	2021-01-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-4BB45F/2021	EPI_ISL_922494	2021-01-15	Europe / United Kingdom / Wales	Human	Original			Illumina		Insertion of 9 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-1031F42/2021	EPI_ISL_923724	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-1032011/2021	EPI_ISL_923736	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-103221B/2021	EPI_ISL_923765	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-1032424/2021	EPI_ISL_923794	2021-01-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/England/QEUH-1033A9A/2021	EPI_ISL_924016	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-1033BC4/2021	EPI_ISL_924028	2021-01-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-1033DEC/2021	EPI_ISL_924056	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-1033E16/2021	EPI_ISL_924058	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-1033E25/2021	EPI_ISL_924059	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Denmark/DCGC-36105/2021	EPI_ISL_927246	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36836/2021	EPI_ISL_927977	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37372/2020	EPI_ISL_928513	2020-11-16	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37379/2021	EPI_ISL_928520	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37390/2021	EPI_ISL_928531	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37393/2021	EPI_ISL_928534	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38726/2021	EPI_ISL_929868	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38754/2021	EPI_ISL_929896	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-11496BA/2021	EPI_ISL_933105	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-119A0F8/2021	EPI_ISL_945034	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-F6DA7D/2021	EPI_ISL_945135	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-114E7EF/2021	EPI_ISL_947690	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-114F423/2021	EPI_ISL_947725	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-114EC86/2021	EPI_ISL_948025	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/BIRM-6B610/2020	EPI_ISL_949359	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6B7A4/2020	EPI_ISL_949369	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6BF60/2020	EPI_ISL_949384	2020-11-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/England/BIRM-6F3D9/2020	EPI_ISL_949391	2020-12-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-4BF1DC/2021	EPI_ISL_951616	2021-01-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BF206/2021	EPI_ISL_951619	2021-01-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C24FB/2021	EPI_ISL_952244	2021-01-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-4C2552/2021	EPI_ISL_952250	2021-01-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-4C283B/2021	EPI_ISL_952280	2021-01-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C284A/2021	EPI_ISL_952281	2021-01-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-1032FE7/2021	EPI_ISL_952912	2021-01-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.58	GV
hCoV-19/Scotland/QEUH-1033BB5/2021	EPI_ISL_952939	2021-01-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/QEUH-1033BD3/2021	EPI_ISL_952940	2021-01-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-119B288/2021	EPI_ISL_963603	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-119B349/2021	EPI_ISL_963607	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11BEAF0/2021	EPI_ISL_969701	2021-01-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11BE4A7/2021	EPI_ISL_969748	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11BED8E/2021	EPI_ISL_970173	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-39766/2021	EPI_ISL_971441	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39772/2021	EPI_ISL_971455	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39773/2021	EPI_ISL_971456	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39774/2021	EPI_ISL_971458	2021-01-25	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39811/2021	EPI_ISL_971488	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39837/2021	EPI_ISL_971514	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41079/2021	EPI_ISL_972756	2021-01-25	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41120/2021	EPI_ISL_972797	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/QEUH-120BAF3/2021	EPI_ISL_986255	2021-02-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-12205BB/2021	EPI_ISL_987044	2021-02-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-11CBC72/2021	EPI_ISL_989601	2021-02-01	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-11CBAF0/2021	EPI_ISL_989633	2021-02-01	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-11CBCBE/2021	EPI_ISL_989657	2021-02-01	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-11CBC63/2021	EPI_ISL_989693	2021-02-01	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-118401F/2021	EPI_ISL_990620	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11850E1/2021	EPI_ISL_990622	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-100D9E7/2021	EPI_ISL_991927	2021-01-13	Europe / United Kingdom / Wales	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-109C446/2021	EPI_ISL_994122	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-109C419/2021	EPI_ISL_994130	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-109C5F8/2021	EPI_ISL_994164	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Northern Ireland/NIRE-23B7F6/2021	EPI_ISL_998220	2021-01-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.58	GV
hCoV-19/Wales/PHWC-4C35D9/2021	EPI_ISL_999575	2021-02-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/SHEF-10CF84E/2021	EPI_ISL_1000725	2021-01-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Switzerland/SZ-ETHZ-460244/2021	EPI_ISL_1003267	2021-01-19	Europe / Switzerland / Schwyz	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Switzerland/SZ-ETHZ-460290/2021	EPI_ISL_1003269	2021-01-19	Europe / Switzerland / Schwyz	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Switzerland/SO-ETHZ-440736/2021	EPI_ISL_1004517	2021-01-03	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/England/MILK-125219E/2021	EPI_ISL_1005857	2021-02-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Austria/CeMM2674/2021	EPI_ISL_1008027	2021-01-01	Europe / Austria / Burgenland	Human	Original	Swab		Illumina NovaSeq	bwa			B.1.177.62	GV
hCoV-19/England/ALDP-125D0A5/2021	EPI_ISL_1011778	2021-02-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-43340/2021	EPI_ISL_1023652	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-43410/2021	EPI_ISL_1023754	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44602/2021	EPI_ISL_1024980	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44611/2021	EPI_ISL_1024989	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44612/2021	EPI_ISL_1024990	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44615/2021	EPI_ISL_1024993	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Norway/0276/2021	EPI_ISL_1034316	2021-01-07	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Norway/7028/2020	EPI_ISL_1034317	2020-12-12	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Norway/7377/2020	EPI_ISL_1034318	2020-12-29	Europe / Norway / Rogaland	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Norway/0919/2021	EPI_ISL_1034319	2021-01-06	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Norway/0501/2021	EPI_ISL_1034320	2021-01-11	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Norway/0877/2021	EPI_ISL_1034321	2021-01-17	Europe / Norway / Agder	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Netherlands/GE-RIVM-12689/2021	EPI_ISL_1035710	2021-02-01	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/England/RAND-120E586/2021	EPI_ISL_1046307	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/RAND-120E814/2021	EPI_ISL_1046322	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Northern Ireland/RAND-11ED524/2021	EPI_ISL_1046394	2021-01-30	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/Wales/PHWC-4CAB1C/2021	EPI_ISL_1053257	2021-02-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Switzerland/SH-ETHZ-461435/2021	EPI_ISL_1059687	2021-01-19	Europe / Switzerland / Schaffhausen	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Switzerland/SZ-ETHZ-490881/2021	EPI_ISL_1059699	2021-02-09	Europe / Switzerland / Schwyz	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Switzerland/SZ-ETHZ-481369/2021	EPI_ISL_1059708	2021-01-04	Europe / Switzerland / Schwyz	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/England/ALDP-12AA953/2021	EPI_ISL_1061928	2021-02-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-45698/2020	EPI_ISL_1065208	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-45707/2020	EPI_ISL_1065217	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-45746/2021	EPI_ISL_1065256	2021-02-15	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46010/2021	EPI_ISL_1065520	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46016/2021	EPI_ISL_1065526	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46026/2021	EPI_ISL_1065536	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-46060/2021	EPI_ISL_1065570	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46991/2021	EPI_ISL_1066502	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46996/2021	EPI_ISL_1066507	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47024/2020	EPI_ISL_1066535	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47025/2021	EPI_ISL_1066536	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47081/2021	EPI_ISL_1066593	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47354/2021	EPI_ISL_1066889	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Poland/Mazowieckie_MWB_176/2021	EPI_ISL_1084633	2021-01-20	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.177.8	GV
hCoV-19/Poland/Mazowieckie_MWB_247/2021	EPI_ISL_1084662	2021-01-27	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.177.8	GV
hCoV-19/Poland/Mazowieckie_MWB_248/2021	EPI_ISL_1084663	2021-01-27	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.177.8	GV
hCoV-19/Poland/Mazowieckie_MWB_249/2021	EPI_ISL_1084664	2021-01-27	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.177.8	GV
hCoV-19/Ireland/WD-NVRL-72IRL08037/2020	EPI_ISL_528452	2020-08-10	Europe / Ireland / Waterford	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177	GV
hCoV-19/Ireland/CO-NVRL-72IRL19451/2020	EPI_ISL_528480	2020-08-13	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.177	GV
hCoV-19/England/QEUH-96DE59/2020	EPI_ISL_530748	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Spain/CT-IrsiCaixa-2020090134/2020	EPI_ISL_535575	2020-08-31	Europe / Spain / Catalunya / Gerona / Palamos	Human	Original	Nasopharyngeal swab	Medical worker	Illumina MiSeq	Bowtie2/Samtools			B.1.177	GV
hCoV-19/England/QEUH-99037C/2020	EPI_ISL_540098	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-98FBE1/2020	EPI_ISL_540103	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-998787/2020	EPI_ISL_540108	2020-08-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-98F7FC/2020	EPI_ISL_540134	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-993555/2020	EPI_ISL_552090	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-9C2256/2020	EPI_ISL_566552	2020-09-11	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9C2D64/2020	EPI_ISL_566599	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9C460D/2020	EPI_ISL_566696	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9C3EF7/2020	EPI_ISL_566701	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9C40A5/2020	EPI_ISL_566745	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9C3BA5/2020	EPI_ISL_566774	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BE554/2020	EPI_ISL_567893	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BC6AE/2020	EPI_ISL_567897	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BE34B/2020	EPI_ISL_567898	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/SHEF-CBAA9/2020	EPI_ISL_573728	2020-09-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	G
hCoV-19/Scotland/QEUH-9AEAC1/2020	EPI_ISL_573800	2020-09-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-9AEAD0/2020	EPI_ISL_573801	2020-09-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9AEAEF/2020	EPI_ISL_573802	2020-09-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-9BA181/2020	EPI_ISL_573811	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-9BA585/2020	EPI_ISL_573816	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-9BA664/2020	EPI_ISL_573822	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-9BA8D7/2020	EPI_ISL_573828	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-9BA8E6/2020	EPI_ISL_573829	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-9BA8F5/2020	EPI_ISL_573830	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-9BAC35/2020	EPI_ISL_573835	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9BAC44/2020	EPI_ISL_573836	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9BAE4E/2020	EPI_ISL_573843	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-9BAE6C/2020	EPI_ISL_573845	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-9BAE7B/2020	EPI_ISL_573846	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9BAE99/2020	EPI_ISL_573848	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-9D1597/2020	EPI_ISL_573856	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9D1719/2020	EPI_ISL_573857	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-9D196E/2020	EPI_ISL_573860	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-9D1AD4/2020	EPI_ISL_573862	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-9D1AE3/2020	EPI_ISL_573863	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9D1BB3/2020	EPI_ISL_573864	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-16B679/2020	EPI_ISL_573884	2020-09-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16B72B/2020	EPI_ISL_573893	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-9C87E8/2020	EPI_ISL_576000	2020-09-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9C7D32/2020	EPI_ISL_576020	2020-09-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9C8830/2020	EPI_ISL_576024	2020-09-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9C8E5C/2020	EPI_ISL_576033	2020-09-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-9C7CBD/2020	EPI_ISL_576037	2020-09-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9C8F3B/2020	EPI_ISL_576039	2020-09-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9C9A66/2020	EPI_ISL_576046	2020-09-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9C9CE8/2020	EPI_ISL_576049	2020-09-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9CA467/2020	EPI_ISL_576075	2020-09-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9C92AA/2020	EPI_ISL_576079	2020-09-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9AE9C4/2020	EPI_ISL_577261	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-9AE9E2/2020	EPI_ISL_577263	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB7797/2020	EPI_ISL_577358	2020-09-18	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-9AE557/2020	EPI_ISL_577359	2020-09-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-9AE724/2020	EPI_ISL_577369	2020-09-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Wales/MILK-9E1558/2020	EPI_ISL_577408	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16D60E/2020	EPI_ISL_577420	2020-09-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16D677/2020	EPI_ISL_577427	2020-09-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16D6A4/2020	EPI_ISL_577430	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-9E5624/2020	EPI_ISL_579860	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9DC550/2020	EPI_ISL_580859	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9DC523/2020	EPI_ISL_580968	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-9E128E/2020	EPI_ISL_580979	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9DC857/2020	EPI_ISL_580982	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-16E333/2020	EPI_ISL_585702	2020-09-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16E4D6/2020	EPI_ISL_585726	2020-09-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16EA3E/2020	EPI_ISL_585808	2020-10-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16EF02/2020	EPI_ISL_585884	2020-10-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-9FD164/2020	EPI_ISL_588027	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9FCF4D/2020	EPI_ISL_588044	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9FD331/2020	EPI_ISL_588047	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9FAE06/2020	EPI_ISL_588062	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9FA871/2020	EPI_ISL_588080	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F9511/2020	EPI_ISL_589239	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9F9793/2020	EPI_ISL_589249	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E58E2/2020	EPI_ISL_589359	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E5CC8/2020	EPI_ISL_589413	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9E58F1/2020	EPI_ISL_589414	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9B51C2/2020	EPI_ISL_590240	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9B5784/2020	EPI_ISL_590366	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/NOTT-114F1A/2020	EPI_ISL_595236	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-115508/2020	EPI_ISL_595245	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11559F/2020	EPI_ISL_595248	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-1157D5/2020	EPI_ISL_595265	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11581E/2020	EPI_ISL_595267	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11583C/2020	EPI_ISL_595269	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11584B/2020	EPI_ISL_595270	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-115939/2020	EPI_ISL_595274	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-1159DF/2020	EPI_ISL_595279	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-115A54/2020	EPI_ISL_595282	2020-10-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-115ACD/2020	EPI_ISL_595283	2020-10-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-115B42/2020	EPI_ISL_595286	2020-10-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-115CB8/2020	EPI_ISL_595289	2020-10-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-115D5B/2020	EPI_ISL_595292	2020-10-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/ALDP-A50720/2020	EPI_ISL_597701	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A5077B/2020	EPI_ISL_597815	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A5082D/2020	EPI_ISL_597823	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A4FE4D/2020	EPI_ISL_597835	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A51042/2020	EPI_ISL_597860	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A0084A/2020	EPI_ISL_600156	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9FF38A/2020	EPI_ISL_600162	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9FFFD1/2020	EPI_ISL_600165	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A003A3/2020	EPI_ISL_600181	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-9FFCCB/2020	EPI_ISL_600195	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9FFE89/2020	EPI_ISL_600214	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-A00473/2020	EPI_ISL_600232	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9FF7BB/2020	EPI_ISL_600244	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-9FFA67/2020	EPI_ISL_600269	2020-09-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-A00419/2020	EPI_ISL_600270	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9E061A/2020	EPI_ISL_601463	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9DA8C2/2020	EPI_ISL_601479	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-9D1D62/2020	EPI_ISL_601499	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-9D1D44/2020	EPI_ISL_601515	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-9D4D8D/2020	EPI_ISL_601542	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9D4F5A/2020	EPI_ISL_601552	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9D4F78/2020	EPI_ISL_601561	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-9D3FC4/2020	EPI_ISL_601593	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7C050/2020	EPI_ISL_606327	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7D8A2/2020	EPI_ISL_606363	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7AE76/2020	EPI_ISL_606376	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7AE49/2020	EPI_ISL_606457	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7B877/2020	EPI_ISL_607613	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7C9CE/2020	EPI_ISL_607622	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6DBE8/2020	EPI_ISL_607628	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A700B6/2020	EPI_ISL_607629	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6DA36/2020	EPI_ISL_607664	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6EA26/2020	EPI_ISL_607670	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A70520/2020	EPI_ISL_607677	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6F481/2020	EPI_ISL_607703	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A7070C/2020	EPI_ISL_607708	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A704D8/2020	EPI_ISL_607711	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6F991/2020	EPI_ISL_607742	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6E895/2020	EPI_ISL_607754	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6F65E/2020	EPI_ISL_607771	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6DE76/2020	EPI_ISL_607772	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A67D15/2020	EPI_ISL_608920	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A691AE/2020	EPI_ISL_608925	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-A68A0E/2020	EPI_ISL_608930	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68A3B/2020	EPI_ISL_608957	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A69320/2020	EPI_ISL_608963	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68A86/2020	EPI_ISL_608970	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68084/2020	EPI_ISL_608984	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/EDB8376/2020	EPI_ISL_612187	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/Scotland/EDB8429/2020	EPI_ISL_612188	2020-10-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/Scotland/EDB8430/2020	EPI_ISL_612189	2020-10-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/England/BIRM-65CAB/2020	EPI_ISL_612217	2020-10-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/BIRM-65CBA/2020	EPI_ISL_612218	2020-10-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/CAMB-1B6D3E/2020	EPI_ISL_612279	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B6D5C/2020	EPI_ISL_612280	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4634/2020	EPI_ISL_612287	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4646/2020	EPI_ISL_612291	2020-09-25	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4653/2020	EPI_ISL_612295	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4660/2020	EPI_ISL_612298	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4661/2020	EPI_ISL_612299	2020-09-28	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/France/BRE-BR9061/2020	EPI_ISL_613550	2020-08-31	Europe / France / Bretagne / Rennes	Human	Original			Illumina NextSeq 500	CLC Genomics Suite			B.1.177	GV
hCoV-19/England/ALDP-AA2ABD/2020	EPI_ISL_624104	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA56D4/2020	EPI_ISL_624111	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AADCF8/2020	EPI_ISL_624132	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-AA3788/2020	EPI_ISL_624136	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA2B41/2020	EPI_ISL_624138	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AAD3C6/2020	EPI_ISL_624147	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA2F90/2020	EPI_ISL_624171	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA372E/2020	EPI_ISL_624172	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-AA5179/2020	EPI_ISL_624178	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AAEEE2/2020	EPI_ISL_624181	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA3199/2020	EPI_ISL_624183	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA415C/2020	EPI_ISL_624193	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-AA283B/2020	EPI_ISL_624207	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA2E2A/2020	EPI_ISL_624219	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA282C/2020	EPI_ISL_624229	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-AA47B4/2020	EPI_ISL_624241	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA1F82/2020	EPI_ISL_624267	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA1C9A/2020	EPI_ISL_624279	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-AA1AFA/2020	EPI_ISL_624298	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-A6B106/2020	EPI_ISL_625407	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/MILK-A69E01/2020	EPI_ISL_625410	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/MILK-A69E5C/2020	EPI_ISL_625411	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Wales/MILK-A6B5A0/2020	EPI_ISL_625414	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/MILK-A69E10/2020	EPI_ISL_625419	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/MILK-A6B7B9/2020	EPI_ISL_625420	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/ALDP-A6951B/2020	EPI_ISL_625423	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/CAMC-A64E7F/2020	EPI_ISL_625432	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/CAMC-A41BEA/2020	EPI_ISL_625443	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/CAMC-A3F736/2020	EPI_ISL_625446	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/CAMC-A3F1A1/2020	EPI_ISL_625447	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/CAMC-A3F763/2020	EPI_ISL_625448	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/CAMC-A3E588/2020	EPI_ISL_625451	2020-10-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ACD13F/2020	EPI_ISL_630054	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-AC75B1/2020	EPI_ISL_630061	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Netherlands/GE-EMC-327/2020	EPI_ISL_632711	2020-10-14	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.177	GV
hCoV-19/Netherlands/GE-EMC-328/2020	EPI_ISL_632712	2020-10-17	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.177	GV
hCoV-19/Netherlands/GE-EMC-329/2020	EPI_ISL_632713	2020-10-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.177	GV
hCoV-19/England/QEUH-AD27DB/2020	EPI_ISL_633904	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD288D/2020	EPI_ISL_633929	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD59A5/2020	EPI_ISL_633933	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD1341/2020	EPI_ISL_633961	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_W45stop results in 63.6% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-AD0E14/2020	EPI_ISL_633973	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD0807/2020	EPI_ISL_633979	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD1AD3/2020	EPI_ISL_633994	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-A375F8/2020	EPI_ISL_638729	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/QEUH-A778F3/2020	EPI_ISL_638738	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A7817F/2020	EPI_ISL_638745	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/QEUH-A78889/2020	EPI_ISL_638769	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A789D1/2020	EPI_ISL_638772	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A792B7/2020	EPI_ISL_638797	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A79545/2020	EPI_ISL_638809	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A89BF5/2020	EPI_ISL_638815	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A8A857/2020	EPI_ISL_638851	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A8A954/2020	EPI_ISL_638862	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B0E0E9/2020	EPI_ISL_642021	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B0EB42/2020	EPI_ISL_642027	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-B0EA36/2020	EPI_ISL_642029	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B0E3E0/2020	EPI_ISL_642046	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B0DE0E/2020	EPI_ISL_642051	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B0DE4A/2020	EPI_ISL_642055	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B0E91B/2020	EPI_ISL_642082	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B0E24D/2020	EPI_ISL_642083	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B0E18C/2020	EPI_ISL_642087	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B0FC5D/2020	EPI_ISL_642095	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B0E0CB/2020	EPI_ISL_642099	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B0B073/2020	EPI_ISL_643316	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B0CA92/2020	EPI_ISL_643336	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B0843E/2020	EPI_ISL_643377	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B0B2B9/2020	EPI_ISL_643380	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1C0E8/2020	EPI_ISL_645921	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B222CB/2020	EPI_ISL_645930	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1C491/2020	EPI_ISL_645936	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1C16D/2020	EPI_ISL_645939	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1B24D/2020	EPI_ISL_645963	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1BD3D/2020	EPI_ISL_645966	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1AD6B/2020	EPI_ISL_645975	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1AC7D/2020	EPI_ISL_645986	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-B1C0F7/2020	EPI_ISL_645996	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Sweden/20-53280/2020	EPI_ISL_648157	2020-10-30	Europe / Sweden	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.177.80	GV
hCoV-19/Sweden/20-23684/2020	EPI_ISL_648188	2020-10-06	Europe / Sweden	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-B48F9B/2020	EPI_ISL_649413	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B4856C/2020	EPI_ISL_649415	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B4807A/2020	EPI_ISL_649416	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B4863C/2020	EPI_ISL_649436	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-B4803E/2020	EPI_ISL_649441	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B49343/2020	EPI_ISL_649447	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B486F0/2020	EPI_ISL_649452	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B47FBA/2020	EPI_ISL_649459	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B48F40/2020	EPI_ISL_649473	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B48FF5/2020	EPI_ISL_649474	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B47F23/2020	EPI_ISL_649477	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B20843/2020	EPI_ISL_649493	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B12FC7/2020	EPI_ISL_649495	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B105C7/2020	EPI_ISL_649497	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B0F121/2020	EPI_ISL_649498	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B13FA8/2020	EPI_ISL_649499	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B13B4A/2020	EPI_ISL_649500	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B0F07F/2020	EPI_ISL_649504	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B13F20/2020	EPI_ISL_649505	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B106D3/2020	EPI_ISL_649513	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B0F024/2020	EPI_ISL_649514	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B0F015/2020	EPI_ISL_649516	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B0DAEC/2020	EPI_ISL_649517	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B0DB25/2020	EPI_ISL_649520	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B0DA91/2020	EPI_ISL_649525	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B11010/2020	EPI_ISL_649529	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B0DA46/2020	EPI_ISL_649531	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B0DB07/2020	EPI_ISL_649532	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B10FAB/2020	EPI_ISL_649534	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B11001/2020	EPI_ISL_649538	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B0E386/2020	EPI_ISL_649541	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177.8	GV
hCoV-19/Scotland/QEUH-B0DABF/2020	EPI_ISL_649544	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B10FD8/2020	EPI_ISL_649545	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B10FC9/2020	EPI_ISL_649546	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B1103E/2020	EPI_ISL_649547	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/MILK-B027D1/2020	EPI_ISL_649549	2020-10-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A8BC0F/2020	EPI_ISL_649556	2020-10-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B11405/2020	EPI_ISL_649570	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B132BE/2020	EPI_ISL_649579	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-B128EA/2020	EPI_ISL_649581	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B10AAA/2020	EPI_ISL_649584	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-B10AF5/2020	EPI_ISL_649587	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B11E07/2020	EPI_ISL_649592	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B13324/2020	EPI_ISL_649594	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-B1055E/2020	EPI_ISL_649595	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMB-1B9D4A/2020	EPI_ISL_651709	2020-11-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMC-B23215/2020	EPI_ISL_651723	2020-11-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5288/2020	EPI_ISL_651740	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5301/2020	EPI_ISL_651745	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5307/2020	EPI_ISL_651747	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5315/2020	EPI_ISL_651752	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5316/2020	EPI_ISL_651753	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5317/2020	EPI_ISL_651754	2020-10-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5321/2020	EPI_ISL_651755	2020-10-24	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5326/2020	EPI_ISL_651759	2020-10-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5328/2020	EPI_ISL_651760	2020-10-24	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5330/2020	EPI_ISL_651762	2020-10-24	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5332/2020	EPI_ISL_651763	2020-10-24	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5334/2020	EPI_ISL_651765	2020-10-24	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5335/2020	EPI_ISL_651766	2020-10-24	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5346/2020	EPI_ISL_651769	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5347/2020	EPI_ISL_651770	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5348/2020	EPI_ISL_651771	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5351/2020	EPI_ISL_651772	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5352/2020	EPI_ISL_651773	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5353/2020	EPI_ISL_651774	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5391/2020	EPI_ISL_651794	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5400/2020	EPI_ISL_651799	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5408/2020	EPI_ISL_651804	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5416/2020	EPI_ISL_651810	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5474/2020	EPI_ISL_651811	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5478/2020	EPI_ISL_651812	2020-10-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5512/2020	EPI_ISL_651821	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5513/2020	EPI_ISL_651822	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5514/2020	EPI_ISL_651823	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5515/2020	EPI_ISL_651824	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5516/2020	EPI_ISL_651825	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5519/2020	EPI_ISL_651826	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5521/2020	EPI_ISL_651827	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5524/2020	EPI_ISL_651828	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5528/2020	EPI_ISL_651829	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5537/2020	EPI_ISL_651830	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5541/2020	EPI_ISL_651831	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5551/2020	EPI_ISL_651835	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5560/2020	EPI_ISL_651837	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5561/2020	EPI_ISL_651838	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5563/2020	EPI_ISL_651840	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5567/2020	EPI_ISL_651842	2020-10-28	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5572/2020	EPI_ISL_651846	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5574/2020	EPI_ISL_651847	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5576/2020	EPI_ISL_651848	2020-10-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5579/2020	EPI_ISL_651849	2020-10-28	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5584/2020	EPI_ISL_651850	2020-10-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5586/2020	EPI_ISL_651851	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5587/2020	EPI_ISL_651852	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5588/2020	EPI_ISL_651853	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5589/2020	EPI_ISL_651854	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5603/2020	EPI_ISL_651863	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5611/2020	EPI_ISL_651866	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5613/2020	EPI_ISL_651867	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5615/2020	EPI_ISL_651868	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5624/2020	EPI_ISL_651874	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5626/2020	EPI_ISL_651875	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5627/2020	EPI_ISL_651876	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5628/2020	EPI_ISL_651877	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5629/2020	EPI_ISL_651878	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5630/2020	EPI_ISL_651879	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5631/2020	EPI_ISL_651880	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5632/2020	EPI_ISL_651881	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5656/2020	EPI_ISL_651887	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5661/2020	EPI_ISL_651891	2020-11-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5664/2020	EPI_ISL_651894	2020-11-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5671/2020	EPI_ISL_651896	2020-11-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5674/2020	EPI_ISL_651899	2020-11-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/204490695/2020	EPI_ISL_654009	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/ALDP-B630D3/2020	EPI_ISL_655293	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B43C/2020	EPI_ISL_655296	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62F04/2020	EPI_ISL_655301	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B63DAF/2020	EPI_ISL_655302	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B135/2020	EPI_ISL_655318	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B1CC/2020	EPI_ISL_655324	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-B5E660/2020	EPI_ISL_655330	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5BA3A/2020	EPI_ISL_655331	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B4B4/2020	EPI_ISL_655350	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B94C/2020	EPI_ISL_655353	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B724/2020	EPI_ISL_655359	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62DFB/2020	EPI_ISL_655362	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5E67F/2020	EPI_ISL_655377	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5BA49/2020	EPI_ISL_655394	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5BB46/2020	EPI_ISL_655396	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62960/2020	EPI_ISL_656609	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B6346E/2020	EPI_ISL_656613	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B6310D/2020	EPI_ISL_656614	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62A30/2020	EPI_ISL_656623	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B63871/2020	EPI_ISL_656629	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B63431/2020	EPI_ISL_656635	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B636D1/2020	EPI_ISL_656639	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62A7C/2020	EPI_ISL_656644	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62872/2020	EPI_ISL_656647	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B63792/2020	EPI_ISL_656651	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-B550D4/2020	EPI_ISL_657930	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B5216B/2020	EPI_ISL_657935	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B51C7A/2020	EPI_ISL_657952	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B66902/2020	EPI_ISL_662406	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6A41C/2020	EPI_ISL_662416	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6A19D/2020	EPI_ISL_662422	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-B73A2D/2020	EPI_ISL_662433	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6B1AB/2020	EPI_ISL_662436	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6A42B/2020	EPI_ISL_662442	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6A467/2020	EPI_ISL_662456	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B73920/2020	EPI_ISL_662478	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B73568/2020	EPI_ISL_662492	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6A34C/2020	EPI_ISL_662497	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6A476/2020	EPI_ISL_662510	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6B1E7/2020	EPI_ISL_662532	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6B008/2020	EPI_ISL_662565	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6B062/2020	EPI_ISL_662566	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6B17E/2020	EPI_ISL_662572	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B7389C/2020	EPI_ISL_662576	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-B735FF/2020	EPI_ISL_662579	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AA06BB/2020	EPI_ISL_666002	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/QEUH-AF1387/2020	EPI_ISL_666010	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-AF13B4/2020	EPI_ISL_666011	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-AF1615/2020	EPI_ISL_666017	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.58	GV
hCoV-19/Scotland/CVR5784/2020	EPI_ISL_666024	2020-11-10	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5796/2020	EPI_ISL_666025	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5801/2020	EPI_ISL_666028	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5809/2020	EPI_ISL_666029	2020-11-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5813/2020	EPI_ISL_666031	2020-11-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5820/2020	EPI_ISL_666033	2020-11-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5830/2020	EPI_ISL_666037	2020-11-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5840/2020	EPI_ISL_666040	2020-11-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5848/2020	EPI_ISL_666043	2020-11-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5850/2020	EPI_ISL_666045	2020-11-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5851/2020	EPI_ISL_666046	2020-11-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5852/2020	EPI_ISL_666047	2020-11-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5853/2020	EPI_ISL_666048	2020-11-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5854/2020	EPI_ISL_666049	2020-11-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5860/2020	EPI_ISL_666051	2020-11-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5867/2020	EPI_ISL_666057	2020-11-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB9160/2020	EPI_ISL_666061	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB9242/2020	EPI_ISL_666064	2020-11-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB9328/2020	EPI_ISL_666076	2020-11-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB9360/2020	EPI_ISL_666082	2020-11-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A613CE/2020	EPI_ISL_666085	2020-10-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A61C96/2020	EPI_ISL_666087	2020-10-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Denmark/DCGC-9546/2020	EPI_ISL_668608	2020-11-09	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/CAMC-B091EB/2020	EPI_ISL_673115	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B09F96/2020	EPI_ISL_673148	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B08D8E/2020	EPI_ISL_673178	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B090DF/2020	EPI_ISL_673182	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B0A50C/2020	EPI_ISL_673204	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B09D14/2020	EPI_ISL_673221	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B09BDE/2020	EPI_ISL_673227	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B09D8D/2020	EPI_ISL_673228	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B09BED/2020	EPI_ISL_673230	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B99748/2020	EPI_ISL_673237	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B99B4C/2020	EPI_ISL_673247	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B9A8AE/2020	EPI_ISL_673250	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B99793/2020	EPI_ISL_673251	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B9AAC6/2020	EPI_ISL_673259	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8C159/2020	EPI_ISL_674401	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B83DD6/2020	EPI_ISL_674409	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B849FF/2020	EPI_ISL_674413	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B84C9C/2020	EPI_ISL_674429	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B84054/2020	EPI_ISL_674434	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B84C6F/2020	EPI_ISL_674446	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8C353/2020	EPI_ISL_674460	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B85439/2020	EPI_ISL_674471	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8E8CB/2020	EPI_ISL_674517	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7D72C/2020	EPI_ISL_674528	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8DC66/2020	EPI_ISL_674532	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7CFAD/2020	EPI_ISL_674550	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8F52D/2020	EPI_ISL_674560	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8DCC0/2020	EPI_ISL_674562	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B7F57B/2020	EPI_ISL_674563	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8DFD6/2020	EPI_ISL_674568	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B8095D/2020	EPI_ISL_674569	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B7CF34/2020	EPI_ISL_674590	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8DF9A/2020	EPI_ISL_674597	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B85A28/2020	EPI_ISL_675720	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B85A19/2020	EPI_ISL_675746	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B897B4/2020	EPI_ISL_675753	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8C8BE/2020	EPI_ISL_675792	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B848A7/2020	EPI_ISL_675798	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-B84CF6/2020	EPI_ISL_675818	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B84D7B/2020	EPI_ISL_675820	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B88B5F/2020	EPI_ISL_675828	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B88E92/2020	EPI_ISL_675862	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8CAF4/2020	EPI_ISL_675871	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8C748/2020	EPI_ISL_675872	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8965D/2020	EPI_ISL_675879	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B84E78/2020	EPI_ISL_675894	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BBCCF5/2020	EPI_ISL_679275	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Northern Ireland/NIRE-233345/2020	EPI_ISL_680282	2020-09-29	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Northern Ireland/NIRE-2341A4/2020	EPI_ISL_680349	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Northern Ireland/NIRE-2341C2/2020	EPI_ISL_680351	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Northern Ireland/NIRE-234353/2020	EPI_ISL_680373	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.58	GV
hCoV-19/Northern Ireland/NIRE-23439F/2020	EPI_ISL_680377	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.58	GV
hCoV-19/Northern Ireland/NIRE-234432/2020	EPI_ISL_680387	2020-10-18	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/MILK-BAAC45/2020	EPI_ISL_681573	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/MILK-BA9B67/2020	EPI_ISL_681578	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BA9ED7/2020	EPI_ISL_681589	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/MILK-BAB7CB/2020	EPI_ISL_681611	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAA02B/2020	EPI_ISL_681620	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAC636/2020	EPI_ISL_681640	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B08FF1/2020	EPI_ISL_681656	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B88E65/2020	EPI_ISL_681660	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB32A1/2020	EPI_ISL_703001	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB5904/2020	EPI_ISL_703011	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB944B/2020	EPI_ISL_703047	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB57CE/2020	EPI_ISL_703078	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB941E/2020	EPI_ISL_703079	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB2B89/2020	EPI_ISL_703091	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BCCAE9/2020	EPI_ISL_704396	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-BBB75F/2020	EPI_ISL_705561	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMC-BBC32D/2020	EPI_ISL_705592	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-BBCAFB/2020	EPI_ISL_705608	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.58	GV
hCoV-19/Scotland/CVR5761/2020	EPI_ISL_705636	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5762/2020	EPI_ISL_705637	2020-11-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5887/2020	EPI_ISL_705647	2020-11-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5892/2020	EPI_ISL_705651	2020-11-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5893/2020	EPI_ISL_705652	2020-11-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5894/2020	EPI_ISL_705653	2020-11-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5897/2020	EPI_ISL_705656	2020-11-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5901/2020	EPI_ISL_705659	2020-11-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5902/2020	EPI_ISL_705660	2020-11-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5906/2020	EPI_ISL_705664	2020-11-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5915/2020	EPI_ISL_705668	2020-11-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5918/2020	EPI_ISL_705669	2020-11-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5920/2020	EPI_ISL_705670	2020-11-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5925/2020	EPI_ISL_705674	2020-11-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5926/2020	EPI_ISL_705675	2020-11-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5930/2020	EPI_ISL_705676	2020-11-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5932/2020	EPI_ISL_705677	2020-11-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5933/2020	EPI_ISL_705678	2020-11-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5934/2020	EPI_ISL_705679	2020-11-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5937/2020	EPI_ISL_705681	2020-11-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5940/2020	EPI_ISL_705682	2020-11-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5945/2020	EPI_ISL_705686	2020-11-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5946/2020	EPI_ISL_705687	2020-11-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5948/2020	EPI_ISL_705688	2020-11-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5950/2020	EPI_ISL_705689	2020-11-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5952/2020	EPI_ISL_705691	2020-11-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5954/2020	EPI_ISL_705693	2020-11-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5956/2020	EPI_ISL_705695	2020-11-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5957/2020	EPI_ISL_705696	2020-11-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR5958/2020	EPI_ISL_705697	2020-11-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/QEUH-A35DB6/2020	EPI_ISL_706893	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-A35EFF/2020	EPI_ISL_706901	2020-10-04	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/QEUH-A3676C/2020	EPI_ISL_706916	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A61A6F/2020	EPI_ISL_706937	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A62002/2020	EPI_ISL_706953	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A6254F/2020	EPI_ISL_706969	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/SHEF-10CAC65/2020	EPI_ISL_706977	2020-12-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-BF0C7D/2020	EPI_ISL_709144	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BFBFF1/2020	EPI_ISL_709169	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BF0D3E/2020	EPI_ISL_709231	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-C480F1/2020	EPI_ISL_718888	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C48255/2020	EPI_ISL_718911	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C49B68/2020	EPI_ISL_718922	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-C47520/2020	EPI_ISL_718940	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C47CEF/2020	EPI_ISL_718950	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C4813A/2020	EPI_ISL_718957	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C4989E/2020	EPI_ISL_718962	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-C42482/2020	EPI_ISL_718985	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20283/2020	EPI_ISL_723423	2020-11-20	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20285/2020	EPI_ISL_723424	2020-11-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20286/2020	EPI_ISL_723425	2020-11-14	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20287/2020	EPI_ISL_723426	2020-11-14	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20290/2020	EPI_ISL_723429	2020-11-21	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20291/2020	EPI_ISL_723430	2020-11-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20292/2020	EPI_ISL_723431	2020-11-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20293/2020	EPI_ISL_723432	2020-11-17	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20294/2020	EPI_ISL_723433	2020-11-17	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20295/2020	EPI_ISL_723434	2020-11-16	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20296/2020	EPI_ISL_723435	2020-11-16	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20297/2020	EPI_ISL_723436	2020-11-16	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20298/2020	EPI_ISL_723437	2020-11-14	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20299/2020	EPI_ISL_723438	2020-11-12	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20300/2020	EPI_ISL_723439	2020-11-08	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20309/2020	EPI_ISL_723448	2020-11-13	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20310/2020	EPI_ISL_723449	2020-11-21	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20311/2020	EPI_ISL_723450	2020-11-20	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20312/2020	EPI_ISL_723451	2020-11-20	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-20329/2020	EPI_ISL_723459	2020-11-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/England/MILK-B877C5/2020	EPI_ISL_724799	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B8783B/2020	EPI_ISL_724805	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B87938/2020	EPI_ISL_724814	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORT-1B7227E/2020	EPI_ISL_724863	2020-11-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-498027/2020	EPI_ISL_727013	2020-11-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4980CD/2020	EPI_ISL_727023	2020-11-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49831F/2020	EPI_ISL_727056	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49842B/2020	EPI_ISL_727073	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-498485/2020	EPI_ISL_727079	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4984C1/2020	EPI_ISL_727083	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49850A/2020	EPI_ISL_727086	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-498546/2020	EPI_ISL_727090	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-498591/2020	EPI_ISL_727094	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Germany/TH-IIMK-CaSe-18/2020	EPI_ISL_728341	2020-12-06	Europe / Germany / Thuringia	Human	Original			Nanopore MinION	ARTIC	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-ChVir9009/2020	EPI_ISL_729603	2020-09-22	Europe / Germany / Berlin	Human	Original			MiSeq	bowtie2			B.1.177	GV
hCoV-19/Germany/SH-ChVir9999/2020	EPI_ISL_729667	2020-11-04	Europe / Germany / Schleswig-Holstein	Human	Original			MiSeq	bowtie2			B.1.177.62	GV
hCoV-19/England/ALDP-C3D903/2020	EPI_ISL_730658	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3D693/2020	EPI_ISL_731834	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3D1B0/2020	EPI_ISL_731845	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3DCEC/2020	EPI_ISL_731862	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3BE24/2020	EPI_ISL_731864	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3AAA9/2020	EPI_ISL_731874	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3CC1A/2020	EPI_ISL_731879	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-C3B4F5/2020	EPI_ISL_731881	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3D38D/2020	EPI_ISL_731890	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C34605/2020	EPI_ISL_734101	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C342A7/2020	EPI_ISL_734116	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C3333C/2020	EPI_ISL_734121	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C611D1/2020	EPI_ISL_735512	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/MILK-C610C5/2020	EPI_ISL_735515	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-C48510/2020	EPI_ISL_736701	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C506C7/2020	EPI_ISL_736716	2020-12-11	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C484C8/2020	EPI_ISL_736720	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3D305/2020	EPI_ISL_736766	2020-12-10	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3BCC0/2020	EPI_ISL_736768	2020-12-11	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-C3D2CC/2020	EPI_ISL_736769	2020-12-10	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3D129/2020	EPI_ISL_736770	2020-12-10	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3D2BD/2020	EPI_ISL_736771	2020-12-10	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A23B39/2020	EPI_ISL_741348	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.58	GV
hCoV-19/England/MILK-A91A48/2020	EPI_ISL_741353	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3D3BB/2020	EPI_ISL_741367	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3D9F5/2020	EPI_ISL_741378	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49C418/2020	EPI_ISL_742555	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49C779/2020	EPI_ISL_742598	2020-11-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49C9DD/2020	EPI_ISL_742628	2020-11-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49CAE9/2020	EPI_ISL_742644	2020-12-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49CB6E/2020	EPI_ISL_742651	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49CC6B/2020	EPI_ISL_742667	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49CC7A/2020	EPI_ISL_742668	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49CC98/2020	EPI_ISL_742670	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49CCC5/2020	EPI_ISL_742673	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49CE1A/2020	EPI_ISL_742693	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49CE56/2020	EPI_ISL_742697	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A1D8E/2020	EPI_ISL_743811	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A1D9D/2020	EPI_ISL_743812	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A1EF4/2020	EPI_ISL_743830	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A2190/2020	EPI_ISL_743855	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A21AF/2020	EPI_ISL_743856	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A21BE/2020	EPI_ISL_743857	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A2251/2020	EPI_ISL_743863	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A22CA/2020	EPI_ISL_743870	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A22D9/2020	EPI_ISL_743871	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A2549/2020	EPI_ISL_743904	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A2655/2020	EPI_ISL_743921	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A28B9/2020	EPI_ISL_743954	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A2A2C/2020	EPI_ISL_743968	2020-12-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-20870/2020	EPI_ISL_759420	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177	GV
hCoV-19/England/QEUH-CC3BFD/2020	EPI_ISL_760422	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC5320/2020	EPI_ISL_760431	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC3B84/2020	EPI_ISL_760465	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC5900/2020	EPI_ISL_760472	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CBDEDF/2020	EPI_ISL_760498	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-CB55E1/2020	EPI_ISL_761700	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB5DDA/2020	EPI_ISL_761702	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB5183/2020	EPI_ISL_761704	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB5569/2020	EPI_ISL_761709	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB587F/2020	EPI_ISL_761717	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB3677/2020	EPI_ISL_761724	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB6726/2020	EPI_ISL_761727	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-CB55C3/2020	EPI_ISL_761750	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB5235/2020	EPI_ISL_761751	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB6A2D/2020	EPI_ISL_761759	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-CB561B/2020	EPI_ISL_761762	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB63E6/2020	EPI_ISL_761768	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-CB4412/2020	EPI_ISL_761772	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB55A5/2020	EPI_ISL_761775	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB5BB2/2020	EPI_ISL_761787	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-CB6A96/2020	EPI_ISL_761798	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-4A690D/2020	EPI_ISL_764063	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina		NS8_Q18stop results in 86.0% truncation of the protein sequence. Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/205260308/2020	EPI_ISL_766513	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205260317/2020	EPI_ISL_766517	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205260320/2020	EPI_ISL_766518	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205260325/2020	EPI_ISL_766519	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205260395/2020	EPI_ISL_766520	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205260396/2020	EPI_ISL_766521	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/205260397/2020	EPI_ISL_766522	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/Australia/NSW1324/2020	EPI_ISL_767890	2020-12-19	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-C8D0D2/2020	EPI_ISL_777217	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C948EF/2020	EPI_ISL_777255	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C8CC2A/2020	EPI_ISL_777262	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-C8D0F0/2020	EPI_ISL_777291	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C8EA00/2020	EPI_ISL_777296	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C8BCB2/2020	EPI_ISL_777319	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C8C02E/2020	EPI_ISL_777326	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C6C974/2020	EPI_ISL_778583	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C60D74/2020	EPI_ISL_778641	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Spain/IB-IBV-99011522/2020	EPI_ISL_779865	2020-12-23	Europe / Spain / Balear Islands / Palma de Mallorca	Human	Original			Illumina MiSeq	BWA/IVAR	NS7a_E95stop results in 22.3% truncation of the protein sequence.	info	B.1.177.61	GV
hCoV-19/Spain/IB-IBV-99011526/2020	EPI_ISL_779866	2020-12-18	Europe / Spain / Balear Islands / Palma de Mallorca	Human	Original			Illumina MiSeq	BWA/IVAR	NS7a_E95stop results in 22.3% truncation of the protein sequence.	info	B.1.177.61	GV
hCoV-19/Spain/IB-IBV-99011553/2020	EPI_ISL_779868	2020-12-11	Europe / Spain / Balear Islands / Palma de Mallorca	Human	Original			Illumina MiSeq	BWA/IVAR	NS7a_E95stop results in 22.3% truncation of the protein sequence.	info	B.1.177.61	GV
hCoV-19/England/ALDP-C23672/2020	EPI_ISL_783032	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-C26D2F/2020	EPI_ISL_783036	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C23636/2020	EPI_ISL_783052	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAC19F/2020	EPI_ISL_783104	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAB145/2020	EPI_ISL_783127	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-BAC29C/2020	EPI_ISL_783139	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAC171/2020	EPI_ISL_783144	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAB321/2020	EPI_ISL_783155	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAA28F/2020	EPI_ISL_783174	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAA44D/2020	EPI_ISL_783177	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAB770/2020	EPI_ISL_783180	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAB6DD/2020	EPI_ISL_783181	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Switzerland/SO-ETHZ-430211/2020	EPI_ISL_796494	2020-12-26	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177	GV
hCoV-19/England/ALDP-DB62BB/2021	EPI_ISL_797673	2021-01-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D8ECBE/2020	EPI_ISL_797782	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D8A423/2020	EPI_ISL_797798	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CE16AD/2020	EPI_ISL_800075	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CE1537/2020	EPI_ISL_800081	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CE29FE/2020	EPI_ISL_800130	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-D0E630/2020	EPI_ISL_800139	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CE29EF/2020	EPI_ISL_800148	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CE2008/2020	EPI_ISL_800169	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D11FC6/2020	EPI_ISL_800188	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/EXET-137BD1/2020	EPI_ISL_813388	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/EXET-13FF46/2020	EPI_ISL_813507	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-49D5BA/2020	EPI_ISL_814703	2020-12-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A6D7A/2020	EPI_ISL_814756	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A6DB6/2020	EPI_ISL_814760	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A70AD/2020	EPI_ISL_814798	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A7368/2020	EPI_ISL_814829	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A7429/2020	EPI_ISL_814839	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A75AE/2020	EPI_ISL_814858	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A75BD/2020	EPI_ISL_814859	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/TFCI-26FC0FC/2020	EPI_ISL_817094	2020-12-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/England/LOND-E2909/2020	EPI_ISL_819502	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/LOND-E273C/2020	EPI_ISL_819519	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/LOND-E2541/2020	EPI_ISL_819534	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/LOND-E23ED/2020	EPI_ISL_819542	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/LOND-E2462/2020	EPI_ISL_819543	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/LOND-E256F/2020	EPI_ISL_819545	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/LOND-E275A/2020	EPI_ISL_819548	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/LOND-E26D5/2020	EPI_ISL_819555	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/LOND-E258D/2020	EPI_ISL_819564	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.58	GV
hCoV-19/England/LOND-E2602/2020	EPI_ISL_819565	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.58	GV
hCoV-19/England/LOND-E26F3/2020	EPI_ISL_819566	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/NORW-2236A9/2020	EPI_ISL_820541	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-223779/2020	EPI_ISL_820546	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-223CF2/2020	EPI_ISL_820554	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-223F26/2020	EPI_ISL_820557	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Netherlands/FR-RIVM-21109/2020	EPI_ISL_824043	2020-12-28	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/FR-RIVM-21110/2020	EPI_ISL_824044	2020-12-28	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/FR-RIVM-21136/2020	EPI_ISL_824059	2020-12-28	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/UT-RIVM-21280/2020	EPI_ISL_824202	2020-12-31	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/LI-RIVM-21304/2020	EPI_ISL_824224	2020-12-22	Europe / Netherlands / Limburg	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/England/204340301/2020	EPI_ISL_825583	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/204340302/2020	EPI_ISL_825584	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/204460679/2020	EPI_ISL_825589	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/Iceland/3129/2020	EPI_ISL_826803	2020-10-27	Europe / Iceland / Reykjavik	Human	Original			Illumina Miseq	MPileup			B.1.177	GV
hCoV-19/Iceland/3199/2020	EPI_ISL_826891	2020-12-18	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/NW-RKI-I-0102/2020	EPI_ISL_831398	2020-12-09	Europe / Germany / North Rhine-Westphalia	Human	Original			Illumina Iseq	covpipe	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29321/2021	EPI_ISL_843368	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/France/IDF-IPP00139/2021	EPI_ISL_855357	2021-01-08	Europe / France / Ile de France / Montreuil	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500	CLC Genomics Suite			B.1.177	GV
hCoV-19/Denmark/DCGC-32088/2021	EPI_ISL_856504	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32093/2021	EPI_ISL_856509	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32098/2021	EPI_ISL_856514	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32108/2021	EPI_ISL_856524	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32123/2021	EPI_ISL_856539	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32164/2021	EPI_ISL_856580	2021-01-04	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32165/2021	EPI_ISL_856581	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32231/2020	EPI_ISL_856647	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32250/2020	EPI_ISL_856666	2020-12-14	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Scotland/QEUH-F8F7F6/2021	EPI_ISL_857895	2021-01-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Wales/ALDP-F827C6/2021	EPI_ISL_857985	2021-01-08	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMB-A9D912/2021	EPI_ISL_864954	2021-01-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.21	GV
hCoV-19/Scotland/CVR6343/2020	EPI_ISL_864960	2020-12-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR6452/2021	EPI_ISL_864981	2021-01-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6469/2021	EPI_ISL_864998	2021-01-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6470/2021	EPI_ISL_864999	2021-01-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Wales/PHWC-4B78FD/2021	EPI_ISL_867230	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B7936/2021	EPI_ISL_867232	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B7945/2021	EPI_ISL_867233	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B7AE8/2021	EPI_ISL_867258	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B7BA9/2021	EPI_ISL_867269	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B8346/2021	EPI_ISL_867379	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-32807/2021	EPI_ISL_869811	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32880/2021	EPI_ISL_869884	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33817/2021	EPI_ISL_870827	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33820/2021	EPI_ISL_870830	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33838/2021	EPI_ISL_870848	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33858/2021	EPI_ISL_870868	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33933/2021	EPI_ISL_870943	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-33949/2021	EPI_ISL_870959	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-1004661/2021	EPI_ISL_874355	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-1003E00/2021	EPI_ISL_874374	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-109165A/2021	EPI_ISL_878026	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10690A8/2021	EPI_ISL_879193	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1068D57/2021	EPI_ISL_879206	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1035CED/2021	EPI_ISL_879393	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-103063F/2021	EPI_ISL_880254	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10311E2/2021	EPI_ISL_880255	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1030B5E/2021	EPI_ISL_880334	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-103158C/2021	EPI_ISL_880364	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10143B2/2021	EPI_ISL_881516	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1014006/2021	EPI_ISL_881529	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1013E2B/2021	EPI_ISL_881580	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-100E6B2/2021	EPI_ISL_881582	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1013FBF/2021	EPI_ISL_881608	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FA3501/2021	EPI_ISL_881674	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-100924A/2021	EPI_ISL_892174	2021-01-12	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq		Insertion of 9 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/Spain/PV-IBV-97011452/2020	EPI_ISL_892310	2020-12-09	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Spain/PV-IBV-97011453/2020	EPI_ISL_892311	2020-12-09	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/Spain/PV-IBV-97011454/2020	EPI_ISL_892312	2020-12-09	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GV
hCoV-19/England/CAMC-106F01B/2021	EPI_ISL_908249	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10DE6E8/2021	EPI_ISL_908274	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10E3BE1/2021	EPI_ISL_908299	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10DE3D2/2021	EPI_ISL_908301	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10E3B69/2021	EPI_ISL_908368	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10DE83D/2021	EPI_ISL_908389	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10B82D1/2021	EPI_ISL_909531	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Luxembourg/LNS0324254/2020	EPI_ISL_910633	2020-12-28	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.177	GV
hCoV-19/England/ALDP-10128D3/2021	EPI_ISL_916658	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-100D7FC/2021	EPI_ISL_916703	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-106772D/2021	EPI_ISL_917919	2021-01-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-1067620/2021	EPI_ISL_917929	2021-01-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-106775A/2021	EPI_ISL_917931	2021-01-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-10669DD/2021	EPI_ISL_917962	2021-01-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-1067B9A/2021	EPI_ISL_917969	2021-01-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-1066C4D/2021	EPI_ISL_917974	2021-01-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-1067602/2021	EPI_ISL_917975	2021-01-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-1067D1C/2021	EPI_ISL_917976	2021-01-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMB-A9E085/2021	EPI_ISL_919003	2021-01-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NORT-1B73B27/2020	EPI_ISL_921204	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORT-1B7C3BD/2021	EPI_ISL_921320	2021-01-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.58	GV
hCoV-19/Wales/PHWC-4BB5C5/2021	EPI_ISL_922512	2021-01-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-4BB5E3/2021	EPI_ISL_922514	2021-01-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-4BBAE4/2021	EPI_ISL_922587	2021-01-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BBB1E/2021	EPI_ISL_922589	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BBC2A/2021	EPI_ISL_922606	2021-01-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BBC39/2021	EPI_ISL_922607	2021-01-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BBC48/2021	EPI_ISL_922608	2021-01-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BBCB1/2021	EPI_ISL_922614	2021-01-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BBCC0/2021	EPI_ISL_922615	2021-01-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BBCEE/2021	EPI_ISL_922617	2021-01-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BBD18/2021	EPI_ISL_922620	2021-01-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BBD27/2021	EPI_ISL_922621	2021-01-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BBD81/2021	EPI_ISL_922625	2021-01-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BBDAF/2021	EPI_ISL_922627	2021-01-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-10326A6/2021	EPI_ISL_923804	2021-01-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.58	GV
hCoV-19/England/QEUH-1032C3B/2021	EPI_ISL_923863	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-1032CB3/2021	EPI_ISL_923867	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-10332ED/2021	EPI_ISL_923926	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-10334D8/2021	EPI_ISL_923934	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-10335E4/2021	EPI_ISL_923950	2021-01-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Denmark/DCGC-34870/2021	EPI_ISL_926010	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34882/2021	EPI_ISL_926022	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36181/2021	EPI_ISL_927322	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36182/2021	EPI_ISL_927323	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36227/2021	EPI_ISL_927368	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36236/2021	EPI_ISL_927377	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37463/2021	EPI_ISL_928604	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37473/2021	EPI_ISL_928614	2021-01-25	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37475/2021	EPI_ISL_928616	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37483/2021	EPI_ISL_928624	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37530/2021	EPI_ISL_928671	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37533/2021	EPI_ISL_928674	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37540/2021	EPI_ISL_928681	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-37541/2020	EPI_ISL_928682	2020-11-02	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	G
hCoV-19/Denmark/DCGC-37542/2020	EPI_ISL_928683	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38799/2021	EPI_ISL_929941	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-38842/2021	EPI_ISL_929984	2021-01-18	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Switzerland/BL-UHB-42494504/2020	EPI_ISL_930961	2020-10-20	Europe / Switzerland / Basel-Stadt / Basel	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	In-house pipelIne COVGAP			B.1.177	GV
hCoV-19/Switzerland/BS-UHB-42496686/2020	EPI_ISL_930979	2020-10-21	Europe / Switzerland	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	In-house pipelIne COVGAP	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Switzerland/BS-UHB-42496687/2020	EPI_ISL_930980	2020-10-21	Europe / Switzerland / Basel-Stadt / Basel	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	In-house pipelIne COVGAP	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-118220C/2021	EPI_ISL_932069	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-10FC198/2021	EPI_ISL_933255	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-1109768/2021	EPI_ISL_933330	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Austria/CeMM2388/2021	EPI_ISL_934518	2021-01-06	Europe / Austria / Burgenland	Human	Original			Illumina NovaSeq	bwa			B.1.177	GV
hCoV-19/Austria/CeMM2393/2021	EPI_ISL_934523	2021-01-06	Europe / Austria / Burgenland	Human	Original			Illumina NovaSeq	bwa			B.1.177	GV
hCoV-19/Austria/CeMM2397/2021	EPI_ISL_934527	2021-01-06	Europe / Austria / Burgenland	Human	Original			Illumina NovaSeq	bwa			B.1.177	GV
hCoV-19/Austria/CeMM2611/2021	EPI_ISL_934548	2021-01-12	Europe / Austria / Styria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	GV
hCoV-19/Austria/CeMM2613/2021	EPI_ISL_934550	2021-01-12	Europe / Austria / Styria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	GV
hCoV-19/Austria/CeMM2619/2021	EPI_ISL_934556	2021-01-12	Europe / Austria / Carinthia	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	GV
hCoV-19/Austria/CeMM2630/2021	EPI_ISL_934565	2021-01-13	Europe / Austria / Styria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	GV
hCoV-19/England/MILK-1151BA1/2021	EPI_ISL_939373	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Portugal/PT2634/2021	EPI_ISL_941636	2021-01-12	Europe / Portugal	Human	Original			Illumina MiSeq	INSaFLU			B.1.177	GV
hCoV-19/Portugal/PT2638/2021	EPI_ISL_941640	2021-01-14	Europe / Portugal	Human	Original			Illumina MiSeq	INSaFLU			B.1.177	GV
hCoV-19/Portugal/PT2642/2021	EPI_ISL_941643	2021-01-16	Europe / Portugal	Human	Original			Illumina MiSeq	INSaFLU			B.1.177	GV
hCoV-19/Portugal/PT2643/2021	EPI_ISL_941644	2021-01-15	Europe / Portugal	Human	Original			Illumina MiSeq	INSaFLU			B.1.177	GV
hCoV-19/Portugal/PT2645/2021	EPI_ISL_941646	2021-01-16	Europe / Portugal	Human	Original			Illumina MiSeq	INSaFLU			B.1.177	GV
hCoV-19/Netherlands/GE-RIVM-10984/2021	EPI_ISL_942999	2021-01-04	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/MILK-F72F2B/2021	EPI_ISL_945177	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-114EAE6/2021	EPI_ISL_947924	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-114E178/2021	EPI_ISL_947933	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/OXON-F481EC/2020	EPI_ISL_951007	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F48ED6/2020	EPI_ISL_951049	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F499A7/2021	EPI_ISL_951078	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.58	GV
hCoV-19/England/OXON-F4A083/2021	EPI_ISL_951089	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F4C722/2021	EPI_ISL_951180	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C2AF9/2021	EPI_ISL_952317	2021-01-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C2D96/2021	EPI_ISL_952333	2021-01-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C2E93/2021	EPI_ISL_952347	2021-01-31	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4C2EA2/2021	EPI_ISL_952348	2021-01-31	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-11CB37D/2021	EPI_ISL_957165	2021-01-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-11CB35F/2021	EPI_ISL_957168	2021-01-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/MILK-11A2EC6/2021	EPI_ISL_958666	2021-01-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Germany/ST-MD562/2021	EPI_ISL_960900	2021-02-03	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD564/2021	EPI_ISL_960901	2021-02-03	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD399/2021	EPI_ISL_960902	2021	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD400/2021	EPI_ISL_960903	2021	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD380/2021	EPI_ISL_960904	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD384/2021	EPI_ISL_960905	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD386/2021	EPI_ISL_960906	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD393/2021	EPI_ISL_960907	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD396/2021	EPI_ISL_960908	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD448/2021	EPI_ISL_960909	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD450/2021	EPI_ISL_960910	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD476/2021	EPI_ISL_960911	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD478/2021	EPI_ISL_960912	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD479/2021	EPI_ISL_960913	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD482/2021	EPI_ISL_960914	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD484/2021	EPI_ISL_960915	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD485/2021	EPI_ISL_960916	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD487/2021	EPI_ISL_960917	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD490/2021	EPI_ISL_960918	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD495/2021	EPI_ISL_960919	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD497/2021	EPI_ISL_960920	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD498/2021	EPI_ISL_960921	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD500/2021	EPI_ISL_960922	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD502/2021	EPI_ISL_960923	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD503/2021	EPI_ISL_960924	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD504/2021	EPI_ISL_960925	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD512/2021	EPI_ISL_960926	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD514/2021	EPI_ISL_960927	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD515/2021	EPI_ISL_960928	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD519/2021	EPI_ISL_960929	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD523/2021	EPI_ISL_960930	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD524/2021	EPI_ISL_960931	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD528/2021	EPI_ISL_960932	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD533/2021	EPI_ISL_960933	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD534/2021	EPI_ISL_960934	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD579/2021	EPI_ISL_960935	2021-02-03	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD580/2021	EPI_ISL_960936	2021-02-03	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD582/2021	EPI_ISL_960937	2021-02-03	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD584/2021	EPI_ISL_960938	2021-02-03	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD594/2021	EPI_ISL_960939	2021-02-03	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	G
hCoV-19/Germany/ST-MD599/2021	EPI_ISL_960940	2021-02-03	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/ST-MD449/2021	EPI_ISL_960961	2021-01-26	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/England/ALDP-11CD0FC/2021	EPI_ISL_963003	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11CE28C/2021	EPI_ISL_963007	2021-01-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11BA511/2021	EPI_ISL_964207	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11C6011/2021	EPI_ISL_970061	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-39732/2021	EPI_ISL_971346	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39739/2021	EPI_ISL_971366	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39979/2021	EPI_ISL_971656	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39987/2021	EPI_ISL_971664	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39991/2021	EPI_ISL_971668	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39994/2021	EPI_ISL_971671	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40954/2021	EPI_ISL_972631	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41000/2021	EPI_ISL_972677	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41005/2021	EPI_ISL_972682	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41027/2021	EPI_ISL_972704	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41033/2021	EPI_ISL_972710	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41061/2020	EPI_ISL_972738	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-121EE88/2021	EPI_ISL_985935	2021-02-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/CAMC-11E3588/2021	EPI_ISL_988234	2021-01-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-11CBA78/2021	EPI_ISL_989537	2021-02-01	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-11CBAB4/2021	EPI_ISL_989565	2021-02-01	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-11CBF4C/2021	EPI_ISL_989568	2021-02-01	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-11CBD51/2021	EPI_ISL_989578	2021-02-01	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-11CB44D/2021	EPI_ISL_989820	2021-02-01	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA NovaSeq				B.1	GV
hCoV-19/Scotland/QEUH-11CB629/2021	EPI_ISL_989826	2021-02-01	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-11B6B8C/2021	EPI_ISL_989846	2021-01-31	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-1184905/2021	EPI_ISL_990509	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-118510C/2021	EPI_ISL_990512	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1184C48/2021	EPI_ISL_990581	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS6_E55stop results in 11.5% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-115C5F3/2021	EPI_ISL_991834	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10E8D9B/2021	EPI_ISL_993007	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-10AE371/2021	EPI_ISL_993091	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-109D4DC/2021	EPI_ISL_994071	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-1066A8F/2021	EPI_ISL_994311	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1068258/2021	EPI_ISL_994338	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMB-AA0E59/2021	EPI_ISL_996654	2021-01-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-AA0E95/2021	EPI_ISL_996657	2021-01-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Switzerland/SH-ETHZ-460708/2021	EPI_ISL_1003000	2021-01-15	Europe / Switzerland / Schaffhausen	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Switzerland/VS-ETHZ-460799/2021	EPI_ISL_1003020	2021-01-15	Europe / Switzerland / Valais	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/England/ALDP-121FFB1/2021	EPI_ISL_1006939	2021-02-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-1203439/2021	EPI_ISL_1012681	2021-02-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-118460E/2021	EPI_ISL_1012761	2021-01-25	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-11846E0/2021	EPI_ISL_1012762	2021-01-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-115BD1A/2021	EPI_ISL_1012798	2021-01-23	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-125DCB0/2021	EPI_ISL_1018961	2021-02-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Denmark/DCGC-43117/2021	EPI_ISL_1023395	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-43217/2021	EPI_ISL_1023508	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44247/2021	EPI_ISL_1024625	2021-02-01	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-44260/2021	EPI_ISL_1024638	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44292/2021	EPI_ISL_1024670	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44303/2021	EPI_ISL_1024681	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44373/2021	EPI_ISL_1024751	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-44392/2021	EPI_ISL_1024770	2021-02-01	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-44416/2021	EPI_ISL_1024794	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Netherlands/UT-RIVM-13197/2021	EPI_ISL_1035317	2021-02-10	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/UT-RIVM-13123/2021	EPI_ISL_1035372	2021-02-10	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Netherlands/UT-RIVM-12705/2021	EPI_ISL_1035471	2021-01-25	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/England/RAND-126872A/2021	EPI_ISL_1042601	2021-02-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-126A218/2021	EPI_ISL_1042630	2021-02-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-11CA578/2021	EPI_ISL_1050903	2021-01-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Switzerland/AG-ETHZ-481426/2021	EPI_ISL_1059452	2021-01-04	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Denmark/DCGC-45660/2021	EPI_ISL_1065170	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-45685/2021	EPI_ISL_1065195	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-45687/2021	EPI_ISL_1065197	2021-02-08	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-45768/2021	EPI_ISL_1065278	2021-02-15	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-45794/2020	EPI_ISL_1065304	2020-12-21	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-45806/2021	EPI_ISL_1065316	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46985/2021	EPI_ISL_1066496	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-46987/2021	EPI_ISL_1066498	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47096/2021	EPI_ISL_1066608	2021-02-15	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-47177/2020	EPI_ISL_1066690	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Turkey/HSGM-D383/2021	EPI_ISL_1073730	2021-02-08	Europe / Turkey	Human	Orginal	Oropharyngeal swab		Illumina Miseq	Burrows-Wheeler Alignerv.07.17-r1188			B.1.177.62	GV
hCoV-19/Netherlands/LI-RIVM-13569/2021	EPI_ISL_1090127	2021-02-10	Europe / Netherlands / Limburg	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/England/QEUH-96E0E9/2020	EPI_ISL_530565	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-96E571/2020	EPI_ISL_530571	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Northern Ireland/QEUH-96D044/2020	EPI_ISL_530623	2020-08-21	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Northern Ireland/QEUH-96D633/2020	EPI_ISL_530626	2020-08-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-998796/2020	EPI_ISL_540001	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-9901AF/2020	EPI_ISL_540010	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-998A24/2020	EPI_ISL_540034	2020-08-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-98FB69/2020	EPI_ISL_540043	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-99D12A/2020	EPI_ISL_549903	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-99CDDC/2020	EPI_ISL_549940	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9A9FD6/2020	EPI_ISL_550917	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.65	GV
hCoV-19/England/MILK-9AA38E/2020	EPI_ISL_550961	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9AA9B9/2020	EPI_ISL_550967	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9AA60D/2020	EPI_ISL_550990	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-97070D/2020	EPI_ISL_553185	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-97153F/2020	EPI_ISL_553209	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-9B1D1D/2020	EPI_ISL_566519	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9C2D0A/2020	EPI_ISL_566621	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9C271B/2020	EPI_ISL_566632	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-9C5772/2020	EPI_ISL_567782	2020-09-10	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9C6322/2020	EPI_ISL_567793	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9C5736/2020	EPI_ISL_567794	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9C58AC/2020	EPI_ISL_567820	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9C57DC/2020	EPI_ISL_567853	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9C57CD/2020	EPI_ISL_567868	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9C4FF3/2020	EPI_ISL_567876	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-9BE1D8/2020	EPI_ISL_567907	2020-09-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BC6EA/2020	EPI_ISL_567915	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BE33C/2020	EPI_ISL_567935	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-9BE92B/2020	EPI_ISL_567944	2020-09-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BE563/2020	EPI_ISL_567959	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BDA29/2020	EPI_ISL_567961	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BDD20/2020	EPI_ISL_567964	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BE3B4/2020	EPI_ISL_567971	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BDD99/2020	EPI_ISL_567974	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BE30F/2020	EPI_ISL_567976	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BDE3C/2020	EPI_ISL_567980	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9BC94B/2020	EPI_ISL_567987	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9BA89B/2020	EPI_ISL_573607	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-9BAF4B/2020	EPI_ISL_573639	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/SHEF-D1EC2/2020	EPI_ISL_573752	2020-09-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4112/2020	EPI_ISL_573765	2020-09-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4116/2020	EPI_ISL_573766	2020-09-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR4321/2020	EPI_ISL_573772	2020-09-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4326/2020	EPI_ISL_573775	2020-09-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4329/2020	EPI_ISL_573776	2020-09-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4337/2020	EPI_ISL_573778	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4339/2020	EPI_ISL_573780	2020-09-10	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4352/2020	EPI_ISL_573784	2020-09-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR4364/2020	EPI_ISL_573787	2020-09-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR4367/2020	EPI_ISL_573789	2020-09-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR4369/2020	EPI_ISL_573791	2020-09-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR4374/2020	EPI_ISL_573793	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB7772/2020	EPI_ISL_573794	2020-09-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-1140CC/2020	EPI_ISL_577137	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-114518/2020	EPI_ISL_577171	2020-10-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-1145CD/2020	EPI_ISL_577178	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-9E50AE/2020	EPI_ISL_579762	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9E56BB/2020	EPI_ISL_579783	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9E491D/2020	EPI_ISL_579792	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9E433D/2020	EPI_ISL_579804	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/QEUH-9E5527/2020	EPI_ISL_579809	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9E4151/2020	EPI_ISL_579844	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9E4F39/2020	EPI_ISL_579853	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9E5563/2020	EPI_ISL_579910	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9E4476/2020	EPI_ISL_579915	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-9EA030/2020	EPI_ISL_579958	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9F0741/2020	EPI_ISL_580729	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-9F06F9/2020	EPI_ISL_580773	2020-09-25	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9F078D/2020	EPI_ISL_580818	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9DC541/2020	EPI_ISL_580942	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-9EBAAA/2020	EPI_ISL_584396	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMC-9EBB98/2020	EPI_ISL_584402	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMC-9EBD92/2020	EPI_ISL_584420	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A0C1BC/2020	EPI_ISL_585603	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/Wales/PHWC-16DE60/2020	EPI_ISL_585631	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16DECA/2020	EPI_ISL_585637	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16DF6D/2020	EPI_ISL_585645	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16E12A/2020	EPI_ISL_585672	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16E579/2020	EPI_ISL_585735	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16E5A6/2020	EPI_ISL_585738	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-16E649/2020	EPI_ISL_585747	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-A2E099/2020	EPI_ISL_586903	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2E05D/2020	EPI_ISL_586908	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2D71D/2020	EPI_ISL_586915	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/Wales/ALDP-A2D513/2020	EPI_ISL_586926	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2F195/2020	EPI_ISL_586958	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2EEBD/2020	EPI_ISL_586977	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A2EAE6/2020	EPI_ISL_586979	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Wales/MILK-9F2A0A/2020	EPI_ISL_589161	2020-09-25	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-9F2A28/2020	EPI_ISL_589196	2020-09-25	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9CF408/2020	EPI_ISL_590125	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9CF22C/2020	EPI_ISL_590150	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9CE72E/2020	EPI_ISL_590156	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9CF927/2020	EPI_ISL_590164	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A5605C/2020	EPI_ISL_595130	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-F05AA/2020	EPI_ISL_595184	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-A502A7/2020	EPI_ISL_597607	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A508C3/2020	EPI_ISL_597619	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A4FE7A/2020	EPI_ISL_597622	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A4FD5F/2020	EPI_ISL_597638	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A50E58/2020	EPI_ISL_597643	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-A50ACD/2020	EPI_ISL_597680	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A5084B/2020	EPI_ISL_597686	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A50359/2020	EPI_ISL_597713	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A4FC16/2020	EPI_ISL_597780	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-A506C9/2020	EPI_ISL_597786	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A1E551/2020	EPI_ISL_598903	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A225A5/2020	EPI_ISL_598922	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A1FF25/2020	EPI_ISL_598925	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A1FA51/2020	EPI_ISL_598926	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1FEFB/2020	EPI_ISL_598929	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1FEEC/2020	EPI_ISL_598933	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A20E7F/2020	EPI_ISL_598939	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1FD76/2020	EPI_ISL_598949	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1FD85/2020	EPI_ISL_598951	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A1FEDD/2020	EPI_ISL_598952	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A20E24/2020	EPI_ISL_598954	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A203DA/2020	EPI_ISL_598958	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A1F505/2020	EPI_ISL_598963	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A1F7E1/2020	EPI_ISL_598966	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A210C3/2020	EPI_ISL_598968	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1FFCB/2020	EPI_ISL_598980	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A20431/2020	EPI_ISL_598981	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1FD2B/2020	EPI_ISL_598982	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1F963/2020	EPI_ISL_598983	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A1FC3D/2020	EPI_ISL_598985	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1FA42/2020	EPI_ISL_598993	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A1F936/2020	EPI_ISL_598996	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A1F5F6/2020	EPI_ISL_598997	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/MILK-A0653E/2020	EPI_ISL_600021	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/MILK-A057DF/2020	EPI_ISL_600041	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A064E6/2020	EPI_ISL_600079	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A0546F/2020	EPI_ISL_600096	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9DAA53/2020	EPI_ISL_601315	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-9E0C27/2020	EPI_ISL_601316	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9E0629/2020	EPI_ISL_601326	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-9E0805/2020	EPI_ISL_601337	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/MILK-9E060B/2020	EPI_ISL_601346	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9DA8B3/2020	EPI_ISL_601348	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9DBE38/2020	EPI_ISL_601423	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-9DBE0B/2020	EPI_ISL_601429	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-9E02F8/2020	EPI_ISL_601448	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A87201/2020	EPI_ISL_606108	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A87429/2020	EPI_ISL_606114	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/ALDP-A87632/2020	EPI_ISL_606116	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A86211/2020	EPI_ISL_606120	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A86D4D/2020	EPI_ISL_606121	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A86EA4/2020	EPI_ISL_606122	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A86CC8/2020	EPI_ISL_606138	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A8740B/2020	EPI_ISL_606143	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A860BD/2020	EPI_ISL_606147	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A87A36/2020	EPI_ISL_606149	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A87535/2020	EPI_ISL_606151	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A87D1F/2020	EPI_ISL_606157	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A875F9/2020	EPI_ISL_606165	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A86E2C/2020	EPI_ISL_606166	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A87605/2020	EPI_ISL_606172	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A86CE6/2020	EPI_ISL_606193	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A8734A/2020	EPI_ISL_606194	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-A87B15/2020	EPI_ISL_606196	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A873FF/2020	EPI_ISL_606200	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A87E76/2020	EPI_ISL_606202	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A86CB9/2020	EPI_ISL_606204	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A86CF5/2020	EPI_ISL_606236	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A86FDE/2020	EPI_ISL_606246	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A8724D/2020	EPI_ISL_606278	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-A8631E/2020	EPI_ISL_606280	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A87896/2020	EPI_ISL_606281	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A8616F/2020	EPI_ISL_606287	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A877E4/2020	EPI_ISL_606293	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A86475/2020	EPI_ISL_606295	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7B0CA/2020	EPI_ISL_607458	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7B2E2/2020	EPI_ISL_607514	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7C75B/2020	EPI_ISL_607525	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7C788/2020	EPI_ISL_607531	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7BC11/2020	EPI_ISL_607564	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/MILK-A7B543/2020	EPI_ISL_607570	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A7AF55/2020	EPI_ISL_607585	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A69D22/2020	EPI_ISL_608767	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A6B25E/2020	EPI_ISL_608779	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A6ACAC/2020	EPI_ISL_608791	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A6B24F/2020	EPI_ISL_608817	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-A69D04/2020	EPI_ISL_608828	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68A59/2020	EPI_ISL_608851	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/MILK-A6C132/2020	EPI_ISL_608854	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A6835E/2020	EPI_ISL_608858	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68A4A/2020	EPI_ISL_608862	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68AD1/2020	EPI_ISL_608865	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A68B0B/2020	EPI_ISL_608883	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-A69144/2020	EPI_ISL_608890	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A75E7B/2020	EPI_ISL_613307	2020-10-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/England/QEUH-A75E99/2020	EPI_ISL_613308	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A75EA8/2020	EPI_ISL_613309	2020-10-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/England/QEUH-A75EB7/2020	EPI_ISL_613310	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-A76320/2020	EPI_ISL_613317	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-A767CA/2020	EPI_ISL_613329	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-A7694C/2020	EPI_ISL_613336	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A76988/2020	EPI_ISL_613339	2020-10-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-A769E2/2020	EPI_ISL_613342	2020-10-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A76A3A/2020	EPI_ISL_613346	2020-10-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/QEUH-A77FB2/2020	EPI_ISL_613348	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-A78018/2020	EPI_ISL_613352	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-A78045/2020	EPI_ISL_613354	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/SHEF-C9346/2020	EPI_ISL_613376	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/SHEF-C9461/2020	EPI_ISL_613377	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/SHEF-D1DB6/2020	EPI_ISL_613402	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/SHEF-D27B7/2020	EPI_ISL_613405	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Denmark/DCGC-5222/2020	EPI_ISL_621760	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Scotland/QEUH-AAE8F3/2020	EPI_ISL_624018	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-AA0703/2020	EPI_ISL_624020	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-AA416B/2020	EPI_ISL_624021	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-AAE51A/2020	EPI_ISL_624049	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-AA31F3/2020	EPI_ISL_624070	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A9E98A/2020	EPI_ISL_625319	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A9B352/2020	EPI_ISL_625322	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A9EA0F/2020	EPI_ISL_625323	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A9B45F/2020	EPI_ISL_625339	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A9EAC3/2020	EPI_ISL_625344	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A9B422/2020	EPI_ISL_625350	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A9E94E/2020	EPI_ISL_625351	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A9B343/2020	EPI_ISL_625354	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A9EA1E/2020	EPI_ISL_625355	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A9B46E/2020	EPI_ISL_625361	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A9B49B/2020	EPI_ISL_625366	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A9B334/2020	EPI_ISL_625367	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A9EDF7/2020	EPI_ISL_625368	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-A9EE4F/2020	EPI_ISL_625377	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A9EA87/2020	EPI_ISL_625381	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-A9B5E3/2020	EPI_ISL_625388	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-A9B361/2020	EPI_ISL_625392	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Wales/ALDP-A86369/2020	EPI_ISL_625397	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/MILK-A6A046/2020	EPI_ISL_625406	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Wales/PHWC-483BD3/2020	EPI_ISL_627906	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-483D73/2020	EPI_ISL_627927	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-483FAA/2020	EPI_ISL_627951	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-48401F/2020	EPI_ISL_627956	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	G
hCoV-19/Wales/PHWC-484343/2020	EPI_ISL_627992	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMC-AAF731/2020	EPI_ISL_631105	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ABBF85/2020	EPI_ISL_631122	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ABBE97/2020	EPI_ISL_631126	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/MILK-ABBF76/2020	EPI_ISL_631130	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ABBBCD/2020	EPI_ISL_631138	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AAFA29/2020	EPI_ISL_631191	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ABBC42/2020	EPI_ISL_631201	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ABBD9A/2020	EPI_ISL_631213	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AAF977/2020	EPI_ISL_631221	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AAF5EC/2020	EPI_ISL_631225	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ABB88A/2020	EPI_ISL_631251	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AAF7C8/2020	EPI_ISL_631254	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AAF8C5/2020	EPI_ISL_631266	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-AAF8D4/2020	EPI_ISL_631271	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ABC379/2020	EPI_ISL_631275	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-AD138D/2020	EPI_ISL_633717	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD0B2C/2020	EPI_ISL_633718	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD59C3/2020	EPI_ISL_633724	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD5D6D/2020	EPI_ISL_633749	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD32D9/2020	EPI_ISL_633758	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD59F0/2020	EPI_ISL_633761	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD3628/2020	EPI_ISL_633763	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD3181/2020	EPI_ISL_633768	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD38D7/2020	EPI_ISL_633776	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD353A/2020	EPI_ISL_633778	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD0A4D/2020	EPI_ISL_633785	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD3691/2020	EPI_ISL_633797	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-AD5D5E/2020	EPI_ISL_633897	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/NOTT-11ABE3/2020	EPI_ISL_638603	2020-11-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/NOTT-11ADA1/2020	EPI_ISL_638605	2020-11-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-9F531B/2020	EPI_ISL_638663	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-9F53A2/2020	EPI_ISL_638669	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-9F5481/2020	EPI_ISL_638680	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-A36975/2020	EPI_ISL_638685	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A369EE/2020	EPI_ISL_638688	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/QEUH-A36B06/2020	EPI_ISL_638697	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-A36BF7/2020	EPI_ISL_638703	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/QEUH-A36D1F/2020	EPI_ISL_638709	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/QEUH-A8BBC6/2020	EPI_ISL_643130	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A8C828/2020	EPI_ISL_643169	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A8B980/2020	EPI_ISL_643186	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A8BC3C/2020	EPI_ISL_643188	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A8BF24/2020	EPI_ISL_643207	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A8C10F/2020	EPI_ISL_643221	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A8C6F1/2020	EPI_ISL_643225	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A8C63D/2020	EPI_ISL_643256	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A8B70E/2020	EPI_ISL_643259	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A8B373/2020	EPI_ISL_643260	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A8C1F0/2020	EPI_ISL_643262	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-A8B58C/2020	EPI_ISL_643282	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/France/PAC-MEPHI-1671/2020	EPI_ISL_644416	2020-09-14	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.177	GV
hCoV-19/England/ALDP-B1BF0A/2020	EPI_ISL_645721	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1B08F/2020	EPI_ISL_645745	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1B386/2020	EPI_ISL_645749	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1B5DB/2020	EPI_ISL_645775	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1BFDD/2020	EPI_ISL_645776	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1CF36/2020	EPI_ISL_645807	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1B27A/2020	EPI_ISL_645812	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1C534/2020	EPI_ISL_645820	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1AFB0/2020	EPI_ISL_645822	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1B5AE/2020	EPI_ISL_645823	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B19F48/2020	EPI_ISL_645824	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1B23E/2020	EPI_ISL_645825	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B220D0/2020	EPI_ISL_645832	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1F5D7/2020	EPI_ISL_645848	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1ACF5/2020	EPI_ISL_645859	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-B1C09D/2020	EPI_ISL_645862	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1C112/2020	EPI_ISL_645863	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1ADC5/2020	EPI_ISL_645864	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/CAMC-B222F8/2020	EPI_ISL_645886	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B1A3F0/2020	EPI_ISL_645891	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B484D8/2020	EPI_ISL_649291	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B4FF76/2020	EPI_ISL_649305	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B4F9F0/2020	EPI_ISL_649309	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B48520/2020	EPI_ISL_649311	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B49361/2020	EPI_ISL_649315	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B48441/2020	EPI_ISL_649338	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B4FB09/2020	EPI_ISL_649368	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B50060/2020	EPI_ISL_649369	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B485F3/2020	EPI_ISL_649372	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B47DA1/2020	EPI_ISL_649376	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B48502/2020	EPI_ISL_649377	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B49246/2020	EPI_ISL_649379	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B4F6EA/2020	EPI_ISL_649389	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/BIRM-67483/2020	EPI_ISL_651610	2020-10-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/QEUH-AACB65/2020	EPI_ISL_652900	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Scotland/QEUH-AACBCF/2020	EPI_ISL_652904	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/QEUH-AACD23/2020	EPI_ISL_652913	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-AACDD8/2020	EPI_ISL_652916	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/QEUH-AACE4E/2020	EPI_ISL_652918	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-AACE7B/2020	EPI_ISL_652920	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-AAD0ED/2020	EPI_ISL_652940	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-AAD126/2020	EPI_ISL_652942	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177	GV
hCoV-19/Scotland/QEUH-AADE2F/2020	EPI_ISL_652954	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.177.8	GV
hCoV-19/England/QEUH-AAE741/2020	EPI_ISL_652976	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-AAEC8E/2020	EPI_ISL_652995	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-B69732/2020	EPI_ISL_655103	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6C122/2020	EPI_ISL_655113	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B682E7/2020	EPI_ISL_655119	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B6C16E/2020	EPI_ISL_655150	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B69ED3/2020	EPI_ISL_655151	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/QEUH-B6ACAB/2020	EPI_ISL_655166	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B68AB2/2020	EPI_ISL_655169	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6A2B8/2020	EPI_ISL_655211	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-B6AC9C/2020	EPI_ISL_655217	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6ACC9/2020	EPI_ISL_655228	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6BE95/2020	EPI_ISL_655238	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B695FC/2020	EPI_ISL_655245	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6888B/2020	EPI_ISL_655264	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B69E97/2020	EPI_ISL_655268	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-B62F5F/2020	EPI_ISL_655274	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62F6E/2020	EPI_ISL_655275	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5B95B/2020	EPI_ISL_655280	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5BC34/2020	EPI_ISL_655286	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B63404/2020	EPI_ISL_656404	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62098/2020	EPI_ISL_656407	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62933/2020	EPI_ISL_656414	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B63325/2020	EPI_ISL_656419	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62010/2020	EPI_ISL_656434	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B63853/2020	EPI_ISL_656452	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B620B6/2020	EPI_ISL_656464	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B637FC/2020	EPI_ISL_656465	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B628CD/2020	EPI_ISL_656466	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B624E7/2020	EPI_ISL_656476	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B61F6F/2020	EPI_ISL_656479	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-B62915/2020	EPI_ISL_656481	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B6347D/2020	EPI_ISL_656515	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62863/2020	EPI_ISL_656516	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B6389F/2020	EPI_ISL_656523	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62881/2020	EPI_ISL_656541	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B6210E/2020	EPI_ISL_656542	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B636A4/2020	EPI_ISL_656552	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B6212C/2020	EPI_ISL_656557	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B624C9/2020	EPI_ISL_656558	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B6398D/2020	EPI_ISL_656570	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B620A7/2020	EPI_ISL_656575	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B637DE/2020	EPI_ISL_656589	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B62775/2020	EPI_ISL_656593	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/CAMC-B531A6/2020	EPI_ISL_657707	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B51E65/2020	EPI_ISL_657725	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B554F6/2020	EPI_ISL_657732	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B51490/2020	EPI_ISL_657739	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B51296/2020	EPI_ISL_657746	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B511C6/2020	EPI_ISL_657765	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B52013/2020	EPI_ISL_657790	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B51269/2020	EPI_ISL_657807	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B51F62/2020	EPI_ISL_657809	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B51E83/2020	EPI_ISL_657817	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B5108D/2020	EPI_ISL_657825	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B55432/2020	EPI_ISL_657829	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B55405/2020	EPI_ISL_657835	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B51E38/2020	EPI_ISL_657839	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B54E17/2020	EPI_ISL_657843	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B510BA/2020	EPI_ISL_657876	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B51C6B/2020	EPI_ISL_657883	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B51524/2020	EPI_ISL_657884	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B69125/2020	EPI_ISL_662264	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B7386F/2020	EPI_ISL_662320	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-B6AA1A/2020	EPI_ISL_662355	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B736ED/2020	EPI_ISL_662365	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B7388D/2020	EPI_ISL_662369	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6A79B/2020	EPI_ISL_662379	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B6A986/2020	EPI_ISL_662386	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B74163/2020	EPI_ISL_664903	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B7427F/2020	EPI_ISL_664912	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B75A85/2020	EPI_ISL_664931	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B75AEF/2020	EPI_ISL_664934	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/CAMB-1B95F7/2020	EPI_ISL_664942	2020-11-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B98B2/2020	EPI_ISL_664946	2020-11-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B98C1/2020	EPI_ISL_664947	2020-11-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B98FE/2020	EPI_ISL_664948	2020-11-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B990A/2020	EPI_ISL_664949	2020-11-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B9919/2020	EPI_ISL_664950	2020-11-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B9928/2020	EPI_ISL_664951	2020-11-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B9937/2020	EPI_ISL_664952	2020-11-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B9964/2020	EPI_ISL_664953	2020-11-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B9973/2020	EPI_ISL_664954	2020-11-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B9982/2020	EPI_ISL_664955	2020-11-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B9991/2020	EPI_ISL_664956	2020-11-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B99A0/2020	EPI_ISL_664957	2020-11-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1B9A07/2020	EPI_ISL_664958	2020-11-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1BA63F/2020	EPI_ISL_664991	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/CAMB-1BA6C6/2020	EPI_ISL_664993	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1BA72D/2020	EPI_ISL_664994	2020-11-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1BA7A5/2020	EPI_ISL_664996	2020-11-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1BA7C3/2020	EPI_ISL_664997	2020-11-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Denmark/DCGC-10235/2020	EPI_ISL_669850	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.80	GV
hCoV-19/England/CAMC-B094E2/2020	EPI_ISL_673006	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B09DC9/2020	EPI_ISL_673017	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B0A575/2020	EPI_ISL_673021	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B0A092/2020	EPI_ISL_673055	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B08B84/2020	EPI_ISL_673058	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B09D50/2020	EPI_ISL_673083	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B886B8/2020	EPI_ISL_674238	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B886A9/2020	EPI_ISL_674239	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B8526C/2020	EPI_ISL_674241	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B882D2/2020	EPI_ISL_674244	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/MILK-B8C58A/2020	EPI_ISL_674248	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B843F1/2020	EPI_ISL_674249	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8C06B/2020	EPI_ISL_674252	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B883EE/2020	EPI_ISL_674257	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8869A/2020	EPI_ISL_674269	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B84A47/2020	EPI_ISL_674287	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B88287/2020	EPI_ISL_674290	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/MILK-B8C2CF/2020	EPI_ISL_674302	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B851C9/2020	EPI_ISL_674308	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8858E/2020	EPI_ISL_674330	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B84D02/2020	EPI_ISL_674341	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B8C362/2020	EPI_ISL_674349	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B853B4/2020	EPI_ISL_674352	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B85493/2020	EPI_ISL_674370	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B8435B/2020	EPI_ISL_674374	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B85527/2020	EPI_ISL_674391	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B84C05/2020	EPI_ISL_674399	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B830CE/2020	EPI_ISL_675571	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B8533C/2020	EPI_ISL_675575	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B852C6/2020	EPI_ISL_675593	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-B854C0/2020	EPI_ISL_675642	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B832AA/2020	EPI_ISL_675649	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B854DF/2020	EPI_ISL_675651	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B8300A/2020	EPI_ISL_675654	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B852D5/2020	EPI_ISL_675674	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/MILK-B89C1F/2020	EPI_ISL_675694	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-B89C2E/2020	EPI_ISL_675698	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/BIRM-6A936/2020	EPI_ISL_679101	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/BIRM-6A945/2020	EPI_ISL_679102	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/CAMB-1BA5D8/2020	EPI_ISL_679157	2020-11-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/SHEF-CCA8A/2020	EPI_ISL_680181	2020-11-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Northern Ireland/NIRE-10966E/2020	EPI_ISL_680211	2020-10-22	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-BA9BC1/2020	EPI_ISL_681402	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BA9FA7/2020	EPI_ISL_681454	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/MILK-BAB46A/2020	EPI_ISL_681476	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAB50D/2020	EPI_ISL_681481	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAB048/2020	EPI_ISL_681494	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAAA96/2020	EPI_ISL_681500	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAA841/2020	EPI_ISL_681545	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAA39B/2020	EPI_ISL_681556	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/204682063/2020	EPI_ISL_693419	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.5	GV
hCoV-19/England/204682089/2020	EPI_ISL_693423	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177	GV
hCoV-19/England/ALDP-BB555B/2020	EPI_ISL_703106	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB3292/2020	EPI_ISL_703108	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BB52DC/2020	EPI_ISL_703112	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BCD5D8/2020	EPI_ISL_704407	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BCB5CB/2020	EPI_ISL_704426	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BCE1C4/2020	EPI_ISL_704464	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-BCB516/2020	EPI_ISL_704514	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BCC20F/2020	EPI_ISL_704552	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BCE2C1/2020	EPI_ISL_704556	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/CVR5965/2020	EPI_ISL_705702	2020-11-24	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5966/2020	EPI_ISL_705703	2020-11-24	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5968/2020	EPI_ISL_705705	2020-11-24	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/CVR5969/2020	EPI_ISL_705706	2020-11-24	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR5972/2020	EPI_ISL_705707	2020-11-24	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6038/2020	EPI_ISL_705714	2020-11-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6040/2020	EPI_ISL_705715	2020-11-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6049/2020	EPI_ISL_705716	2020-11-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6052/2020	EPI_ISL_705718	2020-11-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6055/2020	EPI_ISL_705721	2020-11-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6063/2020	EPI_ISL_705724	2020-11-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6067/2020	EPI_ISL_705726	2020-11-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/CVR6077/2020	EPI_ISL_705729	2020-11-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/CVR6108/2020	EPI_ISL_705732	2020-12-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Scotland/EDB10249/2020	EPI_ISL_705735	2020-11-25	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB10295/2020	EPI_ISL_705739	2020-11-25	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB10296/2020	EPI_ISL_705740	2020-11-25	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB10313/2020	EPI_ISL_705742	2020-11-25	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB10409/2020	EPI_ISL_705749	2020-11-28	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB10442/2020	EPI_ISL_705760	2020-11-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB10475/2020	EPI_ISL_705770	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB10479/2020	EPI_ISL_705771	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB10480/2020	EPI_ISL_705772	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB10520/2020	EPI_ISL_705777	2020-11-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB10557/2020	EPI_ISL_705779	2020-10-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB10573/2020	EPI_ISL_705780	2020-11-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB10597/2020	EPI_ISL_705785	2020-12-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.5	GV
hCoV-19/Scotland/EDB10622/2020	EPI_ISL_705786	2020-12-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB10631/2020	EPI_ISL_705787	2020-12-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB9053/2020	EPI_ISL_705798	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB9268/2020	EPI_ISL_705799	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB9335/2020	EPI_ISL_705800	2020-11-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Scotland/EDB9351/2020	EPI_ISL_705801	2020-11-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/England/LIVE-DC19E5/2020	EPI_ISL_705814	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DC1BB2/2020	EPI_ISL_705816	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DC1C55/2020	EPI_ISL_705819	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DC27EA/2020	EPI_ISL_705826	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DC2B48/2020	EPI_ISL_705837	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DC2BB1/2020	EPI_ISL_705839	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DC2C09/2020	EPI_ISL_705840	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DC2C81/2020	EPI_ISL_705842	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DC2CFA/2020	EPI_ISL_705845	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DC2DD9/2020	EPI_ISL_705847	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DC41BD/2020	EPI_ISL_705888	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/LIVE-DC45B1/2020	EPI_ISL_705896	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/QEUH-BF11AA/2020	EPI_ISL_709248	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-BFBB1B/2020	EPI_ISL_709252	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.177	GV
hCoV-19/England/ALDP-C061FC/2020	EPI_ISL_709300	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-C06174/2020	EPI_ISL_709313	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C06921/2020	EPI_ISL_709315	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C06D52/2020	EPI_ISL_709322	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C1498A/2020	EPI_ISL_709358	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C06077/2020	EPI_ISL_709372	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-C06D9E/2020	EPI_ISL_709390	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B9F5FD/2020	EPI_ISL_721042	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-B9FC52/2020	EPI_ISL_721059	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-BA2D68/2020	EPI_ISL_721069	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BA34DB/2020	EPI_ISL_721071	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-BA413D/2020	EPI_ISL_721094	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-B5DC32/2020	EPI_ISL_723576	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/ALDP-B5E23F/2020	EPI_ISL_723643	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B5E24E/2020	EPI_ISL_723644	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B5E396/2020	EPI_ISL_723655	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B5E475/2020	EPI_ISL_723658	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B5E484/2020	EPI_ISL_723659	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B75C52/2020	EPI_ISL_723688	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-B75C61/2020	EPI_ISL_723689	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORT-1B72302/2020	EPI_ISL_724869	2020-11-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-4986AD/2020	EPI_ISL_727110	2020-11-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-498713/2020	EPI_ISL_727116	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4987AA/2020	EPI_ISL_727121	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-498C50/2020	EPI_ISL_727192	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-498D3F/2020	EPI_ISL_727203	2020-11-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-498DB7/2020	EPI_ISL_727210	2020-11-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Germany/SH-ChVir20826/2020	EPI_ISL_729728	2020-11-30	Europe / Germany / Schleswig-Holstein	Human	Original			NextSeq	bowtie2			B.1.177.62	GV
hCoV-19/England/QEUH-C30F95/2020	EPI_ISL_730718	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3D7EB/2020	EPI_ISL_730729	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3DBB2/2020	EPI_ISL_730731	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3A960/2020	EPI_ISL_730739	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C3142C/2020	EPI_ISL_730795	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3DEAA/2020	EPI_ISL_730823	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3DDBC/2020	EPI_ISL_730825	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3DD52/2020	EPI_ISL_730839	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-C3A599/2020	EPI_ISL_730853	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C61DEC/2020	EPI_ISL_735542	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C62B3C/2020	EPI_ISL_735554	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C61836/2020	EPI_ISL_735555	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	GV
hCoV-19/England/MILK-C61502/2020	EPI_ISL_735582	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-C610B6/2020	EPI_ISL_735642	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Japan/IC-0420/2020	EPI_ISL_736892	2020-12-20	Asia / Japan	Human	Original	Saliva		Illumina iSeq	SKESA v. 2.3.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/MILK-B3DE41/2020	EPI_ISL_741401	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3DEBA/2020	EPI_ISL_741406	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/MILK-B3E314/2020	EPI_ISL_741420	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-21FF0F/2020	EPI_ISL_741485	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NORW-220B25/2020	EPI_ISL_741489	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49CEDE/2020	EPI_ISL_742704	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49CFF9/2020	EPI_ISL_742719	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49D06E/2020	EPI_ISL_742726	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49D13E/2020	EPI_ISL_742738	2020-12-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49D259/2020	EPI_ISL_742755	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49D444/2020	EPI_ISL_742783	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina		Insertion of 1 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/Wales/PHWC-49D4F9/2020	EPI_ISL_742793	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49D523/2020	EPI_ISL_742795	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49D541/2020	EPI_ISL_742797	2020-12-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49D59C/2020	EPI_ISL_742802	2020-12-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-49D857/2020	EPI_ISL_742838	2020-12-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-19899/2020	EPI_ISL_747612	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19942/2020	EPI_ISL_747617	2020-12-07	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-19992/2020	EPI_ISL_747618	2020-12-07	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20154/2020	EPI_ISL_747622	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20206/2020	EPI_ISL_747624	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20227/2020	EPI_ISL_747625	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-20309/2020	EPI_ISL_747630	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Scotland/QEUH-C5B86C/2020	EPI_ISL_757034	2020-12-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C5C77D/2020	EPI_ISL_757041	2020-12-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C543BD/2020	EPI_ISL_757043	2020-12-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-C543EA/2020	EPI_ISL_757048	2020-12-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C5455D/2020	EPI_ISL_757050	2020-12-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-C54326/2020	EPI_ISL_757052	2020-12-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_K53stop results in 57.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/Scotland/QEUH-C541B3/2020	EPI_ISL_757059	2020-12-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-C54371/2020	EPI_ISL_757060	2020-12-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C54159/2020	EPI_ISL_757061	2020-12-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-C5448D/2020	EPI_ISL_757064	2020-12-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-C540D4/2020	EPI_ISL_757068	2020-12-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-C54380/2020	EPI_ISL_757069	2020-12-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C542CF/2020	EPI_ISL_757074	2020-12-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C54414/2020	EPI_ISL_757075	2020-12-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C54308/2020	EPI_ISL_757079	2020-12-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C4BE4F/2020	EPI_ISL_757088	2020-12-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-C4BF3D/2020	EPI_ISL_757096	2020-12-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-C4C1AF/2020	EPI_ISL_757099	2020-12-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC7625/2020	EPI_ISL_760506	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC3B57/2020	EPI_ISL_760519	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC3577/2020	EPI_ISL_760539	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC3304/2020	EPI_ISL_760541	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/QEUH-CC3911/2020	EPI_ISL_760575	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/QEUH-CC3D24/2020	EPI_ISL_760592	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CBDE0C/2020	EPI_ISL_760623	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-CBF59C/2020	EPI_ISL_760628	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC339B/2020	EPI_ISL_760636	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC2E5F/2020	EPI_ISL_760643	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-CC2E8C/2020	EPI_ISL_760646	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CBE4DC/2020	EPI_ISL_760663	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-CC393F/2020	EPI_ISL_760687	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB4C92/2020	EPI_ISL_761800	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB55F0/2020	EPI_ISL_761811	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB6A87/2020	EPI_ISL_761817	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-CB6252/2020	EPI_ISL_761820	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB5DE9/2020	EPI_ISL_761821	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB503B/2020	EPI_ISL_761822	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB6AE1/2020	EPI_ISL_761829	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB5587/2020	EPI_ISL_761830	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB3A7B/2020	EPI_ISL_761837	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB5CCE/2020	EPI_ISL_761844	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB66FC/2020	EPI_ISL_761850	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB5262/2020	EPI_ISL_761869	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB5147/2020	EPI_ISL_761873	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB445E/2020	EPI_ISL_761885	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB3A4E/2020	EPI_ISL_761901	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CB6629/2020	EPI_ISL_761911	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-CB5CDD/2020	EPI_ISL_761915	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/OXON-F409FB/2020	EPI_ISL_764117	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	GV
hCoV-19/Northern Ireland/NIRE-2352EC/2020	EPI_ISL_764127	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina		NS7a_E92stop results in 24.8% truncation of the protein sequence.	info	B.1.177.5	GV
hCoV-19/Sweden/20-13179/2020	EPI_ISL_766721	2020-12-22	Europe / Sweden / Stockholm	Human	Original			Ion Torrent Genexus System, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with fill from reference and majority wins			B.1.177.80	GV
hCoV-19/Sweden/20-13180/2020	EPI_ISL_766722	2020-12-22	Europe / Sweden / Stockholm	Human	Original			Ion Torrent Genexus System, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with fill from reference and majority wins			B.1.177.80	GV
hCoV-19/England/CAMC-C99756/2020	EPI_ISL_777453	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C93F18/2020	EPI_ISL_777474	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/QEUH-C9615B/2020	EPI_ISL_777484	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D0CEEF/2020	EPI_ISL_782017	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-D0BD2F/2020	EPI_ISL_782026	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BA9DF8/2020	EPI_ISL_783206	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAA53B/2020	EPI_ISL_783215	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAA094/2020	EPI_ISL_783219	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BA9F4D/2020	EPI_ISL_783225	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BA9D43/2020	EPI_ISL_783238	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAB3F4/2020	EPI_ISL_783252	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BA9D8F/2020	EPI_ISL_783284	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAA51D/2020	EPI_ISL_783296	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAAD7F/2020	EPI_ISL_783297	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAAC90/2020	EPI_ISL_783313	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BABCCC/2020	EPI_ISL_783338	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/MILK-BAA6ED/2020	EPI_ISL_783351	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-BAADCA/2020	EPI_ISL_783353	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-B77F84/2020	EPI_ISL_783370	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Denmark/DCGC-24333/2020	EPI_ISL_795213	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24350/2020	EPI_ISL_795214	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24489/2020	EPI_ISL_795215	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24493/2020	EPI_ISL_795216	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24536/2020	EPI_ISL_795217	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24555/2020	EPI_ISL_795218	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24611/2020	EPI_ISL_795219	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24631/2020	EPI_ISL_795220	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24644/2020	EPI_ISL_795221	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24645/2020	EPI_ISL_795222	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24653/2020	EPI_ISL_795223	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24674/2020	EPI_ISL_795224	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24676/2020	EPI_ISL_795225	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24712/2020	EPI_ISL_795226	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24726/2020	EPI_ISL_795227	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24737/2020	EPI_ISL_795228	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24765/2020	EPI_ISL_795229	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24788/2020	EPI_ISL_795230	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24790/2020	EPI_ISL_795231	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24839/2020	EPI_ISL_795233	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24944/2020	EPI_ISL_795234	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-24976/2020	EPI_ISL_795235	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25112/2020	EPI_ISL_795236	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25127/2020	EPI_ISL_795237	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25178/2020	EPI_ISL_795238	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25199/2020	EPI_ISL_795239	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25201/2020	EPI_ISL_795240	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25216/2020	EPI_ISL_795241	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Switzerland/ZH-ETHZ-430292/2020	EPI_ISL_796628	2020-12-27	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1	GV
hCoV-19/Norway/7033/2020	EPI_ISL_796684	2020-12-11	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.177	GV
hCoV-19/England/QEUH-D95DEE/2020	EPI_ISL_797811	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D991FD/2020	EPI_ISL_797821	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-D91A27/2020	EPI_ISL_797967	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-CE2949/2020	EPI_ISL_800216	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CE12C7/2020	EPI_ISL_800222	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-D10589/2020	EPI_ISL_800258	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CE242A/2020	EPI_ISL_800301	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CE2642/2020	EPI_ISL_800347	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CE1AED/2020	EPI_ISL_800350	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-CE1300/2020	EPI_ISL_800362	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-D11A01/2020	EPI_ISL_800373	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Australia/NSW3905/2021	EPI_ISL_812347	2021-01-10	Oceania / Australia / New South Wales / Sydney	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/Wales/PHWC-4A7948/2020	EPI_ISL_814907	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A7BAC/2020	EPI_ISL_814931	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A7BE8/2020	EPI_ISL_814935	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A7ED0/2020	EPI_ISL_814960	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4A81A9/2020	EPI_ISL_814985	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-25604/2021	EPI_ISL_818301	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25692/2021	EPI_ISL_818302	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25750/2021	EPI_ISL_818303	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25787/2021	EPI_ISL_818304	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25828/2021	EPI_ISL_818305	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25914/2021	EPI_ISL_818306	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26021/2021	EPI_ISL_818307	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26249/2021	EPI_ISL_818308	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26413/2021	EPI_ISL_818309	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25480/2021	EPI_ISL_818310	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25587/2021	EPI_ISL_818311	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25601/2021	EPI_ISL_818312	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25813/2021	EPI_ISL_818313	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25829/2021	EPI_ISL_818314	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25945/2021	EPI_ISL_818316	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25970/2021	EPI_ISL_818317	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26081/2021	EPI_ISL_818318	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26353/2021	EPI_ISL_818319	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26169/2021	EPI_ISL_818320	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25544/2021	EPI_ISL_818321	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25678/2021	EPI_ISL_818322	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25712/2021	EPI_ISL_818323	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25852/2021	EPI_ISL_818324	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26161/2021	EPI_ISL_818325	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25780/2021	EPI_ISL_818328	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25918/2021	EPI_ISL_818330	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26135/2021	EPI_ISL_818331	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26236/2021	EPI_ISL_818332	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25425/2021	EPI_ISL_818484	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 21575 (frameshift confirmed by the submitter).	info	B.1.177	GV
hCoV-19/Denmark/DCGC-25509/2021	EPI_ISL_818486	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26055/2021	EPI_ISL_818487	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-25648/2021	EPI_ISL_818488	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-26305/2021	EPI_ISL_818489	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/OXON-F427C2/2020	EPI_ISL_819661	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F43B98/2020	EPI_ISL_819670	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/NOTT-121706/2020	EPI_ISL_819731	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/OXON-F437B2/2020	EPI_ISL_819747	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F43EBD/2020	EPI_ISL_819754	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F44010/2020	EPI_ISL_819755	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/ALDP-C6B5AE/2020	EPI_ISL_820619	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-C63EAB/2020	EPI_ISL_820641	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMC-DEAC0B/2020	EPI_ISL_821935	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-DB1809/2021	EPI_ISL_821988	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/204480189/2020	EPI_ISL_825590	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.8	GV
hCoV-19/England/204590615/2020	EPI_ISL_825596	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.8	GV
hCoV-19/England/205340548/2020	EPI_ISL_825610	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.5	GV
hCoV-19/England/205340549/2020	EPI_ISL_825611	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.5	GV
hCoV-19/England/205340561/2020	EPI_ISL_825612	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.5	GV
hCoV-19/Germany/BW-RKI-I-0144/2020	EPI_ISL_831416	2020-12-05	Europe / Germany / Baden-Wurttemberg	Human	Original			Illumina Iseq	covpipe			B.1.177	GV
hCoV-19/Germany/BE-RKI-I-0090/2020	EPI_ISL_831463	2020	Europe / Germany / Berlin	Human	Original			Illumina Iseq	covpipe	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BE-RKI-I-0153/2020	EPI_ISL_831464	2020	Europe / Germany / Berlin	Human	Original			Illumina Iseq	covpipe	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Germany/BB-RKI-I-0095/2020	EPI_ISL_831469	2020	Europe / Germany / Brandenburg	Human	Original			Illumina Iseq	covpipe			B.1.177	GV
hCoV-19/England/ALDP-F54068/2021	EPI_ISL_833991	2021-01-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-EE910C/2021	EPI_ISL_835006	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/MILK-ECBE54/2021	EPI_ISL_836229	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/MILK-ECBEBE/2021	EPI_ISL_836349	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Northern Ireland/QEUH-A4C402/2020	EPI_ISL_842112	2020-10-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/Northern Ireland/QEUH-A4D058/2020	EPI_ISL_842115	2020-10-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.177.5	GV
hCoV-19/England/QEUH-A8CE71/2020	EPI_ISL_842195	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-29254/2021	EPI_ISL_843301	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29272/2021	EPI_ISL_843319	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29274/2021	EPI_ISL_843321	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29360/2021	EPI_ISL_843407	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29361/2021	EPI_ISL_843408	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29379/2021	EPI_ISL_843426	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.58	GV
hCoV-19/Denmark/DCGC-29387/2021	EPI_ISL_843434	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29419/2021	EPI_ISL_843466	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29435/2021	EPI_ISL_843482	2021-01-04	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29437/2021	EPI_ISL_843484	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28225/2021	EPI_ISL_844766	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28245/2021	EPI_ISL_844767	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28302/2021	EPI_ISL_844768	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28480/2021	EPI_ISL_844769	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28609/2021	EPI_ISL_844770	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28661/2021	EPI_ISL_844771	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28681/2021	EPI_ISL_844772	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28881/2021	EPI_ISL_844773	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28894/2021	EPI_ISL_844774	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28906/2021	EPI_ISL_844775	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28993/2021	EPI_ISL_844776	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28924/2021	EPI_ISL_844778	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29149/2021	EPI_ISL_844780	2021-01-04	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28430/2021	EPI_ISL_844781	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28537/2021	EPI_ISL_844782	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28634/2021	EPI_ISL_844783	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28796/2021	EPI_ISL_844784	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28800/2021	EPI_ISL_844785	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28812/2021	EPI_ISL_844786	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29111/2021	EPI_ISL_844787	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28575/2021	EPI_ISL_844789	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-28898/2021	EPI_ISL_844790	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29026/2021	EPI_ISL_844792	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-29071/2021	EPI_ISL_844793	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Scotland/QEUH-F8F7AB/2021	EPI_ISL_857901	2021-01-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-F8F78D/2021	EPI_ISL_857903	2021-01-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Scotland/QEUH-F8A8AD/2021	EPI_ISL_857914	2021-01-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-F8AB68/2021	EPI_ISL_857923	2021-01-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-F8A6A3/2021	EPI_ISL_857940	2021-01-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/Scotland/QEUH-F8A834/2021	EPI_ISL_857941	2021-01-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/MILK-EB6FA4/2021	EPI_ISL_863725	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-10053A5/2021	EPI_ISL_863884	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1006070/2021	EPI_ISL_863906	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10052F3/2021	EPI_ISL_863927	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Wales/PHWC-4B855F/2021	EPI_ISL_867410	2021-01-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B88A1/2021	EPI_ISL_867455	2021-01-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B89F9/2021	EPI_ISL_867474	2021-01-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B8A14/2021	EPI_ISL_867476	2021-01-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B8A23/2021	EPI_ISL_867477	2021-01-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B8A41/2021	EPI_ISL_867479	2021-01-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B8A50/2021	EPI_ISL_867480	2021-01-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B8A6F/2021	EPI_ISL_867481	2021-01-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4B8B11/2021	EPI_ISL_867491	2021-01-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-32910/2021	EPI_ISL_869914	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-32936/2021	EPI_ISL_869940	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-10075F8/2021	EPI_ISL_874402	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10074EC/2021	EPI_ISL_874414	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1006535/2021	EPI_ISL_874437	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-10047AA/2021	EPI_ISL_874450	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.5	GV
hCoV-19/England/ALDP-1004D02/2021	EPI_ISL_874508	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1003E6A/2021	EPI_ISL_874550	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-1007367/2021	EPI_ISL_874568	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Spike_Y1272stop results in 0.2% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-100417F/2021	EPI_ISL_874577	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.58	GV
hCoV-19/England/ALDP-10657D4/2021	EPI_ISL_878119	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-106519A/2021	EPI_ISL_878120	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-106507F/2021	EPI_ISL_878130	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1064993/2021	EPI_ISL_878141	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-106525B/2021	EPI_ISL_878147	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-106567D/2021	EPI_ISL_878173	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1035D44/2021	EPI_ISL_879446	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1031513/2021	EPI_ISL_880443	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1030EFB/2021	EPI_ISL_880461	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 20 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-10308FD/2021	EPI_ISL_880491	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FA265A/2021	EPI_ISL_881728	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FA220B/2021	EPI_ISL_881740	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-FA3817/2021	EPI_ISL_881764	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-108FEFD/2021	EPI_ISL_885166	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10902A2/2021	EPI_ISL_885291	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Germany/BW-FR0381/2020	EPI_ISL_893743	2020-12-25	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177.62	GV
hCoV-19/Switzerland/SZ-ETHZ-430828/2020	EPI_ISL_899764	2020-12-25	Europe / Switzerland / Schwyz	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.177.62	GV
hCoV-19/Netherlands/FR-RIVM-10582/2021	EPI_ISL_904774	2021-01-15	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/FR-RIVM-21672/2020	EPI_ISL_904784	2020-12-29	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/FR-RIVM-21674/2020	EPI_ISL_904785	2020-12-28	Europe / Netherlands / Friesland	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/OV-RIVM-10670/2021	EPI_ISL_904877	2021-01-12	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177.62	GV
hCoV-19/Netherlands/OV-RIVM-10681/2021	EPI_ISL_904882	2021-01-11	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/England/ALDP-10E3E33/2021	EPI_ISL_908432	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10E3862/2021	EPI_ISL_908436	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-10DE800/2021	EPI_ISL_908494	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC917E/2020	EPI_ISL_915441	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC8D6C/2020	EPI_ISL_915454	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC978B/2020	EPI_ISL_915455	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC99FE/2020	EPI_ISL_915456	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC9BBC/2020	EPI_ISL_915492	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-BC9C22/2020	EPI_ISL_915493	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC97E5/2020	EPI_ISL_915517	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BCA007/2020	EPI_ISL_915520	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC9AA0/2020	EPI_ISL_915523	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC9B25/2020	EPI_ISL_915524	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC9B61/2020	EPI_ISL_915527	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC8E87/2020	EPI_ISL_915530	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC97C7/2020	EPI_ISL_915534	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC9509/2020	EPI_ISL_915540	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC916F/2020	EPI_ISL_915545	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-BC9C6E/2020	EPI_ISL_915551	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC9A91/2020	EPI_ISL_915566	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC9ADD/2020	EPI_ISL_915573	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC93A5/2020	EPI_ISL_915583	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC9CF5/2020	EPI_ISL_915588	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC9D6B/2020	EPI_ISL_915598	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC9044/2020	EPI_ISL_915599	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-BC8E5A/2020	EPI_ISL_915605	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-BC9211/2020	EPI_ISL_915608	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-101282E/2021	EPI_ISL_916729	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS6_E55stop results in 11.5% truncation of the protein sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-1012D3E/2021	EPI_ISL_916741	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1013A45/2021	EPI_ISL_916790	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-1014FFA/2021	EPI_ISL_916850	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-100F9E5/2021	EPI_ISL_916904	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-100DC1B/2021	EPI_ISL_916928	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMB-A9F127/2021	EPI_ISL_919119	2021	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.21	GV
hCoV-19/England/CAMB-A9FA4A/2021	EPI_ISL_919171	2021-01-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.21	GV
hCoV-19/Scotland/CVR6579/2021	EPI_ISL_919195	2021-01-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.177.8	GV
hCoV-19/Wales/PHWC-4BC597/2021	EPI_ISL_922742	2021-01-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BC5D3/2021	EPI_ISL_922746	2021-01-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BC791/2021	EPI_ISL_922774	2021-01-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Wales/PHWC-4BC8DA/2021	EPI_ISL_922792	2021-01-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.177	GV
hCoV-19/Denmark/DCGC-34960/2021	EPI_ISL_926100	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34979/2021	EPI_ISL_926119	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34984/2020	EPI_ISL_926124	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-34991/2021	EPI_ISL_926131	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-35098/2021	EPI_ISL_926238	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-35106/2021	EPI_ISL_926246	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-35118/2021	EPI_ISL_926258	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-35145/2021	EPI_ISL_926285	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36298/2020	EPI_ISL_927439	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36300/2021	EPI_ISL_927441	2021-01-25	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (frameshift confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36333/2020	EPI_ISL_927474	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36351/2021	EPI_ISL_927492	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36352/2020	EPI_ISL_927493	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36357/2021	EPI_ISL_927498	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36374/2021	EPI_ISL_927515	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36392/2021	EPI_ISL_927533	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36429/2021	EPI_ISL_927570	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-36446/2021	EPI_ISL_927587	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37587/2021	EPI_ISL_928728	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37591/2021	EPI_ISL_928732	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37615/2021	EPI_ISL_928756	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37756/2021	EPI_ISL_928897	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37760/2021	EPI_ISL_928901	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37777/2021	EPI_ISL_928918	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37779/2021	EPI_ISL_928920	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-37786/2021	EPI_ISL_928927	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-11822EE/2021	EPI_ISL_932158	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/QEUH-114D22B/2021	EPI_ISL_939426	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Portugal/PT2824/2021	EPI_ISL_941809	2021-01-12	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.177	GV
hCoV-19/Portugal/PT2831/2021	EPI_ISL_941815	2021-01-15	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.177	GV
hCoV-19/England/ALDP-118ABDC/2021	EPI_ISL_946758	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/OXON-F4A4D2/2021	EPI_ISL_951101	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F4A8E5/2021	EPI_ISL_951107	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F4A8F4/2021	EPI_ISL_951108	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F4B4B3/2021	EPI_ISL_951135	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F4F042/2021	EPI_ISL_951231	2021-01-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/PORT-2E104F/2021	EPI_ISL_952515	2021	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177	GV
hCoV-19/England/QEUH-11CAD8F/2021	EPI_ISL_957268	2021-01-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Germany/ST-MD443/2021	EPI_ISL_960899	2021	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/England/ALDP-11CE231/2021	EPI_ISL_963213	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	B.1.177	GV
hCoV-19/England/ALDP-11CD29C/2021	EPI_ISL_963214	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-11CCDF6/2021	EPI_ISL_963265	2021-01-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/Netherlands/LI-MUMC-76/2020	EPI_ISL_965784	2020-11-11	Europe / Netherlands / Limburg / Stein	Human	Original	Oropharyngeal swab		Nanopore				B.1.177	GV
hCoV-19/England/ALDP-11BF1EB/2021	EPI_ISL_970275	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177.8	GV
hCoV-19/Denmark/DCGC-39883/2021	EPI_ISL_971560	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39884/2021	EPI_ISL_971561	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39913/2021	EPI_ISL_971590	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39915/2021	EPI_ISL_971592	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.177.80	GV
hCoV-19/Denmark/DCGC-39925/2021	EPI_ISL_971602	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39926/2021	EPI_ISL_971603	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-39945/2021	EPI_ISL_971622	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40038/2021	EPI_ISL_971715	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40079/2021	EPI_ISL_971756	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40088/2021	EPI_ISL_971765	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-40093/2021	EPI_ISL_971770	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Denmark/DCGC-41229/2021	EPI_ISL_972906	2021-01-25	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.177.86	GV
hCoV-19/Wales/ALDP-11BD648/2021	EPI_ISL_989750	2021-01-29	Europe / United Kingdom / Wales	Human	Original			ILLUMINA NovaSeq				B.1.177	GV
hCoV-19/Scotland/QEUH-119A368/2021	EPI_ISL_989897	2021-01-29	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA NovaSeq				B.1.177.8	GV
hCoV-19/England/ALDP-1184AB7/2021	EPI_ISL_990758	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/ALDP-1182D92/2021	EPI_ISL_990843	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.177	GV
hCoV-19/England/CAMB-AA2103/2021	EPI_ISL_996846	2021-02-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.177.58	GV
hCoV-19/England/OXON-F58899/2021	EPI_ISL_999186	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
hCoV-19/England/OXON-F5CDA5/2021	EPI_ISL_999279	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.177	GV
